id	sid	tid	token	lemma	pos
ejnm-325	1	1	https://doi.org/10.15218/ejnm.2025.05	https://doi.org/10.15218/ejnm.2025.05	NOUN
ejnm-325	1	2	erbil	erbil	PROPN
ejnm-325	1	3	j.	j.	PROPN
ejnm-325	1	4	nurs	nurs	PROPN
ejnm-325	1	5	.	.	PUNCT
ejnm-325	2	1	midwifery	midwifery	ADJ
ejnm-325	2	2	,	,	PUNCT
ejnm-325	2	3	vol	vol	NOUN
ejnm-325	2	4	.	.	PROPN
ejnm-325	2	5	8	8	NUM
ejnm-325	2	6	,	,	PUNCT
ejnm-325	2	7	no	no	INTJ
ejnm-325	2	8	.	.	PUNCT
ejnm-325	3	1	(	(	PUNCT
ejnm-325	3	2	1	1	NUM
ejnm-325	3	3	)	)	PUNCT
ejnm-325	3	4	,	,	PUNCT
ejnm-325	3	5	may2025	may2025	ADJ
ejnm-325	3	6	original	original	ADJ
ejnm-325	3	7	article	article	NOUN
ejnm-325	3	8	evaluation	evaluation	NOUN
ejnm-325	3	9	of	of	ADP
ejnm-325	3	10	pulmonary	pulmonary	ADJ
ejnm-325	3	11	function	function	NOUN
ejnm-325	3	12	test	test	NOUN
ejnm-325	3	13	in	in	ADP
ejnm-325	3	14	post	post	ADJ
ejnm-325	3	15	-	-	ADJ
ejnm-325	3	16	covid-19	covid-19	ADJ
ejnm-325	3	17	patients	patient	NOUN
ejnm-325	3	18	abstract	abstract	ADJ
ejnm-325	3	19	background	background	NOUN
ejnm-325	3	20	and	and	CCONJ
ejnm-325	3	21	objectives	objective	NOUN
ejnm-325	3	22	:	:	PUNCT
ejnm-325	3	23	sars	sar	NOUN
ejnm-325	3	24	-	-	PUNCT
ejnm-325	3	25	cov-2	cov-2	NOUN
ejnm-325	3	26	emerged	emerge	VERB
ejnm-325	3	27	,	,	PUNCT
ejnm-325	3	28	leading	lead	VERB
ejnm-325	3	29	to	to	ADP
ejnm-325	3	30	a	a	DET
ejnm-325	3	31	global	global	ADJ
ejnm-325	3	32	pandemic	pandemic	NOUN
ejnm-325	3	33	with	with	ADP
ejnm-325	3	34	significant	significant	ADJ
ejnm-325	3	35	morbidity	morbidity	NOUN
ejnm-325	3	36	and	and	CCONJ
ejnm-325	3	37	mortality	mortality	NOUN
ejnm-325	3	38	.	.	PUNCT
ejnm-325	4	1	lung	lung	NOUN
ejnm-325	4	2	injury	injury	NOUN
ejnm-325	4	3	is	be	AUX
ejnm-325	4	4	prevalent	prevalent	ADJ
ejnm-325	4	5	,	,	PUNCT
ejnm-325	4	6	raising	raise	VERB
ejnm-325	4	7	concerns	concern	NOUN
ejnm-325	4	8	about	about	ADP
ejnm-325	4	9	long	long	ADJ
ejnm-325	4	10	-	-	PUNCT
ejnm-325	4	11	term	term	NOUN
ejnm-325	4	12	complications	complication	NOUN
ejnm-325	4	13	.	.	PUNCT
ejnm-325	5	1	current	current	ADJ
ejnm-325	5	2	data	datum	NOUN
ejnm-325	5	3	indicate	indicate	VERB
ejnm-325	5	4	persistent	persistent	ADJ
ejnm-325	5	5	pulmonary	pulmonary	ADJ
ejnm-325	5	6	function	function	NOUN
ejnm-325	5	7	issues	issue	NOUN
ejnm-325	5	8	,	,	PUNCT
ejnm-325	5	9	particularly	particularly	ADV
ejnm-325	5	10	diffusion	diffusion	NOUN
ejnm-325	5	11	capacity	capacity	NOUN
ejnm-325	5	12	,	,	PUNCT
ejnm-325	5	13	in	in	ADP
ejnm-325	5	14	survivors	survivor	NOUN
ejnm-325	5	15	.	.	PUNCT
ejnm-325	6	1	critical	critical	ADJ
ejnm-325	6	2	care	care	NOUN
ejnm-325	6	3	needs	need	NOUN
ejnm-325	6	4	and	and	CCONJ
ejnm-325	6	5	risk	risk	NOUN
ejnm-325	6	6	factors	factor	NOUN
ejnm-325	6	7	for	for	ADP
ejnm-325	6	8	poor	poor	ADJ
ejnm-325	6	9	outcomes	outcome	NOUN
ejnm-325	6	10	are	be	AUX
ejnm-325	6	11	identified	identify	VERB
ejnm-325	6	12	,	,	PUNCT
ejnm-325	6	13	but	but	CCONJ
ejnm-325	6	14	the	the	DET
ejnm-325	6	15	full	full	ADJ
ejnm-325	6	16	impact	impact	NOUN
ejnm-325	6	17	of	of	ADP
ejnm-325	6	18	post	post	ADJ
ejnm-325	6	19	-	-	ADJ
ejnm-325	6	20	covid	covid	ADJ
ejnm-325	6	21	syndromes	syndrome	NOUN
ejnm-325	6	22	remains	remains	AUX
ejnm-325	6	23	inadequately	inadequately	ADV
ejnm-325	6	24	defined	define	VERB
ejnm-325	6	25	.	.	PUNCT
ejnm-325	7	1	further	further	ADJ
ejnm-325	7	2	research	research	NOUN
ejnm-325	7	3	is	be	AUX
ejnm-325	7	4	essential	essential	ADJ
ejnm-325	7	5	to	to	PART
ejnm-325	7	6	understand	understand	VERB
ejnm-325	7	7	the	the	DET
ejnm-325	7	8	long	long	ADJ
ejnm-325	7	9	-	-	PUNCT
ejnm-325	7	10	term	term	NOUN
ejnm-325	7	11	consequences	consequence	NOUN
ejnm-325	7	12	of	of	ADP
ejnm-325	7	13	covid-19	covid-19	PROPN
ejnm-325	7	14	.	.	PUNCT
ejnm-325	8	1	this	this	DET
ejnm-325	8	2	study	study	NOUN
ejnm-325	8	3	aims	aim	VERB
ejnm-325	8	4	to	to	PART
ejnm-325	8	5	evaluate	evaluate	VERB
ejnm-325	8	6	pulmonary	pulmonary	ADJ
ejnm-325	8	7	function	function	NOUN
ejnm-325	8	8	tests	test	NOUN
ejnm-325	8	9	in	in	ADP
ejnm-325	8	10	postcovid-19	postcovid-19	PROPN
ejnm-325	8	11	patients	patient	NOUN
ejnm-325	8	12	.	.	PUNCT
ejnm-325	9	1	methods	method	NOUN
ejnm-325	9	2	:	:	PUNCT
ejnm-325	9	3	a	a	DET
ejnm-325	9	4	quantitative	quantitative	ADJ
ejnm-325	9	5	study	study	NOUN
ejnm-325	9	6	was	be	AUX
ejnm-325	9	7	conducted	conduct	VERB
ejnm-325	9	8	on	on	ADP
ejnm-325	9	9	74	74	NUM
ejnm-325	9	10	post	post	ADJ
ejnm-325	9	11	-	-	ADJ
ejnm-325	9	12	covid-19	covid-19	ADJ
ejnm-325	9	13	patients	patient	NOUN
ejnm-325	9	14	in	in	ADP
ejnm-325	9	15	erbil	erbil	PROPN
ejnm-325	9	16	,	,	PUNCT
ejnm-325	9	17	iraq	iraq	PROPN
ejnm-325	9	18	,	,	PUNCT
ejnm-325	9	19	evaluating	evaluate	VERB
ejnm-325	9	20	demographic	demographic	ADJ
ejnm-325	9	21	and	and	CCONJ
ejnm-325	9	22	clinical	clinical	ADJ
ejnm-325	9	23	characteristics	characteristic	NOUN
ejnm-325	9	24	.	.	PUNCT
ejnm-325	10	1	data	datum	NOUN
ejnm-325	10	2	were	be	AUX
ejnm-325	10	3	collected	collect	VERB
ejnm-325	10	4	via	via	ADP
ejnm-325	10	5	questionnaires	questionnaire	NOUN
ejnm-325	10	6	and	and	CCONJ
ejnm-325	10	7	analyzed	analyze	VERB
ejnm-325	10	8	using	use	VERB
ejnm-325	10	9	spss	spss	PROPN
ejnm-325	10	10	,	,	PUNCT
ejnm-325	10	11	ensuring	ensure	VERB
ejnm-325	10	12	participant	participant	ADJ
ejnm-325	10	13	confidentiality	confidentiality	NOUN
ejnm-325	10	14	and	and	CCONJ
ejnm-325	10	15	voluntary	voluntary	ADJ
ejnm-325	10	16	participation	participation	NOUN
ejnm-325	10	17	throughout	throughout	ADP
ejnm-325	10	18	the	the	DET
ejnm-325	10	19	research	research	NOUN
ejnm-325	10	20	process	process	NOUN
ejnm-325	10	21	.	.	PUNCT
ejnm-325	11	1	results	result	NOUN
ejnm-325	11	2	:	:	PUNCT
ejnm-325	11	3	the	the	DET
ejnm-325	11	4	study	study	NOUN
ejnm-325	11	5	analyzed	analyze	VERB
ejnm-325	11	6	74	74	NUM
ejnm-325	11	7	post	post	ADJ
ejnm-325	11	8	-	-	ADJ
ejnm-325	11	9	covid-19	covid-19	ADJ
ejnm-325	11	10	patients	patient	NOUN
ejnm-325	11	11	,	,	PUNCT
ejnm-325	11	12	revealing	reveal	VERB
ejnm-325	11	13	demographics	demographic	NOUN
ejnm-325	11	14	such	such	ADJ
ejnm-325	11	15	as	as	ADP
ejnm-325	11	16	55.4	55.4	NUM
ejnm-325	11	17	%	%	NOUN
ejnm-325	11	18	aged	aged	ADJ
ejnm-325	11	19	54	54	NUM
ejnm-325	11	20	-	-	SYM
ejnm-325	11	21	69	69	NUM
ejnm-325	11	22	and	and	CCONJ
ejnm-325	11	23	a	a	DET
ejnm-325	11	24	male	male	ADJ
ejnm-325	11	25	predominance	predominance	NOUN
ejnm-325	11	26	(	(	PUNCT
ejnm-325	11	27	63.5	63.5	NUM
ejnm-325	11	28	%	%	NOUN
ejnm-325	11	29	)	)	PUNCT
ejnm-325	11	30	.	.	PUNCT
ejnm-325	12	1	common	common	ADJ
ejnm-325	12	2	symptoms	symptom	NOUN
ejnm-325	12	3	included	include	VERB
ejnm-325	12	4	cough	cough	NOUN
ejnm-325	12	5	(	(	PUNCT
ejnm-325	12	6	66.2	66.2	NUM
ejnm-325	12	7	%	%	NOUN
ejnm-325	12	8	)	)	PUNCT
ejnm-325	12	9	and	and	CCONJ
ejnm-325	12	10	shortness	shortness	NOUN
ejnm-325	12	11	of	of	ADP
ejnm-325	12	12	breath	breath	NOUN
ejnm-325	12	13	(	(	PUNCT
ejnm-325	12	14	73	73	NUM
ejnm-325	12	15	%	%	NOUN
ejnm-325	12	16	)	)	PUNCT
ejnm-325	12	17	.	.	PUNCT
ejnm-325	13	1	half	half	NOUN
ejnm-325	13	2	had	have	VERB
ejnm-325	13	3	high	high	ADJ
ejnm-325	13	4	systolic	systolic	ADJ
ejnm-325	13	5	blood	blood	NOUN
ejnm-325	13	6	pressure	pressure	NOUN
ejnm-325	13	7	,	,	PUNCT
ejnm-325	13	8	and	and	CCONJ
ejnm-325	13	9	significant	significant	ADJ
ejnm-325	13	10	associations	association	NOUN
ejnm-325	13	11	were	be	AUX
ejnm-325	13	12	found	find	VERB
ejnm-325	13	13	between	between	ADP
ejnm-325	13	14	severity	severity	NOUN
ejnm-325	13	15	and	and	CCONJ
ejnm-325	13	16	factors	factor	NOUN
ejnm-325	13	17	like	like	ADP
ejnm-325	13	18	age	age	NOUN
ejnm-325	13	19	,	,	PUNCT
ejnm-325	13	20	spo2	spo2	PROPN
ejnm-325	13	21	,	,	PUNCT
ejnm-325	13	22	and	and	CCONJ
ejnm-325	13	23	pulmonary	pulmonary	ADJ
ejnm-325	13	24	function	function	NOUN
ejnm-325	13	25	tests	test	NOUN
ejnm-325	13	26	.	.	PUNCT
ejnm-325	14	1	conclusion	conclusion	NOUN
ejnm-325	14	2	:	:	PUNCT
ejnm-325	14	3	spirometry	spirometry	NOUN
ejnm-325	14	4	patterns	pattern	NOUN
ejnm-325	14	5	significantly	significantly	ADV
ejnm-325	14	6	correlate	correlate	VERB
ejnm-325	14	7	with	with	ADP
ejnm-325	14	8	the	the	DET
ejnm-325	14	9	severity	severity	NOUN
ejnm-325	14	10	of	of	ADP
ejnm-325	14	11	post	post	ADJ
ejnm-325	14	12	-	-	ADJ
ejnm-325	14	13	covid-19	covid-19	ADJ
ejnm-325	14	14	symptoms	symptom	NOUN
ejnm-325	14	15	,	,	PUNCT
ejnm-325	14	16	suggesting	suggest	VERB
ejnm-325	14	17	their	their	PRON
ejnm-325	14	18	value	value	NOUN
ejnm-325	14	19	as	as	ADP
ejnm-325	14	20	prognostic	prognostic	ADJ
ejnm-325	14	21	markers	marker	NOUN
ejnm-325	14	22	.	.	PUNCT
ejnm-325	15	1	however	however	ADV
ejnm-325	15	2	,	,	PUNCT
ejnm-325	15	3	the	the	DET
ejnm-325	15	4	study	study	NOUN
ejnm-325	15	5	found	find	VERB
ejnm-325	15	6	no	no	DET
ejnm-325	15	7	significant	significant	ADJ
ejnm-325	15	8	link	link	NOUN
ejnm-325	15	9	between	between	ADP
ejnm-325	15	10	spirometry	spirometry	NOUN
ejnm-325	15	11	patterns	pattern	NOUN
ejnm-325	15	12	and	and	CCONJ
ejnm-325	15	13	comorbidities	comorbiditie	NOUN
ejnm-325	15	14	,	,	PUNCT
ejnm-325	15	15	indicating	indicate	VERB
ejnm-325	15	16	a	a	DET
ejnm-325	15	17	need	need	NOUN
ejnm-325	15	18	for	for	ADP
ejnm-325	15	19	further	further	ADJ
ejnm-325	15	20	research	research	NOUN
ejnm-325	15	21	to	to	PART
ejnm-325	15	22	explore	explore	VERB
ejnm-325	15	23	these	these	DET
ejnm-325	15	24	relationships	relationship	NOUN
ejnm-325	15	25	and	and	CCONJ
ejnm-325	15	26	their	their	PRON
ejnm-325	15	27	implications	implication	NOUN
ejnm-325	15	28	for	for	ADP
ejnm-325	15	29	patient	patient	ADJ
ejnm-325	15	30	management	management	NOUN
ejnm-325	15	31	.	.	PUNCT
ejnm-325	16	1	keywords	keyword	NOUN
ejnm-325	16	2	:	:	PUNCT
ejnm-325	16	3	pulmonary	pulmonary	ADJ
ejnm-325	16	4	function	function	NOUN
ejnm-325	16	5	test	test	NOUN
ejnm-325	16	6	;	;	PUNCT
ejnm-325	16	7	spirometry	spirometry	NOUN
ejnm-325	16	8	patterns	pattern	NOUN
ejnm-325	16	9	;	;	PUNCT
ejnm-325	16	10	post	post	NOUN
ejnm-325	16	11	-	-	ADJ
ejnm-325	16	12	covid-19	covid-19	ADJ
ejnm-325	16	13	;	;	PUNCT
ejnm-325	16	14	sars	sar	NOUN
ejnm-325	16	15	-	-	PUNCT
ejnm-325	16	16	cov-2	cov-2	NOUN
ejnm-325	16	17	.	.	PUNCT
ejnm-325	17	1	hemin	hemin	PROPN
ejnm-325	17	2	khalid	khalid	PROPN
ejnm-325	17	3	saber	saber	PROPN
ejnm-325	17	4	;	;	PUNCT
ejnm-325	17	5	department	department	NOUN
ejnm-325	17	6	of	of	ADP
ejnm-325	17	7	medicine	medicine	NOUN
ejnm-325	17	8	,	,	PUNCT
ejnm-325	17	9	college	college	NOUN
ejnm-325	17	10	of	of	ADP
ejnm-325	17	11	medicine	medicine	NOUN
ejnm-325	17	12	,	,	PUNCT
ejnm-325	17	13	hawler	hawler	PROPN
ejnm-325	17	14	medical	medical	PROPN
ejnm-325	17	15	university	university	PROPN
ejnm-325	17	16	,	,	PUNCT
ejnm-325	17	17	erbil	erbil	PROPN
ejnm-325	17	18	,	,	PUNCT
ejnm-325	17	19	kurdistan	kurdistan	PROPN
ejnm-325	17	20	region	region	NOUN
ejnm-325	17	21	,	,	PUNCT
ejnm-325	17	22	iraq	iraq	PROPN
ejnm-325	17	23	.	.	PUNCT
ejnm-325	18	1	baghawan	baghawan	PROPN
ejnm-325	18	2	ahmed	ahmed	PROPN
ejnm-325	18	3	osthman	osthman	PROPN
ejnm-325	18	4	;	;	PUNCT
ejnm-325	18	5	department	department	NOUN
ejnm-325	18	6	of	of	ADP
ejnm-325	18	7	medicine	medicine	NOUN
ejnm-325	18	8	,	,	PUNCT
ejnm-325	18	9	college	college	NOUN
ejnm-325	18	10	of	of	ADP
ejnm-325	18	11	medicine	medicine	NOUN
ejnm-325	18	12	,	,	PUNCT
ejnm-325	18	13	hawler	hawler	PROPN
ejnm-325	18	14	medical	medical	PROPN
ejnm-325	18	15	university	university	PROPN
ejnm-325	18	16	,	,	PUNCT
ejnm-325	18	17	erbil	erbil	PROPN
ejnm-325	18	18	,	,	PUNCT
ejnm-325	18	19	kurdistan	kurdistan	PROPN
ejnm-325	18	20	region	region	NOUN
ejnm-325	18	21	,	,	PUNCT
ejnm-325	18	22	iraq	iraq	PROPN
ejnm-325	18	23	.	.	PUNCT
ejnm-325	19	1	dara	dara	PROPN
ejnm-325	19	2	abdulla	abdulla	PROPN
ejnm-325	19	3	al	al	PROPN
ejnm-325	19	4	-	-	PUNCT
ejnm-325	19	5	banna	banna	PROPN
ejnm-325	19	6	;	;	PUNCT
ejnm-325	19	7	department	department	NOUN
ejnm-325	19	8	of	of	ADP
ejnm-325	19	9	nursing	nursing	NOUN
ejnm-325	19	10	,	,	PUNCT
ejnm-325	19	11	faculty	faculty	NOUN
ejnm-325	19	12	of	of	ADP
ejnm-325	19	13	nursing	nursing	NOUN
ejnm-325	19	14	,	,	PUNCT
ejnm-325	19	15	tishk	tishk	PROPN
ejnm-325	19	16	international	international	ADJ
ejnm-325	19	17	university	university	PROPN
ejnm-325	19	18	,	,	PUNCT
ejnm-325	19	19	erbil	erbil	PROPN
ejnm-325	19	20	,	,	PUNCT
ejnm-325	19	21	kurdistan	kurdistan	PROPN
ejnm-325	19	22	region	region	NOUN
ejnm-325	19	23	,	,	PUNCT
ejnm-325	19	24	iraq	iraq	PROPN
ejnm-325	19	25	.	.	PUNCT
ejnm-325	20	1	(	(	PUNCT
ejnm-325	20	2	correspondence	correspondence	NOUN
ejnm-325	20	3	:	:	PUNCT
ejnm-325	20	4	dara.albanna@hmu.edu.krd	dara.albanna@hmu.edu.krd	NOUN
ejnm-325	20	5	)	)	PUNCT
ejnm-325	20	6	37	37	NUM
ejnm-325	20	7	received	receive	VERB
ejnm-325	20	8	:	:	PUNCT
ejnm-325	20	9	15/02/2025	15/02/2025	NUM
ejnm-325	20	10	accepted	accept	VERB
ejnm-325	20	11	:	:	PUNCT
ejnm-325	20	12	14/03/2025	14/03/2025	NUM
ejnm-325	20	13	published	publish	VERB
ejnm-325	20	14	:	:	PUNCT
ejnm-325	20	15	30/05/2025	30/05/2025	NUM
ejnm-325	20	16	copyright	copyright	NOUN
ejnm-325	20	17	©	©	ADP
ejnm-325	20	18	2025the	2025the	PROPN
ejnm-325	20	19	author(s	author(s	NOUN
ejnm-325	20	20	)	)	PUNCT
ejnm-325	20	21	.	.	PUNCT
ejnm-325	21	1	this	this	PRON
ejnm-325	21	2	is	be	AUX
ejnm-325	21	3	an	an	DET
ejnm-325	21	4	open	open	ADJ
ejnm-325	21	5	access	access	NOUN
ejnm-325	21	6	article	article	NOUN
ejnm-325	21	7	which	which	PRON
ejnm-325	21	8	licensed	license	VERB
ejnm-325	21	9	under	under	ADP
ejnm-325	21	10	the	the	DET
ejnm-325	21	11	terms	term	NOUN
ejnm-325	21	12	and	and	CCONJ
ejnm-325	21	13	conditions	condition	NOUN
ejnm-325	21	14	of	of	ADP
ejnm-325	21	15	the	the	DET
ejnm-325	21	16	creative	creative	ADJ
ejnm-325	21	17	commons	common	NOUN
ejnm-325	21	18	attribution	attribution	NOUN
ejnm-325	21	19	-	-	PUNCT
ejnm-325	21	20	noncommercial	noncommercial	ADJ
ejnm-325	21	21	-	-	PUNCT
ejnm-325	21	22	sharealike	sharealike	ADJ
ejnm-325	21	23	4.0	4.0	NUM
ejnm-325	21	24	international	international	ADJ
ejnm-325	21	25	license	license	NOUN
ejnm-325	21	26	.	.	PUNCT
ejnm-325	22	1	it	it	PRON
ejnm-325	22	2	permits	permit	VERB
ejnm-325	22	3	no	no	DET
ejnm-325	22	4	additional	additional	ADJ
ejnm-325	22	5	restrictions	restriction	NOUN
ejnm-325	22	6	on	on	ADP
ejnm-325	22	7	use	use	NOUN
ejnm-325	22	8	,	,	PUNCT
ejnm-325	22	9	distribution	distribution	NOUN
ejnm-325	22	10	,	,	PUNCT
ejnm-325	22	11	and	and	CCONJ
ejnm-325	22	12	reproduction	reproduction	NOUN
ejnm-325	22	13	in	in	ADP
ejnm-325	22	14	any	any	DET
ejnm-325	22	15	medium	medium	NOUN
ejnm-325	22	16	provided	provide	VERB
ejnm-325	22	17	the	the	DET
ejnm-325	22	18	original	original	ADJ
ejnm-325	22	19	work	work	NOUN
ejnm-325	22	20	is	be	AUX
ejnm-325	22	21	properly	properly	ADV
ejnm-325	22	22	cited	cite	VERB
ejnm-325	22	23	.	.	PUNCT
ejnm-325	23	1	mailto:(correspondence:%20dara.albanna@hmu.edu.krd	mailto:(correspondence:%20dara.albanna@hmu.edu.krd	NOUN
ejnm-325	23	2	)	)	PUNCT
ejnm-325	23	3	mailto:(correspondence:%20dara.albanna@hmu.edu.krd)?subject=(correspondence:%20dara.albanna@hmu.edu.krd	mailto:(correspondence:%20dara.albanna@hmu.edu.krd)?subject=(correspondence:%20dara.albanna@hmu.edu.krd	PROPN
ejnm-325	23	4	)	)	PUNCT
ejnm-325	23	5	mailto:(correspondence:%20dara.albanna@hmu.edu.krd)?subject=(correspondence:%20dara.albanna@hmu.edu.krd	mailto:(correspondence:%20dara.albanna@hmu.edu.krd)?subject=(correspondence:%20dara.albanna@hmu.edu.krd	PROPN
ejnm-325	23	6	)	)	PUNCT
ejnm-325	23	7	mailto:jawdat.baker@hmu.edu.krd?subject=jawdat.baker@hmu.edu.krd%20%20%20	mailto:jawdat.baker@hmu.edu.krd?subject=jawdat.baker@hmu.edu.krd%20%20%20	NOUN
ejnm-325	23	8	https://creativecommons.org/licenses/by-nc-sa/4.0/	https://creativecommons.org/licenses/by-nc-sa/4.0/	PROPN
ejnm-325	23	9	https://doi.org/10.15218/ejnm.2025.05	https://doi.org/10.15218/ejnm.2025.05	PROPN
ejnm-325	23	10	erbil	erbil	PROPN
ejnm-325	23	11	j.	j.	PROPN
ejnm-325	23	12	nurs	nurs	PROPN
ejnm-325	23	13	.	.	PUNCT
ejnm-325	24	1	midwifery	midwifery	ADJ
ejnm-325	24	2	,	,	PUNCT
ejnm-325	24	3	vol	vol	NOUN
ejnm-325	24	4	.	.	PROPN
ejnm-325	24	5	8	8	NUM
ejnm-325	24	6	,	,	PUNCT
ejnm-325	24	7	no	no	INTJ
ejnm-325	24	8	.	.	PUNCT
ejnm-325	25	1	(	(	PUNCT
ejnm-325	25	2	1	1	NUM
ejnm-325	25	3	)	)	PUNCT
ejnm-325	25	4	,	,	PUNCT
ejnm-325	25	5	may2025	may2025	ADJ
ejnm-325	25	6	original	original	ADJ
ejnm-325	25	7	article	article	NOUN
ejnm-325	25	8	in	in	ADP
ejnm-325	25	9	late	late	ADJ
ejnm-325	25	10	2019	2019	NUM
ejnm-325	25	11	,	,	PUNCT
ejnm-325	25	12	a	a	DET
ejnm-325	25	13	novel	novel	ADJ
ejnm-325	25	14	coronavirus	coronavirus	NOUN
ejnm-325	25	15	,	,	PUNCT
ejnm-325	25	16	severe	severe	ADJ
ejnm-325	25	17	acute	acute	ADJ
ejnm-325	25	18	respiratory	respiratory	ADJ
ejnm-325	25	19	syndrome	syndrome	NOUN
ejnm-325	25	20	coronavirus	coronavirus	NOUN
ejnm-325	25	21	2	2	NUM
ejnm-325	25	22	(	(	PUNCT
ejnm-325	25	23	sars	sar	NOUN
ejnm-325	25	24	-	-	PUNCT
ejnm-325	25	25	cov-2	cov-2	NOUN
ejnm-325	25	26	)	)	PUNCT
ejnm-325	25	27	,	,	PUNCT
ejnm-325	25	28	emerged	emerge	VERB
ejnm-325	25	29	in	in	ADP
ejnm-325	25	30	wuhan	wuhan	PROPN
ejnm-325	25	31	,	,	PUNCT
ejnm-325	25	32	china	china	PROPN
ejnm-325	25	33	,	,	PUNCT
ejnm-325	25	34	and	and	CCONJ
ejnm-325	25	35	has	have	AUX
ejnm-325	25	36	since	since	SCONJ
ejnm-325	25	37	spread	spread	VERB
ejnm-325	25	38	globally	globally	ADV
ejnm-325	25	39	,	,	PUNCT
ejnm-325	25	40	infecting	infect	VERB
ejnm-325	25	41	more	more	ADJ
ejnm-325	25	42	than	than	ADP
ejnm-325	25	43	200	200	NUM
ejnm-325	25	44	million	million	NUM
ejnm-325	25	45	people	people	NOUN
ejnm-325	25	46	.	.	PUNCT
ejnm-325	26	1	the	the	DET
ejnm-325	26	2	clinical	clinical	ADJ
ejnm-325	26	3	course	course	NOUN
ejnm-325	26	4	of	of	ADP
ejnm-325	26	5	infection	infection	NOUN
ejnm-325	26	6	appears	appear	VERB
ejnm-325	26	7	to	to	PART
ejnm-325	26	8	be	be	AUX
ejnm-325	26	9	extremely	extremely	ADV
ejnm-325	26	10	variable	variable	ADJ
ejnm-325	26	11	,	,	PUNCT
ejnm-325	26	12	from	from	ADP
ejnm-325	26	13	asymptomatic	asymptomatic	ADJ
ejnm-325	26	14	to	to	ADP
ejnm-325	26	15	severe	severe	ADJ
ejnm-325	26	16	pneumonia	pneumonia	NOUN
ejnm-325	26	17	with	with	ADP
ejnm-325	26	18	multiorgan	multiorgan	NOUN
ejnm-325	26	19	failure	failure	NOUN
ejnm-325	26	20	requiring	require	VERB
ejnm-325	26	21	critical	critical	ADJ
ejnm-325	26	22	care	care	NOUN
ejnm-325	26	23	.	.	PUNCT
ejnm-325	27	1	more	more	ADJ
ejnm-325	27	2	than	than	ADP
ejnm-325	27	3	1,122,036	1,122,036	NUM
ejnm-325	27	4	people	people	NOUN
ejnm-325	27	5	are	be	AUX
ejnm-325	27	6	known	know	VERB
ejnm-325	27	7	to	to	PART
ejnm-325	27	8	have	have	AUX
ejnm-325	27	9	died	die	VERB
ejnm-325	27	10	following	follow	VERB
ejnm-325	27	11	infection	infection	NOUN
ejnm-325	27	12	,	,	PUNCT
ejnm-325	27	13	but	but	CCONJ
ejnm-325	27	14	data	datum	NOUN
ejnm-325	27	15	on	on	ADP
ejnm-325	27	16	morbidity	morbidity	NOUN
ejnm-325	27	17	in	in	ADP
ejnm-325	27	18	survivors	survivor	NOUN
ejnm-325	27	19	are	be	AUX
ejnm-325	27	20	scarce	scarce	ADJ
ejnm-325	27	21	.	.	PUNCT
ejnm-325	28	1	lung	lung	NOUN
ejnm-325	28	2	injury	injury	NOUN
ejnm-325	28	3	is	be	AUX
ejnm-325	28	4	a	a	DET
ejnm-325	28	5	predominant	predominant	ADJ
ejnm-325	28	6	feature	feature	NOUN
ejnm-325	28	7	of	of	ADP
ejnm-325	28	8	acute	acute	ADJ
ejnm-325	28	9	sars	sar	NOUN
ejnm-325	28	10	-	-	PUNCT
ejnm-325	28	11	cov-2	cov-2	NOUN
ejnm-325	28	12	infection	infection	NOUN
ejnm-325	28	13	,	,	PUNCT
ejnm-325	28	14	and	and	CCONJ
ejnm-325	28	15	understanding	understand	VERB
ejnm-325	28	16	the	the	DET
ejnm-325	28	17	longer	long	ADJ
ejnm-325	28	18	-	-	PUNCT
ejnm-325	28	19	term	term	NOUN
ejnm-325	28	20	implications	implication	NOUN
ejnm-325	28	21	is	be	AUX
ejnm-325	28	22	critical	critical	ADJ
ejnm-325	28	23	given	give	VERB
ejnm-325	28	24	the	the	DET
ejnm-325	28	25	number	number	NOUN
ejnm-325	28	26	of	of	ADP
ejnm-325	28	27	affected	affected	ADJ
ejnm-325	28	28	patients	patient	NOUN
ejnm-325	28	29	.	.	PUNCT
ejnm-325	29	1	there	there	PRON
ejnm-325	29	2	is	be	VERB
ejnm-325	29	3	currently	currently	ADV
ejnm-325	29	4	little	little	ADJ
ejnm-325	29	5	known	known	ADJ
ejnm-325	29	6	about	about	ADP
ejnm-325	29	7	the	the	DET
ejnm-325	29	8	post	post	ADJ
ejnm-325	29	9	-	-	ADJ
ejnm-325	29	10	infectious	infectious	ADJ
ejnm-325	29	11	long	long	ADJ
ejnm-325	29	12	-	-	PUNCT
ejnm-325	29	13	term	term	NOUN
ejnm-325	29	14	complications	complication	NOUN
ejnm-325	29	15	from	from	ADP
ejnm-325	29	16	the	the	DET
ejnm-325	29	17	severe	severe	ADJ
ejnm-325	29	18	acute	acute	ADJ
ejnm-325	29	19	respiratory	respiratory	ADJ
ejnm-325	29	20	syndrome	syndrome	NOUN
ejnm-325	29	21	coronavirus	coronavirus	NOUN
ejnm-325	29	22	two	two	NUM
ejnm-325	29	23	(	(	PUNCT
ejnm-325	29	24	sars	sar	NOUN
ejnm-325	29	25	-	-	PUNCT
ejnm-325	29	26	cov2	cov2	PROPN
ejnm-325	29	27	)	)	PUNCT
ejnm-325	29	28	,	,	PUNCT
ejnm-325	29	29	with	with	ADP
ejnm-325	29	30	much	much	ADV
ejnm-325	29	31	extrapolated	extrapolate	VERB
ejnm-325	29	32	from	from	ADP
ejnm-325	29	33	severe	severe	ADJ
ejnm-325	29	34	acute	acute	ADJ
ejnm-325	29	35	respiratory	respiratory	ADJ
ejnm-325	29	36	syndrome	syndrome	NOUN
ejnm-325	29	37	(	(	PUNCT
ejnm-325	29	38	sars	sars	PROPN
ejnm-325	29	39	)	)	PUNCT
ejnm-325	29	40	and	and	CCONJ
ejnm-325	29	41	middle	middle	PROPN
ejnm-325	29	42	east	east	PROPN
ejnm-325	29	43	respiratory	respiratory	ADJ
ejnm-325	29	44	syndrome	syndrome	NOUN
ejnm-325	29	45	(	(	PUNCT
ejnm-325	29	46	mers	mer	NOUN
ejnm-325	29	47	)	)	PUNCT
ejnm-325	29	48	pandemics	pandemic	NOUN
ejnm-325	29	49	during	during	ADP
ejnm-325	29	50	the	the	DET
ejnm-325	29	51	2003	2003	NUM
ejnm-325	29	52	and	and	CCONJ
ejnm-325	29	53	2012	2012	NUM
ejnm-325	29	54	,	,	PUNCT
ejnm-325	29	55	respectively	respectively	ADV
ejnm-325	29	56	(	(	PUNCT
ejnm-325	29	57	zhao	zhao	PROPN
ejnm-325	29	58	.	.	PUNCT
ejnm-325	30	1	et	et	PROPN
ejnm-325	30	2	al	al	PROPN
ejnm-325	30	3	,	,	PUNCT
ejnm-325	30	4	2020	2020	NUM
ejnm-325	30	5	;	;	PUNCT
ejnm-325	30	6	ngia	ngia	ADJ
ejnm-325	30	7	,	,	PUNCT
ejnm-325	30	8	et	et	PROPN
ejnm-325	30	9	al	al	PROPN
ejnm-325	30	10	.	.	PROPN
ejnm-325	30	11	,	,	PUNCT
ejnm-325	30	12	2010).the	2010).the	DET
ejnm-325	30	13	extrapolated	extrapolated	ADJ
ejnm-325	30	14	data	datum	NOUN
ejnm-325	30	15	has	have	AUX
ejnm-325	30	16	shown	show	VERB
ejnm-325	30	17	that	that	SCONJ
ejnm-325	30	18	there	there	PRON
ejnm-325	30	19	are	be	VERB
ejnm-325	30	20	long	long	ADJ
ejnm-325	30	21	-	-	PUNCT
ejnm-325	30	22	term	term	NOUN
ejnm-325	30	23	reductions	reduction	NOUN
ejnm-325	30	24	in	in	ADP
ejnm-325	30	25	pulmonary	pulmonary	ADJ
ejnm-325	30	26	function	function	NOUN
ejnm-325	30	27	,	,	PUNCT
ejnm-325	30	28	as	as	SCONJ
ejnm-325	30	29	measured	measure	VERB
ejnm-325	30	30	by	by	ADP
ejnm-325	30	31	pulmonary	pulmonary	ADJ
ejnm-325	30	32	function	function	NOUN
ejnm-325	30	33	testing	testing	NOUN
ejnm-325	30	34	(	(	PUNCT
ejnm-325	30	35	pft	pft	PROPN
ejnm-325	30	36	)	)	PUNCT
ejnm-325	30	37	,	,	PUNCT
ejnm-325	30	38	most	most	ADV
ejnm-325	30	39	significantly	significantly	ADV
ejnm-325	30	40	for	for	ADP
ejnm-325	30	41	diffusion	diffusion	NOUN
ejnm-325	30	42	capacity	capacity	NOUN
ejnm-325	30	43	for	for	ADP
ejnm-325	30	44	carbon	carbon	NOUN
ejnm-325	30	45	monoxide	monoxide	NOUN
ejnm-325	30	46	(	(	PUNCT
ejnm-325	30	47	dlco	dlco	NOUN
ejnm-325	30	48	)	)	PUNCT
ejnm-325	30	49	for	for	ADP
ejnm-325	30	50	up	up	ADP
ejnm-325	30	51	to	to	PART
ejnm-325	30	52	two	two	NUM
ejnm-325	30	53	years	year	NOUN
ejnm-325	30	54	after	after	ADP
ejnm-325	30	55	infection	infection	NOUN
ejnm-325	30	56	(	(	PUNCT
ejnm-325	30	57	hui	hui	PROPN
ejnm-325	30	58	.	.	PUNCT
ejnm-325	30	59	et	et	PROPN
ejnm-325	31	1	al	al	PROPN
ejnm-325	31	2	.	.	PROPN
ejnm-325	31	3	,	,	PUNCT
ejnm-325	31	4	2005	2005	NUM
ejnm-325	31	5	;	;	PUNCT
ejnm-325	31	6	ong	ong	PROPN
ejnm-325	31	7	.	.	PROPN
ejnm-325	31	8	et	et	PROPN
ejnm-325	31	9	al	al	PROPN
ejnm-325	31	10	.	.	PROPN
ejnm-325	31	11	,	,	PUNCT
ejnm-325	31	12	2004	2004	NUM
ejnm-325	31	13	;	;	PUNCT
ejnm-325	31	14	park	park	NOUN
ejnm-325	31	15	,	,	PUNCT
ejnm-325	31	16	jun	jun	PROPN
ejnm-325	31	17	,	,	PUNCT
ejnm-325	31	18	and	and	CCONJ
ejnm-325	31	19	kim	kim	PROPN
ejnm-325	31	20	,	,	PUNCT
ejnm-325	31	21	2018	2018	NUM
ejnm-325	31	22	)	)	PUNCT
ejnm-325	32	1	[	[	X
ejnm-325	32	2	3,4,5,6,7	3,4,5,6,7	NUM
ejnm-325	32	3	]	]	PUNCT
ejnm-325	32	4	.	.	PUNCT
ejnm-325	33	1	approximately	approximately	ADV
ejnm-325	33	2	1	1	NUM
ejnm-325	33	3	in	in	ADP
ejnm-325	33	4	7	7	NUM
ejnm-325	33	5	hospitalized	hospitalize	VERB
ejnm-325	33	6	patients	patient	NOUN
ejnm-325	33	7	with	with	ADP
ejnm-325	33	8	covid-19	covid-19	PROPN
ejnm-325	33	9	in	in	ADP
ejnm-325	33	10	the	the	DET
ejnm-325	33	11	united	united	PROPN
ejnm-325	33	12	kingdom	kingdom	PROPN
ejnm-325	33	13	required	require	VERB
ejnm-325	33	14	critical	critical	ADJ
ejnm-325	33	15	care	care	NOUN
ejnm-325	33	16	admission	admission	NOUN
ejnm-325	33	17	,	,	PUNCT
ejnm-325	33	18	the	the	DET
ejnm-325	33	19	majority	majority	NOUN
ejnm-325	33	20	for	for	ADP
ejnm-325	33	21	management	management	NOUN
ejnm-325	33	22	of	of	ADP
ejnm-325	33	23	ards	ard	NOUN
ejnm-325	33	24	(	(	PUNCT
ejnm-325	33	25	drake	drake	PROPN
ejnm-325	33	26	.	.	PUNCT
ejnm-325	34	1	et	et	PROPN
ejnm-325	34	2	al	al	PROPN
ejnm-325	34	3	.	.	PROPN
ejnm-325	34	4	,	,	PUNCT
ejnm-325	34	5	2021	2021	NUM
ejnm-325	34	6	)	)	PUNCT
ejnm-325	34	7	.	.	PUNCT
ejnm-325	35	1	the	the	DET
ejnm-325	35	2	onset	onset	NOUN
ejnm-325	35	3	of	of	ADP
ejnm-325	35	4	covidards	covidard	NOUN
ejnm-325	35	5	in	in	ADP
ejnm-325	35	6	the	the	DET
ejnm-325	35	7	second	second	ADJ
ejnm-325	35	8	week	week	NOUN
ejnm-325	35	9	post	post	NOUN
ejnm-325	35	10	-	-	ADJ
ejnm-325	35	11	symptomonset	symptomonset	ADJ
ejnm-325	35	12	(	(	PUNCT
ejnm-325	35	13	at	at	ADP
ejnm-325	35	14	declining	decline	VERB
ejnm-325	35	15	viral	viral	ADJ
ejnm-325	35	16	loads	load	NOUN
ejnm-325	35	17	)	)	PUNCT
ejnm-325	35	18	and	and	CCONJ
ejnm-325	35	19	response	response	NOUN
ejnm-325	35	20	to	to	ADP
ejnm-325	35	21	immunomodulation	immunomodulation	NOUN
ejnm-325	35	22	suggests	suggest	VERB
ejnm-325	35	23	pathogenic	pathogenic	ADJ
ejnm-325	35	24	immune	immune	ADJ
ejnm-325	35	25	dysregulation	dysregulation	NOUN
ejnm-325	35	26	.	.	PUNCT
ejnm-325	36	1	given	give	VERB
ejnm-325	36	2	the	the	DET
ejnm-325	36	3	unprecedented	unprecedented	ADJ
ejnm-325	36	4	scale	scale	NOUN
ejnm-325	36	5	of	of	ADP
ejnm-325	36	6	the	the	DET
ejnm-325	36	7	covid-19	covid-19	PROPN
ejnm-325	36	8	pandemic	pandemic	NOUN
ejnm-325	36	9	,	,	PUNCT
ejnm-325	36	10	even	even	ADV
ejnm-325	36	11	a	a	DET
ejnm-325	36	12	low	low	ADJ
ejnm-325	36	13	event	event	NOUN
ejnm-325	36	14	rate	rate	NOUN
ejnm-325	36	15	may	may	AUX
ejnm-325	36	16	have	have	VERB
ejnm-325	36	17	a	a	DET
ejnm-325	36	18	significant	significant	ADJ
ejnm-325	36	19	population	population	NOUN
ejnm-325	36	20	-	-	PUNCT
ejnm-325	36	21	level	level	NOUN
ejnm-325	36	22	impact	impact	NOUN
ejnm-325	36	23	(	(	PUNCT
ejnm-325	36	24	morbidity	morbidity	NOUN
ejnm-325	36	25	,	,	PUNCT
ejnm-325	36	26	late	late	ADJ
ejnm-325	36	27	mortality	mortality	NOUN
ejnm-325	36	28	)	)	PUNCT
ejnm-325	36	29	.	.	PUNCT
ejnm-325	37	1	most	most	ADJ
ejnm-325	37	2	descriptions	description	NOUN
ejnm-325	37	3	of	of	ADP
ejnm-325	37	4	post	post	ADJ
ejnm-325	37	5	-	-	ADJ
ejnm-325	37	6	covid	covid	ADJ
ejnm-325	37	7	syndromes	syndrome	NOUN
ejnm-325	37	8	stipulate	stipulate	VERB
ejnm-325	37	9	symptom	symptom	NOUN
ejnm-325	37	10	duration	duration	NOUN
ejnm-325	37	11	for	for	ADP
ejnm-325	37	12	 	 	SPACE
ejnm-325	37	13	>	>	PUNCT
ejnm-325	37	14	 	 	SPACE
ejnm-325	37	15	3	3	NUM
ejnm-325	37	16	months	month	NOUN
ejnm-325	37	17	(	(	PUNCT
ejnm-325	37	18	munblit	munblit	VERB
ejnm-325	37	19	,	,	PUNCT
ejnm-325	37	20	o’hara	o’hara	NOUN
ejnm-325	37	21	,	,	PUNCT
ejnm-325	37	22	akrami	akrami	NOUN
ejnm-325	37	23	,	,	PUNCT
ejnm-325	37	24	perego	perego	NOUN
ejnm-325	37	25	,	,	PUNCT
ejnm-325	37	26	olliaro	olliaro	NOUN
ejnm-325	37	27	,	,	PUNCT
ejnm-325	37	28	needham	needham	PROPN
ejnm-325	37	29	,	,	PUNCT
ejnm-325	37	30	2022	2022	NUM
ejnm-325	37	31	)	)	PUNCT
ejnm-325	37	32	.	.	PUNCT
ejnm-325	38	1	clinically	clinically	ADV
ejnm-325	38	2	significant	significant	ADJ
ejnm-325	38	3	ild	ild	PROPN
ejnm-325	38	4	refers	refer	VERB
ejnm-325	38	5	to	to	ADP
ejnm-325	38	6	 	 	SPACE
ejnm-325	38	7	>	>	PUNCT
ejnm-325	38	8	 	 	SPACE
ejnm-325	38	9	10	10	NUM
ejnm-325	38	10	%	%	NOUN
ejnm-325	38	11	lung	lung	NOUN
ejnm-325	38	12	parenchymal	parenchymal	ADJ
ejnm-325	38	13	changes	change	NOUN
ejnm-325	38	14	on	on	ADP
ejnm-325	38	15	chest	chest	NOUN
ejnm-325	38	16	computed	compute	VERB
ejnm-325	38	17	tomography	tomography	NOUN
ejnm-325	38	18	(	(	PUNCT
ejnm-325	38	19	ct	ct	PROPN
ejnm-325	38	20	)	)	PUNCT
ejnm-325	38	21	.	.	PUNCT
ejnm-325	39	1	a	a	DET
ejnm-325	39	2	consensus	consensus	NOUN
ejnm-325	39	3	definition	definition	NOUN
ejnm-325	39	4	and	and	CCONJ
ejnm-325	39	5	the	the	DET
ejnm-325	39	6	true	true	ADJ
ejnm-325	39	7	burden	burden	NOUN
ejnm-325	39	8	of	of	ADP
ejnm-325	39	9	post	post	ADJ
ejnm-325	39	10	-	-	ADJ
ejnm-325	39	11	covid19	covid19	ADJ
ejnm-325	39	12	-	-	PUNCT
ejnm-325	39	13	ild	ild	NOUN
ejnm-325	39	14	have	have	AUX
ejnm-325	39	15	not	not	PART
ejnm-325	39	16	yet	yet	ADV
ejnm-325	39	17	been	be	AUX
ejnm-325	39	18	determined	determine	VERB
ejnm-325	39	19	.	.	PUNCT
ejnm-325	40	1	pc	pc	NOUN
ejnm-325	40	2	-	-	PUNCT
ejnm-325	40	3	ild	ild	NOUN
ejnm-325	40	4	should	should	AUX
ejnm-325	40	5	be	be	AUX
ejnm-325	40	6	considered	consider	VERB
ejnm-325	40	7	in	in	ADP
ejnm-325	40	8	patients	patient	NOUN
ejnm-325	40	9	with	with	ADP
ejnm-325	40	10	persistent	persistent	ADJ
ejnm-325	40	11	respiratory	respiratory	ADJ
ejnm-325	40	12	symptoms	symptom	NOUN
ejnm-325	40	13	(	(	PUNCT
ejnm-325	40	14	e.g.	e.g.	ADV
ejnm-325	40	15	,	,	PUNCT
ejnm-325	40	16	cough	cough	NOUN
ejnm-325	40	17	and	and	CCONJ
ejnm-325	40	18	dyspnea	dyspnea	NOUN
ejnm-325	40	19	)	)	PUNCT
ejnm-325	40	20	3	3	NUM
ejnm-325	40	21	months	month	NOUN
ejnm-325	40	22	post	post	ADJ
ejnm-325	40	23	-	-	ADJ
ejnm-325	40	24	covid-19	covid-19	ADJ
ejnm-325	40	25	symptom	symptom	NOUN
ejnm-325	40	26	-	-	PUNCT
ejnm-325	40	27	onset	onset	NOUN
ejnm-325	40	28	,	,	PUNCT
ejnm-325	40	29	and	and	CCONJ
ejnm-325	40	30	patients	patient	NOUN
ejnm-325	40	31	with	with	ADP
ejnm-325	40	32	 	 	SPACE
ejnm-325	40	33	>	>	PUNCT
ejnm-325	40	34	 	 	SPACE
ejnm-325	40	35	10	10	NUM
ejnm-325	40	36	%	%	NOUN
ejnm-325	41	1	ct	ct	NUM
ejnm-325	41	2	changes	change	NOUN
ejnm-325	41	3	should	should	AUX
ejnm-325	41	4	be	be	AUX
ejnm-325	41	5	monitored	monitor	VERB
ejnm-325	41	6	.	.	PUNCT
ejnm-325	42	1	accumulating	accumulate	VERB
ejnm-325	42	2	data	datum	NOUN
ejnm-325	42	3	suggests	suggest	VERB
ejnm-325	42	4	that	that	SCONJ
ejnm-325	42	5	while	while	SCONJ
ejnm-325	42	6	the	the	DET
ejnm-325	42	7	majority	majority	NOUN
ejnm-325	42	8	of	of	ADP
ejnm-325	42	9	scans	scan	NOUN
ejnm-325	42	10	show	show	VERB
ejnm-325	42	11	improvement	improvement	NOUN
ejnm-325	42	12	,	,	PUNCT
ejnm-325	42	13	at	at	ADP
ejnm-325	42	14	12	12	NUM
ejnm-325	42	15	months	month	NOUN
ejnm-325	42	16	the	the	DET
ejnm-325	42	17	prevalence	prevalence	NOUN
ejnm-325	42	18	of	of	ADP
ejnm-325	42	19	(	(	PUNCT
ejnm-325	42	20	non	non	ADJ
ejnm-325	42	21	-	-	ADJ
ejnm-325	42	22	progressive	progressive	ADJ
ejnm-325	42	23	)	)	PUNCT
ejnm-325	42	24	fibrosis	fibrosis	NOUN
ejnm-325	42	25	is	be	AUX
ejnm-325	42	26	  	  	SPACE
ejnm-325	42	27	~	~	PUNCT
ejnm-325	42	28	 	 	SPACE
ejnm-325	42	29	10	10	NUM
ejnm-325	42	30	%	%	NOUN
ejnm-325	42	31	in	in	ADP
ejnm-325	42	32	hospitalized	hospitalize	VERB
ejnm-325	42	33	patients	patient	NOUN
ejnm-325	42	34	,	,	PUNCT
ejnm-325	42	35	particularly	particularly	ADV
ejnm-325	42	36	in	in	ADP
ejnm-325	42	37	severe	severe	ADJ
ejnm-325	42	38	disease	disease	NOUN
ejnm-325	42	39	and	and	CCONJ
ejnm-325	42	40	older	old	ADJ
ejnm-325	42	41	age	age	NOUN
ejnm-325	42	42	(	(	PUNCT
ejnm-325	42	43	ong	ong	PROPN
ejnm-325	42	44	.	.	PROPN
ejnm-325	42	45	et	et	PROPN
ejnm-325	43	1	al	al	PROPN
ejnm-325	43	2	.	.	PROPN
ejnm-325	43	3	,	,	PUNCT
ejnm-325	43	4	2004	2004	NUM
ejnm-325	43	5	)	)	PUNCT
ejnm-325	43	6	.	.	PUNCT
ejnm-325	44	1	several	several	ADJ
ejnm-325	44	2	clinical	clinical	ADJ
ejnm-325	44	3	features	feature	NOUN
ejnm-325	44	4	and	and	CCONJ
ejnm-325	44	5	comorbidities	comorbiditie	NOUN
ejnm-325	44	6	are	be	AUX
ejnm-325	44	7	associated	associate	VERB
ejnm-325	44	8	with	with	ADP
ejnm-325	44	9	a	a	DET
ejnm-325	44	10	poor	poor	ADJ
ejnm-325	44	11	prognosis	prognosis	NOUN
ejnm-325	44	12	and	and	CCONJ
ejnm-325	44	13	a	a	DET
ejnm-325	44	14	higher	high	ADJ
ejnm-325	44	15	risk	risk	NOUN
ejnm-325	44	16	of	of	ADP
ejnm-325	44	17	mortality	mortality	NOUN
ejnm-325	44	18	from	from	ADP
ejnm-325	44	19	covid-19	covid-19	PROPN
ejnm-325	44	20	.	.	PUNCT
ejnm-325	45	1	these	these	PRON
ejnm-325	45	2	include	include	VERB
ejnm-325	45	3	pre	pre	ADJ
ejnm-325	45	4	-	-	ADJ
ejnm-325	45	5	existing	exist	VERB
ejnm-325	45	6	health	health	NOUN
ejnm-325	45	7	problems	problem	NOUN
ejnm-325	45	8	such	such	ADJ
ejnm-325	45	9	as	as	ADP
ejnm-325	45	10	hypertension	hypertension	NOUN
ejnm-325	45	11	,	,	PUNCT
ejnm-325	45	12	diabetes	diabetes	NOUN
ejnm-325	45	13	,	,	PUNCT
ejnm-325	45	14	cardiovascular	cardiovascular	ADJ
ejnm-325	45	15	disease	disease	NOUN
ejnm-325	45	16	,	,	PUNCT
ejnm-325	45	17	obesity	obesity	NOUN
ejnm-325	45	18	,	,	PUNCT
ejnm-325	45	19	cancer	cancer	NOUN
ejnm-325	45	20	,	,	PUNCT
ejnm-325	45	21	chronic	chronic	ADJ
ejnm-325	45	22	kidney	kidney	NOUN
ejnm-325	45	23	,	,	PUNCT
ejnm-325	45	24	liver	liver	NOUN
ejnm-325	45	25	,	,	PUNCT
ejnm-325	45	26	and	and	CCONJ
ejnm-325	45	27	lung	lung	NOUN
ejnm-325	45	28	diseases	disease	NOUN
ejnm-325	45	29	,	,	PUNCT
ejnm-325	45	30	and	and	CCONJ
ejnm-325	45	31	older	old	ADJ
ejnm-325	45	32	age	age	NOUN
ejnm-325	45	33	,	,	PUNCT
ejnm-325	45	34	male	male	ADJ
ejnm-325	45	35	sex	sex	NOUN
ejnm-325	45	36	,	,	PUNCT
ejnm-325	45	37	smoking	smoking	NOUN
ejnm-325	45	38	,	,	PUNCT
ejnm-325	45	39	and	and	CCONJ
ejnm-325	45	40	race	race	NOUN
ejnm-325	45	41	(	(	PUNCT
ejnm-325	45	42	richardson	richardson	PROPN
ejnm-325	45	43	.	.	PUNCT
ejnm-325	45	44	et	et	PROPN
ejnm-325	45	45	al	al	PROPN
ejnm-325	45	46	.	.	PROPN
ejnm-325	45	47	,	,	PUNCT
ejnm-325	45	48	2020	2020	NUM
ejnm-325	45	49	;	;	PUNCT
ejnm-325	45	50	docherty	docherty	PROPN
ejnm-325	45	51	.	.	PUNCT
ejnm-325	45	52	et	et	PROPN
ejnm-325	45	53	al	al	PROPN
ejnm-325	45	54	.	.	PROPN
ejnm-325	45	55	,	,	PUNCT
ejnm-325	45	56	1985	1985	NUM
ejnm-325	45	57	;	;	PUNCT
ejnm-325	45	58	sze	sze	PROPN
ejnm-325	45	59	.	.	PROPN
ejnm-325	45	60	et	et	PROPN
ejnm-325	45	61	al	al	PROPN
ejnm-325	45	62	.	.	PROPN
ejnm-325	45	63	,	,	PUNCT
ejnm-325	45	64	2020	2020	NUM
ejnm-325	45	65	;	;	PUNCT
ejnm-325	45	66	sanchez	sanchez	PROPN
ejnm-325	45	67	-	-	PUNCT
ejnm-325	45	68	ramirez	ramirez	PROPN
ejnm-325	45	69	and	and	CCONJ
ejnm-325	45	70	mackey	mackey	PROPN
ejnm-325	45	71	,	,	PUNCT
ejnm-325	45	72	2020	2020	NUM
ejnm-325	45	73	)	)	PUNCT
ejnm-325	45	74	.	.	PUNCT
ejnm-325	46	1	whether	whether	SCONJ
ejnm-325	46	2	these	these	DET
ejnm-325	46	3	risk	risk	NOUN
ejnm-325	46	4	factors	factor	NOUN
ejnm-325	46	5	are	be	AUX
ejnm-325	46	6	also	also	ADV
ejnm-325	46	7	predictors	predictor	NOUN
ejnm-325	46	8	of	of	ADP
ejnm-325	46	9	longer	long	ADJ
ejnm-325	46	10	-	-	PUNCT
ejnm-325	46	11	term	term	NOUN
ejnm-325	46	12	outcomes	outcome	NOUN
ejnm-325	46	13	from	from	ADP
ejnm-325	46	14	covid-19	covid-19	PROPN
ejnm-325	46	15	is	be	AUX
ejnm-325	46	16	currently	currently	ADV
ejnm-325	46	17	unclear.the	unclear.the	DET
ejnm-325	46	18	most	most	ADV
ejnm-325	46	19	common	common	ADJ
ejnm-325	46	20	radiological	radiological	ADJ
ejnm-325	46	21	pattern	pattern	NOUN
ejnm-325	46	22	of	of	ADP
ejnm-325	46	23	acute	acute	ADJ
ejnm-325	46	24	infection	infection	NOUN
ejnm-325	46	25	with	with	ADP
ejnm-325	46	26	sars	sar	NOUN
ejnm-325	46	27	-	-	PUNCT
ejnm-325	46	28	cov-2	cov-2	PART
ejnm-325	46	29	is	be	AUX
ejnm-325	46	30	of	of	ADP
ejnm-325	46	31	bilateral	bilateral	ADJ
ejnm-325	46	32	ground	ground	NOUN
ejnm-325	46	33	-	-	PUNCT
ejnm-325	46	34	glass	glass	NOUN
ejnm-325	46	35	opacification	opacification	NOUN
ejnm-325	46	36	with	with	ADP
ejnm-325	46	37	or	or	CCONJ
ejnm-325	46	38	without	without	ADP
ejnm-325	46	39	consolidation	consolidation	NOUN
ejnm-325	46	40	in	in	ADP
ejnm-325	46	41	a	a	DET
ejnm-325	46	42	subpleural	subpleural	ADJ
ejnm-325	46	43	distribution	distribution	NOUN
ejnm-325	46	44	,	,	PUNCT
ejnm-325	46	45	and	and	CCONJ
ejnm-325	46	46	a	a	DET
ejnm-325	46	47	radiological	radiological	ADJ
ejnm-325	46	48	and	and	CCONJ
ejnm-325	46	49	histological	histological	ADJ
ejnm-325	46	50	pattern	pattern	NOUN
ejnm-325	46	51	of	of	ADP
ejnm-325	46	52	organizing	organize	VERB
ejnm-325	46	53	pneumonia	pneumonia	NOUN
ejnm-325	46	54	pattern	pattern	NOUN
ejnm-325	46	55	is	be	AUX
ejnm-325	46	56	described	describe	VERB
ejnm-325	46	57	in	in	ADP
ejnm-325	46	58	many	many	ADJ
ejnm-325	46	59	cases	case	NOUN
ejnm-325	46	60	(	(	PUNCT
ejnm-325	46	61	zhao	zhao	X
ejnm-325	46	62	,	,	PUNCT
ejnm-325	46	63	zhong	zhong	PROPN
ejnm-325	46	64	,	,	PUNCT
ejnm-325	46	65	xie	xie	PROPN
ejnm-325	46	66	,	,	PUNCT
ejnm-325	46	67	yu	yu	PROPN
ejnm-325	46	68	,	,	PUNCT
ejnm-325	46	69	and	and	CCONJ
ejnm-325	46	70	liu	liu	PROPN
ejnm-325	46	71	,	,	PUNCT
ejnm-325	46	72	2020	2020	NUM
ejnm-325	46	73	)	)	PUNCT
ejnm-325	46	74	.	.	PUNCT
ejnm-325	47	1	radiological	radiological	ADJ
ejnm-325	47	2	findings	finding	NOUN
ejnm-325	47	3	alter	alter	VERB
ejnm-325	47	4	as	as	SCONJ
ejnm-325	47	5	the	the	DET
ejnm-325	47	6	disease	disease	NOUN
ejnm-325	47	7	progresses	progress	VERB
ejnm-325	47	8	,	,	PUNCT
ejnm-325	47	9	but	but	CCONJ
ejnm-325	47	10	persistent	persistent	ADJ
ejnm-325	47	11	computed	compute	VERB
ejnm-325	47	12	tomographic	tomographic	NOUN
ejnm-325	47	13	(	(	PUNCT
ejnm-325	47	14	ct	ct	NOUN
ejnm-325	47	15	)	)	PUNCT
ejnm-325	47	16	imaging	imaging	NOUN
ejnm-325	47	17	abnormalities	abnormality	NOUN
ejnm-325	47	18	beyond	beyond	ADP
ejnm-325	47	19	day	day	NOUN
ejnm-325	47	20	14	14	NUM
ejnm-325	47	21	of	of	ADP
ejnm-325	47	22	symptoms	symptom	NOUN
ejnm-325	47	23	and	and	CCONJ
ejnm-325	47	24	up	up	ADP
ejnm-325	47	25	to	to	ADP
ejnm-325	47	26	day	day	NOUN
ejnm-325	47	27	37	37	NUM
ejnm-325	47	28	have	have	AUX
ejnm-325	47	29	been	be	AUX
ejnm-325	47	30	reported	report	VERB
ejnm-325	47	31	(	(	PUNCT
ejnm-325	47	32	pan	pan	PROPN
ejnm-325	47	33	.	.	PROPN
ejnm-325	47	34	et	et	PROPN
ejnm-325	47	35	al	al	PROPN
ejnm-325	47	36	.	.	PROPN
ejnm-325	47	37	,	,	PUNCT
ejnm-325	47	38	2020	2020	NUM
ejnm-325	47	39	;	;	PUNCT
ejnm-325	47	40	wang	wang	PROPN
ejnm-325	47	41	.	.	PUNCT
ejnm-325	48	1	38	38	NUM
ejnm-325	48	2	copyright	copyright	NOUN
ejnm-325	48	3	©	©	PROPN
ejnm-325	48	4	2025	2025	NUM
ejnm-325	48	5	the	the	DET
ejnm-325	48	6	author(s	author(s	NOUN
ejnm-325	48	7	)	)	PUNCT
ejnm-325	48	8	.	.	PUNCT
ejnm-325	49	1	this	this	PRON
ejnm-325	49	2	is	be	AUX
ejnm-325	49	3	an	an	DET
ejnm-325	49	4	open	open	ADJ
ejnm-325	49	5	access	access	NOUN
ejnm-325	49	6	article	article	NOUN
ejnm-325	49	7	which	which	PRON
ejnm-325	49	8	licensed	license	VERB
ejnm-325	49	9	under	under	ADP
ejnm-325	49	10	the	the	DET
ejnm-325	49	11	terms	term	NOUN
ejnm-325	49	12	and	and	CCONJ
ejnm-325	49	13	conditions	condition	NOUN
ejnm-325	49	14	of	of	ADP
ejnm-325	49	15	the	the	DET
ejnm-325	49	16	creative	creative	ADJ
ejnm-325	49	17	commons	common	NOUN
ejnm-325	49	18	attribution	attribution	NOUN
ejnm-325	49	19	-	-	PUNCT
ejnm-325	49	20	noncommercial	noncommercial	ADJ
ejnm-325	49	21	-	-	PUNCT
ejnm-325	49	22	sharealike	sharealike	ADJ
ejnm-325	49	23	4.0	4.0	NUM
ejnm-325	49	24	international	international	ADJ
ejnm-325	49	25	license	license	NOUN
ejnm-325	49	26	.	.	PUNCT
ejnm-325	50	1	it	it	PRON
ejnm-325	50	2	permits	permit	VERB
ejnm-325	50	3	no	no	DET
ejnm-325	50	4	additional	additional	ADJ
ejnm-325	50	5	restrictions	restriction	NOUN
ejnm-325	50	6	on	on	ADP
ejnm-325	50	7	use	use	NOUN
ejnm-325	50	8	,	,	PUNCT
ejnm-325	50	9	distribution	distribution	NOUN
ejnm-325	50	10	,	,	PUNCT
ejnm-325	50	11	and	and	CCONJ
ejnm-325	50	12	reproduction	reproduction	NOUN
ejnm-325	50	13	in	in	ADP
ejnm-325	50	14	any	any	DET
ejnm-325	50	15	medium	medium	NOUN
ejnm-325	50	16	provided	provide	VERB
ejnm-325	50	17	the	the	DET
ejnm-325	50	18	original	original	ADJ
ejnm-325	50	19	work	work	NOUN
ejnm-325	50	20	is	be	AUX
ejnm-325	50	21	properly	properly	ADV
ejnm-325	50	22	cited	cite	VERB
ejnm-325	50	23	.	.	PUNCT
ejnm-325	51	1	introduction	introduction	NOUN
ejnm-325	51	2	https://creativecommons.org/licenses/by-nc-sa/4.0/	https://creativecommons.org/licenses/by-nc-sa/4.0/	PROPN
ejnm-325	51	3	https://doi.org/10.15218/ejnm.2025.05	https://doi.org/10.15218/ejnm.2025.05	PROPN
ejnm-325	51	4	erbil	erbil	PROPN
ejnm-325	51	5	j.	j.	PROPN
ejnm-325	51	6	nurs	nurs	PROPN
ejnm-325	51	7	.	.	PUNCT
ejnm-325	52	1	midwifery	midwifery	ADJ
ejnm-325	52	2	,	,	PUNCT
ejnm-325	52	3	vol	vol	NOUN
ejnm-325	52	4	.	.	PROPN
ejnm-325	52	5	8	8	NUM
ejnm-325	52	6	,	,	PUNCT
ejnm-325	52	7	no	no	INTJ
ejnm-325	52	8	.	.	PUNCT
ejnm-325	53	1	(	(	PUNCT
ejnm-325	53	2	1	1	NUM
ejnm-325	53	3	)	)	PUNCT
ejnm-325	53	4	,	,	PUNCT
ejnm-325	53	5	may2025	may2025	ADJ
ejnm-325	53	6	original	original	ADJ
ejnm-325	53	7	article	article	NOUN
ejnm-325	53	8	obtained	obtain	VERB
ejnm-325	53	9	permission	permission	NOUN
ejnm-325	53	10	from	from	ADP
ejnm-325	53	11	the	the	DET
ejnm-325	53	12	scientific	scientific	ADJ
ejnm-325	53	13	and	and	CCONJ
ejnm-325	53	14	ethical	ethical	ADJ
ejnm-325	53	15	committees	committee	NOUN
ejnm-325	53	16	at	at	ADP
ejnm-325	53	17	the	the	DET
ejnm-325	53	18	college	college	NOUN
ejnm-325	53	19	of	of	ADP
ejnm-325	53	20	medicine	medicine	NOUN
ejnm-325	53	21	,	,	PUNCT
ejnm-325	53	22	hawler	hawler	PROPN
ejnm-325	53	23	medical	medical	PROPN
ejnm-325	53	24	university	university	PROPN
ejnm-325	53	25	.	.	PUNCT
ejnm-325	54	1	on	on	ADP
ejnm-325	54	2	4th	4th	ADJ
ejnm-325	54	3	june	june	PROPN
ejnm-325	54	4	2022	2022	NUM
ejnm-325	54	5	.	.	PUNCT
ejnm-325	55	1	the	the	DET
ejnm-325	55	2	other	other	ADJ
ejnm-325	55	3	official	official	ADJ
ejnm-325	55	4	permission	permission	NOUN
ejnm-325	55	5	from	from	ADP
ejnm-325	55	6	the	the	DET
ejnm-325	55	7	erbil	erbil	PROPN
ejnm-325	55	8	directorate	directorate	NOUN
ejnm-325	55	9	of	of	ADP
ejnm-325	55	10	health	health	NOUN
ejnm-325	55	11	and	and	CCONJ
ejnm-325	55	12	the	the	DET
ejnm-325	55	13	administrative	administrative	ADJ
ejnm-325	55	14	units	unit	NOUN
ejnm-325	55	15	of	of	ADP
ejnm-325	55	16	the	the	DET
ejnm-325	55	17	teaching	teaching	NOUN
ejnm-325	55	18	hospitals	hospital	NOUN
ejnm-325	55	19	was	be	AUX
ejnm-325	55	20	obtained	obtain	VERB
ejnm-325	55	21	.	.	PUNCT
ejnm-325	56	1	this	this	DET
ejnm-325	56	2	study	study	NOUN
ejnm-325	56	3	includes	include	VERB
ejnm-325	56	4	74	74	NUM
ejnm-325	56	5	patients	patient	NOUN
ejnm-325	56	6	.	.	PUNCT
ejnm-325	57	1	a	a	DET
ejnm-325	57	2	sample	sample	NOUN
ejnm-325	57	3	of	of	ADP
ejnm-325	57	4	post	post	ADJ
ejnm-325	57	5	-	-	ADJ
ejnm-325	57	6	covid	covid	ADJ
ejnm-325	57	7	-19	-19	NOUN
ejnm-325	57	8	patients	patient	NOUN
ejnm-325	57	9	was	be	AUX
ejnm-325	57	10	recruited	recruit	VERB
ejnm-325	57	11	in	in	ADP
ejnm-325	57	12	this	this	DET
ejnm-325	57	13	study	study	NOUN
ejnm-325	57	14	based	base	VERB
ejnm-325	57	15	on	on	ADP
ejnm-325	57	16	a	a	DET
ejnm-325	57	17	convenience	convenience	NOUN
ejnm-325	57	18	(	(	PUNCT
ejnm-325	57	19	purposeful	purposeful	ADJ
ejnm-325	57	20	)	)	PUNCT
ejnm-325	57	21	sampling	sample	VERB
ejnm-325	57	22	technique	technique	NOUN
ejnm-325	57	23	,	,	PUNCT
ejnm-325	57	24	according	accord	VERB
ejnm-325	57	25	to	to	ADP
ejnm-325	57	26	the	the	DET
ejnm-325	57	27	inclusion	inclusion	NOUN
ejnm-325	57	28	and	and	CCONJ
ejnm-325	57	29	exclusion	exclusion	NOUN
ejnm-325	57	30	criteria	criterion	NOUN
ejnm-325	57	31	.	.	PUNCT
ejnm-325	58	1	ages	age	NOUN
ejnm-325	58	2	more	more	ADJ
ejnm-325	58	3	than	than	ADP
ejnm-325	58	4	18	18	NUM
ejnm-325	58	5	years	year	NOUN
ejnm-325	58	6	,	,	PUNCT
ejnm-325	58	7	both	both	DET
ejnm-325	58	8	genders	gender	NOUN
ejnm-325	58	9	,	,	PUNCT
ejnm-325	58	10	with	with	ADP
ejnm-325	58	11	good	good	ADJ
ejnm-325	58	12	communication	communication	NOUN
ejnm-325	58	13	were	be	AUX
ejnm-325	58	14	included	include	VERB
ejnm-325	58	15	.	.	PUNCT
ejnm-325	59	1	this	this	DET
ejnm-325	59	2	study	study	NOUN
ejnm-325	59	3	was	be	AUX
ejnm-325	59	4	carried	carry	VERB
ejnm-325	59	5	out	out	ADP
ejnm-325	59	6	from	from	ADP
ejnm-325	59	7	november	november	PROPN
ejnm-325	59	8	2022	2022	NUM
ejnm-325	59	9	to	to	ADP
ejnm-325	59	10	april	april	PROPN
ejnm-325	59	11	2023	2023	NUM
ejnm-325	59	12	.	.	PUNCT
ejnm-325	60	1	the	the	DET
ejnm-325	60	2	duration	duration	NOUN
ejnm-325	60	3	of	of	ADP
ejnm-325	60	4	the	the	DET
ejnm-325	60	5	data	data	NOUN
ejnm-325	60	6	collection	collection	NOUN
ejnm-325	60	7	was	be	AUX
ejnm-325	60	8	around	around	ADV
ejnm-325	60	9	four	four	NUM
ejnm-325	60	10	months	month	NOUN
ejnm-325	60	11	.	.	PUNCT
ejnm-325	61	1	a	a	DET
ejnm-325	61	2	questionnaire	questionnaire	NOUN
ejnm-325	61	3	was	be	AUX
ejnm-325	61	4	designed	design	VERB
ejnm-325	61	5	,	,	PUNCT
ejnm-325	61	6	and	and	CCONJ
ejnm-325	61	7	it	it	PRON
ejnm-325	61	8	consisted	consist	VERB
ejnm-325	61	9	of	of	ADP
ejnm-325	61	10	two	two	NUM
ejnm-325	61	11	main	main	ADJ
ejnm-325	61	12	parts	part	NOUN
ejnm-325	61	13	.	.	PUNCT
ejnm-325	62	1	part	part	NOUN
ejnm-325	62	2	one	one	NUM
ejnm-325	62	3	included	include	VERB
ejnm-325	62	4	demographic	demographic	ADJ
ejnm-325	62	5	and	and	CCONJ
ejnm-325	62	6	clinical	clinical	ADJ
ejnm-325	62	7	characteristics	characteristic	NOUN
ejnm-325	62	8	.	.	PUNCT
ejnm-325	63	1	part	part	NOUN
ejnm-325	63	2	two	two	NUM
ejnm-325	63	3	included	include	VERB
ejnm-325	63	4	laboratory	laboratory	NOUN
ejnm-325	63	5	and	and	CCONJ
ejnm-325	63	6	non	non	ADJ
ejnm-325	63	7	-	-	ADJ
ejnm-325	63	8	laboratory	laboratory	ADJ
ejnm-325	63	9	investigations	investigation	NOUN
ejnm-325	63	10	of	of	ADP
ejnm-325	63	11	sbp	sbp	PROPN
ejnm-325	63	12	,	,	PUNCT
ejnm-325	63	13	dbp	dbp	PROPN
ejnm-325	63	14	,	,	PUNCT
ejnm-325	63	15	spo2	spo2	PROPN
ejnm-325	63	16	,	,	PUNCT
ejnm-325	63	17	pr	pr	NOUN
ejnm-325	63	18	,	,	PUNCT
ejnm-325	63	19	temp	temp	NOUN
ejnm-325	63	20	,	,	PUNCT
ejnm-325	63	21	pmh	pmh	NOUN
ejnm-325	63	22	,	,	PUNCT
ejnm-325	63	23	crp	crp	PROPN
ejnm-325	63	24	,	,	PUNCT
ejnm-325	63	25	d.	d.	PROPN
ejnm-325	63	26	dimer	dimer	PROPN
ejnm-325	63	27	,	,	PUNCT
ejnm-325	63	28	ldh	ldh	PROPN
ejnm-325	63	29	,	,	PUNCT
ejnm-325	63	30	wbcs	wbc	NOUN
ejnm-325	63	31	,	,	PUNCT
ejnm-325	63	32	pulmonary	pulmonary	ADJ
ejnm-325	63	33	function	function	NOUN
ejnm-325	63	34	tests	test	NOUN
ejnm-325	63	35	,	,	PUNCT
ejnm-325	63	36	forced	force	VERB
ejnm-325	63	37	vital	vital	ADJ
ejnm-325	63	38	capacity	capacity	NOUN
ejnm-325	63	39	,	,	PUNCT
ejnm-325	63	40	and	and	CCONJ
ejnm-325	63	41	the	the	DET
ejnm-325	63	42	ratio	ratio	NOUN
ejnm-325	63	43	of	of	ADP
ejnm-325	63	44	fev1	fev1	PROPN
ejnm-325	63	45	/	/	SYM
ejnm-325	63	46	fvc	fvc	PROPN
ejnm-325	63	47	.	.	PUNCT
ejnm-325	64	1	the	the	DET
ejnm-325	64	2	data	datum	NOUN
ejnm-325	64	3	was	be	AUX
ejnm-325	64	4	collected	collect	VERB
ejnm-325	64	5	through	through	ADP
ejnm-325	64	6	a	a	DET
ejnm-325	64	7	direct	direct	ADJ
ejnm-325	64	8	interview	interview	NOUN
ejnm-325	64	9	method	method	NOUN
ejnm-325	64	10	(	(	PUNCT
ejnm-325	64	11	face	face	NOUN
ejnm-325	64	12	-	-	PUNCT
ejnm-325	64	13	to	to	ADP
ejnm-325	64	14	-	-	PUNCT
ejnm-325	64	15	face	face	NOUN
ejnm-325	64	16	)	)	PUNCT
ejnm-325	64	17	with	with	ADP
ejnm-325	64	18	the	the	DET
ejnm-325	64	19	patients	patient	NOUN
ejnm-325	64	20	.	.	PUNCT
ejnm-325	65	1	informal	informal	ADJ
ejnm-325	65	2	oral	oral	ADJ
ejnm-325	65	3	consent	consent	NOUN
ejnm-325	65	4	was	be	AUX
ejnm-325	65	5	obtained	obtain	VERB
ejnm-325	65	6	from	from	ADP
ejnm-325	65	7	each	each	DET
ejnm-325	65	8	participant	participant	NOUN
ejnm-325	65	9	.	.	PUNCT
ejnm-325	66	1	the	the	DET
ejnm-325	66	2	researchers	researcher	NOUN
ejnm-325	66	3	promised	promise	VERB
ejnm-325	66	4	to	to	PART
ejnm-325	66	5	keep	keep	VERB
ejnm-325	66	6	the	the	DET
ejnm-325	66	7	participant	participant	NOUN
ejnm-325	66	8	’s	’s	PART
ejnm-325	66	9	information	information	NOUN
ejnm-325	66	10	confidential	confidential	ADJ
ejnm-325	66	11	and	and	CCONJ
ejnm-325	66	12	use	use	VERB
ejnm-325	66	13	this	this	DET
ejnm-325	66	14	data	datum	NOUN
ejnm-325	66	15	for	for	ADP
ejnm-325	66	16	this	this	DET
ejnm-325	66	17	study	study	NOUN
ejnm-325	66	18	only	only	ADV
ejnm-325	66	19	,	,	PUNCT
ejnm-325	66	20	then	then	ADV
ejnm-325	66	21	explained	explain	VERB
ejnm-325	66	22	the	the	DET
ejnm-325	66	23	purpose	purpose	NOUN
ejnm-325	66	24	of	of	ADP
ejnm-325	66	25	this	this	DET
ejnm-325	66	26	study	study	NOUN
ejnm-325	66	27	to	to	ADP
ejnm-325	66	28	each	each	DET
ejnm-325	66	29	participant	participant	NOUN
ejnm-325	66	30	.	.	PUNCT
ejnm-325	67	1	in	in	ADP
ejnm-325	67	2	addition	addition	NOUN
ejnm-325	67	3	to	to	ADP
ejnm-325	67	4	the	the	DET
ejnm-325	67	5	above	above	NOUN
ejnm-325	67	6	,	,	PUNCT
ejnm-325	67	7	the	the	DET
ejnm-325	67	8	researchers	researcher	NOUN
ejnm-325	67	9	told	tell	VERB
ejnm-325	67	10	each	each	DET
ejnm-325	67	11	participant	participant	NOUN
ejnm-325	67	12	that	that	SCONJ
ejnm-325	67	13	this	this	PRON
ejnm-325	67	14	is	be	AUX
ejnm-325	67	15	voluntary	voluntary	ADJ
ejnm-325	67	16	work	work	NOUN
ejnm-325	67	17	,	,	PUNCT
ejnm-325	67	18	and	and	CCONJ
ejnm-325	67	19	they	they	PRON
ejnm-325	67	20	could	could	AUX
ejnm-325	67	21	leave	leave	VERB
ejnm-325	67	22	at	at	ADP
ejnm-325	67	23	any	any	DET
ejnm-325	67	24	time	time	NOUN
ejnm-325	67	25	even	even	ADV
ejnm-325	67	26	if	if	SCONJ
ejnm-325	67	27	the	the	DET
ejnm-325	67	28	process	process	NOUN
ejnm-325	67	29	is	be	AUX
ejnm-325	67	30	not	not	PART
ejnm-325	67	31	completed	complete	VERB
ejnm-325	67	32	.	.	PUNCT
ejnm-325	68	1	the	the	DET
ejnm-325	68	2	data	datum	NOUN
ejnm-325	68	3	was	be	AUX
ejnm-325	68	4	analyzed	analyze	VERB
ejnm-325	68	5	through	through	ADP
ejnm-325	68	6	statistical	statistical	ADJ
ejnm-325	68	7	software	software	NOUN
ejnm-325	68	8	(	(	PUNCT
ejnm-325	68	9	statistical	statistical	ADJ
ejnm-325	68	10	package	package	NOUN
ejnm-325	68	11	for	for	ADP
ejnm-325	68	12	science	science	NOUN
ejnm-325	68	13	service	service	NOUN
ejnm-325	68	14	-	-	PUNCT
ejnm-325	68	15	spss	spss	PROPN
ejnm-325	68	16	v.26	v.26	NOUN
ejnm-325	68	17	)	)	PUNCT
ejnm-325	68	18	which	which	PRON
ejnm-325	68	19	includes	include	VERB
ejnm-325	68	20	descriptive	descriptive	ADJ
ejnm-325	68	21	statistical	statistical	ADJ
ejnm-325	68	22	analysis	analysis	NOUN
ejnm-325	68	23	as	as	ADP
ejnm-325	68	24	frequency	frequency	NOUN
ejnm-325	68	25	and	and	CCONJ
ejnm-325	68	26	percentage	percentage	NOUN
ejnm-325	68	27	and	and	CCONJ
ejnm-325	68	28	inferential	inferential	ADJ
ejnm-325	68	29	statistical	statistical	ADJ
ejnm-325	68	30	analysis	analysis	NOUN
ejnm-325	68	31	including	include	VERB
ejnm-325	68	32	pearson	pearson	NOUN
ejnm-325	68	33	correlation	correlation	NOUN
ejnm-325	68	34	,	,	PUNCT
ejnm-325	68	35	chisquare	chisquare	NOUN
ejnm-325	68	36	,	,	PUNCT
ejnm-325	68	37	and	and	CCONJ
ejnm-325	68	38	fisher	fisher	PROPN
ejnm-325	68	39	’s	’s	PART
ejnm-325	68	40	exact	exact	ADJ
ejnm-325	68	41	tests	test	NOUN
ejnm-325	68	42	.	.	PUNCT
ejnm-325	69	1	the	the	DET
ejnm-325	69	2	pvalue	pvalue	NOUN
ejnm-325	69	3	is	be	AUX
ejnm-325	69	4	considered	consider	VERB
ejnm-325	69	5	significant	significant	ADJ
ejnm-325	69	6	if	if	SCONJ
ejnm-325	69	7	it	it	PRON
ejnm-325	69	8	is	be	AUX
ejnm-325	69	9	less	less	ADJ
ejnm-325	69	10	than	than	ADP
ejnm-325	69	11	or	or	CCONJ
ejnm-325	69	12	equal	equal	ADJ
ejnm-325	69	13	to	to	ADP
ejnm-325	69	14	0.05	0.05	NUM
ejnm-325	69	15	.	.	PUNCT
ejnm-325	70	1	et	et	PROPN
ejnm-325	70	2	al	al	PROPN
ejnm-325	70	3	.	.	PROPN
ejnm-325	70	4	,	,	PUNCT
ejnm-325	70	5	2020	2020	NUM
ejnm-325	70	6	)	)	PUNCT
ejnm-325	70	7	.	.	PUNCT
ejnm-325	71	1	however	however	ADV
ejnm-325	71	2	,	,	PUNCT
ejnm-325	71	3	no	no	DET
ejnm-325	71	4	data	datum	NOUN
ejnm-325	71	5	exist	exist	VERB
ejnm-325	71	6	as	as	ADP
ejnm-325	71	7	to	to	ADP
ejnm-325	71	8	the	the	DET
ejnm-325	71	9	natural	natural	ADJ
ejnm-325	71	10	history	history	NOUN
ejnm-325	71	11	of	of	ADP
ejnm-325	71	12	inflammatory	inflammatory	ADJ
ejnm-325	71	13	infiltrates	infiltrate	NOUN
ejnm-325	71	14	during	during	ADP
ejnm-325	71	15	recovery	recovery	NOUN
ejnm-325	71	16	from	from	ADP
ejnm-325	71	17	sars	sar	NOUN
ejnm-325	71	18	-	-	PUNCT
ejnm-325	71	19	cov-2	cov-2	NOUN
ejnm-325	71	20	or	or	CCONJ
ejnm-325	71	21	the	the	DET
ejnm-325	71	22	utility	utility	NOUN
ejnm-325	71	23	of	of	ADP
ejnm-325	71	24	any	any	DET
ejnm-325	71	25	treatment	treatment	NOUN
ejnm-325	71	26	in	in	ADP
ejnm-325	71	27	patients	patient	NOUN
ejnm-325	71	28	with	with	ADP
ejnm-325	71	29	persistent	persistent	ADJ
ejnm-325	71	30	inflammatory	inflammatory	ADJ
ejnm-325	71	31	interstitial	interstitial	ADJ
ejnm-325	71	32	lung	lung	NOUN
ejnm-325	71	33	disease	disease	NOUN
ejnm-325	71	34	(	(	PUNCT
ejnm-325	71	35	ild	ild	PROPN
ejnm-325	71	36	)	)	PUNCT
ejnm-325	71	37	following	follow	VERB
ejnm-325	71	38	infection	infection	NOUN
ejnm-325	71	39	with	with	ADP
ejnm-325	71	40	coronavirus	coronavirus	NOUN
ejnm-325	71	41	.	.	PUNCT
ejnm-325	72	1	however	however	ADV
ejnm-325	72	2	,	,	PUNCT
ejnm-325	72	3	corticosteroids	corticosteroid	NOUN
ejnm-325	72	4	are	be	AUX
ejnm-325	72	5	the	the	DET
ejnm-325	72	6	mainstay	mainstay	NOUN
ejnm-325	72	7	of	of	ADP
ejnm-325	72	8	treatment	treatment	NOUN
ejnm-325	72	9	for	for	ADP
ejnm-325	72	10	organizing	organize	VERB
ejnm-325	72	11	pneumonia	pneumonia	NOUN
ejnm-325	72	12	of	of	ADP
ejnm-325	72	13	other	other	ADJ
ejnm-325	72	14	causes	cause	NOUN
ejnm-325	72	15	(	(	PUNCT
ejnm-325	72	16	cordier	cordier	NOUN
ejnm-325	72	17	,	,	PUNCT
ejnm-325	72	18	2000	2000	NUM
ejnm-325	72	19	)	)	PUNCT
ejnm-325	72	20	,	,	PUNCT
ejnm-325	72	21	and	and	CCONJ
ejnm-325	72	22	when	when	SCONJ
ejnm-325	72	23	used	use	VERB
ejnm-325	72	24	acutely	acutely	ADV
ejnm-325	72	25	in	in	ADP
ejnm-325	72	26	the	the	DET
ejnm-325	72	27	management	management	NOUN
ejnm-325	72	28	of	of	ADP
ejnm-325	72	29	acute	acute	ADJ
ejnm-325	72	30	respiratory	respiratory	ADJ
ejnm-325	72	31	distress	distress	NOUN
ejnm-325	72	32	syndrome	syndrome	NOUN
ejnm-325	72	33	(	(	PUNCT
ejnm-325	72	34	ards	ard	NOUN
ejnm-325	72	35	)	)	PUNCT
ejnm-325	72	36	caused	cause	VERB
ejnm-325	72	37	by	by	ADP
ejnm-325	72	38	sars	sar	NOUN
ejnm-325	72	39	-	-	PUNCT
ejnm-325	72	40	cov-2	cov-2	NOUN
ejnm-325	72	41	they	they	PRON
ejnm-325	72	42	have	have	AUX
ejnm-325	72	43	been	be	AUX
ejnm-325	72	44	associated	associate	VERB
ejnm-325	72	45	with	with	ADP
ejnm-325	72	46	a	a	DET
ejnm-325	72	47	reduction	reduction	NOUN
ejnm-325	72	48	in	in	ADP
ejnm-325	72	49	mortality	mortality	NOUN
ejnm-325	72	50	(	(	PUNCT
ejnm-325	72	51	horby	horby	PROPN
ejnm-325	72	52	.	.	PUNCT
ejnm-325	73	1	et	et	PROPN
ejnm-325	73	2	al	al	PROPN
ejnm-325	73	3	.	.	PROPN
ejnm-325	73	4	,	,	PUNCT
ejnm-325	73	5	2020	2020	NUM
ejnm-325	73	6	;	;	PUNCT
ejnm-325	73	7	sterne	sterne	PROPN
ejnm-325	73	8	.	.	PUNCT
ejnm-325	74	1	et	et	PROPN
ejnm-325	74	2	al	al	PROPN
ejnm-325	74	3	.	.	PROPN
ejnm-325	74	4	,	,	PUNCT
ejnm-325	74	5	2020	2020	NUM
ejnm-325	74	6	)	)	PUNCT
ejnm-325	74	7	.	.	PUNCT
ejnm-325	75	1	whether	whether	SCONJ
ejnm-325	75	2	pc	pc	NOUN
ejnm-325	75	3	-	-	PUNCT
ejnm-325	75	4	ild	ild	NOUN
ejnm-325	75	5	should	should	AUX
ejnm-325	75	6	be	be	AUX
ejnm-325	75	7	divided	divide	VERB
ejnm-325	75	8	into	into	ADP
ejnm-325	75	9	binary	binary	ADJ
ejnm-325	75	10	“	"	PUNCT
ejnm-325	75	11	inflammatory	inflammatory	ADJ
ejnm-325	75	12	”	"	PUNCT
ejnm-325	75	13	and	and	CCONJ
ejnm-325	75	14	“	"	PUNCT
ejnm-325	75	15	fibrotic	fibrotic	ADJ
ejnm-325	75	16	”	"	PUNCT
ejnm-325	75	17	categories	category	NOUN
ejnm-325	75	18	based	base	VERB
ejnm-325	75	19	on	on	ADP
ejnm-325	75	20	radiological	radiological	ADJ
ejnm-325	75	21	patterns	pattern	NOUN
ejnm-325	75	22	remains	remain	VERB
ejnm-325	75	23	controversial	controversial	ADJ
ejnm-325	75	24	,	,	PUNCT
ejnm-325	75	25	given	give	VERB
ejnm-325	75	26	the	the	DET
ejnm-325	75	27	ambiguity	ambiguity	NOUN
ejnm-325	75	28	of	of	ADP
ejnm-325	75	29	some	some	DET
ejnm-325	75	30	features	feature	NOUN
ejnm-325	75	31	(	(	PUNCT
ejnm-325	75	32	e.g.	e.g.	ADV
ejnm-325	75	33	,	,	PUNCT
ejnm-325	75	34	irregular	irregular	ADJ
ejnm-325	75	35	lines	line	NOUN
ejnm-325	75	36	)	)	PUNCT
ejnm-325	75	37	,	,	PUNCT
ejnm-325	75	38	absence	absence	NOUN
ejnm-325	75	39	of	of	ADP
ejnm-325	75	40	histological	histological	ADJ
ejnm-325	75	41	correlates	correlate	NOUN
ejnm-325	75	42	,	,	PUNCT
ejnm-325	75	43	uncertain	uncertain	ADJ
ejnm-325	75	44	course	course	NOUN
ejnm-325	75	45	,	,	PUNCT
ejnm-325	75	46	and	and	CCONJ
ejnm-325	75	47	likelihood	likelihood	NOUN
ejnm-325	75	48	of	of	ADP
ejnm-325	75	49	reversibility	reversibility	NOUN
ejnm-325	75	50	.	.	PUNCT
ejnm-325	76	1	persistent	persistent	ADJ
ejnm-325	76	2	ground	ground	NOUN
ejnm-325	76	3	-	-	PUNCT
ejnm-325	76	4	glass	glass	NOUN
ejnm-325	76	5	changes	change	NOUN
ejnm-325	76	6	may	may	AUX
ejnm-325	76	7	indicate	indicate	VERB
ejnm-325	76	8	fine	fine	ADJ
ejnm-325	76	9	/	/	SYM
ejnm-325	76	10	immature	immature	ADJ
ejnm-325	76	11	fibrosis	fibrosis	NOUN
ejnm-325	76	12	rather	rather	ADV
ejnm-325	76	13	than	than	ADP
ejnm-325	76	14	inflammation	inflammation	NOUN
ejnm-325	76	15	,	,	PUNCT
ejnm-325	76	16	and	and	CCONJ
ejnm-325	76	17	fibrotic	fibrotic	ADJ
ejnm-325	76	18	-	-	PUNCT
ejnm-325	76	19	like	like	ADJ
ejnm-325	76	20	changes	change	NOUN
ejnm-325	76	21	may	may	AUX
ejnm-325	76	22	be	be	AUX
ejnm-325	76	23	capable	capable	ADJ
ejnm-325	76	24	of	of	ADP
ejnm-325	76	25	regression	regression	NOUN
ejnm-325	76	26	and	and	CCONJ
ejnm-325	76	27	remodeling	remodeling	NOUN
ejnm-325	76	28	,	,	PUNCT
ejnm-325	76	29	albeit	albeit	SCONJ
ejnm-325	76	30	at	at	ADP
ejnm-325	76	31	a	a	DET
ejnm-325	76	32	slower	slow	ADJ
ejnm-325	76	33	rate	rate	NOUN
ejnm-325	76	34	.	.	PUNCT
ejnm-325	77	1	idiopathic	idiopathic	ADJ
ejnm-325	77	2	pulmonary	pulmonary	ADJ
ejnm-325	77	3	fibrosis	fibrosis	NOUN
ejnm-325	77	4	(	(	PUNCT
ejnm-325	77	5	ipf	ipf	X
ejnm-325	77	6	)	)	PUNCT
ejnm-325	77	7	is	be	AUX
ejnm-325	77	8	the	the	DET
ejnm-325	77	9	archetypal	archetypal	ADJ
ejnm-325	77	10	fibrotic	fibrotic	ADJ
ejnm-325	77	11	ild	ild	PROPN
ejnm-325	77	12	(	(	PUNCT
ejnm-325	77	13	f	f	NOUN
ejnm-325	77	14	-ild	-ild	NOUN
ejnm-325	77	15	)	)	PUNCT
ejnm-325	77	16	,	,	PUNCT
ejnm-325	77	17	but	but	CCONJ
ejnm-325	77	18	most	most	ADJ
ejnm-325	77	19	existing	exist	VERB
ejnm-325	77	20	ild	ild	NOUN
ejnm-325	77	21	syndromes	syndrome	NOUN
ejnm-325	77	22	are	be	AUX
ejnm-325	77	23	thought	think	VERB
ejnm-325	77	24	to	to	PART
ejnm-325	77	25	reside	reside	VERB
ejnm-325	77	26	on	on	ADP
ejnm-325	77	27	an	an	DET
ejnm-325	77	28	overlapping	overlap	VERB
ejnm-325	77	29	fibroinflammatory	fibroinflammatory	NOUN
ejnm-325	77	30	spectrum	spectrum	NOUN
ejnm-325	77	31	,	,	PUNCT
ejnm-325	77	32	e.g.	e.g.	ADV
ejnm-325	77	33	,	,	PUNCT
ejnm-325	77	34	hypersensitivity	hypersensitivity	NOUN
ejnm-325	77	35	pneumonitis	pneumonitis	NOUN
ejnm-325	77	36	,	,	PUNCT
ejnm-325	77	37	an	an	DET
ejnm-325	77	38	exaggerated	exaggerated	ADJ
ejnm-325	77	39	aeroantigen	aeroantigen	ADV
ejnm-325	77	40	-	-	PUNCT
ejnm-325	77	41	induced	induce	VERB
ejnm-325	77	42	immune	immune	ADJ
ejnm-325	77	43	response	response	NOUN
ejnm-325	77	44	,	,	PUNCT
ejnm-325	77	45	and	and	CCONJ
ejnm-325	77	46	rheumatic	rheumatic	ADJ
ejnm-325	77	47	-	-	PUNCT
ejnm-325	77	48	associated	associate	VERB
ejnm-325	77	49	ild	ild	NOUN
ejnm-325	77	50	.	.	PUNCT
ejnm-325	78	1	this	this	DET
ejnm-325	78	2	arbitrary	arbitrary	ADJ
ejnm-325	78	3	stratification	stratification	NOUN
ejnm-325	78	4	into	into	ADP
ejnm-325	78	5	predominant	predominant	ADJ
ejnm-325	78	6	fibrotic	fibrotic	ADJ
ejnm-325	78	7	or	or	CCONJ
ejnm-325	78	8	inflammatory	inflammatory	ADJ
ejnm-325	78	9	phenotypes	phenotype	NOUN
ejnm-325	78	10	may	may	AUX
ejnm-325	78	11	have	have	VERB
ejnm-325	78	12	therapeutic	therapeutic	ADJ
ejnm-325	78	13	and	and	CCONJ
ejnm-325	78	14	prognostic	prognostic	ADJ
ejnm-325	78	15	implications	implication	NOUN
ejnm-325	78	16	(	(	PUNCT
ejnm-325	78	17	although	although	SCONJ
ejnm-325	78	18	targeted	targeted	ADJ
ejnm-325	78	19	treatments	treatment	NOUN
ejnm-325	78	20	may	may	AUX
ejnm-325	78	21	be	be	AUX
ejnm-325	78	22	used	use	VERB
ejnm-325	78	23	concurrently	concurrently	ADV
ejnm-325	78	24	)	)	PUNCT
ejnm-325	78	25	,	,	PUNCT
ejnm-325	78	26	with	with	ADP
ejnm-325	78	27	potential	potential	ADJ
ejnm-325	78	28	extrapolation	extrapolation	NOUN
ejnm-325	78	29	to	to	ADP
ejnm-325	78	30	pc	pc	NOUN
ejnm-325	78	31	-	-	PUNCT
ejnm-325	78	32	il	il	PROPN
ejnm-325	78	33	(	(	PUNCT
ejnm-325	78	34	mehta	mehta	PROPN
ejnm-325	78	35	,	,	PUNCT
ejnm-325	78	36	ivan	ivan	PROPN
ejnm-325	78	37	,	,	PUNCT
ejnm-325	78	38	rosas	rosa	NOUN
ejnm-325	78	39	,	,	PUNCT
ejnm-325	78	40	and	and	CCONJ
ejnm-325	78	41	singer	singer	NOUN
ejnm-325	78	42	,	,	PUNCT
ejnm-325	78	43	2022	2022	NUM
ejnm-325	78	44	)	)	PUNCT
ejnm-325	78	45	.	.	PUNCT
ejnm-325	79	1	a	a	DET
ejnm-325	79	2	quantitative	quantitative	ADJ
ejnm-325	79	3	,	,	PUNCT
ejnm-325	79	4	descriptive	descriptive	ADJ
ejnm-325	79	5	study	study	NOUN
ejnm-325	79	6	design	design	NOUN
ejnm-325	79	7	was	be	AUX
ejnm-325	79	8	conducted	conduct	VERB
ejnm-325	79	9	on	on	ADP
ejnm-325	79	10	post	post	ADJ
ejnm-325	79	11	-	-	ADJ
ejnm-325	79	12	covid-19	covid-19	ADJ
ejnm-325	79	13	patients	patient	NOUN
ejnm-325	79	14	at	at	ADP
ejnm-325	79	15	the	the	DET
ejnm-325	79	16	medical	medical	ADJ
ejnm-325	79	17	wards	ward	NOUN
ejnm-325	79	18	in	in	ADP
ejnm-325	79	19	rizgary	rizgary	PROPN
ejnm-325	79	20	and	and	CCONJ
ejnm-325	79	21	hawler	hawler	NOUN
ejnm-325	79	22	teaching	teach	VERB
ejnm-325	79	23	hospitals	hospital	NOUN
ejnm-325	79	24	in	in	ADP
ejnm-325	79	25	erbil	erbil	PROPN
ejnm-325	79	26	city	city	PROPN
ejnm-325	79	27	in	in	ADP
ejnm-325	79	28	the	the	DET
ejnm-325	79	29	kurdistan	kurdistan	ADJ
ejnm-325	79	30	region	region	NOUN
ejnm-325	79	31	of	of	ADP
ejnm-325	79	32	iraq	iraq	PROPN
ejnm-325	79	33	.	.	PUNCT
ejnm-325	80	1	the	the	DET
ejnm-325	80	2	researchers	researcher	NOUN
ejnm-325	80	3	39	39	NUM
ejnm-325	80	4	copyright	copyright	NOUN
ejnm-325	80	5	©	©	PROPN
ejnm-325	80	6	2025the	2025the	PROPN
ejnm-325	80	7	author(s	author(s	NOUN
ejnm-325	80	8	)	)	PUNCT
ejnm-325	80	9	.	.	PUNCT
ejnm-325	81	1	this	this	PRON
ejnm-325	81	2	is	be	AUX
ejnm-325	81	3	an	an	DET
ejnm-325	81	4	open	open	ADJ
ejnm-325	81	5	access	access	NOUN
ejnm-325	81	6	article	article	NOUN
ejnm-325	81	7	which	which	PRON
ejnm-325	81	8	licensed	license	VERB
ejnm-325	81	9	under	under	ADP
ejnm-325	81	10	the	the	DET
ejnm-325	81	11	terms	term	NOUN
ejnm-325	81	12	and	and	CCONJ
ejnm-325	81	13	conditions	condition	NOUN
ejnm-325	81	14	of	of	ADP
ejnm-325	81	15	the	the	DET
ejnm-325	81	16	creative	creative	ADJ
ejnm-325	81	17	commons	common	NOUN
ejnm-325	81	18	attribution	attribution	NOUN
ejnm-325	81	19	-	-	PUNCT
ejnm-325	81	20	noncommercial	noncommercial	ADJ
ejnm-325	81	21	-	-	PUNCT
ejnm-325	81	22	sharealike	sharealike	ADJ
ejnm-325	81	23	4.0	4.0	NUM
ejnm-325	81	24	international	international	ADJ
ejnm-325	81	25	license	license	NOUN
ejnm-325	81	26	.	.	PUNCT
ejnm-325	82	1	it	it	PRON
ejnm-325	82	2	permits	permit	VERB
ejnm-325	82	3	no	no	DET
ejnm-325	82	4	additional	additional	ADJ
ejnm-325	82	5	restrictions	restriction	NOUN
ejnm-325	82	6	on	on	ADP
ejnm-325	82	7	use	use	NOUN
ejnm-325	82	8	,	,	PUNCT
ejnm-325	82	9	distribution	distribution	NOUN
ejnm-325	82	10	,	,	PUNCT
ejnm-325	82	11	and	and	CCONJ
ejnm-325	82	12	reproduction	reproduction	NOUN
ejnm-325	82	13	in	in	ADP
ejnm-325	82	14	any	any	DET
ejnm-325	82	15	medium	medium	NOUN
ejnm-325	82	16	provided	provide	VERB
ejnm-325	82	17	the	the	DET
ejnm-325	82	18	original	original	ADJ
ejnm-325	82	19	work	work	NOUN
ejnm-325	82	20	is	be	AUX
ejnm-325	82	21	properly	properly	ADV
ejnm-325	82	22	cited	cite	VERB
ejnm-325	82	23	.	.	PUNCT
ejnm-325	83	1	methods	method	NOUN
ejnm-325	83	2	https://creativecommons.org/licenses/by-nc-sa/4.0/	https://creativecommons.org/licenses/by-nc-sa/4.0/	PROPN
ejnm-325	83	3	https://doi.org/10.15218/ejnm.2025.05	https://doi.org/10.15218/ejnm.2025.05	PROPN
ejnm-325	83	4	erbil	erbil	PROPN
ejnm-325	83	5	j.	j.	PROPN
ejnm-325	83	6	nurs	nurs	PROPN
ejnm-325	83	7	.	.	PUNCT
ejnm-325	84	1	midwifery	midwifery	ADJ
ejnm-325	84	2	,	,	PUNCT
ejnm-325	84	3	vol	vol	NOUN
ejnm-325	84	4	.	.	PROPN
ejnm-325	84	5	8	8	NUM
ejnm-325	84	6	,	,	PUNCT
ejnm-325	84	7	no	no	INTJ
ejnm-325	84	8	.	.	PUNCT
ejnm-325	85	1	(	(	PUNCT
ejnm-325	85	2	1	1	NUM
ejnm-325	85	3	)	)	PUNCT
ejnm-325	85	4	,	,	PUNCT
ejnm-325	85	5	may2025	may2025	ADJ
ejnm-325	85	6	original	original	ADJ
ejnm-325	85	7	article	article	NOUN
ejnm-325	85	8	table	table	NOUN
ejnm-325	85	9	1	1	NUM
ejnm-325	85	10	shows	show	VERB
ejnm-325	85	11	the	the	DET
ejnm-325	85	12	demographic	demographic	ADJ
ejnm-325	85	13	and	and	CCONJ
ejnm-325	85	14	clinical	clinical	ADJ
ejnm-325	85	15	characteristics	characteristic	NOUN
ejnm-325	85	16	of	of	ADP
ejnm-325	85	17	the	the	DET
ejnm-325	85	18	post	post	ADJ
ejnm-325	85	19	-	-	ADJ
ejnm-325	85	20	covid-19	covid-19	ADJ
ejnm-325	85	21	patients	patient	NOUN
ejnm-325	85	22	.	.	PUNCT
ejnm-325	86	1	regarding	regard	VERB
ejnm-325	86	2	the	the	DET
ejnm-325	86	3	age	age	NOUN
ejnm-325	86	4	group	group	NOUN
ejnm-325	86	5	,	,	PUNCT
ejnm-325	86	6	more	more	ADJ
ejnm-325	86	7	than	than	ADP
ejnm-325	86	8	half	half	NOUN
ejnm-325	86	9	of	of	ADP
ejnm-325	86	10	the	the	DET
ejnm-325	86	11	study	study	NOUN
ejnm-325	86	12	sample	sample	NOUN
ejnm-325	86	13	in	in	ADP
ejnm-325	86	14	the	the	DET
ejnm-325	86	15	age	age	NOUN
ejnm-325	86	16	group	group	NOUN
ejnm-325	86	17	between	between	ADP
ejnm-325	86	18	54	54	NUM
ejnm-325	86	19	-	-	SYM
ejnm-325	86	20	69	69	NUM
ejnm-325	86	21	years	year	NOUN
ejnm-325	86	22	old	old	ADJ
ejnm-325	86	23	(	(	PUNCT
ejnm-325	86	24	55.4	55.4	NUM
ejnm-325	86	25	%	%	NOUN
ejnm-325	86	26	)	)	PUNCT
ejnm-325	86	27	and	and	CCONJ
ejnm-325	86	28	others	other	NOUN
ejnm-325	86	29	are	be	AUX
ejnm-325	86	30	between	between	ADP
ejnm-325	86	31	22	22	NUM
ejnm-325	86	32	-	-	SYM
ejnm-325	86	33	37	37	NUM
ejnm-325	86	34	and	and	CCONJ
ejnm-325	86	35	38	38	NUM
ejnm-325	86	36	-	-	SYM
ejnm-325	86	37	53	53	NUM
ejnm-325	86	38	years	year	NOUN
ejnm-325	86	39	old	old	ADJ
ejnm-325	86	40	(	(	PUNCT
ejnm-325	86	41	17.6	17.6	NUM
ejnm-325	86	42	%	%	NOUN
ejnm-325	86	43	and	and	CCONJ
ejnm-325	86	44	27	27	NUM
ejnm-325	86	45	%	%	NOUN
ejnm-325	86	46	respectively	respectively	ADV
ejnm-325	86	47	)	)	PUNCT
ejnm-325	86	48	.	.	PUNCT
ejnm-325	87	1	about	about	ADV
ejnm-325	87	2	63.5	63.5	NUM
ejnm-325	87	3	%	%	NOUN
ejnm-325	87	4	were	be	AUX
ejnm-325	87	5	male	male	ADJ
ejnm-325	87	6	and	and	CCONJ
ejnm-325	87	7	36.5	36.5	NUM
ejnm-325	87	8	%	%	NOUN
ejnm-325	87	9	female	female	NOUN
ejnm-325	87	10	.	.	PUNCT
ejnm-325	88	1	regarding	regard	VERB
ejnm-325	88	2	the	the	DET
ejnm-325	88	3	symptoms	symptom	NOUN
ejnm-325	88	4	,	,	PUNCT
ejnm-325	88	5	66.2	66.2	NUM
ejnm-325	88	6	%	%	NOUN
ejnm-325	88	7	had	have	VERB
ejnm-325	88	8	a	a	DET
ejnm-325	88	9	cough	cough	NOUN
ejnm-325	88	10	,	,	PUNCT
ejnm-325	88	11	32.4	32.4	NUM
ejnm-325	88	12	%	%	NOUN
ejnm-325	88	13	had	have	VERB
ejnm-325	88	14	a	a	DET
ejnm-325	88	15	fever	fever	NOUN
ejnm-325	88	16	,	,	PUNCT
ejnm-325	88	17	and	and	CCONJ
ejnm-325	88	18	73	73	NUM
ejnm-325	88	19	%	%	NOUN
ejnm-325	88	20	had	have	VERB
ejnm-325	88	21	a	a	DET
ejnm-325	88	22	shortness	shortness	NOUN
ejnm-325	88	23	of	of	ADP
ejnm-325	88	24	concerning	concern	VERB
ejnm-325	88	25	blood	blood	NOUN
ejnm-325	88	26	pressure	pressure	NOUN
ejnm-325	88	27	,	,	PUNCT
ejnm-325	88	28	half	half	NOUN
ejnm-325	88	29	of	of	ADP
ejnm-325	88	30	the	the	DET
ejnm-325	88	31	patients	patient	NOUN
ejnm-325	88	32	have	have	VERB
ejnm-325	88	33	high	high	ADJ
ejnm-325	88	34	systolic	systolic	ADJ
ejnm-325	88	35	blood	blood	NOUN
ejnm-325	88	36	pressure	pressure	NOUN
ejnm-325	88	37	(	(	PUNCT
ejnm-325	88	38	50	50	NUM
ejnm-325	88	39	%	%	NOUN
ejnm-325	88	40	)	)	PUNCT
ejnm-325	88	41	and	and	CCONJ
ejnm-325	88	42	only	only	ADV
ejnm-325	88	43	35.1	35.1	NUM
ejnm-325	88	44	%	%	NOUN
ejnm-325	88	45	have	have	VERB
ejnm-325	88	46	high	high	ADJ
ejnm-325	88	47	diastolic	diastolic	ADJ
ejnm-325	88	48	blood	blood	NOUN
ejnm-325	88	49	pressure	pressure	NOUN
ejnm-325	88	50	.	.	PUNCT
ejnm-325	89	1	about	about	ADV
ejnm-325	89	2	81.1	81.1	NUM
ejnm-325	89	3	%	%	NOUN
ejnm-325	89	4	of	of	ADP
ejnm-325	89	5	covid-19	covid-19	PROPN
ejnm-325	89	6	patients	patient	NOUN
ejnm-325	89	7	suffer	suffer	VERB
ejnm-325	89	8	from	from	ADP
ejnm-325	89	9	hypoxemia	hypoxemia	PROPN
ejnm-325	89	10	.	.	PUNCT
ejnm-325	90	1	the	the	DET
ejnm-325	90	2	highest	high	ADJ
ejnm-325	90	3	percentage	percentage	NOUN
ejnm-325	90	4	of	of	ADP
ejnm-325	90	5	the	the	DET
ejnm-325	90	6	study	study	NOUN
ejnm-325	90	7	samples	sample	NOUN
ejnm-325	90	8	have	have	VERB
ejnm-325	90	9	tachycardia	tachycardia	NOUN
ejnm-325	90	10	(	(	PUNCT
ejnm-325	90	11	64.9	64.9	NUM
ejnm-325	90	12	%	%	NOUN
ejnm-325	90	13	)	)	PUNCT
ejnm-325	90	14	with	with	ADP
ejnm-325	90	15	normal	normal	ADJ
ejnm-325	90	16	body	body	NOUN
ejnm-325	90	17	temperature	temperature	NOUN
ejnm-325	90	18	(	(	PUNCT
ejnm-325	90	19	40.5	40.5	NUM
ejnm-325	90	20	%	%	NOUN
ejnm-325	90	21	)	)	PUNCT
ejnm-325	90	22	and	and	CCONJ
ejnm-325	90	23	only	only	ADV
ejnm-325	90	24	28.4	28.4	NUM
ejnm-325	90	25	%	%	NOUN
ejnm-325	90	26	have	have	VERB
ejnm-325	90	27	hypothermia	hypothermia	NOUN
ejnm-325	90	28	.	.	PUNCT
ejnm-325	91	1	breathing	breathing	NOUN
ejnm-325	91	2	.	.	PUNCT
ejnm-325	92	1	concerning	concern	VERB
ejnm-325	92	2	the	the	DET
ejnm-325	92	3	past	past	ADJ
ejnm-325	92	4	medical	medical	ADJ
ejnm-325	92	5	history	history	NOUN
ejnm-325	92	6	,	,	PUNCT
ejnm-325	92	7	the	the	DET
ejnm-325	92	8	highest	high	ADJ
ejnm-325	92	9	percentage	percentage	NOUN
ejnm-325	92	10	have	have	VERB
ejnm-325	92	11	other	other	ADJ
ejnm-325	92	12	diseases	disease	NOUN
ejnm-325	92	13	(	(	PUNCT
ejnm-325	92	14	37.8	37.8	NUM
ejnm-325	92	15	%	%	NOUN
ejnm-325	92	16	)	)	PUNCT
ejnm-325	92	17	,	,	PUNCT
ejnm-325	92	18	while	while	SCONJ
ejnm-325	92	19	6.8	6.8	NUM
ejnm-325	92	20	%	%	NOUN
ejnm-325	92	21	of	of	ADP
ejnm-325	92	22	the	the	DET
ejnm-325	92	23	participants	participant	NOUN
ejnm-325	92	24	have	have	VERB
ejnm-325	92	25	copd	copd	NOUN
ejnm-325	92	26	and	and	CCONJ
ejnm-325	92	27	only	only	ADV
ejnm-325	92	28	2.7	2.7	NUM
ejnm-325	92	29	%	%	NOUN
ejnm-325	92	30	have	have	AUX
ejnm-325	92	31	asthma	asthma	NOUN
ejnm-325	92	32	,	,	PUNCT
ejnm-325	92	33	the	the	DET
ejnm-325	92	34	rest	rest	NOUN
ejnm-325	92	35	of	of	ADP
ejnm-325	92	36	them	they	PRON
ejnm-325	92	37	have	have	VERB
ejnm-325	92	38	no	no	DET
ejnm-325	92	39	past	past	ADJ
ejnm-325	92	40	medical	medical	ADJ
ejnm-325	92	41	history	history	NOUN
ejnm-325	92	42	(	(	PUNCT
ejnm-325	92	43	52.7	52.7	NUM
ejnm-325	92	44	%	%	NOUN
ejnm-325	92	45	)	)	PUNCT
ejnm-325	92	46	.	.	PUNCT
ejnm-325	93	1	about	about	ADV
ejnm-325	93	2	66.2	66.2	NUM
ejnm-325	93	3	%	%	NOUN
ejnm-325	93	4	were	be	AUX
ejnm-325	93	5	nonsmokers	nonsmoker	NOUN
ejnm-325	93	6	,	,	PUNCT
ejnm-325	93	7	the	the	DET
ejnm-325	93	8	smokers	smoker	NOUN
ejnm-325	93	9	were	be	AUX
ejnm-325	93	10	10.8	10.8	NUM
ejnm-325	93	11	%	%	NOUN
ejnm-325	93	12	and	and	CCONJ
ejnm-325	93	13	exsmokers	exsmoker	NOUN
ejnm-325	93	14	21.6	21.6	NUM
ejnm-325	93	15	%	%	NOUN
ejnm-325	93	16	with	with	ADP
ejnm-325	93	17	only	only	ADV
ejnm-325	93	18	one	one	NUM
ejnm-325	93	19	case	case	NOUN
ejnm-325	93	20	of	of	ADP
ejnm-325	93	21	passive	passive	ADJ
ejnm-325	93	22	smoker	smoker	NOUN
ejnm-325	93	23	.	.	PUNCT
ejnm-325	94	1	the	the	DET
ejnm-325	94	2	highest	high	ADJ
ejnm-325	94	3	percentage	percentage	NOUN
ejnm-325	94	4	of	of	ADP
ejnm-325	94	5	the	the	DET
ejnm-325	94	6	study	study	NOUN
ejnm-325	94	7	sample	sample	NOUN
ejnm-325	94	8	have	have	VERB
ejnm-325	94	9	high	high	ADJ
ejnm-325	94	10	crp	crp	NOUN
ejnm-325	94	11	(	(	PUNCT
ejnm-325	94	12	77	77	NUM
ejnm-325	94	13	%	%	NOUN
ejnm-325	94	14	)	)	PUNCT
ejnm-325	94	15	,	,	PUNCT
ejnm-325	94	16	high	high	PROPN
ejnm-325	94	17	d.	d.	PROPN
ejnm-325	94	18	dimer	dimer	NOUN
ejnm-325	94	19	(	(	PUNCT
ejnm-325	94	20	62.2	62.2	NUM
ejnm-325	94	21	%	%	NOUN
ejnm-325	94	22	)	)	PUNCT
ejnm-325	94	23	,	,	PUNCT
ejnm-325	94	24	normal	normal	ADJ
ejnm-325	94	25	ldh	ldh	NOUN
ejnm-325	94	26	(	(	PUNCT
ejnm-325	94	27	48.6	48.6	NUM
ejnm-325	94	28	%	%	NOUN
ejnm-325	94	29	)	)	PUNCT
ejnm-325	94	30	,	,	PUNCT
ejnm-325	94	31	normal	normal	ADJ
ejnm-325	94	32	wbc	wbc	NOUN
ejnm-325	94	33	(	(	PUNCT
ejnm-325	94	34	66.2	66.2	NUM
ejnm-325	94	35	%	%	NOUN
ejnm-325	94	36	)	)	PUNCT
ejnm-325	94	37	,	,	PUNCT
ejnm-325	94	38	low	low	ADJ
ejnm-325	94	39	forced	force	VERB
ejnm-325	94	40	expiratory	expiratory	NOUN
ejnm-325	94	41	volume	volume	NOUN
ejnm-325	94	42	in	in	ADP
ejnm-325	94	43	one	one	NUM
ejnm-325	94	44	second	second	ADJ
ejnm-325	94	45	(	(	PUNCT
ejnm-325	94	46	58.1	58.1	NUM
ejnm-325	94	47	%	%	NOUN
ejnm-325	94	48	)	)	PUNCT
ejnm-325	94	49	,	,	PUNCT
ejnm-325	94	50	low	low	ADJ
ejnm-325	94	51	forced	force	VERB
ejnm-325	94	52	vital	vital	ADJ
ejnm-325	94	53	capacity	capacity	NOUN
ejnm-325	94	54	(	(	PUNCT
ejnm-325	94	55	63.5	63.5	NUM
ejnm-325	94	56	%	%	NOUN
ejnm-325	94	57	)	)	PUNCT
ejnm-325	94	58	,	,	PUNCT
ejnm-325	94	59	more	more	ADJ
ejnm-325	94	60	than	than	ADP
ejnm-325	94	61	normal	normal	ADJ
ejnm-325	94	62	ratio	ratio	NOUN
ejnm-325	94	63	of	of	ADP
ejnm-325	94	64	fev1	fev1	PROPN
ejnm-325	94	65	/	/	SYM
ejnm-325	94	66	fvc	fvc	PROPN
ejnm-325	94	67	(	(	PUNCT
ejnm-325	94	68	98.6	98.6	NUM
ejnm-325	94	69	%	%	NOUN
ejnm-325	94	70	)	)	PUNCT
ejnm-325	94	71	,	,	PUNCT
ejnm-325	94	72	with	with	ADP
ejnm-325	94	73	normal	normal	ADJ
ejnm-325	94	74	pattern	pattern	NOUN
ejnm-325	94	75	(	(	PUNCT
ejnm-325	94	76	71.6	71.6	NUM
ejnm-325	94	77	%	%	NOUN
ejnm-325	94	78	)	)	PUNCT
ejnm-325	94	79	.	.	PUNCT
ejnm-325	95	1	40	40	NUM
ejnm-325	95	2	copyright	copyright	NOUN
ejnm-325	95	3	©	©	PROPN
ejnm-325	95	4	2025	2025	NUM
ejnm-325	95	5	the	the	DET
ejnm-325	95	6	author(s	author(s	NOUN
ejnm-325	95	7	)	)	PUNCT
ejnm-325	95	8	.	.	PUNCT
ejnm-325	96	1	this	this	PRON
ejnm-325	96	2	is	be	AUX
ejnm-325	96	3	an	an	DET
ejnm-325	96	4	open	open	ADJ
ejnm-325	96	5	access	access	NOUN
ejnm-325	96	6	article	article	NOUN
ejnm-325	96	7	which	which	PRON
ejnm-325	96	8	licensed	license	VERB
ejnm-325	96	9	under	under	ADP
ejnm-325	96	10	the	the	DET
ejnm-325	96	11	terms	term	NOUN
ejnm-325	96	12	and	and	CCONJ
ejnm-325	96	13	conditions	condition	NOUN
ejnm-325	96	14	of	of	ADP
ejnm-325	96	15	the	the	DET
ejnm-325	96	16	creative	creative	ADJ
ejnm-325	96	17	commons	common	NOUN
ejnm-325	96	18	attribution	attribution	NOUN
ejnm-325	96	19	-	-	PUNCT
ejnm-325	96	20	noncommercial	noncommercial	ADJ
ejnm-325	96	21	-	-	PUNCT
ejnm-325	96	22	sharealike	sharealike	ADJ
ejnm-325	96	23	4.0	4.0	NUM
ejnm-325	96	24	international	international	ADJ
ejnm-325	96	25	license	license	NOUN
ejnm-325	96	26	.	.	PUNCT
ejnm-325	97	1	it	it	PRON
ejnm-325	97	2	permits	permit	VERB
ejnm-325	97	3	no	no	DET
ejnm-325	97	4	additional	additional	ADJ
ejnm-325	97	5	restrictions	restriction	NOUN
ejnm-325	97	6	on	on	ADP
ejnm-325	97	7	use	use	NOUN
ejnm-325	97	8	,	,	PUNCT
ejnm-325	97	9	distribution	distribution	NOUN
ejnm-325	97	10	,	,	PUNCT
ejnm-325	97	11	and	and	CCONJ
ejnm-325	97	12	reproduction	reproduction	NOUN
ejnm-325	97	13	in	in	ADP
ejnm-325	97	14	any	any	DET
ejnm-325	97	15	medium	medium	NOUN
ejnm-325	97	16	provided	provide	VERB
ejnm-325	97	17	the	the	DET
ejnm-325	97	18	original	original	ADJ
ejnm-325	97	19	work	work	NOUN
ejnm-325	97	20	is	be	AUX
ejnm-325	97	21	properly	properly	ADV
ejnm-325	97	22	cited	cite	VERB
ejnm-325	97	23	.	.	PUNCT
ejnm-325	98	1	table	table	NOUN
ejnm-325	98	2	1	1	NUM
ejnm-325	98	3	:	:	PUNCT
ejnm-325	98	4	demographic	demographic	ADJ
ejnm-325	98	5	and	and	CCONJ
ejnm-325	98	6	clinical	clinical	ADJ
ejnm-325	98	7	characteristics	characteristic	NOUN
ejnm-325	98	8	demographic	demographic	ADJ
ejnm-325	98	9	and	and	CCONJ
ejnm-325	98	10	clinical	clinical	ADJ
ejnm-325	98	11	characteristics	characteristic	NOUN
ejnm-325	98	12	f.	f.	PROPN
ejnm-325	98	13	(	(	PUNCT
ejnm-325	98	14	%	%	INTJ
ejnm-325	98	15	)	)	PUNCT
ejnm-325	98	16	age	age	NOUN
ejnm-325	98	17	groups	group	NOUN
ejnm-325	98	18	(	(	PUNCT
ejnm-325	98	19	years	year	NOUN
ejnm-325	98	20	)	)	PUNCT
ejnm-325	98	21	22	22	NUM
ejnm-325	98	22	-	-	SYM
ejnm-325	98	23	37	37	NUM
ejnm-325	98	24	13	13	NUM
ejnm-325	98	25	(	(	PUNCT
ejnm-325	98	26	17.6	17.6	NUM
ejnm-325	98	27	)	)	PUNCT
ejnm-325	98	28	38	38	NUM
ejnm-325	98	29	-	-	SYM
ejnm-325	98	30	53	53	NUM
ejnm-325	98	31	20	20	NUM
ejnm-325	98	32	(	(	PUNCT
ejnm-325	98	33	27	27	NUM
ejnm-325	98	34	)	)	PUNCT
ejnm-325	98	35	54	54	NUM
ejnm-325	98	36	-	-	SYM
ejnm-325	98	37	69	69	NUM
ejnm-325	98	38	41	41	NUM
ejnm-325	98	39	(	(	PUNCT
ejnm-325	98	40	55.4	55.4	NUM
ejnm-325	98	41	)	)	PUNCT
ejnm-325	98	42	sex	sex	NOUN
ejnm-325	98	43	male	male	NOUN
ejnm-325	98	44	47	47	NUM
ejnm-325	98	45	(	(	PUNCT
ejnm-325	98	46	63.5	63.5	NUM
ejnm-325	98	47	)	)	PUNCT
ejnm-325	98	48	female	female	NOUN
ejnm-325	98	49	27	27	NUM
ejnm-325	98	50	(	(	PUNCT
ejnm-325	98	51	36.5	36.5	NUM
ejnm-325	98	52	)	)	PUNCT
ejnm-325	98	53	cough	cough	NOUN
ejnm-325	99	1	no	no	DET
ejnm-325	99	2	25	25	NUM
ejnm-325	99	3	(	(	PUNCT
ejnm-325	99	4	33.8	33.8	NUM
ejnm-325	99	5	)	)	PUNCT
ejnm-325	99	6	yes	yes	INTJ
ejnm-325	99	7	49	49	NUM
ejnm-325	99	8	(	(	PUNCT
ejnm-325	99	9	66.2	66.2	NUM
ejnm-325	99	10	)	)	PUNCT
ejnm-325	99	11	fever	fever	NOUN
ejnm-325	99	12	no	no	DET
ejnm-325	99	13	50	50	NUM
ejnm-325	99	14	(	(	PUNCT
ejnm-325	99	15	67.6	67.6	NUM
ejnm-325	99	16	)	)	PUNCT
ejnm-325	99	17	yes	yes	INTJ
ejnm-325	99	18	24	24	NUM
ejnm-325	99	19	(	(	PUNCT
ejnm-325	99	20	32.4	32.4	NUM
ejnm-325	99	21	)	)	PUNCT
ejnm-325	99	22	shortness	shortness	NOUN
ejnm-325	99	23	of	of	ADP
ejnm-325	99	24	breath	breath	NOUN
ejnm-325	99	25	no	no	DET
ejnm-325	99	26	20	20	NUM
ejnm-325	99	27	(	(	PUNCT
ejnm-325	99	28	27	27	NUM
ejnm-325	99	29	)	)	PUNCT
ejnm-325	99	30	yes	yes	INTJ
ejnm-325	99	31	54	54	NUM
ejnm-325	99	32	(	(	PUNCT
ejnm-325	99	33	73	73	NUM
ejnm-325	99	34	)	)	PUNCT
ejnm-325	99	35	others	other	NOUN
ejnm-325	99	36	no	no	DET
ejnm-325	99	37	13	13	NUM
ejnm-325	99	38	(	(	PUNCT
ejnm-325	99	39	17.6	17.6	NUM
ejnm-325	99	40	)	)	PUNCT
ejnm-325	100	1	yes	yes	ADV
ejnm-325	100	2	61	61	NUM
ejnm-325	100	3	(	(	PUNCT
ejnm-325	100	4	82.4	82.4	NUM
ejnm-325	100	5	)	)	PUNCT
ejnm-325	100	6	past	past	ADP
ejnm-325	100	7	medical	medical	ADJ
ejnm-325	100	8	history	history	NOUN
ejnm-325	100	9	none	none	NOUN
ejnm-325	100	10	39	39	NUM
ejnm-325	100	11	(	(	PUNCT
ejnm-325	100	12	52.7	52.7	NUM
ejnm-325	100	13	)	)	PUNCT
ejnm-325	100	14	asthma	asthma	NOUN
ejnm-325	100	15	2	2	NUM
ejnm-325	100	16	(	(	PUNCT
ejnm-325	100	17	2.7	2.7	NUM
ejnm-325	100	18	)	)	PUNCT
ejnm-325	100	19	copd	copd	NOUN
ejnm-325	100	20	5	5	NUM
ejnm-325	100	21	(	(	PUNCT
ejnm-325	100	22	6.8	6.8	NUM
ejnm-325	100	23	)	)	PUNCT
ejnm-325	100	24	others	other	NOUN
ejnm-325	100	25	28	28	NUM
ejnm-325	100	26	(	(	PUNCT
ejnm-325	100	27	37.8	37.8	NUM
ejnm-325	100	28	)	)	PUNCT
ejnm-325	100	29	smoking	smoking	NOUN
ejnm-325	100	30	no	no	PRON
ejnm-325	100	31	smoker	smoker	NOUN
ejnm-325	100	32	49	49	NUM
ejnm-325	100	33	(	(	PUNCT
ejnm-325	100	34	66.2	66.2	NUM
ejnm-325	100	35	)	)	PUNCT
ejnm-325	100	36	smoker	smoker	ADV
ejnm-325	100	37	8	8	NUM
ejnm-325	100	38	(	(	PUNCT
ejnm-325	100	39	10.8	10.8	NUM
ejnm-325	100	40	)	)	PUNCT
ejnm-325	100	41	ex	ex	NOUN
ejnm-325	100	42	-	-	NOUN
ejnm-325	100	43	smoker	smoker	ADJ
ejnm-325	100	44	16	16	NUM
ejnm-325	100	45	(	(	PUNCT
ejnm-325	100	46	21.6	21.6	NUM
ejnm-325	100	47	)	)	PUNCT
ejnm-325	100	48	passive	passive	ADJ
ejnm-325	100	49	-	-	PUNCT
ejnm-325	100	50	smoker	smoker	NOUN
ejnm-325	100	51	1	1	NUM
ejnm-325	100	52	(	(	PUNCT
ejnm-325	100	53	1.4	1.4	NUM
ejnm-325	100	54	)	)	PUNCT
ejnm-325	100	55	results	result	VERB
ejnm-325	100	56	https://creativecommons.org/licenses/by-nc-sa/4.0/	https://creativecommons.org/licenses/by-nc-sa/4.0/	PROPN
ejnm-325	100	57	https://doi.org/10.15218/ejnm.2025.05	https://doi.org/10.15218/ejnm.2025.05	PROPN
ejnm-325	100	58	erbil	erbil	PROPN
ejnm-325	100	59	j.	j.	PROPN
ejnm-325	100	60	nurs	nurs	PROPN
ejnm-325	100	61	.	.	PUNCT
ejnm-325	101	1	midwifery	midwifery	ADJ
ejnm-325	101	2	,	,	PUNCT
ejnm-325	101	3	vol	vol	NOUN
ejnm-325	101	4	.	.	PROPN
ejnm-325	101	5	8	8	NUM
ejnm-325	101	6	,	,	PUNCT
ejnm-325	101	7	no	no	INTJ
ejnm-325	101	8	.	.	PUNCT
ejnm-325	102	1	(	(	PUNCT
ejnm-325	102	2	1	1	NUM
ejnm-325	102	3	)	)	PUNCT
ejnm-325	102	4	,	,	PUNCT
ejnm-325	102	5	may2025	may2025	ADJ
ejnm-325	102	6	original	original	ADJ
ejnm-325	102	7	article	article	NOUN
ejnm-325	102	8	41	41	NUM
ejnm-325	102	9	moderate	moderate	ADJ
ejnm-325	102	10	and	and	CCONJ
ejnm-325	102	11	severe	severe	ADJ
ejnm-325	102	12	(	(	PUNCT
ejnm-325	102	13	28.4	28.4	NUM
ejnm-325	102	14	%	%	NOUN
ejnm-325	102	15	and	and	CCONJ
ejnm-325	102	16	25.7	25.7	NUM
ejnm-325	102	17	%	%	NOUN
ejnm-325	102	18	respectively	respectively	ADV
ejnm-325	102	19	)	)	PUNCT
ejnm-325	102	20	.	.	PUNCT
ejnm-325	103	1	regarding	regard	VERB
ejnm-325	103	2	the	the	DET
ejnm-325	103	3	severity	severity	NOUN
ejnm-325	103	4	,	,	PUNCT
ejnm-325	103	5	the	the	DET
ejnm-325	103	6	highest	high	ADJ
ejnm-325	103	7	percentage	percentage	NOUN
ejnm-325	103	8	was	be	AUX
ejnm-325	103	9	mild	mild	ADJ
ejnm-325	103	10	(	(	PUNCT
ejnm-325	103	11	43.2	43.2	NUM
ejnm-325	103	12	%	%	NOUN
ejnm-325	103	13	)	)	PUNCT
ejnm-325	103	14	followed	follow	VERB
ejnm-325	103	15	by	by	ADP
ejnm-325	103	16	copyright	copyright	NOUN
ejnm-325	103	17	©	©	PROPN
ejnm-325	103	18	2025	2025	NUM
ejnm-325	103	19	the	the	DET
ejnm-325	103	20	author(s	author(s	NOUN
ejnm-325	103	21	)	)	PUNCT
ejnm-325	103	22	.	.	PUNCT
ejnm-325	104	1	this	this	PRON
ejnm-325	104	2	is	be	AUX
ejnm-325	104	3	an	an	DET
ejnm-325	104	4	open	open	ADJ
ejnm-325	104	5	access	access	NOUN
ejnm-325	104	6	article	article	NOUN
ejnm-325	104	7	which	which	PRON
ejnm-325	104	8	licensed	license	VERB
ejnm-325	104	9	under	under	ADP
ejnm-325	104	10	the	the	DET
ejnm-325	104	11	terms	term	NOUN
ejnm-325	104	12	and	and	CCONJ
ejnm-325	104	13	conditions	condition	NOUN
ejnm-325	104	14	of	of	ADP
ejnm-325	104	15	the	the	DET
ejnm-325	104	16	creative	creative	ADJ
ejnm-325	104	17	commons	common	NOUN
ejnm-325	104	18	attribution	attribution	NOUN
ejnm-325	104	19	-	-	PUNCT
ejnm-325	104	20	noncommercial	noncommercial	ADJ
ejnm-325	104	21	-	-	PUNCT
ejnm-325	104	22	sharealike	sharealike	ADJ
ejnm-325	104	23	4.0	4.0	NUM
ejnm-325	104	24	international	international	ADJ
ejnm-325	104	25	license	license	NOUN
ejnm-325	104	26	.	.	PUNCT
ejnm-325	105	1	it	it	PRON
ejnm-325	105	2	permits	permit	VERB
ejnm-325	105	3	no	no	DET
ejnm-325	105	4	additional	additional	ADJ
ejnm-325	105	5	restrictions	restriction	NOUN
ejnm-325	105	6	on	on	ADP
ejnm-325	105	7	use	use	NOUN
ejnm-325	105	8	,	,	PUNCT
ejnm-325	105	9	distribution	distribution	NOUN
ejnm-325	105	10	,	,	PUNCT
ejnm-325	105	11	and	and	CCONJ
ejnm-325	105	12	reproduction	reproduction	NOUN
ejnm-325	105	13	in	in	ADP
ejnm-325	105	14	any	any	DET
ejnm-325	105	15	medium	medium	NOUN
ejnm-325	105	16	provided	provide	VERB
ejnm-325	105	17	the	the	DET
ejnm-325	105	18	original	original	ADJ
ejnm-325	105	19	work	work	NOUN
ejnm-325	105	20	is	be	AUX
ejnm-325	105	21	properly	properly	ADV
ejnm-325	105	22	cited	cite	VERB
ejnm-325	105	23	.	.	PUNCT
ejnm-325	106	1	table	table	NOUN
ejnm-325	106	2	2	2	NUM
ejnm-325	106	3	:	:	PUNCT
ejnm-325	106	4	laboratory	laboratory	NOUN
ejnm-325	106	5	and	and	CCONJ
ejnm-325	106	6	non	non	ADJ
ejnm-325	106	7	-	-	ADJ
ejnm-325	106	8	laboratory	laboratory	ADJ
ejnm-325	106	9	investigations	investigation	NOUN
ejnm-325	106	10	of	of	ADP
ejnm-325	106	11	post	post	ADJ
ejnm-325	106	12	-	-	ADJ
ejnm-325	106	13	covid-19	covid-19	ADJ
ejnm-325	106	14	patients	patient	NOUN
ejnm-325	106	15	laboratory	laboratory	NOUN
ejnm-325	106	16	and	and	CCONJ
ejnm-325	106	17	non	non	ADJ
ejnm-325	106	18	-	-	ADJ
ejnm-325	106	19	laboratory	laboratory	ADJ
ejnm-325	106	20	investigations	investigation	NOUN
ejnm-325	107	1	f.	f.	NOUN
ejnm-325	107	2	(	(	PUNCT
ejnm-325	107	3	%	%	INTJ
ejnm-325	107	4	)	)	PUNCT
ejnm-325	107	5	sbp	sbp	PROPN
ejnm-325	107	6	low	low	ADJ
ejnm-325	107	7	systolic	systolic	ADJ
ejnm-325	107	8	blood	blood	NOUN
ejnm-325	107	9	pressure	pressure	NOUN
ejnm-325	107	10	4	4	NUM
ejnm-325	107	11	(	(	PUNCT
ejnm-325	107	12	5.4	5.4	NUM
ejnm-325	107	13	)	)	PUNCT
ejnm-325	107	14	normal	normal	ADJ
ejnm-325	107	15	systolic	systolic	ADJ
ejnm-325	107	16	blood	blood	NOUN
ejnm-325	107	17	pressure	pressure	NOUN
ejnm-325	107	18	33	33	NUM
ejnm-325	107	19	(	(	PUNCT
ejnm-325	107	20	44.6	44.6	NUM
ejnm-325	107	21	)	)	PUNCT
ejnm-325	107	22	high	high	ADJ
ejnm-325	107	23	systolic	systolic	ADJ
ejnm-325	107	24	blood	blood	NOUN
ejnm-325	107	25	pressure	pressure	NOUN
ejnm-325	107	26	37	37	NUM
ejnm-325	107	27	(	(	PUNCT
ejnm-325	107	28	50	50	NUM
ejnm-325	107	29	)	)	PUNCT
ejnm-325	107	30	dbp	dbp	PROPN
ejnm-325	107	31	low	low	PROPN
ejnm-325	107	32	diastolic	diastolic	NOUN
ejnm-325	107	33	blood	blood	NOUN
ejnm-325	107	34	pressure	pressure	NOUN
ejnm-325	107	35	4	4	NUM
ejnm-325	107	36	(	(	PUNCT
ejnm-325	107	37	5.4	5.4	NUM
ejnm-325	107	38	)	)	PUNCT
ejnm-325	107	39	normal	normal	ADJ
ejnm-325	107	40	diastolic	diastolic	NOUN
ejnm-325	107	41	blood	blood	NOUN
ejnm-325	107	42	pressure	pressure	NOUN
ejnm-325	107	43	44	44	NUM
ejnm-325	107	44	(	(	PUNCT
ejnm-325	107	45	59.5	59.5	NUM
ejnm-325	107	46	)	)	PUNCT
ejnm-325	107	47	high	high	ADJ
ejnm-325	107	48	diastolic	diastolic	NOUN
ejnm-325	107	49	blood	blood	NOUN
ejnm-325	107	50	pressure	pressure	NOUN
ejnm-325	107	51	26	26	NUM
ejnm-325	107	52	(	(	PUNCT
ejnm-325	107	53	35.1	35.1	NUM
ejnm-325	107	54	)	)	PUNCT
ejnm-325	107	55	spo2	spo2	PROPN
ejnm-325	107	56	hypoxemia	hypoxemia	NOUN
ejnm-325	107	57	60	60	NUM
ejnm-325	107	58	(	(	PUNCT
ejnm-325	107	59	81.1	81.1	NUM
ejnm-325	107	60	)	)	PUNCT
ejnm-325	107	61	normal	normal	ADJ
ejnm-325	107	62	spo2	spo2	PROPN
ejnm-325	107	63	14	14	NUM
ejnm-325	107	64	(	(	PUNCT
ejnm-325	107	65	18.9	18.9	NUM
ejnm-325	107	66	)	)	PUNCT
ejnm-325	107	67	pr	pr	VERB
ejnm-325	107	68	bradycardia	bradycardia	NOUN
ejnm-325	107	69	0	0	PUNCT
ejnm-325	108	1	(	(	PUNCT
ejnm-325	108	2	0	0	NUM
ejnm-325	108	3	)	)	PUNCT
ejnm-325	108	4	normal	normal	ADJ
ejnm-325	108	5	pulse	pulse	NOUN
ejnm-325	108	6	rate	rate	NOUN
ejnm-325	108	7	26	26	NUM
ejnm-325	108	8	(	(	PUNCT
ejnm-325	108	9	35.1	35.1	NUM
ejnm-325	108	10	)	)	PUNCT
ejnm-325	108	11	tachycardia	tachycardia	NOUN
ejnm-325	108	12	48	48	NUM
ejnm-325	108	13	(	(	PUNCT
ejnm-325	108	14	64.9	64.9	NUM
ejnm-325	108	15	)	)	PUNCT
ejnm-325	108	16	temp	temp	NOUN
ejnm-325	108	17	hypothermia	hypothermia	NOUN
ejnm-325	108	18	21	21	NUM
ejnm-325	108	19	(	(	PUNCT
ejnm-325	108	20	28.4	28.4	NUM
ejnm-325	108	21	)	)	PUNCT
ejnm-325	108	22	normal	normal	ADJ
ejnm-325	108	23	body	body	NOUN
ejnm-325	108	24	temperature	temperature	NOUN
ejnm-325	108	25	30	30	NUM
ejnm-325	108	26	(	(	PUNCT
ejnm-325	108	27	40.5	40.5	NUM
ejnm-325	108	28	)	)	PUNCT
ejnm-325	108	29	hyperthermia	hyperthermia	NOUN
ejnm-325	108	30	23	23	NUM
ejnm-325	108	31	(	(	PUNCT
ejnm-325	108	32	31.1	31.1	NUM
ejnm-325	108	33	)	)	PUNCT
ejnm-325	108	34	crp	crp	PROPN
ejnm-325	108	35	normal	normal	ADJ
ejnm-325	108	36	crp	crp	PROPN
ejnm-325	108	37	17	17	NUM
ejnm-325	108	38	(	(	PUNCT
ejnm-325	108	39	23	23	NUM
ejnm-325	108	40	)	)	PUNCT
ejnm-325	108	41	high	high	ADJ
ejnm-325	108	42	crp	crp	PROPN
ejnm-325	108	43	57	57	NUM
ejnm-325	108	44	(	(	PUNCT
ejnm-325	108	45	77	77	NUM
ejnm-325	108	46	)	)	PUNCT
ejnm-325	108	47	d.	d.	NOUN
ejnm-325	108	48	dimer	dimer	VERB
ejnm-325	108	49	normal	normal	ADJ
ejnm-325	108	50	d	d	PROPN
ejnm-325	108	51	dimer	dimer	NOUN
ejnm-325	108	52	28	28	NUM
ejnm-325	108	53	(	(	PUNCT
ejnm-325	108	54	37.8	37.8	NUM
ejnm-325	108	55	)	)	PUNCT
ejnm-325	108	56	high	high	ADJ
ejnm-325	108	57	d	d	NOUN
ejnm-325	108	58	dimer	dimer	NOUN
ejnm-325	108	59	46	46	NUM
ejnm-325	108	60	(	(	PUNCT
ejnm-325	108	61	62.2	62.2	NUM
ejnm-325	108	62	)	)	PUNCT
ejnm-325	108	63	ldh	ldh	PROPN
ejnm-325	108	64	low	low	ADJ
ejnm-325	108	65	ldh	ldh	PROPN
ejnm-325	108	66	22	22	NUM
ejnm-325	108	67	(	(	PUNCT
ejnm-325	108	68	29.7	29.7	NUM
ejnm-325	108	69	)	)	PUNCT
ejnm-325	108	70	normal	normal	ADJ
ejnm-325	108	71	ldh	ldh	PROPN
ejnm-325	108	72	36	36	NUM
ejnm-325	108	73	(	(	PUNCT
ejnm-325	108	74	48.6	48.6	NUM
ejnm-325	108	75	)	)	PUNCT
ejnm-325	108	76	high	high	ADJ
ejnm-325	108	77	ldh	ldh	PROPN
ejnm-325	108	78	16	16	NUM
ejnm-325	108	79	(	(	PUNCT
ejnm-325	108	80	21.6	21.6	NUM
ejnm-325	108	81	)	)	PUNCT
ejnm-325	108	82	wbc	wbc	PROPN
ejnm-325	108	83	leukopenia	leukopenia	NOUN
ejnm-325	108	84	20	20	NUM
ejnm-325	108	85	(	(	PUNCT
ejnm-325	108	86	27	27	NUM
ejnm-325	108	87	)	)	PUNCT
ejnm-325	108	88	normal	normal	ADJ
ejnm-325	108	89	wbc	wbc	NOUN
ejnm-325	108	90	49	49	NUM
ejnm-325	108	91	(	(	PUNCT
ejnm-325	108	92	66.2	66.2	NUM
ejnm-325	108	93	)	)	PUNCT
ejnm-325	108	94	leukocytosis	leukocytosis	NOUN
ejnm-325	108	95	5	5	NUM
ejnm-325	108	96	(	(	PUNCT
ejnm-325	108	97	6.8	6.8	NUM
ejnm-325	108	98	)	)	PUNCT
ejnm-325	108	99	forced	force	VERB
ejnm-325	108	100	expiratory	expiratory	NOUN
ejnm-325	108	101	volume	volume	NOUN
ejnm-325	108	102	in	in	ADP
ejnm-325	108	103	one	one	NUM
ejnm-325	108	104	second	second	ADJ
ejnm-325	108	105	low	low	ADJ
ejnm-325	108	106	fev1	fev1	PROPN
ejnm-325	108	107	43	43	NUM
ejnm-325	108	108	(	(	PUNCT
ejnm-325	108	109	58.1	58.1	NUM
ejnm-325	108	110	)	)	PUNCT
ejnm-325	108	111	normal	normal	ADJ
ejnm-325	108	112	fev1	fev1	PROPN
ejnm-325	108	113	30	30	NUM
ejnm-325	108	114	(	(	PUNCT
ejnm-325	108	115	40.5	40.5	NUM
ejnm-325	108	116	)	)	PUNCT
ejnm-325	108	117	high	high	ADJ
ejnm-325	108	118	fev1	fev1	PROPN
ejnm-325	108	119	1	1	NUM
ejnm-325	108	120	(	(	PUNCT
ejnm-325	108	121	1.4	1.4	NUM
ejnm-325	108	122	)	)	PUNCT
ejnm-325	108	123	forced	force	VERB
ejnm-325	108	124	vital	vital	ADJ
ejnm-325	108	125	capacity	capacity	NOUN
ejnm-325	108	126	low	low	ADJ
ejnm-325	108	127	fvc	fvc	PROPN
ejnm-325	108	128	47	47	NUM
ejnm-325	108	129	(	(	PUNCT
ejnm-325	108	130	63.5	63.5	NUM
ejnm-325	108	131	)	)	PUNCT
ejnm-325	108	132	normal	normal	ADJ
ejnm-325	108	133	fvc	fvc	PROPN
ejnm-325	108	134	24	24	NUM
ejnm-325	108	135	(	(	PUNCT
ejnm-325	108	136	32.4	32.4	NUM
ejnm-325	108	137	)	)	PUNCT
ejnm-325	108	138	high	high	ADJ
ejnm-325	108	139	fvc	fvc	PROPN
ejnm-325	108	140	3	3	NUM
ejnm-325	108	141	(	(	PUNCT
ejnm-325	108	142	4.1	4.1	NUM
ejnm-325	108	143	)	)	PUNCT
ejnm-325	108	144	fev1	fev1	PROPN
ejnm-325	108	145	/	/	SYM
ejnm-325	108	146	fvc	fvc	PROPN
ejnm-325	108	147	airflow	airflow	NOUN
ejnm-325	108	148	limitation	limitation	NOUN
ejnm-325	108	149	1	1	NUM
ejnm-325	108	150	(	(	PUNCT
ejnm-325	108	151	1.4	1.4	NUM
ejnm-325	108	152	)	)	PUNCT
ejnm-325	108	153	normal	normal	ADJ
ejnm-325	108	154	fev1	fev1	PROPN
ejnm-325	108	155	/	/	SYM
ejnm-325	108	156	fvc	fvc	PROPN
ejnm-325	108	157	0	0	NUM
ejnm-325	108	158	(	(	PUNCT
ejnm-325	108	159	0	0	NUM
ejnm-325	108	160	)	)	PUNCT
ejnm-325	108	161	more	more	ADJ
ejnm-325	108	162	than	than	ADP
ejnm-325	108	163	normal	normal	ADJ
ejnm-325	108	164	73	73	NUM
ejnm-325	108	165	(	(	PUNCT
ejnm-325	108	166	98.6	98.6	NUM
ejnm-325	108	167	)	)	PUNCT
ejnm-325	108	168	pattern	pattern	NOUN
ejnm-325	108	169	normal	normal	ADJ
ejnm-325	108	170	53	53	NUM
ejnm-325	108	171	(	(	PUNCT
ejnm-325	108	172	71.6	71.6	NUM
ejnm-325	108	173	)	)	PUNCT
ejnm-325	108	174	obstructive	obstructive	ADJ
ejnm-325	108	175	3	3	NUM
ejnm-325	108	176	(	(	PUNCT
ejnm-325	108	177	4.1	4.1	NUM
ejnm-325	108	178	)	)	PUNCT
ejnm-325	108	179	restrictive	restrictive	ADJ
ejnm-325	108	180	18	18	NUM
ejnm-325	108	181	(	(	PUNCT
ejnm-325	108	182	24.3	24.3	NUM
ejnm-325	108	183	)	)	PUNCT
ejnm-325	108	184	table	table	NOUN
ejnm-325	108	185	3	3	NUM
ejnm-325	108	186	:	:	PUNCT
ejnm-325	108	187	severity	severity	NOUN
ejnm-325	108	188	severity	severity	NOUN
ejnm-325	108	189	f.	f.	PROPN
ejnm-325	108	190	(	(	PUNCT
ejnm-325	108	191	%	%	INTJ
ejnm-325	108	192	)	)	PUNCT
ejnm-325	108	193	mild	mild	ADJ
ejnm-325	108	194	32	32	NUM
ejnm-325	108	195	(	(	PUNCT
ejnm-325	108	196	43.2	43.2	NUM
ejnm-325	108	197	)	)	PUNCT
ejnm-325	108	198	moderate	moderate	ADJ
ejnm-325	108	199	21	21	NUM
ejnm-325	108	200	(	(	PUNCT
ejnm-325	108	201	28.4	28.4	NUM
ejnm-325	108	202	)	)	PUNCT
ejnm-325	108	203	severe	severe	ADJ
ejnm-325	108	204	19	19	NUM
ejnm-325	108	205	(	(	PUNCT
ejnm-325	108	206	25.7	25.7	NUM
ejnm-325	108	207	)	)	PUNCT
ejnm-325	108	208	critical	critical	ADJ
ejnm-325	108	209	2	2	NUM
ejnm-325	108	210	(	(	PUNCT
ejnm-325	108	211	2.7	2.7	NUM
ejnm-325	108	212	)	)	PUNCT
ejnm-325	108	213	total	total	NOUN
ejnm-325	108	214	74	74	NUM
ejnm-325	108	215	(	(	PUNCT
ejnm-325	108	216	100	100	NUM
ejnm-325	108	217	)	)	PUNCT
ejnm-325	108	218	https://creativecommons.org/licenses/by-nc-sa/4.0/	https://creativecommons.org/licenses/by-nc-sa/4.0/	PROPN
ejnm-325	108	219	https://doi.org/10.15218/ejnm.2025.05	https://doi.org/10.15218/ejnm.2025.05	PROPN
ejnm-325	108	220	erbil	erbil	PROPN
ejnm-325	108	221	j.	j.	PROPN
ejnm-325	108	222	nurs	nurs	PROPN
ejnm-325	108	223	.	.	PUNCT
ejnm-325	109	1	midwifery	midwifery	ADJ
ejnm-325	109	2	,	,	PUNCT
ejnm-325	109	3	vol	vol	NOUN
ejnm-325	109	4	.	.	PROPN
ejnm-325	109	5	8	8	NUM
ejnm-325	109	6	,	,	PUNCT
ejnm-325	109	7	no	no	INTJ
ejnm-325	109	8	.	.	PUNCT
ejnm-325	110	1	(	(	PUNCT
ejnm-325	110	2	1	1	NUM
ejnm-325	110	3	)	)	PUNCT
ejnm-325	110	4	,	,	PUNCT
ejnm-325	110	5	may2025	may2025	ADJ
ejnm-325	110	6	original	original	ADJ
ejnm-325	110	7	article	article	NOUN
ejnm-325	110	8	concerning	concern	VERB
ejnm-325	110	9	the	the	DET
ejnm-325	110	10	association	association	NOUN
ejnm-325	110	11	between	between	ADP
ejnm-325	110	12	investigations	investigation	NOUN
ejnm-325	110	13	and	and	CCONJ
ejnm-325	110	14	severity	severity	NOUN
ejnm-325	110	15	,	,	PUNCT
ejnm-325	110	16	there	there	PRON
ejnm-325	110	17	is	be	VERB
ejnm-325	110	18	a	a	DET
ejnm-325	110	19	significant	significant	ADJ
ejnm-325	110	20	association	association	NOUN
ejnm-325	110	21	between	between	ADP
ejnm-325	110	22	spo2	spo2	PROPN
ejnm-325	110	23	,	,	PUNCT
ejnm-325	110	24	pr	pr	PROPN
ejnm-325	110	25	,	,	PUNCT
ejnm-325	110	26	d.	d.	PROPN
ejnm-325	110	27	dimer	dimer	PROPN
ejnm-325	110	28	,	,	PUNCT
ejnm-325	110	29	wbc	wbc	PROPN
ejnm-325	110	30	,	,	PUNCT
ejnm-325	110	31	pulmonary	pulmonary	ADJ
ejnm-325	110	32	function	function	NOUN
ejnm-325	110	33	tests	test	NOUN
ejnm-325	110	34	,	,	PUNCT
ejnm-325	110	35	and	and	CCONJ
ejnm-325	110	36	forced	force	VERB
ejnm-325	110	37	vital	vital	ADJ
ejnm-325	110	38	capacity	capacity	NOUN
ejnm-325	110	39	with	with	ADP
ejnm-325	110	40	the	the	DET
ejnm-325	110	41	severity	severity	NOUN
ejnm-325	110	42	(	(	PUNCT
ejnm-325	110	43	pvalue	pvalue	NOUN
ejnm-325	110	44	≤	≤	NOUN
ejnm-325	110	45	0.05	0.05	NUM
ejnm-325	110	46	)	)	PUNCT
ejnm-325	110	47	.	.	PUNCT
ejnm-325	111	1	the	the	DET
ejnm-325	111	2	other	other	ADJ
ejnm-325	111	3	associations	association	NOUN
ejnm-325	111	4	are	be	AUX
ejnm-325	111	5	non	non	ADJ
ejnm-325	111	6	-	-	ADJ
ejnm-325	111	7	significant	significant	ADJ
ejnm-325	111	8	(	(	PUNCT
ejnm-325	111	9	p	p	NOUN
ejnm-325	111	10	-	-	PUNCT
ejnm-325	111	11	value	value	NOUN
ejnm-325	111	12	>	>	NOUN
ejnm-325	111	13	0.05	0.05	NUM
ejnm-325	111	14	)	)	PUNCT
ejnm-325	111	15	.	.	PUNCT
ejnm-325	112	1	42	42	NUM
ejnm-325	112	2	concerning	concern	VERB
ejnm-325	112	3	the	the	DET
ejnm-325	112	4	association	association	NOUN
ejnm-325	112	5	between	between	ADP
ejnm-325	112	6	demographic	demographic	ADJ
ejnm-325	112	7	and	and	CCONJ
ejnm-325	112	8	clinical	clinical	ADJ
ejnm-325	112	9	characteristics	characteristic	NOUN
ejnm-325	112	10	with	with	ADP
ejnm-325	112	11	the	the	DET
ejnm-325	112	12	severity	severity	NOUN
ejnm-325	112	13	,	,	PUNCT
ejnm-325	112	14	there	there	PRON
ejnm-325	112	15	is	be	VERB
ejnm-325	112	16	a	a	DET
ejnm-325	112	17	very	very	ADV
ejnm-325	112	18	highly	highly	ADV
ejnm-325	112	19	significant	significant	ADJ
ejnm-325	112	20	association	association	NOUN
ejnm-325	112	21	between	between	ADP
ejnm-325	112	22	age	age	NOUN
ejnm-325	112	23	groups	group	NOUN
ejnm-325	112	24	and	and	CCONJ
ejnm-325	112	25	sob	sob	VERB
ejnm-325	112	26	with	with	ADP
ejnm-325	112	27	the	the	DET
ejnm-325	112	28	severity	severity	NOUN
ejnm-325	112	29	(	(	PUNCT
ejnm-325	112	30	p	p	NOUN
ejnm-325	112	31	-	-	PUNCT
ejnm-325	112	32	value	value	NOUN
ejnm-325	112	33	<	<	NOUN
ejnm-325	112	34	0.001	0.001	NUM
ejnm-325	112	35	)	)	PUNCT
ejnm-325	112	36	.	.	PUNCT
ejnm-325	113	1	the	the	DET
ejnm-325	113	2	other	other	ADJ
ejnm-325	113	3	associations	association	NOUN
ejnm-325	113	4	are	be	AUX
ejnm-325	113	5	nonsignificant	nonsignificant	ADJ
ejnm-325	113	6	(	(	PUNCT
ejnm-325	113	7	p	p	NOUN
ejnm-325	113	8	-	-	PUNCT
ejnm-325	113	9	value	value	NOUN
ejnm-325	113	10	>	>	NOUN
ejnm-325	113	11	0.05	0.05	NUM
ejnm-325	113	12	)	)	PUNCT
ejnm-325	113	13	.	.	PUNCT
ejnm-325	114	1	copyright	copyright	NOUN
ejnm-325	114	2	©	©	PROPN
ejnm-325	114	3	2025the	2025the	PROPN
ejnm-325	114	4	author(s	author(s	NOUN
ejnm-325	114	5	)	)	PUNCT
ejnm-325	114	6	.	.	PUNCT
ejnm-325	115	1	this	this	PRON
ejnm-325	115	2	is	be	AUX
ejnm-325	115	3	an	an	DET
ejnm-325	115	4	open	open	ADJ
ejnm-325	115	5	access	access	NOUN
ejnm-325	115	6	article	article	NOUN
ejnm-325	115	7	which	which	PRON
ejnm-325	115	8	licensed	license	VERB
ejnm-325	115	9	under	under	ADP
ejnm-325	115	10	the	the	DET
ejnm-325	115	11	terms	term	NOUN
ejnm-325	115	12	and	and	CCONJ
ejnm-325	115	13	conditions	condition	NOUN
ejnm-325	115	14	of	of	ADP
ejnm-325	115	15	the	the	DET
ejnm-325	115	16	creative	creative	ADJ
ejnm-325	115	17	commons	common	NOUN
ejnm-325	115	18	attribution	attribution	NOUN
ejnm-325	115	19	-	-	PUNCT
ejnm-325	115	20	noncommercial	noncommercial	ADJ
ejnm-325	115	21	-	-	PUNCT
ejnm-325	115	22	sharealike	sharealike	ADJ
ejnm-325	115	23	4.0	4.0	NUM
ejnm-325	115	24	international	international	ADJ
ejnm-325	115	25	license	license	NOUN
ejnm-325	115	26	.	.	PUNCT
ejnm-325	116	1	it	it	PRON
ejnm-325	116	2	permits	permit	VERB
ejnm-325	116	3	no	no	DET
ejnm-325	116	4	additional	additional	ADJ
ejnm-325	116	5	restrictions	restriction	NOUN
ejnm-325	116	6	on	on	ADP
ejnm-325	116	7	use	use	NOUN
ejnm-325	116	8	,	,	PUNCT
ejnm-325	116	9	distribution	distribution	NOUN
ejnm-325	116	10	,	,	PUNCT
ejnm-325	116	11	and	and	CCONJ
ejnm-325	116	12	reproduction	reproduction	NOUN
ejnm-325	116	13	in	in	ADP
ejnm-325	116	14	any	any	DET
ejnm-325	116	15	medium	medium	NOUN
ejnm-325	116	16	provided	provide	VERB
ejnm-325	116	17	the	the	DET
ejnm-325	116	18	original	original	ADJ
ejnm-325	116	19	work	work	NOUN
ejnm-325	116	20	is	be	AUX
ejnm-325	116	21	properly	properly	ADV
ejnm-325	116	22	cited	cite	VERB
ejnm-325	116	23	.	.	PUNCT
ejnm-325	117	1	table	table	NOUN
ejnm-325	117	2	4	4	NUM
ejnm-325	117	3	.	.	X
ejnm-325	117	4	association	association	NOUN
ejnm-325	117	5	between	between	ADP
ejnm-325	117	6	demographic	demographic	ADJ
ejnm-325	117	7	and	and	CCONJ
ejnm-325	117	8	clinical	clinical	ADJ
ejnm-325	117	9	characteristics	characteristic	NOUN
ejnm-325	117	10	with	with	ADP
ejnm-325	117	11	severity	severity	NOUN
ejnm-325	117	12	demographic	demographic	ADJ
ejnm-325	117	13	and	and	CCONJ
ejnm-325	117	14	clinical	clinical	ADJ
ejnm-325	117	15	characteristics	characteristic	NOUN
ejnm-325	117	16	severity	severity	NOUN
ejnm-325	117	17	p	p	ADJ
ejnm-325	117	18	-	-	PUNCT
ejnm-325	117	19	value	value	NOUN
ejnm-325	117	20	mild	mild	ADJ
ejnm-325	117	21	moderate	moderate	ADJ
ejnm-325	117	22	severe	severe	ADJ
ejnm-325	117	23	critical	critical	ADJ
ejnm-325	117	24	f.	f.	PROPN
ejnm-325	117	25	(	(	PUNCT
ejnm-325	117	26	%	%	INTJ
ejnm-325	117	27	)	)	PUNCT
ejnm-325	118	1	f.	f.	PROPN
ejnm-325	118	2	(	(	PUNCT
ejnm-325	118	3	%	%	INTJ
ejnm-325	118	4	)	)	PUNCT
ejnm-325	119	1	f.	f.	PROPN
ejnm-325	119	2	(	(	PUNCT
ejnm-325	119	3	%	%	INTJ
ejnm-325	119	4	)	)	PUNCT
ejnm-325	120	1	f.	f.	PROPN
ejnm-325	120	2	(	(	PUNCT
ejnm-325	120	3	%	%	INTJ
ejnm-325	120	4	)	)	PUNCT
ejnm-325	120	5	age	age	NOUN
ejnm-325	120	6	groups	group	NOUN
ejnm-325	120	7	(	(	PUNCT
ejnm-325	120	8	years	year	NOUN
ejnm-325	120	9	)	)	PUNCT
ejnm-325	120	10	22	22	NUM
ejnm-325	120	11	-	-	SYM
ejnm-325	120	12	37	37	NUM
ejnm-325	120	13	10	10	NUM
ejnm-325	120	14	(	(	PUNCT
ejnm-325	120	15	76.9	76.9	NUM
ejnm-325	120	16	)	)	PUNCT
ejnm-325	120	17	2	2	NUM
ejnm-325	120	18	(	(	PUNCT
ejnm-325	120	19	15.4	15.4	NUM
ejnm-325	120	20	)	)	PUNCT
ejnm-325	120	21	1	1	NUM
ejnm-325	120	22	(	(	PUNCT
ejnm-325	120	23	7.7	7.7	NUM
ejnm-325	120	24	)	)	PUNCT
ejnm-325	120	25	0	0	NUM
ejnm-325	121	1	(	(	PUNCT
ejnm-325	121	2	0	0	NUM
ejnm-325	121	3	)	)	PUNCT
ejnm-325	121	4	<	<	X
ejnm-325	121	5	0.001	0.001	NUM
ejnm-325	121	6	vhs	vhs	NOUN
ejnm-325	121	7	38	38	NUM
ejnm-325	121	8	-	-	SYM
ejnm-325	121	9	53	53	NUM
ejnm-325	121	10	15	15	NUM
ejnm-325	121	11	(	(	PUNCT
ejnm-325	121	12	75	75	NUM
ejnm-325	121	13	)	)	SYM
ejnm-325	121	14	2	2	NUM
ejnm-325	121	15	(	(	PUNCT
ejnm-325	121	16	10	10	NUM
ejnm-325	121	17	)	)	PUNCT
ejnm-325	121	18	3	3	NUM
ejnm-325	121	19	(	(	PUNCT
ejnm-325	121	20	15	15	NUM
ejnm-325	121	21	)	)	PUNCT
ejnm-325	121	22	0	0	NUM
ejnm-325	121	23	(	(	PUNCT
ejnm-325	121	24	0	0	NUM
ejnm-325	121	25	)	)	PUNCT
ejnm-325	121	26	54	54	NUM
ejnm-325	121	27	-	-	SYM
ejnm-325	121	28	69	69	NUM
ejnm-325	121	29	7	7	NUM
ejnm-325	121	30	(	(	PUNCT
ejnm-325	121	31	17.1	17.1	NUM
ejnm-325	121	32	)	)	PUNCT
ejnm-325	121	33	17	17	NUM
ejnm-325	121	34	(	(	PUNCT
ejnm-325	121	35	41.5	41.5	NUM
ejnm-325	121	36	)	)	PUNCT
ejnm-325	121	37	15	15	NUM
ejnm-325	121	38	(	(	PUNCT
ejnm-325	121	39	36.6	36.6	NUM
ejnm-325	121	40	)	)	SYM
ejnm-325	121	41	2	2	NUM
ejnm-325	121	42	(	(	PUNCT
ejnm-325	121	43	4.9	4.9	NUM
ejnm-325	121	44	)	)	PUNCT
ejnm-325	121	45	sex	sex	NOUN
ejnm-325	121	46	male	male	NOUN
ejnm-325	121	47	19	19	NUM
ejnm-325	121	48	(	(	PUNCT
ejnm-325	121	49	40.4	40.4	NUM
ejnm-325	121	50	)	)	PUNCT
ejnm-325	121	51	16	16	NUM
ejnm-325	121	52	(	(	PUNCT
ejnm-325	121	53	34	34	NUM
ejnm-325	121	54	)	)	PUNCT
ejnm-325	121	55	11	11	NUM
ejnm-325	121	56	(	(	PUNCT
ejnm-325	121	57	23.4	23.4	NUM
ejnm-325	121	58	)	)	SYM
ejnm-325	121	59	1	1	NUM
ejnm-325	121	60	(	(	PUNCT
ejnm-325	121	61	2.1	2.1	NUM
ejnm-325	121	62	)	)	PUNCT
ejnm-325	121	63	0.550	0.550	NUM
ejnm-325	121	64	ns	ns	NUM
ejnm-325	121	65	female	female	ADJ
ejnm-325	121	66	13	13	NUM
ejnm-325	121	67	(	(	PUNCT
ejnm-325	121	68	48.1	48.1	NUM
ejnm-325	121	69	)	)	SYM
ejnm-325	121	70	5	5	NUM
ejnm-325	121	71	(	(	PUNCT
ejnm-325	121	72	18.5	18.5	NUM
ejnm-325	121	73	)	)	PUNCT
ejnm-325	121	74	8	8	NUM
ejnm-325	121	75	(	(	PUNCT
ejnm-325	121	76	29.6	29.6	NUM
ejnm-325	121	77	)	)	SYM
ejnm-325	121	78	1	1	NUM
ejnm-325	121	79	(	(	PUNCT
ejnm-325	121	80	3.7	3.7	NUM
ejnm-325	121	81	)	)	PUNCT
ejnm-325	121	82	cough	cough	NOUN
ejnm-325	121	83	no	no	DET
ejnm-325	121	84	14	14	NUM
ejnm-325	121	85	(	(	PUNCT
ejnm-325	121	86	56	56	NUM
ejnm-325	121	87	)	)	PUNCT
ejnm-325	121	88	6	6	NUM
ejnm-325	121	89	(	(	PUNCT
ejnm-325	121	90	24	24	NUM
ejnm-325	121	91	)	)	PUNCT
ejnm-325	121	92	4	4	NUM
ejnm-325	121	93	(	(	PUNCT
ejnm-325	121	94	16	16	NUM
ejnm-325	121	95	)	)	SYM
ejnm-325	121	96	1	1	NUM
ejnm-325	121	97	(	(	PUNCT
ejnm-325	121	98	4	4	NUM
ejnm-325	121	99	)	)	PUNCT
ejnm-325	121	100	0.349	0.349	NUM
ejnm-325	121	101	ns	ns	NUM
ejnm-325	121	102	yes	yes	INTJ
ejnm-325	121	103	18	18	NUM
ejnm-325	121	104	(	(	PUNCT
ejnm-325	121	105	36.7	36.7	NUM
ejnm-325	121	106	)	)	PUNCT
ejnm-325	121	107	15	15	NUM
ejnm-325	121	108	(	(	PUNCT
ejnm-325	121	109	30.6	30.6	NUM
ejnm-325	121	110	)	)	PUNCT
ejnm-325	121	111	15	15	NUM
ejnm-325	121	112	(	(	PUNCT
ejnm-325	121	113	30.6	30.6	NUM
ejnm-325	121	114	)	)	SYM
ejnm-325	121	115	1	1	NUM
ejnm-325	121	116	(	(	PUNCT
ejnm-325	121	117	2	2	NUM
ejnm-325	121	118	)	)	PUNCT
ejnm-325	121	119	fever	fever	NOUN
ejnm-325	121	120	no	no	DET
ejnm-325	121	121	21	21	NUM
ejnm-325	121	122	(	(	PUNCT
ejnm-325	121	123	42	42	NUM
ejnm-325	121	124	)	)	PUNCT
ejnm-325	121	125	17	17	NUM
ejnm-325	121	126	(	(	PUNCT
ejnm-325	121	127	34	34	NUM
ejnm-325	121	128	)	)	PUNCT
ejnm-325	121	129	12	12	NUM
ejnm-325	121	130	(	(	PUNCT
ejnm-325	121	131	24	24	NUM
ejnm-325	121	132	)	)	PUNCT
ejnm-325	121	133	0	0	NUM
ejnm-325	122	1	(	(	PUNCT
ejnm-325	122	2	0	0	NUM
ejnm-325	122	3	)	)	PUNCT
ejnm-325	123	1	0.107	0.107	NUM
ejnm-325	123	2	ns	ns	NUM
ejnm-325	123	3	yes	yes	INTJ
ejnm-325	123	4	11	11	NUM
ejnm-325	123	5	(	(	PUNCT
ejnm-325	123	6	45.8	45.8	NUM
ejnm-325	123	7	)	)	PUNCT
ejnm-325	123	8	4	4	NUM
ejnm-325	123	9	(	(	PUNCT
ejnm-325	123	10	16.7	16.7	NUM
ejnm-325	123	11	)	)	PUNCT
ejnm-325	123	12	7	7	NUM
ejnm-325	123	13	(	(	PUNCT
ejnm-325	123	14	29.2	29.2	NUM
ejnm-325	123	15	)	)	SYM
ejnm-325	123	16	2	2	NUM
ejnm-325	123	17	(	(	PUNCT
ejnm-325	123	18	8.3	8.3	NUM
ejnm-325	123	19	)	)	PUNCT
ejnm-325	123	20	sob	sob	VERB
ejnm-325	123	21	no	no	DET
ejnm-325	123	22	15	15	NUM
ejnm-325	123	23	(	(	PUNCT
ejnm-325	123	24	75	75	NUM
ejnm-325	123	25	)	)	SYM
ejnm-325	123	26	2	2	NUM
ejnm-325	123	27	(	(	PUNCT
ejnm-325	123	28	10	10	NUM
ejnm-325	123	29	)	)	SYM
ejnm-325	123	30	1	1	NUM
ejnm-325	123	31	(	(	PUNCT
ejnm-325	123	32	5	5	NUM
ejnm-325	123	33	)	)	SYM
ejnm-325	123	34	2	2	NUM
ejnm-325	123	35	(	(	PUNCT
ejnm-325	123	36	10	10	NUM
ejnm-325	123	37	)	)	PUNCT
ejnm-325	123	38	<	<	X
ejnm-325	123	39	0.001	0.001	NUM
ejnm-325	123	40	vhs	vhs	NOUN
ejnm-325	124	1	yes	yes	INTJ
ejnm-325	124	2	17	17	NUM
ejnm-325	124	3	(	(	PUNCT
ejnm-325	124	4	31.5	31.5	NUM
ejnm-325	124	5	)	)	PUNCT
ejnm-325	124	6	19	19	NUM
ejnm-325	124	7	(	(	PUNCT
ejnm-325	124	8	35.2	35.2	NUM
ejnm-325	124	9	)	)	PUNCT
ejnm-325	124	10	18	18	NUM
ejnm-325	124	11	(	(	PUNCT
ejnm-325	124	12	33.3	33.3	NUM
ejnm-325	124	13	)	)	PUNCT
ejnm-325	124	14	0	0	NUM
ejnm-325	125	1	(	(	PUNCT
ejnm-325	125	2	0	0	X
ejnm-325	125	3	)	)	PUNCT
ejnm-325	125	4	others	other	NOUN
ejnm-325	125	5	no	no	DET
ejnm-325	125	6	9	9	NUM
ejnm-325	125	7	(	(	PUNCT
ejnm-325	125	8	69.2	69.2	NUM
ejnm-325	125	9	)	)	PUNCT
ejnm-325	125	10	3	3	NUM
ejnm-325	125	11	(	(	PUNCT
ejnm-325	125	12	23.1	23.1	NUM
ejnm-325	125	13	)	)	PUNCT
ejnm-325	125	14	1	1	NUM
ejnm-325	125	15	(	(	PUNCT
ejnm-325	125	16	7.7	7.7	NUM
ejnm-325	125	17	)	)	PUNCT
ejnm-325	125	18	0	0	NUM
ejnm-325	126	1	(	(	PUNCT
ejnm-325	126	2	0	0	NUM
ejnm-325	126	3	)	)	PUNCT
ejnm-325	126	4	0.169	0.169	NUM
ejnm-325	126	5	ns	ns	NUM
ejnm-325	127	1	yes	yes	INTJ
ejnm-325	127	2	23	23	NUM
ejnm-325	127	3	(	(	PUNCT
ejnm-325	127	4	37.7	37.7	NUM
ejnm-325	127	5	)	)	SYM
ejnm-325	127	6	18	18	NUM
ejnm-325	127	7	(	(	PUNCT
ejnm-325	127	8	29.5	29.5	NUM
ejnm-325	127	9	)	)	SYM
ejnm-325	127	10	18	18	NUM
ejnm-325	127	11	(	(	PUNCT
ejnm-325	127	12	29.5	29.5	NUM
ejnm-325	127	13	)	)	SYM
ejnm-325	127	14	2	2	NUM
ejnm-325	127	15	(	(	PUNCT
ejnm-325	127	16	3.3	3.3	NUM
ejnm-325	127	17	)	)	PUNCT
ejnm-325	127	18	pmh	pmh	NOUN
ejnm-325	127	19	none	none	NOUN
ejnm-325	127	20	20	20	NUM
ejnm-325	127	21	(	(	PUNCT
ejnm-325	127	22	51.3	51.3	NUM
ejnm-325	127	23	)	)	PUNCT
ejnm-325	127	24	9	9	NUM
ejnm-325	127	25	(	(	PUNCT
ejnm-325	127	26	23.1	23.1	NUM
ejnm-325	127	27	)	)	PUNCT
ejnm-325	127	28	9	9	NUM
ejnm-325	127	29	(	(	PUNCT
ejnm-325	127	30	23.1	23.1	NUM
ejnm-325	127	31	)	)	PUNCT
ejnm-325	127	32	1	1	NUM
ejnm-325	127	33	(	(	PUNCT
ejnm-325	127	34	2.6	2.6	NUM
ejnm-325	127	35	)	)	PUNCT
ejnm-325	127	36	0.620	0.620	NUM
ejnm-325	127	37	ns	ns	NUM
ejnm-325	127	38	asthma	asthma	NOUN
ejnm-325	127	39	1	1	NUM
ejnm-325	127	40	(	(	PUNCT
ejnm-325	127	41	50	50	NUM
ejnm-325	127	42	)	)	PUNCT
ejnm-325	127	43	1	1	NUM
ejnm-325	127	44	(	(	PUNCT
ejnm-325	127	45	50	50	NUM
ejnm-325	127	46	)	)	PUNCT
ejnm-325	127	47	0	0	NUM
ejnm-325	128	1	(	(	PUNCT
ejnm-325	128	2	0	0	NUM
ejnm-325	128	3	)	)	PUNCT
ejnm-325	128	4	0	0	NUM
ejnm-325	129	1	(	(	PUNCT
ejnm-325	129	2	0	0	X
ejnm-325	129	3	)	)	PUNCT
ejnm-325	129	4	copd	copd	NOUN
ejnm-325	129	5	2	2	NUM
ejnm-325	129	6	(	(	PUNCT
ejnm-325	129	7	40	40	NUM
ejnm-325	129	8	)	)	PUNCT
ejnm-325	129	9	3	3	NUM
ejnm-325	129	10	(	(	PUNCT
ejnm-325	129	11	60	60	NUM
ejnm-325	129	12	)	)	PUNCT
ejnm-325	129	13	0	0	NUM
ejnm-325	129	14	(	(	PUNCT
ejnm-325	129	15	0	0	NUM
ejnm-325	129	16	)	)	PUNCT
ejnm-325	129	17	0	0	NUM
ejnm-325	130	1	(	(	PUNCT
ejnm-325	130	2	0	0	X
ejnm-325	130	3	)	)	PUNCT
ejnm-325	130	4	others	other	NOUN
ejnm-325	130	5	9	9	NUM
ejnm-325	130	6	(	(	PUNCT
ejnm-325	130	7	32.1	32.1	NUM
ejnm-325	130	8	)	)	PUNCT
ejnm-325	130	9	8	8	NUM
ejnm-325	130	10	(	(	PUNCT
ejnm-325	130	11	28.6	28.6	NUM
ejnm-325	130	12	)	)	PUNCT
ejnm-325	130	13	10	10	NUM
ejnm-325	130	14	(	(	PUNCT
ejnm-325	130	15	35.7	35.7	NUM
ejnm-325	130	16	)	)	SYM
ejnm-325	130	17	1	1	NUM
ejnm-325	130	18	(	(	PUNCT
ejnm-325	130	19	3.6	3.6	NUM
ejnm-325	130	20	)	)	PUNCT
ejnm-325	130	21	smoking	smoke	VERB
ejnm-325	130	22	no	no	PRON
ejnm-325	130	23	smoker	smoker	NOUN
ejnm-325	130	24	23	23	NUM
ejnm-325	130	25	(	(	PUNCT
ejnm-325	130	26	46.9	46.9	NUM
ejnm-325	130	27	)	)	PUNCT
ejnm-325	130	28	12	12	NUM
ejnm-325	130	29	(	(	PUNCT
ejnm-325	130	30	24.5	24.5	NUM
ejnm-325	130	31	)	)	PUNCT
ejnm-325	130	32	14	14	NUM
ejnm-325	130	33	(	(	PUNCT
ejnm-325	130	34	28.6	28.6	NUM
ejnm-325	130	35	)	)	PUNCT
ejnm-325	130	36	0	0	NUM
ejnm-325	131	1	(	(	PUNCT
ejnm-325	131	2	0	0	NUM
ejnm-325	131	3	)	)	PUNCT
ejnm-325	131	4	0.149	0.149	NUM
ejnm-325	131	5	ns	ns	NUM
ejnm-325	131	6	smoker	smoker	ADP
ejnm-325	131	7	5	5	NUM
ejnm-325	131	8	(	(	PUNCT
ejnm-325	131	9	62.5	62.5	NUM
ejnm-325	131	10	)	)	SYM
ejnm-325	131	11	2	2	NUM
ejnm-325	131	12	(	(	PUNCT
ejnm-325	131	13	25	25	NUM
ejnm-325	131	14	)	)	PUNCT
ejnm-325	131	15	0	0	NUM
ejnm-325	132	1	(	(	PUNCT
ejnm-325	132	2	0	0	NUM
ejnm-325	132	3	)	)	SYM
ejnm-325	132	4	1	1	NUM
ejnm-325	132	5	(	(	PUNCT
ejnm-325	132	6	12	12	NUM
ejnm-325	132	7	.	.	NOUN
ejnm-325	132	8	5	5	NUM
ejnm-325	132	9	)	)	PUNCT
ejnm-325	132	10	ex	ex	NOUN
ejnm-325	132	11	-	-	NOUN
ejnm-325	132	12	smoker	smoker	ADJ
ejnm-325	132	13	3	3	NUM
ejnm-325	132	14	(	(	PUNCT
ejnm-325	132	15	18.8	18.8	NUM
ejnm-325	132	16	)	)	PUNCT
ejnm-325	132	17	7	7	NUM
ejnm-325	132	18	(	(	PUNCT
ejnm-325	132	19	43.8	43.8	NUM
ejnm-325	132	20	)	)	PUNCT
ejnm-325	132	21	5	5	NUM
ejnm-325	132	22	(	(	PUNCT
ejnm-325	132	23	31.3	31.3	NUM
ejnm-325	132	24	)	)	PUNCT
ejnm-325	132	25	1	1	NUM
ejnm-325	132	26	(	(	PUNCT
ejnm-325	132	27	6.3	6.3	NUM
ejnm-325	132	28	)	)	PUNCT
ejnm-325	132	29	passivesmoker	passivesmoker	NOUN
ejnm-325	132	30	1	1	NUM
ejnm-325	132	31	(	(	PUNCT
ejnm-325	132	32	100	100	NUM
ejnm-325	132	33	)	)	PUNCT
ejnm-325	132	34	0	0	NUM
ejnm-325	133	1	(	(	PUNCT
ejnm-325	133	2	0	0	NUM
ejnm-325	133	3	)	)	PUNCT
ejnm-325	133	4	0	0	NUM
ejnm-325	134	1	(	(	PUNCT
ejnm-325	134	2	0	0	NUM
ejnm-325	134	3	)	)	PUNCT
ejnm-325	134	4	0	0	NUM
ejnm-325	135	1	(	(	PUNCT
ejnm-325	135	2	0	0	NUM
ejnm-325	135	3	)	)	PUNCT
ejnm-325	135	4	https://creativecommons.org/licenses/by-nc-sa/4.0/	https://creativecommons.org/licenses/by-nc-sa/4.0/	PROPN
ejnm-325	135	5	https://doi.org/10.15218/ejnm.2025.05	https://doi.org/10.15218/ejnm.2025.05	PROPN
ejnm-325	135	6	erbil	erbil	PROPN
ejnm-325	135	7	j.	j.	PROPN
ejnm-325	135	8	nurs	nurs	PROPN
ejnm-325	135	9	.	.	PUNCT
ejnm-325	136	1	midwifery	midwifery	ADJ
ejnm-325	136	2	,	,	PUNCT
ejnm-325	136	3	vol	vol	NOUN
ejnm-325	136	4	.	.	PROPN
ejnm-325	136	5	8	8	NUM
ejnm-325	136	6	,	,	PUNCT
ejnm-325	136	7	no	no	INTJ
ejnm-325	136	8	.	.	PUNCT
ejnm-325	137	1	(	(	PUNCT
ejnm-325	137	2	1	1	NUM
ejnm-325	137	3	)	)	PUNCT
ejnm-325	137	4	,	,	PUNCT
ejnm-325	137	5	may2025	may2025	ADJ
ejnm-325	137	6	original	original	ADJ
ejnm-325	137	7	article	article	NOUN
ejnm-325	137	8	43	43	NUM
ejnm-325	137	9	copyright	copyright	NOUN
ejnm-325	137	10	©	©	PROPN
ejnm-325	137	11	2025	2025	NUM
ejnm-325	137	12	the	the	DET
ejnm-325	137	13	author(s	author(s	NOUN
ejnm-325	137	14	)	)	PUNCT
ejnm-325	137	15	.	.	PUNCT
ejnm-325	138	1	this	this	PRON
ejnm-325	138	2	is	be	AUX
ejnm-325	138	3	an	an	DET
ejnm-325	138	4	open	open	ADJ
ejnm-325	138	5	access	access	NOUN
ejnm-325	138	6	article	article	NOUN
ejnm-325	138	7	which	which	PRON
ejnm-325	138	8	licensed	license	VERB
ejnm-325	138	9	under	under	ADP
ejnm-325	138	10	the	the	DET
ejnm-325	138	11	terms	term	NOUN
ejnm-325	138	12	and	and	CCONJ
ejnm-325	138	13	conditions	condition	NOUN
ejnm-325	138	14	of	of	ADP
ejnm-325	138	15	the	the	DET
ejnm-325	138	16	creative	creative	ADJ
ejnm-325	138	17	commons	common	NOUN
ejnm-325	138	18	attribution	attribution	NOUN
ejnm-325	138	19	-	-	PUNCT
ejnm-325	138	20	noncommercial	noncommercial	ADJ
ejnm-325	138	21	-	-	PUNCT
ejnm-325	138	22	sharealike	sharealike	ADJ
ejnm-325	138	23	4.0	4.0	NUM
ejnm-325	138	24	international	international	ADJ
ejnm-325	138	25	license	license	NOUN
ejnm-325	138	26	.	.	PUNCT
ejnm-325	139	1	it	it	PRON
ejnm-325	139	2	permits	permit	VERB
ejnm-325	139	3	no	no	DET
ejnm-325	139	4	additional	additional	ADJ
ejnm-325	139	5	restrictions	restriction	NOUN
ejnm-325	139	6	on	on	ADP
ejnm-325	139	7	use	use	NOUN
ejnm-325	139	8	,	,	PUNCT
ejnm-325	139	9	distribution	distribution	NOUN
ejnm-325	139	10	,	,	PUNCT
ejnm-325	139	11	and	and	CCONJ
ejnm-325	139	12	reproduction	reproduction	NOUN
ejnm-325	139	13	in	in	ADP
ejnm-325	139	14	any	any	DET
ejnm-325	139	15	medium	medium	NOUN
ejnm-325	139	16	provided	provide	VERB
ejnm-325	139	17	the	the	DET
ejnm-325	139	18	original	original	ADJ
ejnm-325	139	19	work	work	NOUN
ejnm-325	139	20	is	be	AUX
ejnm-325	139	21	properly	properly	ADV
ejnm-325	139	22	cited	cite	VERB
ejnm-325	139	23	.	.	PUNCT
ejnm-325	140	1	table	table	NOUN
ejnm-325	140	2	5	5	NUM
ejnm-325	140	3	:	:	PUNCT
ejnm-325	140	4	association	association	NOUN
ejnm-325	140	5	between	between	ADP
ejnm-325	140	6	investigations	investigation	NOUN
ejnm-325	140	7	with	with	ADP
ejnm-325	140	8	the	the	DET
ejnm-325	140	9	severity	severity	NOUN
ejnm-325	140	10	investigations	investigation	NOUN
ejnm-325	140	11	severity	severity	NOUN
ejnm-325	140	12	p	p	NOUN
ejnm-325	140	13	–	–	PUNCT
ejnm-325	140	14	value	value	NOUN
ejnm-325	140	15	mild	mild	ADJ
ejnm-325	140	16	moderate	moderate	ADJ
ejnm-325	140	17	severe	severe	ADJ
ejnm-325	140	18	critical	critical	ADJ
ejnm-325	140	19	f.	f.	PROPN
ejnm-325	140	20	(	(	PUNCT
ejnm-325	140	21	%	%	INTJ
ejnm-325	140	22	)	)	PUNCT
ejnm-325	141	1	f.	f.	PROPN
ejnm-325	141	2	(	(	PUNCT
ejnm-325	141	3	%	%	INTJ
ejnm-325	141	4	)	)	PUNCT
ejnm-325	142	1	f.	f.	PROPN
ejnm-325	142	2	(	(	PUNCT
ejnm-325	142	3	%	%	INTJ
ejnm-325	142	4	)	)	PUNCT
ejnm-325	143	1	f.	f.	PROPN
ejnm-325	143	2	(	(	PUNCT
ejnm-325	143	3	%	%	INTJ
ejnm-325	143	4	)	)	PUNCT
ejnm-325	143	5	sbp	sbp	PROPN
ejnm-325	143	6	low	low	ADJ
ejnm-325	143	7	systolic	systolic	ADJ
ejnm-325	143	8	blood	blood	NOUN
ejnm-325	143	9	pressure	pressure	NOUN
ejnm-325	143	10	0	0	NUM
ejnm-325	144	1	(	(	PUNCT
ejnm-325	144	2	0	0	NUM
ejnm-325	144	3	)	)	SYM
ejnm-325	144	4	2	2	NUM
ejnm-325	144	5	(	(	PUNCT
ejnm-325	144	6	50	50	NUM
ejnm-325	144	7	)	)	SYM
ejnm-325	144	8	2	2	NUM
ejnm-325	144	9	(	(	PUNCT
ejnm-325	144	10	50	50	NUM
ejnm-325	144	11	)	)	PUNCT
ejnm-325	144	12	0	0	NUM
ejnm-325	145	1	(	(	PUNCT
ejnm-325	145	2	0	0	NUM
ejnm-325	145	3	)	)	PUNCT
ejnm-325	145	4	0.148	0.148	NUM
ejnm-325	145	5	ns	ns	NUM
ejnm-325	145	6	normal	normal	ADJ
ejnm-325	145	7	systolic	systolic	ADJ
ejnm-325	145	8	blood	blood	NOUN
ejnm-325	145	9	pressure	pressure	NOUN
ejnm-325	145	10	20	20	NUM
ejnm-325	145	11	(	(	PUNCT
ejnm-325	145	12	60.6	60.6	NUM
ejnm-325	145	13	)	)	PUNCT
ejnm-325	145	14	6	6	NUM
ejnm-325	145	15	(	(	PUNCT
ejnm-325	145	16	18.2	18.2	NUM
ejnm-325	145	17	)	)	PUNCT
ejnm-325	145	18	6	6	NUM
ejnm-325	145	19	(	(	PUNCT
ejnm-325	145	20	18.2	18.2	NUM
ejnm-325	145	21	)	)	SYM
ejnm-325	145	22	1	1	NUM
ejnm-325	145	23	(	(	PUNCT
ejnm-325	145	24	3	3	NUM
ejnm-325	145	25	)	)	PUNCT
ejnm-325	145	26	high	high	ADJ
ejnm-325	145	27	systolic	systolic	ADJ
ejnm-325	145	28	blood	blood	NOUN
ejnm-325	145	29	pressure	pressure	NOUN
ejnm-325	145	30	12	12	NUM
ejnm-325	145	31	(	(	PUNCT
ejnm-325	145	32	32.4	32.4	NUM
ejnm-325	145	33	)	)	PUNCT
ejnm-325	145	34	13	13	NUM
ejnm-325	145	35	(	(	PUNCT
ejnm-325	145	36	35.1	35.1	NUM
ejnm-325	145	37	)	)	PUNCT
ejnm-325	145	38	11	11	NUM
ejnm-325	145	39	(	(	PUNCT
ejnm-325	145	40	29.7	29.7	NUM
ejnm-325	145	41	)	)	SYM
ejnm-325	145	42	1	1	NUM
ejnm-325	145	43	(	(	PUNCT
ejnm-325	145	44	2.7	2.7	NUM
ejnm-325	145	45	)	)	PUNCT
ejnm-325	145	46	dbp	dbp	PROPN
ejnm-325	145	47	low	low	PROPN
ejnm-325	145	48	diastolic	diastolic	NOUN
ejnm-325	145	49	blood	blood	NOUN
ejnm-325	145	50	pressure	pressure	NOUN
ejnm-325	145	51	1	1	NUM
ejnm-325	145	52	(	(	PUNCT
ejnm-325	145	53	25	25	NUM
ejnm-325	145	54	)	)	SYM
ejnm-325	145	55	1	1	NUM
ejnm-325	145	56	(	(	PUNCT
ejnm-325	145	57	25	25	NUM
ejnm-325	145	58	)	)	SYM
ejnm-325	145	59	2	2	NUM
ejnm-325	145	60	(	(	PUNCT
ejnm-325	145	61	50	50	NUM
ejnm-325	145	62	)	)	PUNCT
ejnm-325	145	63	0	0	NUM
ejnm-325	146	1	(	(	PUNCT
ejnm-325	146	2	0	0	NUM
ejnm-325	146	3	)	)	PUNCT
ejnm-325	146	4	0.348	0.348	NUM
ejnm-325	147	1	ns	ns	NUM
ejnm-325	147	2	normal	normal	ADJ
ejnm-325	147	3	diastolic	diastolic	NOUN
ejnm-325	147	4	blood	blood	NOUN
ejnm-325	147	5	pressure	pressure	NOUN
ejnm-325	147	6	24	24	NUM
ejnm-325	147	7	(	(	PUNCT
ejnm-325	147	8	54.5	54.5	NUM
ejnm-325	147	9	)	)	PUNCT
ejnm-325	147	10	11	11	NUM
ejnm-325	147	11	(	(	PUNCT
ejnm-325	147	12	25	25	NUM
ejnm-325	147	13	)	)	PUNCT
ejnm-325	147	14	8	8	NUM
ejnm-325	147	15	(	(	PUNCT
ejnm-325	147	16	18.2	18.2	NUM
ejnm-325	147	17	)	)	SYM
ejnm-325	147	18	1	1	NUM
ejnm-325	147	19	(	(	PUNCT
ejnm-325	147	20	2.3	2.3	NUM
ejnm-325	147	21	)	)	PUNCT
ejnm-325	147	22	high	high	ADJ
ejnm-325	147	23	diastolic	diastolic	ADJ
ejnm-325	147	24	blood	blood	NOUN
ejnm-325	147	25	pressure	pressure	NOUN
ejnm-325	147	26	7	7	NUM
ejnm-325	147	27	(	(	PUNCT
ejnm-325	147	28	26.9	26.9	NUM
ejnm-325	147	29	)	)	PUNCT
ejnm-325	147	30	9	9	NUM
ejnm-325	147	31	(	(	PUNCT
ejnm-325	147	32	34.6	34.6	NUM
ejnm-325	147	33	)	)	PUNCT
ejnm-325	147	34	9	9	NUM
ejnm-325	147	35	(	(	PUNCT
ejnm-325	147	36	34.6	34.6	NUM
ejnm-325	147	37	)	)	PUNCT
ejnm-325	147	38	1	1	NUM
ejnm-325	147	39	(	(	PUNCT
ejnm-325	147	40	3.8	3.8	NUM
ejnm-325	147	41	)	)	PUNCT
ejnm-325	147	42	spo2	spo2	PROPN
ejnm-325	147	43	hypoxemia	hypoxemia	PROPN
ejnm-325	147	44	18	18	NUM
ejnm-325	147	45	(	(	PUNCT
ejnm-325	147	46	30	30	NUM
ejnm-325	147	47	)	)	SYM
ejnm-325	147	48	21	21	NUM
ejnm-325	147	49	(	(	PUNCT
ejnm-325	147	50	35	35	NUM
ejnm-325	147	51	)	)	SYM
ejnm-325	147	52	19	19	NUM
ejnm-325	147	53	(	(	PUNCT
ejnm-325	147	54	31.7	31.7	NUM
ejnm-325	147	55	)	)	SYM
ejnm-325	147	56	2	2	NUM
ejnm-325	147	57	(	(	PUNCT
ejnm-325	147	58	3.3	3.3	NUM
ejnm-325	147	59	)	)	PUNCT
ejnm-325	147	60	<	<	X
ejnm-325	147	61	0.001	0.001	NUM
ejnm-325	147	62	vhs	vhs	NOUN
ejnm-325	147	63	normal	normal	ADJ
ejnm-325	147	64	spo2	spo2	PROPN
ejnm-325	147	65	14	14	NUM
ejnm-325	147	66	(	(	PUNCT
ejnm-325	147	67	100	100	NUM
ejnm-325	147	68	)	)	PUNCT
ejnm-325	147	69	0	0	NUM
ejnm-325	148	1	(	(	PUNCT
ejnm-325	148	2	0	0	NUM
ejnm-325	148	3	)	)	PUNCT
ejnm-325	148	4	0	0	NUM
ejnm-325	149	1	(	(	PUNCT
ejnm-325	149	2	0	0	NUM
ejnm-325	149	3	)	)	PUNCT
ejnm-325	149	4	0	0	NUM
ejnm-325	150	1	(	(	PUNCT
ejnm-325	150	2	0	0	NUM
ejnm-325	150	3	)	)	PUNCT
ejnm-325	150	4	pr	pr	VERB
ejnm-325	150	5	bradycardia	bradycardia	NOUN
ejnm-325	150	6	0	0	PUNCT
ejnm-325	151	1	(	(	PUNCT
ejnm-325	151	2	0	0	NUM
ejnm-325	151	3	)	)	PUNCT
ejnm-325	151	4	0	0	NUM
ejnm-325	152	1	(	(	PUNCT
ejnm-325	152	2	0	0	NUM
ejnm-325	152	3	)	)	PUNCT
ejnm-325	152	4	0	0	NUM
ejnm-325	153	1	(	(	PUNCT
ejnm-325	153	2	0	0	NUM
ejnm-325	153	3	)	)	PUNCT
ejnm-325	153	4	0	0	NUM
ejnm-325	154	1	(	(	PUNCT
ejnm-325	154	2	0	0	NUM
ejnm-325	154	3	)	)	PUNCT
ejnm-325	154	4	0.002	0.002	NUM
ejnm-325	154	5	hs	hs	PROPN
ejnm-325	154	6	normal	normal	ADJ
ejnm-325	154	7	pulse	pulse	NOUN
ejnm-325	154	8	rate	rate	NOUN
ejnm-325	154	9	18	18	NUM
ejnm-325	154	10	(	(	PUNCT
ejnm-325	154	11	69.2	69.2	NUM
ejnm-325	154	12	)	)	PUNCT
ejnm-325	154	13	7	7	NUM
ejnm-325	154	14	(	(	PUNCT
ejnm-325	154	15	26.9	26.9	NUM
ejnm-325	154	16	)	)	SYM
ejnm-325	154	17	1	1	NUM
ejnm-325	154	18	(	(	PUNCT
ejnm-325	154	19	3.8	3.8	NUM
ejnm-325	154	20	)	)	PUNCT
ejnm-325	154	21	0	0	NUM
ejnm-325	154	22	(	(	PUNCT
ejnm-325	154	23	0	0	NUM
ejnm-325	154	24	)	)	PUNCT
ejnm-325	154	25	tachycardia	tachycardia	NOUN
ejnm-325	154	26	14	14	NUM
ejnm-325	154	27	(	(	PUNCT
ejnm-325	154	28	29.2	29.2	NUM
ejnm-325	154	29	)	)	PUNCT
ejnm-325	154	30	14	14	NUM
ejnm-325	154	31	(	(	PUNCT
ejnm-325	154	32	29.2	29.2	NUM
ejnm-325	154	33	)	)	PUNCT
ejnm-325	154	34	18	18	NUM
ejnm-325	154	35	(	(	PUNCT
ejnm-325	154	36	37.5	37.5	NUM
ejnm-325	154	37	)	)	SYM
ejnm-325	154	38	2	2	NUM
ejnm-325	154	39	(	(	PUNCT
ejnm-325	154	40	4.2	4.2	NUM
ejnm-325	154	41	)	)	PUNCT
ejnm-325	154	42	temp	temp	NOUN
ejnm-325	154	43	hypothermia	hypothermia	NOUN
ejnm-325	154	44	8	8	NUM
ejnm-325	154	45	(	(	PUNCT
ejnm-325	154	46	38.1	38.1	NUM
ejnm-325	154	47	)	)	PUNCT
ejnm-325	154	48	6	6	NUM
ejnm-325	154	49	(	(	PUNCT
ejnm-325	154	50	28.6	28.6	NUM
ejnm-325	154	51	)	)	PUNCT
ejnm-325	154	52	6	6	NUM
ejnm-325	154	53	(	(	PUNCT
ejnm-325	154	54	28.6	28.6	NUM
ejnm-325	154	55	)	)	SYM
ejnm-325	154	56	1	1	NUM
ejnm-325	154	57	(	(	PUNCT
ejnm-325	154	58	4.8	4.8	NUM
ejnm-325	154	59	)	)	PUNCT
ejnm-325	154	60	0.306	0.306	NUM
ejnm-325	154	61	ns	ns	NUM
ejnm-325	154	62	normal	normal	ADJ
ejnm-325	154	63	body	body	NOUN
ejnm-325	154	64	temperature	temperature	NOUN
ejnm-325	154	65	17	17	NUM
ejnm-325	154	66	(	(	PUNCT
ejnm-325	154	67	56.7	56.7	NUM
ejnm-325	154	68	)	)	PUNCT
ejnm-325	154	69	9	9	NUM
ejnm-325	154	70	(	(	PUNCT
ejnm-325	154	71	30	30	NUM
ejnm-325	154	72	)	)	PUNCT
ejnm-325	154	73	4	4	NUM
ejnm-325	154	74	(	(	PUNCT
ejnm-325	154	75	13.3	13.3	NUM
ejnm-325	154	76	)	)	PUNCT
ejnm-325	154	77	0	0	NUM
ejnm-325	155	1	(	(	PUNCT
ejnm-325	155	2	0	0	NUM
ejnm-325	155	3	)	)	PUNCT
ejnm-325	155	4	hyperthermia	hyperthermia	NOUN
ejnm-325	155	5	7	7	NUM
ejnm-325	155	6	(	(	PUNCT
ejnm-325	155	7	30.4	30.4	NUM
ejnm-325	155	8	)	)	PUNCT
ejnm-325	155	9	6	6	NUM
ejnm-325	155	10	(	(	PUNCT
ejnm-325	155	11	26.1	26.1	NUM
ejnm-325	155	12	)	)	PUNCT
ejnm-325	155	13	9	9	NUM
ejnm-325	155	14	(	(	PUNCT
ejnm-325	155	15	39.1	39.1	NUM
ejnm-325	155	16	)	)	PUNCT
ejnm-325	155	17	1	1	NUM
ejnm-325	155	18	(	(	PUNCT
ejnm-325	155	19	4.3	4.3	NUM
ejnm-325	155	20	)	)	PUNCT
ejnm-325	155	21	crp	crp	PROPN
ejnm-325	155	22	normal	normal	ADJ
ejnm-325	155	23	crp	crp	PROPN
ejnm-325	155	24	10	10	NUM
ejnm-325	155	25	(	(	PUNCT
ejnm-325	155	26	58.8	58.8	NUM
ejnm-325	155	27	)	)	PUNCT
ejnm-325	155	28	5	5	NUM
ejnm-325	155	29	(	(	PUNCT
ejnm-325	155	30	29.4	29.4	NUM
ejnm-325	155	31	)	)	SYM
ejnm-325	155	32	2	2	NUM
ejnm-325	155	33	(	(	PUNCT
ejnm-325	155	34	11.8	11.8	NUM
ejnm-325	155	35	)	)	PUNCT
ejnm-325	155	36	0	0	NUM
ejnm-325	156	1	(	(	PUNCT
ejnm-325	156	2	0	0	NUM
ejnm-325	156	3	)	)	PUNCT
ejnm-325	156	4	0.320	0.320	NUM
ejnm-325	156	5	ns	ns	NUM
ejnm-325	156	6	high	high	ADJ
ejnm-325	156	7	crp	crp	PROPN
ejnm-325	156	8	22	22	NUM
ejnm-325	156	9	(	(	PUNCT
ejnm-325	156	10	38.6	38.6	NUM
ejnm-325	156	11	)	)	PUNCT
ejnm-325	156	12	16	16	NUM
ejnm-325	156	13	(	(	PUNCT
ejnm-325	156	14	28.1	28.1	NUM
ejnm-325	156	15	)	)	PUNCT
ejnm-325	156	16	17	17	NUM
ejnm-325	156	17	(	(	PUNCT
ejnm-325	156	18	29.8	29.8	NUM
ejnm-325	156	19	)	)	SYM
ejnm-325	156	20	2	2	NUM
ejnm-325	156	21	(	(	PUNCT
ejnm-325	156	22	3.5	3.5	NUM
ejnm-325	156	23	)	)	PUNCT
ejnm-325	156	24	d.	d.	NOUN
ejnm-325	156	25	dimer	dimer	VERB
ejnm-325	156	26	normal	normal	ADJ
ejnm-325	156	27	d	d	PROPN
ejnm-325	156	28	dimer	dimer	NOUN
ejnm-325	156	29	19	19	NUM
ejnm-325	156	30	(	(	PUNCT
ejnm-325	156	31	67.9	67.9	NUM
ejnm-325	156	32	)	)	PUNCT
ejnm-325	156	33	3	3	NUM
ejnm-325	156	34	(	(	PUNCT
ejnm-325	156	35	10.7	10.7	NUM
ejnm-325	156	36	)	)	PUNCT
ejnm-325	156	37	4	4	NUM
ejnm-325	156	38	(	(	PUNCT
ejnm-325	156	39	14.3	14.3	NUM
ejnm-325	156	40	)	)	PUNCT
ejnm-325	156	41	2	2	NUM
ejnm-325	156	42	(	(	PUNCT
ejnm-325	156	43	7.1	7.1	NUM
ejnm-325	156	44	)	)	PUNCT
ejnm-325	156	45	0.001	0.001	NUM
ejnm-325	156	46	vhs	vhs	NOUN
ejnm-325	156	47	high	high	ADJ
ejnm-325	156	48	d	d	X
ejnm-325	156	49	dimer	dimer	NOUN
ejnm-325	156	50	13	13	NUM
ejnm-325	156	51	(	(	PUNCT
ejnm-325	156	52	28.3	28.3	NUM
ejnm-325	156	53	)	)	SYM
ejnm-325	156	54	18	18	NUM
ejnm-325	156	55	(	(	PUNCT
ejnm-325	156	56	39.1	39.1	NUM
ejnm-325	156	57	)	)	PUNCT
ejnm-325	156	58	15	15	NUM
ejnm-325	156	59	(	(	PUNCT
ejnm-325	156	60	32.6	32.6	NUM
ejnm-325	156	61	)	)	PUNCT
ejnm-325	156	62	0	0	NUM
ejnm-325	157	1	(	(	PUNCT
ejnm-325	157	2	0	0	X
ejnm-325	157	3	)	)	PUNCT
ejnm-325	157	4	ldh	ldh	PROPN
ejnm-325	157	5	low	low	ADJ
ejnm-325	157	6	ldh	ldh	PROPN
ejnm-325	157	7	10	10	NUM
ejnm-325	157	8	(	(	PUNCT
ejnm-325	157	9	45.5	45.5	NUM
ejnm-325	157	10	)	)	PUNCT
ejnm-325	157	11	6	6	NUM
ejnm-325	157	12	(	(	PUNCT
ejnm-325	157	13	27.3	27.3	NUM
ejnm-325	157	14	)	)	PUNCT
ejnm-325	157	15	6	6	NUM
ejnm-325	157	16	(	(	PUNCT
ejnm-325	157	17	27.3	27.3	NUM
ejnm-325	157	18	)	)	PUNCT
ejnm-325	157	19	0	0	NUM
ejnm-325	158	1	(	(	PUNCT
ejnm-325	158	2	0	0	NUM
ejnm-325	158	3	)	)	PUNCT
ejnm-325	158	4	0.271	0.271	NUM
ejnm-325	158	5	ns	ns	NUM
ejnm-325	158	6	normal	normal	ADJ
ejnm-325	158	7	ldh	ldh	PROPN
ejnm-325	158	8	16	16	NUM
ejnm-325	158	9	(	(	PUNCT
ejnm-325	158	10	44.4	44.4	NUM
ejnm-325	158	11	)	)	PUNCT
ejnm-325	158	12	11	11	NUM
ejnm-325	158	13	(	(	PUNCT
ejnm-325	158	14	30.6	30.6	NUM
ejnm-325	158	15	)	)	PUNCT
ejnm-325	158	16	9	9	NUM
ejnm-325	158	17	(	(	PUNCT
ejnm-325	158	18	25	25	NUM
ejnm-325	158	19	)	)	PUNCT
ejnm-325	158	20	0	0	NUM
ejnm-325	159	1	(	(	PUNCT
ejnm-325	159	2	0	0	NUM
ejnm-325	159	3	)	)	PUNCT
ejnm-325	159	4	high	high	ADJ
ejnm-325	159	5	ldh	ldh	PROPN
ejnm-325	159	6	6	6	NUM
ejnm-325	159	7	(	(	PUNCT
ejnm-325	159	8	37.5	37.5	NUM
ejnm-325	159	9	)	)	PUNCT
ejnm-325	159	10	4	4	NUM
ejnm-325	159	11	(	(	PUNCT
ejnm-325	159	12	25	25	NUM
ejnm-325	159	13	)	)	PUNCT
ejnm-325	159	14	4	4	NUM
ejnm-325	159	15	(	(	PUNCT
ejnm-325	159	16	25	25	NUM
ejnm-325	159	17	)	)	SYM
ejnm-325	159	18	2	2	NUM
ejnm-325	159	19	(	(	PUNCT
ejnm-325	159	20	12.5	12.5	NUM
ejnm-325	159	21	)	)	PUNCT
ejnm-325	159	22	wbc	wbc	PROPN
ejnm-325	159	23	leukopenia	leukopenia	NOUN
ejnm-325	159	24	8	8	NUM
ejnm-325	159	25	(	(	PUNCT
ejnm-325	159	26	40	40	NUM
ejnm-325	159	27	)	)	PUNCT
ejnm-325	159	28	7	7	NUM
ejnm-325	159	29	(	(	PUNCT
ejnm-325	159	30	35	35	NUM
ejnm-325	159	31	)	)	SYM
ejnm-325	159	32	5	5	NUM
ejnm-325	159	33	(	(	PUNCT
ejnm-325	159	34	25	25	NUM
ejnm-325	159	35	)	)	PUNCT
ejnm-325	159	36	0	0	NUM
ejnm-325	160	1	(	(	PUNCT
ejnm-325	160	2	0	0	NUM
ejnm-325	160	3	)	)	PUNCT
ejnm-325	161	1	0.010	0.010	NUM
ejnm-325	161	2	s	s	VERB
ejnm-325	161	3	normal	normal	ADJ
ejnm-325	161	4	wbc	wbc	NOUN
ejnm-325	161	5	24	24	NUM
ejnm-325	161	6	(	(	PUNCT
ejnm-325	161	7	49	49	NUM
ejnm-325	161	8	)	)	PUNCT
ejnm-325	161	9	14	14	NUM
ejnm-325	161	10	(	(	PUNCT
ejnm-325	161	11	28.6	28.6	NUM
ejnm-325	161	12	)	)	PUNCT
ejnm-325	161	13	10	10	NUM
ejnm-325	161	14	(	(	PUNCT
ejnm-325	161	15	20.4	20.4	NUM
ejnm-325	161	16	)	)	SYM
ejnm-325	161	17	1	1	NUM
ejnm-325	161	18	(	(	PUNCT
ejnm-325	161	19	2	2	NUM
ejnm-325	161	20	)	)	PUNCT
ejnm-325	161	21	leukocytosis	leukocytosis	NOUN
ejnm-325	161	22	0	0	NUM
ejnm-325	161	23	(	(	PUNCT
ejnm-325	161	24	0	0	NUM
ejnm-325	161	25	)	)	PUNCT
ejnm-325	161	26	0	0	NUM
ejnm-325	161	27	(	(	PUNCT
ejnm-325	161	28	0	0	NUM
ejnm-325	161	29	)	)	PUNCT
ejnm-325	161	30	4	4	NUM
ejnm-325	161	31	(	(	PUNCT
ejnm-325	161	32	80	80	NUM
ejnm-325	161	33	)	)	SYM
ejnm-325	161	34	1	1	NUM
ejnm-325	161	35	(	(	PUNCT
ejnm-325	161	36	20	20	NUM
ejnm-325	161	37	)	)	PUNCT
ejnm-325	161	38	pulmonary	pulmonary	ADJ
ejnm-325	161	39	function	function	NOUN
ejnm-325	161	40	low	low	ADJ
ejnm-325	161	41	fev1	fev1	PROPN
ejnm-325	161	42	7	7	NUM
ejnm-325	161	43	(	(	PUNCT
ejnm-325	161	44	16.3	16.3	NUM
ejnm-325	161	45	)	)	PUNCT
ejnm-325	161	46	15	15	NUM
ejnm-325	161	47	(	(	PUNCT
ejnm-325	161	48	34.9	34.9	NUM
ejnm-325	161	49	)	)	PUNCT
ejnm-325	161	50	19	19	NUM
ejnm-325	161	51	(	(	PUNCT
ejnm-325	161	52	44.2	44.2	NUM
ejnm-325	161	53	)	)	SYM
ejnm-325	161	54	2	2	NUM
ejnm-325	161	55	(	(	PUNCT
ejnm-325	161	56	4.7	4.7	NUM
ejnm-325	161	57	)	)	PUNCT
ejnm-325	161	58	<	<	X
ejnm-325	161	59	0.001	0.001	NUM
ejnm-325	161	60	vhs	vhs	NOUN
ejnm-325	161	61	normal	normal	ADJ
ejnm-325	161	62	fev1	fev1	PROPN
ejnm-325	161	63	24	24	NUM
ejnm-325	161	64	(	(	PUNCT
ejnm-325	161	65	80	80	NUM
ejnm-325	161	66	)	)	PUNCT
ejnm-325	161	67	6	6	NUM
ejnm-325	161	68	(	(	PUNCT
ejnm-325	161	69	20	20	NUM
ejnm-325	161	70	)	)	PUNCT
ejnm-325	161	71	0	0	NUM
ejnm-325	161	72	(	(	PUNCT
ejnm-325	161	73	0	0	NUM
ejnm-325	161	74	)	)	PUNCT
ejnm-325	161	75	0	0	NUM
ejnm-325	162	1	(	(	PUNCT
ejnm-325	162	2	0	0	NUM
ejnm-325	162	3	)	)	PUNCT
ejnm-325	162	4	high	high	ADJ
ejnm-325	162	5	fev1	fev1	PROPN
ejnm-325	162	6	1	1	NUM
ejnm-325	162	7	(	(	PUNCT
ejnm-325	162	8	100	100	NUM
ejnm-325	162	9	)	)	PUNCT
ejnm-325	162	10	0	0	NUM
ejnm-325	162	11	(	(	PUNCT
ejnm-325	162	12	0	0	NUM
ejnm-325	162	13	)	)	PUNCT
ejnm-325	162	14	0	0	NUM
ejnm-325	162	15	(	(	PUNCT
ejnm-325	162	16	0	0	NUM
ejnm-325	162	17	)	)	PUNCT
ejnm-325	162	18	0	0	NUM
ejnm-325	162	19	(	(	PUNCT
ejnm-325	162	20	0	0	NUM
ejnm-325	162	21	)	)	PUNCT
ejnm-325	162	22	forced	force	VERB
ejnm-325	162	23	vital	vital	ADJ
ejnm-325	162	24	capacity	capacity	NOUN
ejnm-325	162	25	low	low	ADJ
ejnm-325	162	26	fvc	fvc	PROPN
ejnm-325	162	27	10	10	NUM
ejnm-325	162	28	(	(	PUNCT
ejnm-325	162	29	21.3	21.3	NUM
ejnm-325	162	30	)	)	PUNCT
ejnm-325	162	31	16	16	NUM
ejnm-325	162	32	(	(	PUNCT
ejnm-325	162	33	34	34	NUM
ejnm-325	162	34	)	)	SYM
ejnm-325	162	35	19	19	NUM
ejnm-325	162	36	(	(	PUNCT
ejnm-325	162	37	40.4	40.4	NUM
ejnm-325	162	38	)	)	SYM
ejnm-325	162	39	2	2	NUM
ejnm-325	162	40	(	(	PUNCT
ejnm-325	162	41	4.3	4.3	NUM
ejnm-325	162	42	)	)	PUNCT
ejnm-325	162	43	<	<	X
ejnm-325	162	44	0.001	0.001	NUM
ejnm-325	162	45	vhs	vhs	NOUN
ejnm-325	162	46	normal	normal	ADJ
ejnm-325	162	47	fvc	fvc	PROPN
ejnm-325	162	48	20	20	NUM
ejnm-325	162	49	(	(	PUNCT
ejnm-325	162	50	83.3	83.3	NUM
ejnm-325	162	51	)	)	PUNCT
ejnm-325	162	52	4	4	NUM
ejnm-325	162	53	(	(	PUNCT
ejnm-325	162	54	16.7	16.7	NUM
ejnm-325	162	55	)	)	PUNCT
ejnm-325	162	56	0	0	NUM
ejnm-325	163	1	(	(	PUNCT
ejnm-325	163	2	0	0	NUM
ejnm-325	163	3	)	)	PUNCT
ejnm-325	163	4	0	0	NUM
ejnm-325	164	1	(	(	PUNCT
ejnm-325	164	2	0	0	NUM
ejnm-325	164	3	)	)	PUNCT
ejnm-325	164	4	high	high	ADJ
ejnm-325	164	5	fvc	fvc	PROPN
ejnm-325	164	6	2	2	NUM
ejnm-325	164	7	(	(	PUNCT
ejnm-325	164	8	66.7	66.7	NUM
ejnm-325	164	9	)	)	PUNCT
ejnm-325	164	10	1	1	NUM
ejnm-325	164	11	(	(	PUNCT
ejnm-325	164	12	33.3	33.3	NUM
ejnm-325	164	13	)	)	PUNCT
ejnm-325	164	14	0	0	NUM
ejnm-325	164	15	(	(	PUNCT
ejnm-325	164	16	0	0	NUM
ejnm-325	164	17	)	)	PUNCT
ejnm-325	164	18	0	0	NUM
ejnm-325	164	19	(	(	PUNCT
ejnm-325	164	20	0	0	X
ejnm-325	164	21	)	)	PUNCT
ejnm-325	164	22	fev1fvc	fev1fvc	NOUN
ejnm-325	164	23	airflow	airflow	NOUN
ejnm-325	164	24	limitation	limitation	NOUN
ejnm-325	164	25	1	1	NUM
ejnm-325	164	26	(	(	PUNCT
ejnm-325	164	27	100	100	NUM
ejnm-325	164	28	)	)	PUNCT
ejnm-325	164	29	0	0	NUM
ejnm-325	164	30	(	(	PUNCT
ejnm-325	164	31	0	0	NUM
ejnm-325	164	32	)	)	PUNCT
ejnm-325	164	33	0	0	NUM
ejnm-325	164	34	(	(	PUNCT
ejnm-325	164	35	0	0	NUM
ejnm-325	164	36	)	)	PUNCT
ejnm-325	164	37	0	0	NUM
ejnm-325	165	1	(	(	PUNCT
ejnm-325	165	2	0	0	NUM
ejnm-325	165	3	)	)	PUNCT
ejnm-325	165	4	0.722	0.722	NUM
ejnm-325	165	5	ns	ns	NUM
ejnm-325	165	6	normal	normal	ADJ
ejnm-325	165	7	fev1	fev1	PROPN
ejnm-325	165	8	/	/	SYM
ejnm-325	165	9	fvc	fvc	PROPN
ejnm-325	165	10	0	0	NUM
ejnm-325	165	11	(	(	PUNCT
ejnm-325	165	12	0	0	NUM
ejnm-325	165	13	)	)	PUNCT
ejnm-325	165	14	0	0	NUM
ejnm-325	165	15	(	(	PUNCT
ejnm-325	165	16	0	0	NUM
ejnm-325	165	17	)	)	PUNCT
ejnm-325	165	18	0	0	NUM
ejnm-325	165	19	(	(	PUNCT
ejnm-325	165	20	0	0	NUM
ejnm-325	165	21	)	)	PUNCT
ejnm-325	165	22	0	0	NUM
ejnm-325	165	23	(	(	PUNCT
ejnm-325	165	24	0	0	NUM
ejnm-325	165	25	)	)	PUNCT
ejnm-325	165	26	more	more	ADJ
ejnm-325	165	27	than	than	ADP
ejnm-325	165	28	normal	normal	ADJ
ejnm-325	165	29	31	31	NUM
ejnm-325	165	30	(	(	PUNCT
ejnm-325	165	31	42.5	42.5	NUM
ejnm-325	165	32	)	)	PUNCT
ejnm-325	165	33	21	21	NUM
ejnm-325	165	34	(	(	PUNCT
ejnm-325	165	35	28.8	28.8	NUM
ejnm-325	165	36	)	)	SYM
ejnm-325	165	37	19	19	NUM
ejnm-325	165	38	(	(	PUNCT
ejnm-325	165	39	26	26	NUM
ejnm-325	165	40	)	)	PUNCT
ejnm-325	165	41	2	2	NUM
ejnm-325	165	42	(	(	PUNCT
ejnm-325	165	43	2.7	2.7	NUM
ejnm-325	165	44	)	)	PUNCT
ejnm-325	165	45	https://creativecommons.org/licenses/by-nc-sa/4.0/	https://creativecommons.org/licenses/by-nc-sa/4.0/	PROPN
ejnm-325	165	46	https://doi.org/10.15218/ejnm.2025.05	https://doi.org/10.15218/ejnm.2025.05	PROPN
ejnm-325	165	47	erbil	erbil	PROPN
ejnm-325	165	48	j.	j.	PROPN
ejnm-325	165	49	nurs	nurs	PROPN
ejnm-325	165	50	.	.	PUNCT
ejnm-325	166	1	midwifery	midwifery	ADJ
ejnm-325	166	2	,	,	PUNCT
ejnm-325	166	3	vol	vol	NOUN
ejnm-325	166	4	.	.	PROPN
ejnm-325	166	5	8	8	NUM
ejnm-325	166	6	,	,	PUNCT
ejnm-325	166	7	no	no	INTJ
ejnm-325	166	8	.	.	PUNCT
ejnm-325	167	1	(	(	PUNCT
ejnm-325	167	2	1	1	NUM
ejnm-325	167	3	)	)	PUNCT
ejnm-325	167	4	,	,	PUNCT
ejnm-325	167	5	may2025	may2025	ADJ
ejnm-325	167	6	original	original	ADJ
ejnm-325	167	7	article	article	NOUN
ejnm-325	167	8	pattern	pattern	NOUN
ejnm-325	167	9	,	,	PUNCT
ejnm-325	167	10	all	all	PRON
ejnm-325	167	11	of	of	ADP
ejnm-325	167	12	the	the	DET
ejnm-325	167	13	associations	association	NOUN
ejnm-325	167	14	are	be	AUX
ejnm-325	167	15	non	non	ADJ
ejnm-325	167	16	-	-	ADJ
ejnm-325	167	17	significant	significant	ADJ
ejnm-325	167	18	(	(	PUNCT
ejnm-325	167	19	p	p	NOUN
ejnm-325	167	20	-value	-value	PROPN
ejnm-325	167	21	>	>	NOUN
ejnm-325	167	22	0.05	0.05	NUM
ejnm-325	167	23	)	)	PUNCT
ejnm-325	167	24	.	.	PUNCT
ejnm-325	168	1	concerning	concern	VERB
ejnm-325	168	2	the	the	DET
ejnm-325	168	3	association	association	NOUN
ejnm-325	168	4	between	between	ADP
ejnm-325	168	5	demographic	demographic	ADJ
ejnm-325	168	6	and	and	CCONJ
ejnm-325	168	7	clinical	clinical	ADJ
ejnm-325	168	8	characteristics	characteristic	NOUN
ejnm-325	168	9	and	and	CCONJ
ejnm-325	168	10	the	the	DET
ejnm-325	168	11	spirometry	spirometry	NOUN
ejnm-325	168	12	44	44	NUM
ejnm-325	168	13	copyright	copyright	NOUN
ejnm-325	168	14	©	©	PROPN
ejnm-325	168	15	2025	2025	NUM
ejnm-325	168	16	the	the	DET
ejnm-325	168	17	author(s	author(s	NOUN
ejnm-325	168	18	)	)	PUNCT
ejnm-325	168	19	.	.	PUNCT
ejnm-325	169	1	this	this	PRON
ejnm-325	169	2	is	be	AUX
ejnm-325	169	3	an	an	DET
ejnm-325	169	4	open	open	ADJ
ejnm-325	169	5	access	access	NOUN
ejnm-325	169	6	article	article	NOUN
ejnm-325	169	7	which	which	PRON
ejnm-325	169	8	licensed	license	VERB
ejnm-325	169	9	under	under	ADP
ejnm-325	169	10	the	the	DET
ejnm-325	169	11	terms	term	NOUN
ejnm-325	169	12	and	and	CCONJ
ejnm-325	169	13	conditions	condition	NOUN
ejnm-325	169	14	of	of	ADP
ejnm-325	169	15	the	the	DET
ejnm-325	169	16	creative	creative	ADJ
ejnm-325	169	17	commons	common	NOUN
ejnm-325	169	18	attribution	attribution	NOUN
ejnm-325	169	19	-	-	PUNCT
ejnm-325	169	20	noncommercial	noncommercial	ADJ
ejnm-325	169	21	-	-	PUNCT
ejnm-325	169	22	sharealike	sharealike	ADJ
ejnm-325	169	23	4.0	4.0	NUM
ejnm-325	169	24	international	international	ADJ
ejnm-325	169	25	license	license	NOUN
ejnm-325	169	26	.	.	PUNCT
ejnm-325	170	1	it	it	PRON
ejnm-325	170	2	permits	permit	VERB
ejnm-325	170	3	no	no	DET
ejnm-325	170	4	additional	additional	ADJ
ejnm-325	170	5	restrictions	restriction	NOUN
ejnm-325	170	6	on	on	ADP
ejnm-325	170	7	use	use	NOUN
ejnm-325	170	8	,	,	PUNCT
ejnm-325	170	9	distribution	distribution	NOUN
ejnm-325	170	10	,	,	PUNCT
ejnm-325	170	11	and	and	CCONJ
ejnm-325	170	12	reproduction	reproduction	NOUN
ejnm-325	170	13	in	in	ADP
ejnm-325	170	14	any	any	DET
ejnm-325	170	15	medium	medium	NOUN
ejnm-325	170	16	provided	provide	VERB
ejnm-325	170	17	the	the	DET
ejnm-325	170	18	original	original	ADJ
ejnm-325	170	19	work	work	NOUN
ejnm-325	170	20	is	be	AUX
ejnm-325	170	21	properly	properly	ADV
ejnm-325	170	22	cited	cite	VERB
ejnm-325	170	23	.	.	PUNCT
ejnm-325	171	1	table	table	NOUN
ejnm-325	171	2	6	6	NUM
ejnm-325	171	3	:	:	PUNCT
ejnm-325	171	4	association	association	NOUN
ejnm-325	171	5	between	between	ADP
ejnm-325	171	6	demographic	demographic	ADJ
ejnm-325	171	7	and	and	CCONJ
ejnm-325	171	8	clinical	clinical	ADJ
ejnm-325	171	9	characteristics	characteristic	NOUN
ejnm-325	171	10	and	and	CCONJ
ejnm-325	171	11	the	the	DET
ejnm-325	171	12	spirometry	spirometry	NOUN
ejnm-325	171	13	pattern	pattern	NOUN
ejnm-325	171	14	demographic	demographic	ADJ
ejnm-325	171	15	and	and	CCONJ
ejnm-325	171	16	clinical	clinical	ADJ
ejnm-325	171	17	characteristics	characteristic	NOUN
ejnm-325	171	18	spirometry	spirometry	NOUN
ejnm-325	171	19	pattern	pattern	NOUN
ejnm-325	171	20	p	p	NOUN
ejnm-325	171	21	-	-	PUNCT
ejnm-325	171	22	value	value	NOUN
ejnm-325	171	23	normal	normal	ADJ
ejnm-325	171	24	obstructive	obstructive	ADJ
ejnm-325	171	25	restrictive	restrictive	ADJ
ejnm-325	171	26	f.	f.	PROPN
ejnm-325	171	27	(	(	PUNCT
ejnm-325	171	28	%	%	INTJ
ejnm-325	171	29	)	)	PUNCT
ejnm-325	172	1	f.	f.	PROPN
ejnm-325	172	2	(	(	PUNCT
ejnm-325	172	3	%	%	INTJ
ejnm-325	172	4	)	)	PUNCT
ejnm-325	173	1	f.	f.	PROPN
ejnm-325	173	2	(	(	PUNCT
ejnm-325	173	3	%	%	INTJ
ejnm-325	173	4	)	)	PUNCT
ejnm-325	173	5	age	age	NOUN
ejnm-325	173	6	groups	group	NOUN
ejnm-325	173	7	(	(	PUNCT
ejnm-325	173	8	years	year	NOUN
ejnm-325	173	9	)	)	PUNCT
ejnm-325	173	10	22	22	NUM
ejnm-325	173	11	-	-	SYM
ejnm-325	173	12	37	37	NUM
ejnm-325	173	13	11	11	NUM
ejnm-325	173	14	(	(	PUNCT
ejnm-325	173	15	84.6	84.6	NUM
ejnm-325	173	16	)	)	PUNCT
ejnm-325	173	17	0	0	NUM
ejnm-325	174	1	(	(	PUNCT
ejnm-325	174	2	0	0	NUM
ejnm-325	174	3	)	)	SYM
ejnm-325	174	4	2	2	NUM
ejnm-325	174	5	(	(	PUNCT
ejnm-325	174	6	15.4	15.4	NUM
ejnm-325	174	7	)	)	PUNCT
ejnm-325	174	8	0.367	0.367	NUM
ejnm-325	174	9	ns	ns	NUM
ejnm-325	174	10	38	38	NUM
ejnm-325	174	11	-	-	SYM
ejnm-325	174	12	53	53	NUM
ejnm-325	174	13	16	16	NUM
ejnm-325	174	14	(	(	PUNCT
ejnm-325	174	15	80	80	NUM
ejnm-325	174	16	)	)	PUNCT
ejnm-325	174	17	0	0	NUM
ejnm-325	175	1	(	(	PUNCT
ejnm-325	175	2	0	0	NUM
ejnm-325	175	3	)	)	PUNCT
ejnm-325	175	4	4	4	NUM
ejnm-325	175	5	(	(	PUNCT
ejnm-325	175	6	20	20	NUM
ejnm-325	175	7	)	)	PUNCT
ejnm-325	175	8	54	54	NUM
ejnm-325	175	9	-	-	SYM
ejnm-325	175	10	69	69	NUM
ejnm-325	175	11	26	26	NUM
ejnm-325	175	12	(	(	PUNCT
ejnm-325	175	13	63.4	63.4	NUM
ejnm-325	175	14	)	)	PUNCT
ejnm-325	175	15	3	3	NUM
ejnm-325	175	16	(	(	PUNCT
ejnm-325	175	17	7.3	7.3	NUM
ejnm-325	175	18	)	)	PUNCT
ejnm-325	175	19	12	12	NUM
ejnm-325	175	20	(	(	PUNCT
ejnm-325	175	21	29.3	29.3	NUM
ejnm-325	175	22	)	)	PUNCT
ejnm-325	175	23	sex	sex	NOUN
ejnm-325	175	24	male	male	NOUN
ejnm-325	175	25	34	34	NUM
ejnm-325	175	26	(	(	PUNCT
ejnm-325	175	27	72.3	72.3	NUM
ejnm-325	175	28	)	)	PUNCT
ejnm-325	175	29	3	3	NUM
ejnm-325	175	30	(	(	PUNCT
ejnm-325	175	31	6.4	6.4	NUM
ejnm-325	175	32	)	)	PUNCT
ejnm-325	175	33	10	10	NUM
ejnm-325	175	34	(	(	PUNCT
ejnm-325	175	35	21.3	21.3	NUM
ejnm-325	175	36	)	)	PUNCT
ejnm-325	175	37	0.329	0.329	NUM
ejnm-325	175	38	ns	ns	NUM
ejnm-325	175	39	female	female	ADJ
ejnm-325	175	40	19	19	NUM
ejnm-325	175	41	(	(	PUNCT
ejnm-325	175	42	70.4	70.4	NUM
ejnm-325	175	43	)	)	PUNCT
ejnm-325	175	44	0	0	NUM
ejnm-325	176	1	(	(	PUNCT
ejnm-325	176	2	0	0	NUM
ejnm-325	176	3	)	)	SYM
ejnm-325	176	4	8	8	NUM
ejnm-325	176	5	(	(	PUNCT
ejnm-325	176	6	29.6	29.6	NUM
ejnm-325	176	7	)	)	PUNCT
ejnm-325	176	8	cough	cough	NOUN
ejnm-325	176	9	no	no	DET
ejnm-325	176	10	17	17	NUM
ejnm-325	176	11	(	(	PUNCT
ejnm-325	176	12	68	68	NUM
ejnm-325	176	13	)	)	SYM
ejnm-325	176	14	1	1	NUM
ejnm-325	176	15	(	(	PUNCT
ejnm-325	176	16	4	4	NUM
ejnm-325	176	17	)	)	PUNCT
ejnm-325	176	18	7	7	NUM
ejnm-325	176	19	(	(	PUNCT
ejnm-325	176	20	28	28	NUM
ejnm-325	176	21	)	)	PUNCT
ejnm-325	176	22	0.870	0.870	NUM
ejnm-325	176	23	ns	ns	NUM
ejnm-325	177	1	yes	yes	INTJ
ejnm-325	177	2	36	36	NUM
ejnm-325	177	3	(	(	PUNCT
ejnm-325	177	4	73.5	73.5	NUM
ejnm-325	177	5	)	)	PUNCT
ejnm-325	177	6	2	2	NUM
ejnm-325	177	7	(	(	PUNCT
ejnm-325	177	8	4.1	4.1	NUM
ejnm-325	177	9	)	)	PUNCT
ejnm-325	177	10	11	11	NUM
ejnm-325	177	11	(	(	PUNCT
ejnm-325	177	12	22.4	22.4	NUM
ejnm-325	177	13	)	)	PUNCT
ejnm-325	177	14	fever	fever	NOUN
ejnm-325	177	15	no	no	DET
ejnm-325	177	16	39	39	NUM
ejnm-325	177	17	(	(	PUNCT
ejnm-325	177	18	78	78	NUM
ejnm-325	177	19	)	)	SYM
ejnm-325	177	20	2	2	NUM
ejnm-325	177	21	(	(	PUNCT
ejnm-325	177	22	4	4	NUM
ejnm-325	177	23	)	)	PUNCT
ejnm-325	177	24	9	9	NUM
ejnm-325	177	25	(	(	PUNCT
ejnm-325	177	26	18	18	NUM
ejnm-325	177	27	)	)	PUNCT
ejnm-325	177	28	0.182	0.182	NUM
ejnm-325	177	29	ns	ns	NUM
ejnm-325	178	1	yes	yes	INTJ
ejnm-325	178	2	14	14	NUM
ejnm-325	178	3	(	(	PUNCT
ejnm-325	178	4	58.3	58.3	NUM
ejnm-325	178	5	)	)	PUNCT
ejnm-325	178	6	1	1	NUM
ejnm-325	178	7	(	(	PUNCT
ejnm-325	178	8	4.2	4.2	NUM
ejnm-325	178	9	)	)	PUNCT
ejnm-325	178	10	9	9	NUM
ejnm-325	178	11	(	(	PUNCT
ejnm-325	178	12	37.5	37.5	NUM
ejnm-325	178	13	)	)	PUNCT
ejnm-325	178	14	sob	sob	VERB
ejnm-325	178	15	no	no	DET
ejnm-325	178	16	15	15	NUM
ejnm-325	178	17	(	(	PUNCT
ejnm-325	178	18	75	75	NUM
ejnm-325	178	19	)	)	SYM
ejnm-325	178	20	1	1	NUM
ejnm-325	178	21	(	(	PUNCT
ejnm-325	178	22	5	5	NUM
ejnm-325	178	23	)	)	PUNCT
ejnm-325	178	24	4	4	NUM
ejnm-325	178	25	(	(	PUNCT
ejnm-325	178	26	20	20	NUM
ejnm-325	178	27	)	)	PUNCT
ejnm-325	178	28	0.854	0.854	NUM
ejnm-325	178	29	ns	ns	NUM
ejnm-325	179	1	yes	yes	INTJ
ejnm-325	179	2	38	38	NUM
ejnm-325	179	3	(	(	PUNCT
ejnm-325	179	4	70.4	70.4	NUM
ejnm-325	179	5	)	)	SYM
ejnm-325	179	6	2	2	NUM
ejnm-325	179	7	(	(	PUNCT
ejnm-325	179	8	3.7	3.7	NUM
ejnm-325	179	9	)	)	PUNCT
ejnm-325	179	10	14	14	NUM
ejnm-325	179	11	(	(	PUNCT
ejnm-325	179	12	25.9	25.9	NUM
ejnm-325	179	13	)	)	PUNCT
ejnm-325	179	14	pregnancy	pregnancy	NOUN
ejnm-325	180	1	no	no	DET
ejnm-325	180	2	53	53	NUM
ejnm-325	180	3	(	(	PUNCT
ejnm-325	180	4	71.6	71.6	NUM
ejnm-325	180	5	)	)	PUNCT
ejnm-325	180	6	3	3	NUM
ejnm-325	180	7	(	(	PUNCT
ejnm-325	180	8	4.1	4.1	NUM
ejnm-325	180	9	)	)	SYM
ejnm-325	180	10	18	18	NUM
ejnm-325	180	11	(	(	PUNCT
ejnm-325	180	12	24.3	24.3	NUM
ejnm-325	180	13	)	)	PUNCT
ejnm-325	180	14	constant	constant	ADJ
ejnm-325	181	1	yes	yes	INTJ
ejnm-325	181	2	0	0	NUM
ejnm-325	182	1	(	(	PUNCT
ejnm-325	182	2	0	0	NUM
ejnm-325	182	3	)	)	PUNCT
ejnm-325	182	4	0	0	NUM
ejnm-325	183	1	(	(	PUNCT
ejnm-325	183	2	0	0	NUM
ejnm-325	183	3	)	)	PUNCT
ejnm-325	183	4	0	0	NUM
ejnm-325	184	1	(	(	PUNCT
ejnm-325	184	2	0	0	NUM
ejnm-325	184	3	)	)	PUNCT
ejnm-325	184	4	sbp	sbp	NOUN
ejnm-325	184	5	low	low	ADJ
ejnm-325	184	6	systolic	systolic	ADJ
ejnm-325	184	7	blood	blood	NOUN
ejnm-325	184	8	pressure	pressure	NOUN
ejnm-325	184	9	3	3	NUM
ejnm-325	184	10	(	(	PUNCT
ejnm-325	184	11	75	75	NUM
ejnm-325	184	12	)	)	PUNCT
ejnm-325	184	13	0	0	NUM
ejnm-325	185	1	(	(	PUNCT
ejnm-325	185	2	0	0	NUM
ejnm-325	185	3	)	)	SYM
ejnm-325	185	4	1	1	NUM
ejnm-325	185	5	(	(	PUNCT
ejnm-325	185	6	25	25	NUM
ejnm-325	185	7	)	)	PUNCT
ejnm-325	185	8	0.775	0.775	NUM
ejnm-325	185	9	ns	ns	NUM
ejnm-325	185	10	normal	normal	ADJ
ejnm-325	185	11	systolic	systolic	ADJ
ejnm-325	185	12	blood	blood	NOUN
ejnm-325	185	13	pressure	pressure	NOUN
ejnm-325	185	14	25	25	NUM
ejnm-325	185	15	(	(	PUNCT
ejnm-325	185	16	75.8	75.8	NUM
ejnm-325	185	17	)	)	SYM
ejnm-325	185	18	2	2	NUM
ejnm-325	185	19	(	(	PUNCT
ejnm-325	185	20	6.1	6.1	NUM
ejnm-325	185	21	)	)	PUNCT
ejnm-325	185	22	6	6	NUM
ejnm-325	185	23	(	(	PUNCT
ejnm-325	185	24	18.2	18.2	NUM
ejnm-325	185	25	)	)	PUNCT
ejnm-325	185	26	high	high	ADJ
ejnm-325	185	27	systolic	systolic	ADJ
ejnm-325	185	28	blood	blood	NOUN
ejnm-325	185	29	pressure	pressure	NOUN
ejnm-325	185	30	25	25	NUM
ejnm-325	185	31	(	(	PUNCT
ejnm-325	185	32	67.6	67.6	NUM
ejnm-325	185	33	)	)	SYM
ejnm-325	185	34	1	1	NUM
ejnm-325	185	35	(	(	PUNCT
ejnm-325	185	36	2.7	2.7	NUM
ejnm-325	185	37	)	)	PUNCT
ejnm-325	185	38	11	11	NUM
ejnm-325	185	39	(	(	PUNCT
ejnm-325	185	40	29.7	29.7	NUM
ejnm-325	185	41	)	)	PUNCT
ejnm-325	185	42	dbp	dbp	PROPN
ejnm-325	185	43	low	low	PROPN
ejnm-325	185	44	diastolic	diastolic	NOUN
ejnm-325	185	45	blood	blood	NOUN
ejnm-325	185	46	pressure	pressure	NOUN
ejnm-325	185	47	3	3	NUM
ejnm-325	185	48	(	(	PUNCT
ejnm-325	185	49	75	75	NUM
ejnm-325	185	50	)	)	PUNCT
ejnm-325	185	51	0	0	NUM
ejnm-325	186	1	(	(	PUNCT
ejnm-325	186	2	0	0	NUM
ejnm-325	186	3	)	)	SYM
ejnm-325	186	4	1	1	NUM
ejnm-325	186	5	(	(	PUNCT
ejnm-325	186	6	25	25	NUM
ejnm-325	186	7	)	)	PUNCT
ejnm-325	186	8	0.987	0.987	NUM
ejnm-325	186	9	ns	ns	NUM
ejnm-325	186	10	normal	normal	ADJ
ejnm-325	186	11	diastolic	diastolic	NOUN
ejnm-325	186	12	blood	blood	NOUN
ejnm-325	186	13	pressure	pressure	NOUN
ejnm-325	186	14	32	32	NUM
ejnm-325	186	15	(	(	PUNCT
ejnm-325	186	16	72.7	72.7	NUM
ejnm-325	186	17	)	)	SYM
ejnm-325	186	18	2	2	NUM
ejnm-325	186	19	(	(	PUNCT
ejnm-325	186	20	4.5	4.5	NUM
ejnm-325	186	21	)	)	PUNCT
ejnm-325	186	22	10	10	NUM
ejnm-325	186	23	(	(	PUNCT
ejnm-325	186	24	22.7	22.7	NUM
ejnm-325	186	25	)	)	PUNCT
ejnm-325	186	26	high	high	ADJ
ejnm-325	186	27	diastolic	diastolic	ADJ
ejnm-325	186	28	blood	blood	NOUN
ejnm-325	186	29	pressure	pressure	NOUN
ejnm-325	186	30	18	18	NUM
ejnm-325	186	31	(	(	PUNCT
ejnm-325	186	32	69.2	69.2	NUM
ejnm-325	186	33	)	)	PUNCT
ejnm-325	186	34	1	1	NUM
ejnm-325	186	35	(	(	PUNCT
ejnm-325	186	36	3.8	3.8	NUM
ejnm-325	186	37	)	)	PUNCT
ejnm-325	186	38	7	7	NUM
ejnm-325	186	39	(	(	PUNCT
ejnm-325	186	40	26.9	26.9	NUM
ejnm-325	186	41	)	)	PUNCT
ejnm-325	186	42	spo2	spo2	PROPN
ejnm-325	186	43	hypoxemia	hypoxemia	PROPN
ejnm-325	186	44	41	41	NUM
ejnm-325	186	45	(	(	PUNCT
ejnm-325	186	46	68.3	68.3	NUM
ejnm-325	186	47	)	)	PUNCT
ejnm-325	186	48	3	3	NUM
ejnm-325	186	49	(	(	PUNCT
ejnm-325	186	50	5	5	NUM
ejnm-325	186	51	)	)	PUNCT
ejnm-325	186	52	16	16	NUM
ejnm-325	186	53	(	(	PUNCT
ejnm-325	186	54	26.7	26.7	NUM
ejnm-325	186	55	)	)	PUNCT
ejnm-325	186	56	0.388	0.388	NUM
ejnm-325	186	57	ns	ns	NUM
ejnm-325	186	58	normal	normal	ADJ
ejnm-325	186	59	spo2	spo2	PROPN
ejnm-325	186	60	12	12	NUM
ejnm-325	186	61	(	(	PUNCT
ejnm-325	186	62	85.7	85.7	NUM
ejnm-325	186	63	)	)	PUNCT
ejnm-325	186	64	0	0	NUM
ejnm-325	186	65	(	(	PUNCT
ejnm-325	186	66	0	0	NUM
ejnm-325	186	67	)	)	SYM
ejnm-325	186	68	2	2	NUM
ejnm-325	186	69	(	(	PUNCT
ejnm-325	186	70	14.3	14.3	NUM
ejnm-325	186	71	)	)	PUNCT
ejnm-325	186	72	temp	temp	NOUN
ejnm-325	186	73	hypothermia	hypothermia	NOUN
ejnm-325	186	74	15	15	NUM
ejnm-325	186	75	(	(	PUNCT
ejnm-325	186	76	71.4	71.4	NUM
ejnm-325	186	77	)	)	PUNCT
ejnm-325	186	78	2	2	NUM
ejnm-325	186	79	(	(	PUNCT
ejnm-325	186	80	9.5	9.5	NUM
ejnm-325	186	81	)	)	PUNCT
ejnm-325	186	82	4	4	NUM
ejnm-325	186	83	(	(	PUNCT
ejnm-325	186	84	19	19	NUM
ejnm-325	186	85	)	)	PUNCT
ejnm-325	186	86	0.371	0.371	NUM
ejnm-325	186	87	ns	ns	ADJ
ejnm-325	186	88	normal	normal	ADJ
ejnm-325	186	89	body	body	NOUN
ejnm-325	186	90	temperature	temperature	NOUN
ejnm-325	186	91	23	23	NUM
ejnm-325	186	92	(	(	PUNCT
ejnm-325	186	93	76.7	76.7	NUM
ejnm-325	186	94	)	)	PUNCT
ejnm-325	186	95	1	1	NUM
ejnm-325	186	96	(	(	PUNCT
ejnm-325	186	97	3.3	3.3	NUM
ejnm-325	186	98	)	)	PUNCT
ejnm-325	186	99	6	6	NUM
ejnm-325	186	100	(	(	PUNCT
ejnm-325	186	101	20	20	NUM
ejnm-325	186	102	)	)	PUNCT
ejnm-325	186	103	hyperthermia	hyperthermia	NOUN
ejnm-325	186	104	15	15	NUM
ejnm-325	186	105	(	(	PUNCT
ejnm-325	186	106	65.2	65.2	NUM
ejnm-325	186	107	)	)	PUNCT
ejnm-325	186	108	0	0	NUM
ejnm-325	186	109	(	(	PUNCT
ejnm-325	186	110	0	0	NUM
ejnm-325	186	111	)	)	SYM
ejnm-325	186	112	8	8	NUM
ejnm-325	186	113	(	(	PUNCT
ejnm-325	186	114	34.8	34.8	NUM
ejnm-325	186	115	)	)	PUNCT
ejnm-325	186	116	pmh	pmh	NOUN
ejnm-325	186	117	none	none	NOUN
ejnm-325	186	118	29	29	NUM
ejnm-325	186	119	(	(	PUNCT
ejnm-325	186	120	74.4	74.4	NUM
ejnm-325	186	121	)	)	PUNCT
ejnm-325	186	122	0	0	NUM
ejnm-325	186	123	(	(	PUNCT
ejnm-325	186	124	0	0	NUM
ejnm-325	186	125	)	)	PUNCT
ejnm-325	186	126	10	10	NUM
ejnm-325	186	127	(	(	PUNCT
ejnm-325	186	128	25.6	25.6	NUM
ejnm-325	186	129	)	)	PUNCT
ejnm-325	186	130	0.244	0.244	NUM
ejnm-325	186	131	ns	ns	NUM
ejnm-325	186	132	asthma	asthma	NOUN
ejnm-325	186	133	2	2	NUM
ejnm-325	186	134	(	(	PUNCT
ejnm-325	186	135	100	100	NUM
ejnm-325	186	136	)	)	PUNCT
ejnm-325	186	137	0	0	NUM
ejnm-325	186	138	(	(	PUNCT
ejnm-325	186	139	0	0	NUM
ejnm-325	186	140	)	)	PUNCT
ejnm-325	186	141	0	0	NUM
ejnm-325	187	1	(	(	PUNCT
ejnm-325	187	2	0	0	X
ejnm-325	187	3	)	)	PUNCT
ejnm-325	187	4	copd	copd	NOUN
ejnm-325	187	5	4	4	NUM
ejnm-325	187	6	(	(	PUNCT
ejnm-325	187	7	80	80	NUM
ejnm-325	187	8	)	)	SYM
ejnm-325	187	9	1	1	NUM
ejnm-325	187	10	(	(	PUNCT
ejnm-325	187	11	20	20	NUM
ejnm-325	187	12	)	)	PUNCT
ejnm-325	187	13	0	0	NUM
ejnm-325	188	1	(	(	PUNCT
ejnm-325	188	2	0	0	X
ejnm-325	188	3	)	)	PUNCT
ejnm-325	188	4	others	other	NOUN
ejnm-325	188	5	18	18	NUM
ejnm-325	188	6	(	(	PUNCT
ejnm-325	188	7	64.3	64.3	NUM
ejnm-325	188	8	)	)	SYM
ejnm-325	188	9	2	2	NUM
ejnm-325	188	10	(	(	PUNCT
ejnm-325	188	11	7.1	7.1	NUM
ejnm-325	188	12	)	)	PUNCT
ejnm-325	188	13	8	8	NUM
ejnm-325	188	14	(	(	PUNCT
ejnm-325	188	15	28.6	28.6	NUM
ejnm-325	188	16	)	)	PUNCT
ejnm-325	188	17	crp	crp	PROPN
ejnm-325	188	18	normal	normal	ADJ
ejnm-325	188	19	crp	crp	PROPN
ejnm-325	188	20	16	16	NUM
ejnm-325	188	21	(	(	PUNCT
ejnm-325	188	22	94.1	94.1	NUM
ejnm-325	188	23	)	)	PUNCT
ejnm-325	188	24	0	0	NUM
ejnm-325	189	1	(	(	PUNCT
ejnm-325	189	2	0	0	NUM
ejnm-325	189	3	)	)	SYM
ejnm-325	189	4	1	1	NUM
ejnm-325	189	5	(	(	PUNCT
ejnm-325	189	6	5.9	5.9	NUM
ejnm-325	189	7	)	)	PUNCT
ejnm-325	189	8	0.069	0.069	NUM
ejnm-325	189	9	ns	ns	NUM
ejnm-325	189	10	high	high	PROPN
ejnm-325	189	11	crp	crp	PROPN
ejnm-325	189	12	37	37	NUM
ejnm-325	189	13	(	(	PUNCT
ejnm-325	189	14	64.9	64.9	NUM
ejnm-325	189	15	)	)	PUNCT
ejnm-325	189	16	3	3	NUM
ejnm-325	189	17	(	(	PUNCT
ejnm-325	189	18	5.3	5.3	NUM
ejnm-325	189	19	)	)	PUNCT
ejnm-325	189	20	17	17	NUM
ejnm-325	189	21	(	(	PUNCT
ejnm-325	189	22	29.8	29.8	NUM
ejnm-325	189	23	)	)	PUNCT
ejnm-325	189	24	d.	d.	NOUN
ejnm-325	189	25	dimer	dimer	VERB
ejnm-325	189	26	normal	normal	ADJ
ejnm-325	189	27	d	d	PROPN
ejnm-325	189	28	dimer	dimer	NOUN
ejnm-325	189	29	19	19	NUM
ejnm-325	189	30	(	(	PUNCT
ejnm-325	189	31	67.9	67.9	NUM
ejnm-325	189	32	)	)	SYM
ejnm-325	189	33	1	1	NUM
ejnm-325	189	34	(	(	PUNCT
ejnm-325	189	35	3.6	3.6	NUM
ejnm-325	189	36	)	)	SYM
ejnm-325	189	37	8	8	NUM
ejnm-325	189	38	(	(	PUNCT
ejnm-325	189	39	28.6	28.6	NUM
ejnm-325	189	40	)	)	PUNCT
ejnm-325	189	41	0.799	0.799	NUM
ejnm-325	189	42	ns	ns	NUM
ejnm-325	189	43	high	high	ADJ
ejnm-325	189	44	d	d	PROPN
ejnm-325	189	45	dimer	dimer	NOUN
ejnm-325	189	46	34	34	NUM
ejnm-325	189	47	(	(	PUNCT
ejnm-325	189	48	73.9	73.9	NUM
ejnm-325	189	49	)	)	SYM
ejnm-325	189	50	2	2	NUM
ejnm-325	189	51	(	(	PUNCT
ejnm-325	189	52	4.3	4.3	NUM
ejnm-325	189	53	)	)	PUNCT
ejnm-325	189	54	10	10	NUM
ejnm-325	189	55	(	(	PUNCT
ejnm-325	189	56	21.7	21.7	NUM
ejnm-325	189	57	)	)	PUNCT
ejnm-325	189	58	smoking	smoke	VERB
ejnm-325	189	59	no	no	PRON
ejnm-325	189	60	smoker	smoker	NOUN
ejnm-325	189	61	35	35	NUM
ejnm-325	189	62	(	(	PUNCT
ejnm-325	189	63	71.4	71.4	NUM
ejnm-325	189	64	)	)	PUNCT
ejnm-325	189	65	2	2	NUM
ejnm-325	189	66	(	(	PUNCT
ejnm-325	189	67	4.1	4.1	NUM
ejnm-325	189	68	)	)	PUNCT
ejnm-325	189	69	12	12	NUM
ejnm-325	189	70	(	(	PUNCT
ejnm-325	189	71	24.5	24.5	NUM
ejnm-325	189	72	)	)	PUNCT
ejnm-325	189	73	0.860	0.860	NUM
ejnm-325	189	74	ns	ns	NUM
ejnm-325	189	75	smoker	smoker	ADP
ejnm-325	189	76	5	5	NUM
ejnm-325	189	77	(	(	PUNCT
ejnm-325	189	78	62.5	62.5	NUM
ejnm-325	189	79	)	)	PUNCT
ejnm-325	189	80	1	1	NUM
ejnm-325	189	81	(	(	PUNCT
ejnm-325	189	82	12.5	12.5	NUM
ejnm-325	189	83	)	)	SYM
ejnm-325	189	84	2	2	NUM
ejnm-325	189	85	(	(	PUNCT
ejnm-325	189	86	25	25	NUM
ejnm-325	189	87	)	)	PUNCT
ejnm-325	189	88	ex	ex	NOUN
ejnm-325	189	89	-	-	NOUN
ejnm-325	189	90	smoker	smoker	ADJ
ejnm-325	189	91	12	12	NUM
ejnm-325	189	92	(	(	PUNCT
ejnm-325	189	93	75	75	NUM
ejnm-325	189	94	)	)	PUNCT
ejnm-325	189	95	0	0	NUM
ejnm-325	190	1	(	(	PUNCT
ejnm-325	190	2	0	0	NUM
ejnm-325	190	3	)	)	PUNCT
ejnm-325	190	4	4	4	NUM
ejnm-325	190	5	(	(	PUNCT
ejnm-325	190	6	25	25	NUM
ejnm-325	190	7	)	)	PUNCT
ejnm-325	190	8	passive	passive	ADJ
ejnm-325	190	9	-	-	PUNCT
ejnm-325	190	10	smoker	smoker	NOUN
ejnm-325	190	11	1	1	NUM
ejnm-325	190	12	(	(	PUNCT
ejnm-325	190	13	100	100	NUM
ejnm-325	190	14	)	)	PUNCT
ejnm-325	190	15	0	0	NUM
ejnm-325	191	1	(	(	PUNCT
ejnm-325	191	2	0	0	NUM
ejnm-325	191	3	)	)	PUNCT
ejnm-325	191	4	0	0	NUM
ejnm-325	192	1	(	(	PUNCT
ejnm-325	192	2	0	0	NUM
ejnm-325	192	3	)	)	PUNCT
ejnm-325	192	4	ns	ns	NUM
ejnm-325	192	5	*	*	NOUN
ejnm-325	192	6	non	non	ADJ
ejnm-325	192	7	-	-	ADJ
ejnm-325	192	8	significant	significant	ADJ
ejnm-325	192	9	https://creativecommons.org/licenses/by-nc-sa/4.0/	https://creativecommons.org/licenses/by-nc-sa/4.0/	PROPN
ejnm-325	192	10	https://doi.org/10.15218/ejnm.2025.05	https://doi.org/10.15218/ejnm.2025.05	NOUN
ejnm-325	192	11	erbil	erbil	PROPN
ejnm-325	192	12	j.	j.	PROPN
ejnm-325	192	13	nurs	nurs	PROPN
ejnm-325	192	14	.	.	PUNCT
ejnm-325	193	1	midwifery	midwifery	ADJ
ejnm-325	193	2	,	,	PUNCT
ejnm-325	193	3	vol	vol	NOUN
ejnm-325	193	4	.	.	PROPN
ejnm-325	193	5	8	8	NUM
ejnm-325	193	6	,	,	PUNCT
ejnm-325	193	7	no	no	INTJ
ejnm-325	193	8	.	.	PUNCT
ejnm-325	194	1	(	(	PUNCT
ejnm-325	194	2	1	1	NUM
ejnm-325	194	3	)	)	PUNCT
ejnm-325	194	4	,	,	PUNCT
ejnm-325	194	5	may2025	may2025	ADJ
ejnm-325	194	6	original	original	ADJ
ejnm-325	194	7	article	article	NOUN
ejnm-325	194	8	significant	significant	ADJ
ejnm-325	194	9	association	association	NOUN
ejnm-325	194	10	between	between	ADP
ejnm-325	194	11	spirometry	spirometry	NOUN
ejnm-325	194	12	pattern	pattern	NOUN
ejnm-325	194	13	and	and	CCONJ
ejnm-325	194	14	the	the	DET
ejnm-325	194	15	severity	severity	NOUN
ejnm-325	194	16	(	(	PUNCT
ejnm-325	194	17	p	p	NOUN
ejnm-325	194	18	-	-	PUNCT
ejnm-325	194	19	value	value	NOUN
ejnm-325	194	20	<	<	NOUN
ejnm-325	194	21	0.001	0.001	NUM
ejnm-325	194	22	)	)	PUNCT
ejnm-325	194	23	.	.	PUNCT
ejnm-325	195	1	between	between	ADP
ejnm-325	195	2	spirometry	spirometry	NOUN
ejnm-325	195	3	pattern	pattern	NOUN
ejnm-325	195	4	and	and	CCONJ
ejnm-325	195	5	the	the	DET
ejnm-325	195	6	comorbidities	comorbiditie	NOUN
ejnm-325	195	7	(	(	PUNCT
ejnm-325	195	8	p	p	NOUN
ejnm-325	195	9	-	-	PUNCT
ejnm-325	195	10	value	value	NOUN
ejnm-325	195	11	0.244	0.244	NUM
ejnm-325	195	12	)	)	PUNCT
ejnm-325	195	13	.	.	PUNCT
ejnm-325	196	1	from	from	ADP
ejnm-325	196	2	acute	acute	ADJ
ejnm-325	196	3	infection	infection	NOUN
ejnm-325	196	4	,	,	PUNCT
ejnm-325	196	5	a	a	DET
ejnm-325	196	6	phenomenon	phenomenon	NOUN
ejnm-325	196	7	reported	report	VERB
ejnm-325	196	8	in	in	ADP
ejnm-325	196	9	several	several	ADJ
ejnm-325	196	10	studies	study	NOUN
ejnm-325	196	11	(	(	PUNCT
ejnm-325	196	12	carfì	carfì	NOUN
ejnm-325	196	13	et	et	PROPN
ejnm-325	196	14	al	al	PROPN
ejnm-325	196	15	.	.	PROPN
ejnm-325	196	16	,	,	PUNCT
ejnm-325	196	17	2020	2020	NUM
ejnm-325	196	18	;	;	PUNCT
ejnm-325	196	19	huang	huang	PROPN
ejnm-325	196	20	et	et	PROPN
ejnm-325	196	21	al	al	PROPN
ejnm-325	196	22	.	.	PROPN
ejnm-325	196	23	,	,	PUNCT
ejnm-325	196	24	2021	2021	NUM
ejnm-325	196	25	)	)	PUNCT
ejnm-325	196	26	.	.	PUNCT
ejnm-325	197	1	comparing	compare	VERB
ejnm-325	197	2	these	these	DET
ejnm-325	197	3	findings	finding	NOUN
ejnm-325	197	4	with	with	ADP
ejnm-325	197	5	existing	exist	VERB
ejnm-325	197	6	literature	literature	NOUN
ejnm-325	197	7	,	,	PUNCT
ejnm-325	197	8	several	several	ADJ
ejnm-325	197	9	similarities	similarity	NOUN
ejnm-325	197	10	and	and	CCONJ
ejnm-325	197	11	differences	difference	NOUN
ejnm-325	197	12	emerge	emerge	VERB
ejnm-325	197	13	.	.	PUNCT
ejnm-325	198	1	for	for	ADP
ejnm-325	198	2	instance	instance	NOUN
ejnm-325	198	3	,	,	PUNCT
ejnm-325	198	4	while	while	SCONJ
ejnm-325	198	5	our	our	PRON
ejnm-325	198	6	study	study	NOUN
ejnm-325	198	7	reports	report	VERB
ejnm-325	198	8	a	a	DET
ejnm-325	198	9	high	high	ADJ
ejnm-325	198	10	prevalence	prevalence	NOUN
ejnm-325	198	11	of	of	ADP
ejnm-325	198	12	cough	cough	NOUN
ejnm-325	198	13	and	and	CCONJ
ejnm-325	198	14	shortness	shortness	NOUN
ejnm-325	198	15	of	of	ADP
ejnm-325	198	16	breath	breath	NOUN
ejnm-325	198	17	,	,	PUNCT
ejnm-325	198	18	huang	huang	PROPN
ejnm-325	198	19	et	et	PROPN
ejnm-325	198	20	al	al	PROPN
ejnm-325	198	21	.	.	PROPN
ejnm-325	199	1	(	(	PUNCT
ejnm-325	199	2	2021	2021	NUM
ejnm-325	199	3	)	)	PUNCT
ejnm-325	199	4	found	find	VERB
ejnm-325	199	5	a	a	DET
ejnm-325	199	6	similar	similar	ADJ
ejnm-325	199	7	pattern	pattern	NOUN
ejnm-325	199	8	of	of	ADP
ejnm-325	199	9	respiratory	respiratory	ADJ
ejnm-325	199	10	symptoms	symptom	NOUN
ejnm-325	199	11	in	in	ADP
ejnm-325	199	12	their	their	PRON
ejnm-325	199	13	cohort	cohort	NOUN
ejnm-325	199	14	of	of	ADP
ejnm-325	199	15	post	post	ADJ
ejnm-325	199	16	-	-	ADJ
ejnm-325	199	17	covid-19	covid-19	ADJ
ejnm-325	199	18	patients	patient	NOUN
ejnm-325	199	19	.	.	PUNCT
ejnm-325	200	1	however	however	ADV
ejnm-325	200	2	,	,	PUNCT
ejnm-325	200	3	the	the	DET
ejnm-325	200	4	prevalence	prevalence	NOUN
ejnm-325	200	5	of	of	ADP
ejnm-325	200	6	fever	fever	NOUN
ejnm-325	200	7	in	in	ADP
ejnm-325	200	8	our	our	PRON
ejnm-325	200	9	study	study	NOUN
ejnm-325	200	10	appears	appear	VERB
ejnm-325	200	11	lower	low	ADJ
ejnm-325	200	12	than	than	SCONJ
ejnm-325	200	13	reported	report	VERB
ejnm-325	200	14	by	by	ADP
ejnm-325	200	15	carfì	carfì	NOUN
ejnm-325	200	16	et	et	PROPN
ejnm-325	200	17	al	al	PROPN
ejnm-325	200	18	.	.	PROPN
ejnm-325	201	1	(	(	PUNCT
ejnm-325	201	2	2020	2020	NUM
ejnm-325	201	3	)	)	PUNCT
ejnm-325	201	4	,	,	PUNCT
ejnm-325	201	5	suggesting	suggest	VERB
ejnm-325	201	6	potential	potential	ADJ
ejnm-325	201	7	variations	variation	NOUN
ejnm-325	201	8	in	in	ADP
ejnm-325	201	9	symptom	symptom	NOUN
ejnm-325	201	10	presentation	presentation	NOUN
ejnm-325	201	11	across	across	ADP
ejnm-325	201	12	different	different	ADJ
ejnm-325	201	13	patient	patient	ADJ
ejnm-325	201	14	populations	population	NOUN
ejnm-325	201	15	or	or	CCONJ
ejnm-325	201	16	study	study	NOUN
ejnm-325	201	17	methodologies	methodology	NOUN
ejnm-325	201	18	.	.	PUNCT
ejnm-325	202	1	elevated	elevated	ADJ
ejnm-325	202	2	blood	blood	NOUN
ejnm-325	202	3	pressure	pressure	NOUN
ejnm-325	202	4	,	,	PUNCT
ejnm-325	202	5	hypoxemia	hypoxemia	NOUN
ejnm-325	202	6	,	,	PUNCT
ejnm-325	202	7	tachycardia	tachycardia	NOUN
ejnm-325	202	8	,	,	PUNCT
ejnm-325	202	9	and	and	CCONJ
ejnm-325	202	10	abnormal	abnormal	ADJ
ejnm-325	202	11	biomarker	biomarker	NOUN
ejnm-325	202	12	levels	level	NOUN
ejnm-325	202	13	x	x	PUNCT
ejnm-325	202	14	concerning	concern	VERB
ejnm-325	202	15	the	the	DET
ejnm-325	202	16	association	association	NOUN
ejnm-325	202	17	between	between	ADP
ejnm-325	202	18	spirometry	spirometry	NOUN
ejnm-325	202	19	pattern	pattern	NOUN
ejnm-325	202	20	with	with	ADP
ejnm-325	202	21	the	the	DET
ejnm-325	202	22	severity	severity	NOUN
ejnm-325	202	23	,	,	PUNCT
ejnm-325	202	24	there	there	PRON
ejnm-325	202	25	is	be	VERB
ejnm-325	202	26	a	a	DET
ejnm-325	202	27	very	very	ADV
ejnm-325	202	28	highly	highly	ADV
ejnm-325	202	29	regarding	regard	VERB
ejnm-325	202	30	the	the	DET
ejnm-325	202	31	association	association	NOUN
ejnm-325	202	32	between	between	ADP
ejnm-325	202	33	the	the	DET
ejnm-325	202	34	spirometry	spirometry	NOUN
ejnm-325	202	35	pattern	pattern	NOUN
ejnm-325	202	36	and	and	CCONJ
ejnm-325	202	37	the	the	DET
ejnm-325	202	38	comorbidities	comorbiditie	NOUN
ejnm-325	202	39	,	,	PUNCT
ejnm-325	202	40	there	there	PRON
ejnm-325	202	41	is	be	VERB
ejnm-325	202	42	a	a	DET
ejnm-325	202	43	nonsignificant	nonsignificant	ADJ
ejnm-325	202	44	association	association	NOUN
ejnm-325	202	45	the	the	DET
ejnm-325	202	46	age	age	NOUN
ejnm-325	202	47	distribution	distribution	NOUN
ejnm-325	202	48	in	in	ADP
ejnm-325	202	49	this	this	DET
ejnm-325	202	50	study	study	NOUN
ejnm-325	202	51	demonstrates	demonstrate	VERB
ejnm-325	202	52	a	a	DET
ejnm-325	202	53	predominance	predominance	NOUN
ejnm-325	202	54	of	of	ADP
ejnm-325	202	55	patients	patient	NOUN
ejnm-325	202	56	between	between	ADP
ejnm-325	202	57	54	54	NUM
ejnm-325	202	58	-	-	SYM
ejnm-325	202	59	69	69	NUM
ejnm-325	202	60	years	year	NOUN
ejnm-325	202	61	old	old	ADJ
ejnm-325	202	62	,	,	PUNCT
ejnm-325	202	63	comprising	comprise	VERB
ejnm-325	202	64	55.4	55.4	NUM
ejnm-325	202	65	%	%	NOUN
ejnm-325	202	66	of	of	ADP
ejnm-325	202	67	the	the	DET
ejnm-325	202	68	sample	sample	NOUN
ejnm-325	202	69	,	,	PUNCT
ejnm-325	202	70	which	which	PRON
ejnm-325	202	71	aligns	align	VERB
ejnm-325	202	72	with	with	ADP
ejnm-325	202	73	previous	previous	ADJ
ejnm-325	202	74	research	research	NOUN
ejnm-325	202	75	indicating	indicate	VERB
ejnm-325	202	76	a	a	DET
ejnm-325	202	77	higher	high	ADJ
ejnm-325	202	78	susceptibility	susceptibility	NOUN
ejnm-325	202	79	to	to	ADP
ejnm-325	202	80	severe	severe	ADJ
ejnm-325	202	81	covid-19	covid-19	PROPN
ejnm-325	202	82	outcomes	outcome	NOUN
ejnm-325	202	83	among	among	ADP
ejnm-325	202	84	older	old	ADJ
ejnm-325	202	85	individuals	individual	NOUN
ejnm-325	202	86	(	(	PUNCT
ejnm-325	202	87	rothan	rothan	ADJ
ejnm-325	202	88	and	and	CCONJ
ejnm-325	202	89	byrareddy	byrareddy	PROPN
ejnm-325	202	90	,	,	PUNCT
ejnm-325	202	91	2020	2020	NUM
ejnm-325	202	92	)	)	PUNCT
ejnm-325	202	93	.	.	PUNCT
ejnm-325	203	1	additionally	additionally	ADV
ejnm-325	203	2	,	,	PUNCT
ejnm-325	203	3	a	a	DET
ejnm-325	203	4	higher	high	ADJ
ejnm-325	203	5	proportion	proportion	NOUN
ejnm-325	203	6	of	of	ADP
ejnm-325	203	7	males	male	NOUN
ejnm-325	203	8	(	(	PUNCT
ejnm-325	203	9	63.5	63.5	NUM
ejnm-325	203	10	%	%	NOUN
ejnm-325	203	11	)	)	PUNCT
ejnm-325	203	12	compared	compare	VERB
ejnm-325	203	13	to	to	ADP
ejnm-325	203	14	females	female	NOUN
ejnm-325	203	15	(	(	PUNCT
ejnm-325	203	16	36.5	36.5	NUM
ejnm-325	203	17	%	%	NOUN
ejnm-325	203	18	)	)	PUNCT
ejnm-325	203	19	was	be	AUX
ejnm-325	203	20	observed	observe	VERB
ejnm-325	203	21	,	,	PUNCT
ejnm-325	203	22	consistent	consistent	ADJ
ejnm-325	203	23	with	with	ADP
ejnm-325	203	24	prior	prior	ADJ
ejnm-325	203	25	observations	observation	NOUN
ejnm-325	203	26	of	of	ADP
ejnm-325	203	27	covid-19	covid-19	PROPN
ejnm-325	203	28	's	's	PART
ejnm-325	203	29	disproportionate	disproportionate	ADJ
ejnm-325	203	30	impact	impact	NOUN
ejnm-325	203	31	on	on	ADP
ejnm-325	203	32	males	male	NOUN
ejnm-325	203	33	(	(	PUNCT
ejnm-325	203	34	jin	jin	NOUN
ejnm-325	203	35	et	et	PROPN
ejnm-325	203	36	al	al	PROPN
ejnm-325	203	37	.	.	PROPN
ejnm-325	203	38	,	,	PUNCT
ejnm-325	203	39	2020	2020	NUM
ejnm-325	203	40	)	)	PUNCT
ejnm-325	203	41	.	.	PUNCT
ejnm-325	204	1	symptomatology	symptomatology	NOUN
ejnm-325	204	2	among	among	ADP
ejnm-325	204	3	post	post	ADJ
ejnm-325	204	4	-	-	ADJ
ejnm-325	204	5	covid-19	covid-19	ADJ
ejnm-325	204	6	patients	patient	NOUN
ejnm-325	204	7	reveals	reveal	VERB
ejnm-325	204	8	a	a	DET
ejnm-325	204	9	significant	significant	ADJ
ejnm-325	204	10	prevalence	prevalence	NOUN
ejnm-325	204	11	of	of	ADP
ejnm-325	204	12	cough	cough	NOUN
ejnm-325	204	13	(	(	PUNCT
ejnm-325	204	14	66.2	66.2	NUM
ejnm-325	204	15	%	%	NOUN
ejnm-325	204	16	)	)	PUNCT
ejnm-325	204	17	,	,	PUNCT
ejnm-325	204	18	fever	fever	NOUN
ejnm-325	204	19	(	(	PUNCT
ejnm-325	204	20	32.4	32.4	NUM
ejnm-325	204	21	%	%	NOUN
ejnm-325	204	22	)	)	PUNCT
ejnm-325	204	23	,	,	PUNCT
ejnm-325	204	24	and	and	CCONJ
ejnm-325	204	25	shortness	shortness	NOUN
ejnm-325	204	26	of	of	ADP
ejnm-325	204	27	breath	breath	NOUN
ejnm-325	204	28	(	(	PUNCT
ejnm-325	204	29	73	73	NUM
ejnm-325	204	30	%	%	NOUN
ejnm-325	204	31	)	)	PUNCT
ejnm-325	204	32	,	,	PUNCT
ejnm-325	204	33	reflecting	reflect	VERB
ejnm-325	204	34	the	the	DET
ejnm-325	204	35	persistence	persistence	NOUN
ejnm-325	204	36	of	of	ADP
ejnm-325	204	37	respiratory	respiratory	ADJ
ejnm-325	204	38	symptoms	symptom	NOUN
ejnm-325	204	39	even	even	ADV
ejnm-325	204	40	after	after	ADP
ejnm-325	204	41	recovery	recovery	NOUN
ejnm-325	204	42	45	45	NUM
ejnm-325	204	43	copyright	copyright	NOUN
ejnm-325	204	44	©	©	PROPN
ejnm-325	204	45	2025	2025	NUM
ejnm-325	204	46	the	the	DET
ejnm-325	204	47	author(s	author(s	NOUN
ejnm-325	204	48	)	)	PUNCT
ejnm-325	204	49	.	.	PUNCT
ejnm-325	205	1	this	this	PRON
ejnm-325	205	2	is	be	AUX
ejnm-325	205	3	an	an	DET
ejnm-325	205	4	open	open	ADJ
ejnm-325	205	5	access	access	NOUN
ejnm-325	205	6	article	article	NOUN
ejnm-325	205	7	which	which	PRON
ejnm-325	205	8	licensed	license	VERB
ejnm-325	205	9	under	under	ADP
ejnm-325	205	10	the	the	DET
ejnm-325	205	11	terms	term	NOUN
ejnm-325	205	12	and	and	CCONJ
ejnm-325	205	13	conditions	condition	NOUN
ejnm-325	205	14	of	of	ADP
ejnm-325	205	15	the	the	DET
ejnm-325	205	16	creative	creative	ADJ
ejnm-325	205	17	commons	common	NOUN
ejnm-325	205	18	attribution	attribution	NOUN
ejnm-325	205	19	-	-	PUNCT
ejnm-325	205	20	noncommercial	noncommercial	ADJ
ejnm-325	205	21	-	-	PUNCT
ejnm-325	205	22	sharealike	sharealike	ADJ
ejnm-325	205	23	4.0	4.0	NUM
ejnm-325	205	24	international	international	ADJ
ejnm-325	205	25	license	license	NOUN
ejnm-325	205	26	.	.	PUNCT
ejnm-325	206	1	it	it	PRON
ejnm-325	206	2	permits	permit	VERB
ejnm-325	206	3	no	no	DET
ejnm-325	206	4	additional	additional	ADJ
ejnm-325	206	5	restrictions	restriction	NOUN
ejnm-325	206	6	on	on	ADP
ejnm-325	206	7	use	use	NOUN
ejnm-325	206	8	,	,	PUNCT
ejnm-325	206	9	distribution	distribution	NOUN
ejnm-325	206	10	,	,	PUNCT
ejnm-325	206	11	and	and	CCONJ
ejnm-325	206	12	reproduction	reproduction	NOUN
ejnm-325	206	13	in	in	ADP
ejnm-325	206	14	any	any	DET
ejnm-325	206	15	medium	medium	NOUN
ejnm-325	206	16	provided	provide	VERB
ejnm-325	206	17	the	the	DET
ejnm-325	206	18	original	original	ADJ
ejnm-325	206	19	work	work	NOUN
ejnm-325	206	20	is	be	AUX
ejnm-325	206	21	properly	properly	ADV
ejnm-325	206	22	cited	cite	VERB
ejnm-325	206	23	.	.	PUNCT
ejnm-325	207	1	table	table	NOUN
ejnm-325	207	2	7	7	NUM
ejnm-325	207	3	:	:	PUNCT
ejnm-325	207	4	association	association	NOUN
ejnm-325	207	5	between	between	ADP
ejnm-325	207	6	spirometry	spirometry	NOUN
ejnm-325	207	7	pattern	pattern	NOUN
ejnm-325	207	8	and	and	CCONJ
ejnm-325	207	9	severity	severity	NOUN
ejnm-325	207	10	severity	severity	NOUN
ejnm-325	207	11	spirometry	spirometry	NOUN
ejnm-325	207	12	pattern	pattern	NOUN
ejnm-325	207	13	p	p	NOUN
ejnm-325	207	14	-	-	PUNCT
ejnm-325	207	15	value	value	NOUN
ejnm-325	207	16	normal	normal	ADJ
ejnm-325	207	17	obstructive	obstructive	ADJ
ejnm-325	207	18	restrictive	restrictive	ADJ
ejnm-325	207	19	f.	f.	PROPN
ejnm-325	207	20	(	(	PUNCT
ejnm-325	207	21	%	%	INTJ
ejnm-325	207	22	)	)	PUNCT
ejnm-325	208	1	f.	f.	PROPN
ejnm-325	208	2	(	(	PUNCT
ejnm-325	208	3	%	%	INTJ
ejnm-325	208	4	)	)	PUNCT
ejnm-325	209	1	f.	f.	PROPN
ejnm-325	209	2	(	(	PUNCT
ejnm-325	209	3	%	%	INTJ
ejnm-325	209	4	)	)	PUNCT
ejnm-325	209	5	mild	mild	ADJ
ejnm-325	209	6	28	28	NUM
ejnm-325	209	7	(	(	PUNCT
ejnm-325	209	8	87.5	87.5	NUM
ejnm-325	209	9	)	)	SYM
ejnm-325	209	10	2	2	NUM
ejnm-325	209	11	(	(	PUNCT
ejnm-325	209	12	6.3	6.3	NUM
ejnm-325	209	13	)	)	PUNCT
ejnm-325	209	14	2	2	NUM
ejnm-325	209	15	(	(	PUNCT
ejnm-325	209	16	6.3	6.3	NUM
ejnm-325	209	17	)	)	PUNCT
ejnm-325	209	18	<	<	X
ejnm-325	209	19	0.001	0.001	NUM
ejnm-325	209	20	vhs	vhs	NOUN
ejnm-325	209	21	*	*	PUNCT
ejnm-325	209	22	moderate	moderate	ADJ
ejnm-325	209	23	19	19	NUM
ejnm-325	209	24	(	(	PUNCT
ejnm-325	209	25	90.5	90.5	NUM
ejnm-325	209	26	)	)	PUNCT
ejnm-325	209	27	0	0	NUM
ejnm-325	210	1	(	(	PUNCT
ejnm-325	210	2	0	0	NUM
ejnm-325	210	3	)	)	SYM
ejnm-325	210	4	2	2	NUM
ejnm-325	210	5	(	(	PUNCT
ejnm-325	210	6	9.5	9.5	NUM
ejnm-325	210	7	)	)	PUNCT
ejnm-325	210	8	severe	severe	ADJ
ejnm-325	210	9	6	6	NUM
ejnm-325	210	10	(	(	PUNCT
ejnm-325	210	11	31.6	31.6	NUM
ejnm-325	210	12	)	)	PUNCT
ejnm-325	210	13	1	1	NUM
ejnm-325	210	14	(	(	PUNCT
ejnm-325	210	15	5.3	5.3	NUM
ejnm-325	210	16	)	)	PUNCT
ejnm-325	210	17	12	12	NUM
ejnm-325	210	18	(	(	PUNCT
ejnm-325	210	19	63.2	63.2	NUM
ejnm-325	210	20	)	)	PUNCT
ejnm-325	210	21	critical	critical	ADJ
ejnm-325	210	22	0	0	NUM
ejnm-325	210	23	(	(	PUNCT
ejnm-325	210	24	0	0	NUM
ejnm-325	210	25	)	)	PUNCT
ejnm-325	210	26	0	0	NUM
ejnm-325	211	1	(	(	PUNCT
ejnm-325	211	2	0	0	NUM
ejnm-325	211	3	)	)	SYM
ejnm-325	211	4	2	2	NUM
ejnm-325	211	5	(	(	PUNCT
ejnm-325	211	6	100	100	NUM
ejnm-325	211	7	)	)	PUNCT
ejnm-325	211	8	vhs	vhs	NOUN
ejnm-325	211	9	*	*	PUNCT
ejnm-325	211	10	very	very	ADV
ejnm-325	211	11	highly	highly	ADV
ejnm-325	211	12	significant	significant	ADJ
ejnm-325	211	13	table	table	NOUN
ejnm-325	211	14	8	8	NUM
ejnm-325	211	15	:	:	PUNCT
ejnm-325	211	16	association	association	NOUN
ejnm-325	211	17	between	between	ADP
ejnm-325	211	18	the	the	DET
ejnm-325	211	19	spirometry	spirometry	NOUN
ejnm-325	211	20	pattern	pattern	NOUN
ejnm-325	211	21	and	and	CCONJ
ejnm-325	211	22	comorbidities	comorbiditie	VERB
ejnm-325	211	23	pmh	pmh	NOUN
ejnm-325	211	24	spirometry	spirometry	NOUN
ejnm-325	211	25	pattern	pattern	NOUN
ejnm-325	211	26	p	p	NOUN
ejnm-325	211	27	-	-	PUNCT
ejnm-325	211	28	value	value	NOUN
ejnm-325	211	29	normal	normal	ADJ
ejnm-325	211	30	obstructive	obstructive	ADJ
ejnm-325	211	31	restrictive	restrictive	ADJ
ejnm-325	211	32	f.	f.	PROPN
ejnm-325	211	33	(	(	PUNCT
ejnm-325	211	34	%	%	INTJ
ejnm-325	211	35	)	)	PUNCT
ejnm-325	212	1	f.	f.	PROPN
ejnm-325	212	2	(	(	PUNCT
ejnm-325	212	3	%	%	INTJ
ejnm-325	212	4	)	)	PUNCT
ejnm-325	213	1	f.	f.	PROPN
ejnm-325	213	2	(	(	PUNCT
ejnm-325	213	3	%	%	INTJ
ejnm-325	213	4	)	)	PUNCT
ejnm-325	213	5	none	none	NOUN
ejnm-325	213	6	29	29	NUM
ejnm-325	213	7	(	(	PUNCT
ejnm-325	213	8	74.4	74.4	NUM
ejnm-325	213	9	)	)	PUNCT
ejnm-325	213	10	0	0	NUM
ejnm-325	214	1	(	(	PUNCT
ejnm-325	214	2	0	0	NUM
ejnm-325	214	3	)	)	PUNCT
ejnm-325	214	4	10	10	NUM
ejnm-325	214	5	(	(	PUNCT
ejnm-325	214	6	25.6	25.6	NUM
ejnm-325	214	7	)	)	PUNCT
ejnm-325	214	8	0.244	0.244	NUM
ejnm-325	214	9	ns	ns	NUM
ejnm-325	214	10	asthma	asthma	NOUN
ejnm-325	214	11	2	2	NUM
ejnm-325	214	12	(	(	PUNCT
ejnm-325	214	13	100	100	NUM
ejnm-325	214	14	)	)	PUNCT
ejnm-325	214	15	0	0	NUM
ejnm-325	215	1	(	(	PUNCT
ejnm-325	215	2	0	0	NUM
ejnm-325	215	3	)	)	PUNCT
ejnm-325	215	4	0	0	NUM
ejnm-325	216	1	(	(	PUNCT
ejnm-325	216	2	0	0	X
ejnm-325	216	3	)	)	PUNCT
ejnm-325	216	4	copd	copd	NOUN
ejnm-325	216	5	4	4	NUM
ejnm-325	216	6	(	(	PUNCT
ejnm-325	216	7	80	80	NUM
ejnm-325	216	8	)	)	SYM
ejnm-325	216	9	1	1	NUM
ejnm-325	216	10	(	(	PUNCT
ejnm-325	216	11	20	20	NUM
ejnm-325	216	12	)	)	PUNCT
ejnm-325	216	13	0	0	NUM
ejnm-325	217	1	(	(	PUNCT
ejnm-325	217	2	0	0	X
ejnm-325	217	3	)	)	PUNCT
ejnm-325	217	4	others	other	NOUN
ejnm-325	217	5	18	18	NUM
ejnm-325	217	6	(	(	PUNCT
ejnm-325	217	7	64.3	64.3	NUM
ejnm-325	217	8	)	)	SYM
ejnm-325	217	9	2	2	NUM
ejnm-325	217	10	(	(	PUNCT
ejnm-325	217	11	7.1	7.1	NUM
ejnm-325	217	12	)	)	PUNCT
ejnm-325	217	13	8	8	NUM
ejnm-325	217	14	(	(	PUNCT
ejnm-325	217	15	28.6	28.6	NUM
ejnm-325	217	16	)	)	PUNCT
ejnm-325	217	17	ns	ns	PROPN
ejnm-325	217	18	*	*	ADJ
ejnm-325	217	19	non	non	ADJ
ejnm-325	217	20	-	-	ADJ
ejnm-325	217	21	significant	significant	ADJ
ejnm-325	217	22	discussion	discussion	NOUN
ejnm-325	217	23	https://creativecommons.org/licenses/by-nc-sa/4.0/	https://creativecommons.org/licenses/by-nc-sa/4.0/	PRON
ejnm-325	217	24	https://doi.org/10.15218/ejnm.2025.05	https://doi.org/10.15218/ejnm.2025.05	PROPN
ejnm-325	217	25	erbil	erbil	PROPN
ejnm-325	217	26	j.	j.	PROPN
ejnm-325	217	27	nurs	nurs	PROPN
ejnm-325	217	28	.	.	PUNCT
ejnm-325	218	1	midwifery	midwifery	ADJ
ejnm-325	218	2	,	,	PUNCT
ejnm-325	218	3	vol	vol	NOUN
ejnm-325	218	4	.	.	PROPN
ejnm-325	218	5	8	8	NUM
ejnm-325	218	6	,	,	PUNCT
ejnm-325	218	7	no	no	INTJ
ejnm-325	218	8	.	.	PUNCT
ejnm-325	219	1	(	(	PUNCT
ejnm-325	219	2	1	1	NUM
ejnm-325	219	3	)	)	PUNCT
ejnm-325	219	4	,	,	PUNCT
ejnm-325	219	5	may2025	may2025	ADJ
ejnm-325	219	6	original	original	ADJ
ejnm-325	219	7	article	article	NOUN
ejnm-325	219	8	(	(	PUNCT
ejnm-325	219	9	williamson	williamson	PROPN
ejnm-325	219	10	et	et	PROPN
ejnm-325	219	11	al	al	PROPN
ejnm-325	219	12	.	.	PROPN
ejnm-325	219	13	,	,	PUNCT
ejnm-325	219	14	2020	2020	NUM
ejnm-325	219	15	)	)	PUNCT
ejnm-325	219	16	,	,	PUNCT
ejnm-325	219	17	the	the	DET
ejnm-325	219	18	association	association	NOUN
ejnm-325	219	19	between	between	ADP
ejnm-325	219	20	symptoms	symptom	NOUN
ejnm-325	219	21	like	like	ADP
ejnm-325	219	22	cough	cough	NOUN
ejnm-325	219	23	and	and	CCONJ
ejnm-325	219	24	fever	fever	NOUN
ejnm-325	219	25	with	with	ADP
ejnm-325	219	26	severity	severity	NOUN
ejnm-325	219	27	may	may	AUX
ejnm-325	219	28	vary	vary	VERB
ejnm-325	219	29	depending	depend	VERB
ejnm-325	219	30	on	on	ADP
ejnm-325	219	31	factors	factor	NOUN
ejnm-325	219	32	like	like	ADP
ejnm-325	219	33	disease	disease	NOUN
ejnm-325	219	34	prevalence	prevalence	NOUN
ejnm-325	219	35	,	,	PUNCT
ejnm-325	219	36	population	population	NOUN
ejnm-325	219	37	demographics	demographic	NOUN
ejnm-325	219	38	,	,	PUNCT
ejnm-325	219	39	and	and	CCONJ
ejnm-325	219	40	study	study	NOUN
ejnm-325	219	41	design	design	NOUN
ejnm-325	219	42	.	.	PUNCT
ejnm-325	220	1	the	the	DET
ejnm-325	220	2	association	association	NOUN
ejnm-325	220	3	between	between	ADP
ejnm-325	220	4	investigative	investigative	ADJ
ejnm-325	220	5	parameters	parameter	NOUN
ejnm-325	220	6	and	and	CCONJ
ejnm-325	220	7	the	the	DET
ejnm-325	220	8	severity	severity	NOUN
ejnm-325	220	9	of	of	ADP
ejnm-325	220	10	post	post	ADJ
ejnm-325	220	11	-	-	ADJ
ejnm-325	220	12	covid-19	covid-19	ADJ
ejnm-325	220	13	symptoms	symptom	NOUN
ejnm-325	220	14	.	.	PUNCT
ejnm-325	221	1	parameters	parameter	NOUN
ejnm-325	221	2	such	such	ADJ
ejnm-325	221	3	as	as	ADP
ejnm-325	221	4	spo2	spo2	PROPN
ejnm-325	221	5	,	,	PUNCT
ejnm-325	221	6	pulse	pulse	NOUN
ejnm-325	221	7	rate	rate	NOUN
ejnm-325	221	8	(	(	PUNCT
ejnm-325	221	9	pr	pr	NOUN
ejnm-325	221	10	)	)	PUNCT
ejnm-325	221	11	,	,	PUNCT
ejnm-325	221	12	d.	d.	PROPN
ejnm-325	221	13	dimer	dimer	PROPN
ejnm-325	221	14	,	,	PUNCT
ejnm-325	221	15	white	white	ADJ
ejnm-325	221	16	blood	blood	NOUN
ejnm-325	221	17	cell	cell	NOUN
ejnm-325	221	18	count	count	NOUN
ejnm-325	221	19	(	(	PUNCT
ejnm-325	221	20	wbc	wbc	PROPN
ejnm-325	221	21	)	)	PUNCT
ejnm-325	221	22	,	,	PUNCT
ejnm-325	221	23	and	and	CCONJ
ejnm-325	221	24	pulmonary	pulmonary	ADJ
ejnm-325	221	25	function	function	NOUN
ejnm-325	221	26	tests	test	NOUN
ejnm-325	221	27	(	(	PUNCT
ejnm-325	221	28	fev1	fev1	PROPN
ejnm-325	221	29	and	and	CCONJ
ejnm-325	221	30	fvc	fvc	PROPN
ejnm-325	221	31	)	)	PUNCT
ejnm-325	221	32	demonstrate	demonstrate	VERB
ejnm-325	221	33	a	a	DET
ejnm-325	221	34	significant	significant	ADJ
ejnm-325	221	35	association	association	NOUN
ejnm-325	221	36	with	with	ADP
ejnm-325	221	37	severity	severity	NOUN
ejnm-325	221	38	(	(	PUNCT
ejnm-325	221	39	p	p	NOUN
ejnm-325	221	40	-	-	PUNCT
ejnm-325	221	41	value	value	NOUN
ejnm-325	221	42	≤	≤	NOUN
ejnm-325	221	43	0.05	0.05	NUM
ejnm-325	221	44	)	)	PUNCT
ejnm-325	221	45	.	.	PUNCT
ejnm-325	222	1	this	this	PRON
ejnm-325	222	2	suggests	suggest	VERB
ejnm-325	222	3	that	that	SCONJ
ejnm-325	222	4	abnormalities	abnormality	NOUN
ejnm-325	222	5	in	in	ADP
ejnm-325	222	6	these	these	DET
ejnm-325	222	7	parameters	parameter	NOUN
ejnm-325	222	8	may	may	AUX
ejnm-325	222	9	serve	serve	VERB
ejnm-325	222	10	as	as	ADP
ejnm-325	222	11	valuable	valuable	ADJ
ejnm-325	222	12	indicators	indicator	NOUN
ejnm-325	222	13	of	of	ADP
ejnm-325	222	14	disease	disease	NOUN
ejnm-325	222	15	severity	severity	NOUN
ejnm-325	222	16	and	and	CCONJ
ejnm-325	222	17	could	could	AUX
ejnm-325	222	18	aid	aid	VERB
ejnm-325	222	19	in	in	ADP
ejnm-325	222	20	risk	risk	NOUN
ejnm-325	222	21	stratification	stratification	NOUN
ejnm-325	222	22	and	and	CCONJ
ejnm-325	222	23	clinical	clinical	ADJ
ejnm-325	222	24	decision	decision	NOUN
ejnm-325	222	25	-	-	PUNCT
ejnm-325	222	26	making	making	NOUN
ejnm-325	222	27	.	.	PUNCT
ejnm-325	223	1	a	a	DET
ejnm-325	223	2	significant	significant	ADJ
ejnm-325	223	3	association	association	NOUN
ejnm-325	223	4	between	between	ADP
ejnm-325	223	5	spirometry	spirometry	NOUN
ejnm-325	223	6	patterns	pattern	NOUN
ejnm-325	223	7	and	and	CCONJ
ejnm-325	223	8	the	the	DET
ejnm-325	223	9	severity	severity	NOUN
ejnm-325	223	10	of	of	ADP
ejnm-325	223	11	post	post	ADJ
ejnm-325	223	12	-	-	ADJ
ejnm-325	223	13	covid	covid	ADJ
ejnm-325	223	14	-19	-19	NOUN
ejnm-325	223	15	symptoms	symptom	NOUN
ejnm-325	223	16	.	.	PUNCT
ejnm-325	224	1	notably	notably	ADV
ejnm-325	224	2	,	,	PUNCT
ejnm-325	224	3	a	a	DET
ejnm-325	224	4	very	very	ADV
ejnm-325	224	5	highly	highly	ADV
ejnm-325	224	6	significant	significant	ADJ
ejnm-325	224	7	association	association	NOUN
ejnm-325	224	8	(	(	PUNCT
ejnm-325	224	9	p	p	NOUN
ejnm-325	224	10	-	-	PUNCT
ejnm-325	224	11	value	value	NOUN
ejnm-325	224	12	<	<	NOUN
ejnm-325	224	13	0.001	0.001	NUM
ejnm-325	224	14	)	)	PUNCT
ejnm-325	224	15	was	be	AUX
ejnm-325	224	16	observed	observe	VERB
ejnm-325	224	17	,	,	PUNCT
ejnm-325	224	18	indicating	indicate	VERB
ejnm-325	224	19	that	that	SCONJ
ejnm-325	224	20	the	the	DET
ejnm-325	224	21	type	type	NOUN
ejnm-325	224	22	of	of	ADP
ejnm-325	224	23	spirometry	spirometry	NOUN
ejnm-325	224	24	pattern	pattern	NOUN
ejnm-325	224	25	exhibited	exhibit	VERB
ejnm-325	224	26	by	by	ADP
ejnm-325	224	27	patients	patient	NOUN
ejnm-325	224	28	is	be	AUX
ejnm-325	224	29	strongly	strongly	ADV
ejnm-325	224	30	correlated	correlate	VERB
ejnm-325	224	31	with	with	ADP
ejnm-325	224	32	the	the	DET
ejnm-325	224	33	severity	severity	NOUN
ejnm-325	224	34	of	of	ADP
ejnm-325	224	35	their	their	PRON
ejnm-325	224	36	symptoms	symptom	NOUN
ejnm-325	224	37	.	.	PUNCT
ejnm-325	225	1	specifically	specifically	ADV
ejnm-325	225	2	,	,	PUNCT
ejnm-325	225	3	patients	patient	NOUN
ejnm-325	225	4	with	with	ADP
ejnm-325	225	5	mild	mild	ADJ
ejnm-325	225	6	or	or	CCONJ
ejnm-325	225	7	moderate	moderate	ADJ
ejnm-325	225	8	symptoms	symptom	NOUN
ejnm-325	225	9	predominantly	predominantly	ADV
ejnm-325	225	10	displayed	display	VERB
ejnm-325	225	11	normal	normal	ADJ
ejnm-325	225	12	or	or	CCONJ
ejnm-325	225	13	obstructive	obstructive	ADJ
ejnm-325	225	14	spirometry	spirometry	NOUN
ejnm-325	225	15	patterns	pattern	NOUN
ejnm-325	225	16	,	,	PUNCT
ejnm-325	225	17	while	while	SCONJ
ejnm-325	225	18	those	those	PRON
ejnm-325	225	19	with	with	ADP
ejnm-325	225	20	severe	severe	ADJ
ejnm-325	225	21	or	or	CCONJ
ejnm-325	225	22	critical	critical	ADJ
ejnm-325	225	23	symptoms	symptom	NOUN
ejnm-325	225	24	were	be	AUX
ejnm-325	225	25	more	more	ADV
ejnm-325	225	26	likely	likely	ADJ
ejnm-325	225	27	to	to	PART
ejnm-325	225	28	exhibit	exhibit	VERB
ejnm-325	225	29	restrictive	restrictive	ADJ
ejnm-325	225	30	patterns	pattern	NOUN
ejnm-325	225	31	.	.	PUNCT
ejnm-325	226	1	this	this	PRON
ejnm-325	226	2	suggests	suggest	VERB
ejnm-325	226	3	that	that	SCONJ
ejnm-325	226	4	spirometry	spirometry	NOUN
ejnm-325	226	5	patterns	pattern	NOUN
ejnm-325	226	6	could	could	AUX
ejnm-325	226	7	serve	serve	VERB
ejnm-325	226	8	as	as	ADP
ejnm-325	226	9	valuable	valuable	ADJ
ejnm-325	226	10	indicators	indicator	NOUN
ejnm-325	226	11	of	of	ADP
ejnm-325	226	12	disease	disease	NOUN
ejnm-325	226	13	severity	severity	NOUN
ejnm-325	226	14	in	in	ADP
ejnm-325	226	15	postcovid-19	postcovid-19	PROPN
ejnm-325	226	16	patients	patient	NOUN
ejnm-325	226	17	,	,	PUNCT
ejnm-325	226	18	aiding	aid	VERB
ejnm-325	226	19	clinicians	clinician	NOUN
ejnm-325	226	20	in	in	ADP
ejnm-325	226	21	risk	risk	NOUN
ejnm-325	226	22	stratification	stratification	NOUN
ejnm-325	226	23	and	and	CCONJ
ejnm-325	226	24	prognostication	prognostication	NOUN
ejnm-325	226	25	.	.	PUNCT
ejnm-325	227	1	a	a	DET
ejnm-325	227	2	nonsignificant	nonsignificant	ADJ
ejnm-325	227	3	association	association	NOUN
ejnm-325	227	4	(	(	PUNCT
ejnm-325	227	5	p	p	NOUN
ejnm-325	227	6	-	-	PUNCT
ejnm-325	227	7	value	value	NOUN
ejnm-325	227	8	0.244	0.244	NUM
ejnm-325	227	9	)	)	PUNCT
ejnm-325	227	10	between	between	ADP
ejnm-325	227	11	spirometry	spirometry	NOUN
ejnm-325	227	12	patterns	pattern	NOUN
ejnm-325	227	13	and	and	CCONJ
ejnm-325	227	14	comorbidities	comorbiditie	NOUN
ejnm-325	227	15	among	among	ADP
ejnm-325	227	16	post	post	ADJ
ejnm-325	227	17	-	-	ADJ
ejnm-325	227	18	covid-19	covid-19	ADJ
ejnm-325	227	19	patients	patient	NOUN
ejnm-325	227	20	.	.	PUNCT
ejnm-325	228	1	despite	despite	SCONJ
ejnm-325	228	2	trends	trend	NOUN
ejnm-325	228	3	indicating	indicate	VERB
ejnm-325	228	4	that	that	SCONJ
ejnm-325	228	5	patients	patient	NOUN
ejnm-325	228	6	with	with	ADP
ejnm-325	228	7	comorbidities	comorbiditie	NOUN
ejnm-325	228	8	such	such	ADJ
ejnm-325	228	9	as	as	ADP
ejnm-325	228	10	asthma	asthma	NOUN
ejnm-325	228	11	and	and	CCONJ
ejnm-325	228	12	copd	copd	PROPN
ejnm-325	228	13	tend	tend	VERB
ejnm-325	228	14	to	to	PART
ejnm-325	228	15	exhibit	exhibit	VERB
ejnm-325	228	16	obstructive	obstructive	ADJ
ejnm-325	228	17	spirometry	spirometry	NOUN
ejnm-325	228	18	patterns	pattern	NOUN
ejnm-325	228	19	,	,	PUNCT
ejnm-325	228	20	while	while	SCONJ
ejnm-325	228	21	those	those	PRON
ejnm-325	228	22	with	with	ADP
ejnm-325	228	23	other	other	ADJ
ejnm-325	228	24	comorbidities	comorbiditie	NOUN
ejnm-325	228	25	display	display	VERB
ejnm-325	228	26	varied	varied	ADJ
ejnm-325	228	27	patterns	pattern	NOUN
ejnm-325	228	28	,	,	PUNCT
ejnm-325	228	29	the	the	DET
ejnm-325	228	30	lack	lack	NOUN
ejnm-325	228	31	of	of	ADP
ejnm-325	228	32	statistical	statistical	ADJ
ejnm-325	228	33	significance	significance	NOUN
ejnm-325	228	34	suggests	suggest	VERB
ejnm-325	228	35	that	that	SCONJ
ejnm-325	228	36	spirometry	spirometry	NOUN
ejnm-325	228	37	patterns	pattern	NOUN
ejnm-325	228	38	may	may	AUX
ejnm-325	228	39	not	not	PART
ejnm-325	228	40	be	be	AUX
ejnm-325	228	41	strongly	strongly	ADV
ejnm-325	228	42	influenced	influence	VERB
ejnm-325	228	43	by	by	ADP
ejnm-325	228	44	comorbidities	comorbiditie	NOUN
ejnm-325	228	45	alone	alone	ADV
ejnm-325	228	46	in	in	ADP
ejnm-325	228	47	this	this	DET
ejnm-325	228	48	cohort	cohort	NOUN
ejnm-325	228	49	.	.	PUNCT
ejnm-325	229	1	further	further	ADJ
ejnm-325	229	2	research	research	NOUN
ejnm-325	229	3	is	be	AUX
ejnm-325	229	4	warranted	warrant	VERB
ejnm-325	229	5	to	to	PART
ejnm-325	229	6	elucidate	elucidate	VERB
ejnm-325	229	7	the	the	DET
ejnm-325	229	8	interplay	interplay	NOUN
ejnm-325	229	9	between	between	ADP
ejnm-325	229	10	comorbidities	comorbiditie	NOUN
ejnm-325	229	11	(	(	PUNCT
ejnm-325	229	12	e.g.	e.g.	ADV
ejnm-325	229	13	,	,	PUNCT
ejnm-325	229	14	crp	crp	PROPN
ejnm-325	229	15	,	,	PUNCT
ejnm-325	229	16	d.	d.	PROPN
ejnm-325	229	17	dimer	dimer	PROPN
ejnm-325	229	18	)	)	PUNCT
ejnm-325	229	19	indicate	indicate	VERB
ejnm-325	229	20	persistent	persistent	ADJ
ejnm-325	229	21	systemic	systemic	ADJ
ejnm-325	229	22	inflammation	inflammation	NOUN
ejnm-325	229	23	and	and	CCONJ
ejnm-325	229	24	cardiovascular	cardiovascular	ADJ
ejnm-325	229	25	involvement	involvement	NOUN
ejnm-325	229	26	in	in	ADP
ejnm-325	229	27	post	post	ADJ
ejnm-325	229	28	-	-	ADJ
ejnm-325	229	29	covid-19	covid-19	ADJ
ejnm-325	229	30	patients	patient	NOUN
ejnm-325	229	31	(	(	PUNCT
ejnm-325	229	32	nalbandian	nalbandian	PROPN
ejnm-325	229	33	et	et	PROPN
ejnm-325	229	34	al	al	PROPN
ejnm-325	229	35	.	.	PROPN
ejnm-325	229	36	,	,	PUNCT
ejnm-325	229	37	2021	2021	NUM
ejnm-325	229	38	;	;	PUNCT
ejnm-325	229	39	libby	libby	PROPN
ejnm-325	229	40	et	et	PROPN
ejnm-325	229	41	al	al	PROPN
ejnm-325	229	42	.	.	PROPN
ejnm-325	229	43	,	,	PUNCT
ejnm-325	229	44	2021	2021	NUM
ejnm-325	229	45	)	)	PUNCT
ejnm-325	229	46	.	.	PUNCT
ejnm-325	230	1	pulmonary	pulmonary	ADJ
ejnm-325	230	2	function	function	NOUN
ejnm-325	230	3	tests	test	NOUN
ejnm-325	230	4	reveal	reveal	VERB
ejnm-325	230	5	a	a	DET
ejnm-325	230	6	high	high	ADJ
ejnm-325	230	7	prevalence	prevalence	NOUN
ejnm-325	230	8	of	of	ADP
ejnm-325	230	9	airflow	airflow	NOUN
ejnm-325	230	10	limitation	limitation	NOUN
ejnm-325	230	11	and	and	CCONJ
ejnm-325	230	12	restrictive	restrictive	ADJ
ejnm-325	230	13	patterns	pattern	NOUN
ejnm-325	230	14	,	,	PUNCT
ejnm-325	230	15	indicative	indicative	ADJ
ejnm-325	230	16	of	of	ADP
ejnm-325	230	17	lingering	linger	VERB
ejnm-325	230	18	respiratory	respiratory	ADJ
ejnm-325	230	19	impairments	impairment	NOUN
ejnm-325	230	20	post	post	ADJ
ejnm-325	230	21	-	-	NOUN
ejnm-325	230	22	recovery	recovery	NOUN
ejnm-325	230	23	(	(	PUNCT
ejnm-325	230	24	george	george	PROPN
ejnm-325	230	25	et	et	PROPN
ejnm-325	230	26	al	al	PROPN
ejnm-325	230	27	.	.	PROPN
ejnm-325	230	28	,	,	PUNCT
ejnm-325	230	29	2020	2020	NUM
ejnm-325	230	30	)	)	PUNCT
ejnm-325	230	31	.	.	PUNCT
ejnm-325	231	1	when	when	SCONJ
ejnm-325	231	2	compared	compare	VERB
ejnm-325	231	3	with	with	ADP
ejnm-325	231	4	similar	similar	ADJ
ejnm-325	231	5	investigations	investigation	NOUN
ejnm-325	231	6	,	,	PUNCT
ejnm-325	231	7	our	our	PRON
ejnm-325	231	8	findings	finding	NOUN
ejnm-325	231	9	corroborate	corroborate	VERB
ejnm-325	231	10	the	the	DET
ejnm-325	231	11	persistence	persistence	NOUN
ejnm-325	231	12	of	of	ADP
ejnm-325	231	13	cardiovascular	cardiovascular	ADJ
ejnm-325	231	14	and	and	CCONJ
ejnm-325	231	15	respiratory	respiratory	ADJ
ejnm-325	231	16	sequelae	sequelae	ADJ
ejnm-325	231	17	post	post	PROPN
ejnm-325	231	18	-	-	PROPN
ejnm-325	231	19	covid-19	covid-19	PROPN
ejnm-325	231	20	.	.	PROPN
ejnm-325	232	1	for	for	ADP
ejnm-325	232	2	instance	instance	NOUN
ejnm-325	232	3	,	,	PUNCT
ejnm-325	232	4	nalbandian	nalbandian	PROPN
ejnm-325	232	5	et	et	PROPN
ejnm-325	232	6	al	al	PROPN
ejnm-325	232	7	.	.	PROPN
ejnm-325	233	1	(	(	PUNCT
ejnm-325	233	2	2021	2021	NUM
ejnm-325	233	3	)	)	PUNCT
ejnm-325	233	4	reported	report	VERB
ejnm-325	233	5	a	a	DET
ejnm-325	233	6	similarly	similarly	ADV
ejnm-325	233	7	high	high	ADJ
ejnm-325	233	8	prevalence	prevalence	NOUN
ejnm-325	233	9	of	of	ADP
ejnm-325	233	10	abnormal	abnormal	ADJ
ejnm-325	233	11	cardiac	cardiac	ADJ
ejnm-325	233	12	biomarkers	biomarker	NOUN
ejnm-325	233	13	and	and	CCONJ
ejnm-325	233	14	pulmonary	pulmonary	ADJ
ejnm-325	233	15	dysfunction	dysfunction	NOUN
ejnm-325	233	16	in	in	ADP
ejnm-325	233	17	their	their	PRON
ejnm-325	233	18	study	study	NOUN
ejnm-325	233	19	cohort	cohort	NOUN
ejnm-325	233	20	.	.	PUNCT
ejnm-325	234	1	however	however	ADV
ejnm-325	234	2	,	,	PUNCT
ejnm-325	234	3	differences	difference	NOUN
ejnm-325	234	4	in	in	ADP
ejnm-325	234	5	the	the	DET
ejnm-325	234	6	prevalence	prevalence	NOUN
ejnm-325	234	7	of	of	ADP
ejnm-325	234	8	specific	specific	ADJ
ejnm-325	234	9	abnormalities	abnormality	NOUN
ejnm-325	234	10	may	may	AUX
ejnm-325	234	11	reflect	reflect	VERB
ejnm-325	234	12	variations	variation	NOUN
ejnm-325	234	13	in	in	ADP
ejnm-325	234	14	patient	patient	ADJ
ejnm-325	234	15	demographics	demographic	NOUN
ejnm-325	234	16	,	,	PUNCT
ejnm-325	234	17	disease	disease	NOUN
ejnm-325	234	18	severity	severity	NOUN
ejnm-325	234	19	,	,	PUNCT
ejnm-325	234	20	or	or	CCONJ
ejnm-325	234	21	follow	follow	VERB
ejnm-325	234	22	-	-	PUNCT
ejnm-325	234	23	up	up	ADP
ejnm-325	234	24	duration	duration	NOUN
ejnm-325	234	25	across	across	ADP
ejnm-325	234	26	studies	study	NOUN
ejnm-325	234	27	.	.	PUNCT
ejnm-325	235	1	the	the	DET
ejnm-325	235	2	distribution	distribution	NOUN
ejnm-325	235	3	of	of	ADP
ejnm-325	235	4	severity	severity	NOUN
ejnm-325	235	5	among	among	ADP
ejnm-325	235	6	post	post	ADJ
ejnm-325	235	7	-	-	ADJ
ejnm-325	235	8	covid-19	covid-19	ADJ
ejnm-325	235	9	patients	patient	NOUN
ejnm-325	235	10	,	,	PUNCT
ejnm-325	235	11	with	with	ADP
ejnm-325	235	12	mild	mild	ADJ
ejnm-325	235	13	cases	case	NOUN
ejnm-325	235	14	being	be	AUX
ejnm-325	235	15	the	the	DET
ejnm-325	235	16	most	most	ADV
ejnm-325	235	17	prevalent	prevalent	ADJ
ejnm-325	235	18	(	(	PUNCT
ejnm-325	235	19	43.2	43.2	NUM
ejnm-325	235	20	%	%	NOUN
ejnm-325	235	21	)	)	PUNCT
ejnm-325	235	22	,	,	PUNCT
ejnm-325	235	23	followed	follow	VERB
ejnm-325	235	24	by	by	ADP
ejnm-325	235	25	moderate	moderate	ADJ
ejnm-325	235	26	(	(	PUNCT
ejnm-325	235	27	28.4	28.4	NUM
ejnm-325	235	28	%	%	NOUN
ejnm-325	235	29	)	)	PUNCT
ejnm-325	235	30	and	and	CCONJ
ejnm-325	235	31	severe	severe	ADJ
ejnm-325	235	32	(	(	PUNCT
ejnm-325	235	33	25.7	25.7	NUM
ejnm-325	235	34	%	%	NOUN
ejnm-325	235	35	)	)	PUNCT
ejnm-325	235	36	cases	case	NOUN
ejnm-325	235	37	.	.	PUNCT
ejnm-325	236	1	this	this	DET
ejnm-325	236	2	distribution	distribution	NOUN
ejnm-325	236	3	underscores	underscore	VERB
ejnm-325	236	4	the	the	DET
ejnm-325	236	5	heterogeneity	heterogeneity	NOUN
ejnm-325	236	6	in	in	ADP
ejnm-325	236	7	symptom	symptom	NOUN
ejnm-325	236	8	presentation	presentation	NOUN
ejnm-325	236	9	and	and	CCONJ
ejnm-325	236	10	the	the	DET
ejnm-325	236	11	need	need	NOUN
ejnm-325	236	12	for	for	ADP
ejnm-325	236	13	tailored	tailor	VERB
ejnm-325	236	14	management	management	NOUN
ejnm-325	236	15	strategies	strategy	NOUN
ejnm-325	236	16	based	base	VERB
ejnm-325	236	17	on	on	ADP
ejnm-325	236	18	the	the	DET
ejnm-325	236	19	severity	severity	NOUN
ejnm-325	236	20	of	of	ADP
ejnm-325	236	21	symptoms	symptom	NOUN
ejnm-325	236	22	.	.	PUNCT
ejnm-325	237	1	the	the	DET
ejnm-325	237	2	association	association	NOUN
ejnm-325	237	3	between	between	ADP
ejnm-325	237	4	demographic	demographic	ADJ
ejnm-325	237	5	/	/	SYM
ejnm-325	237	6	clinical	clinical	ADJ
ejnm-325	237	7	characteristics	characteristic	NOUN
ejnm-325	237	8	and	and	CCONJ
ejnm-325	237	9	the	the	DET
ejnm-325	237	10	severity	severity	NOUN
ejnm-325	237	11	of	of	ADP
ejnm-325	237	12	post	post	ADJ
ejnm-325	237	13	-	-	ADJ
ejnm-325	237	14	covid-19	covid-19	ADJ
ejnm-325	237	15	symptoms	symptom	NOUN
ejnm-325	237	16	.	.	PUNCT
ejnm-325	238	1	notably	notably	ADV
ejnm-325	238	2	,	,	PUNCT
ejnm-325	238	3	age	age	NOUN
ejnm-325	238	4	groups	group	NOUN
ejnm-325	238	5	and	and	CCONJ
ejnm-325	238	6	shortness	shortness	NOUN
ejnm-325	238	7	of	of	ADP
ejnm-325	238	8	breath	breath	NOUN
ejnm-325	238	9	(	(	PUNCT
ejnm-325	238	10	sob	sob	NOUN
ejnm-325	238	11	)	)	PUNCT
ejnm-325	238	12	exhibit	exhibit	VERB
ejnm-325	238	13	a	a	DET
ejnm-325	238	14	highly	highly	ADV
ejnm-325	238	15	significant	significant	ADJ
ejnm-325	238	16	association	association	NOUN
ejnm-325	238	17	with	with	ADP
ejnm-325	238	18	severity	severity	NOUN
ejnm-325	238	19	(	(	PUNCT
ejnm-325	238	20	p	p	NOUN
ejnm-325	238	21	-	-	PUNCT
ejnm-325	238	22	value	value	NOUN
ejnm-325	238	23	<	<	NOUN
ejnm-325	238	24	0.001	0.001	NUM
ejnm-325	238	25	)	)	PUNCT
ejnm-325	238	26	,	,	PUNCT
ejnm-325	238	27	suggesting	suggest	VERB
ejnm-325	238	28	that	that	SCONJ
ejnm-325	238	29	older	old	ADJ
ejnm-325	238	30	age	age	NOUN
ejnm-325	238	31	and	and	CCONJ
ejnm-325	238	32	the	the	DET
ejnm-325	238	33	presence	presence	NOUN
ejnm-325	238	34	of	of	ADP
ejnm-325	238	35	sob	sob	NOUN
ejnm-325	238	36	may	may	AUX
ejnm-325	238	37	predispose	predispose	VERB
ejnm-325	238	38	individuals	individual	NOUN
ejnm-325	238	39	to	to	ADP
ejnm-325	238	40	more	more	ADV
ejnm-325	238	41	severe	severe	ADJ
ejnm-325	238	42	outcomes	outcome	NOUN
ejnm-325	238	43	.	.	PUNCT
ejnm-325	239	1	other	other	ADJ
ejnm-325	239	2	associations	association	NOUN
ejnm-325	239	3	,	,	PUNCT
ejnm-325	239	4	such	such	ADJ
ejnm-325	239	5	as	as	ADP
ejnm-325	239	6	sex	sex	NOUN
ejnm-325	239	7	,	,	PUNCT
ejnm-325	239	8	cough	cough	NOUN
ejnm-325	239	9	,	,	PUNCT
ejnm-325	239	10	fever	fever	NOUN
ejnm-325	239	11	,	,	PUNCT
ejnm-325	239	12	past	past	ADJ
ejnm-325	239	13	medical	medical	ADJ
ejnm-325	239	14	history	history	NOUN
ejnm-325	239	15	,	,	PUNCT
ejnm-325	239	16	and	and	CCONJ
ejnm-325	239	17	smoking	smoking	NOUN
ejnm-325	239	18	status	status	NOUN
ejnm-325	239	19	,	,	PUNCT
ejnm-325	239	20	appear	appear	VERB
ejnm-325	239	21	nonsignificant	nonsignificant	ADJ
ejnm-325	239	22	,	,	PUNCT
ejnm-325	239	23	indicating	indicate	VERB
ejnm-325	239	24	that	that	SCONJ
ejnm-325	239	25	these	these	DET
ejnm-325	239	26	factors	factor	NOUN
ejnm-325	239	27	may	may	AUX
ejnm-325	239	28	not	not	PART
ejnm-325	239	29	independently	independently	ADV
ejnm-325	239	30	predict	predict	VERB
ejnm-325	239	31	the	the	DET
ejnm-325	239	32	severity	severity	NOUN
ejnm-325	239	33	of	of	ADP
ejnm-325	239	34	post	post	ADJ
ejnm-325	239	35	-	-	ADJ
ejnm-325	239	36	covid-19	covid-19	ADJ
ejnm-325	239	37	symptoms	symptom	NOUN
ejnm-325	239	38	in	in	ADP
ejnm-325	239	39	this	this	DET
ejnm-325	239	40	cohort	cohort	NOUN
ejnm-325	239	41	.	.	PUNCT
ejnm-325	240	1	comparing	compare	VERB
ejnm-325	240	2	these	these	DET
ejnm-325	240	3	findings	finding	NOUN
ejnm-325	240	4	with	with	ADP
ejnm-325	240	5	existing	exist	VERB
ejnm-325	240	6	literature	literature	NOUN
ejnm-325	240	7	can	can	AUX
ejnm-325	240	8	provide	provide	VERB
ejnm-325	240	9	further	further	ADJ
ejnm-325	240	10	insights	insight	NOUN
ejnm-325	240	11	.	.	PUNCT
ejnm-325	241	1	for	for	ADP
ejnm-325	241	2	instance	instance	NOUN
ejnm-325	241	3	,	,	PUNCT
ejnm-325	241	4	while	while	SCONJ
ejnm-325	241	5	age	age	NOUN
ejnm-325	241	6	has	have	AUX
ejnm-325	241	7	consistently	consistently	ADV
ejnm-325	241	8	been	be	AUX
ejnm-325	241	9	identified	identify	VERB
ejnm-325	241	10	as	as	ADP
ejnm-325	241	11	a	a	DET
ejnm-325	241	12	significant	significant	ADJ
ejnm-325	241	13	predictor	predictor	NOUN
ejnm-325	241	14	of	of	ADP
ejnm-325	241	15	covid-19	covid-19	PROPN
ejnm-325	241	16	severity	severity	NOUN
ejnm-325	241	17	in	in	ADP
ejnm-325	241	18	numerous	numerous	ADJ
ejnm-325	241	19	studies	study	NOUN
ejnm-325	241	20	46	46	NUM
ejnm-325	241	21	copyright	copyright	NOUN
ejnm-325	241	22	©	©	PROPN
ejnm-325	241	23	2025	2025	NUM
ejnm-325	241	24	the	the	DET
ejnm-325	241	25	author(s	author(s	NOUN
ejnm-325	241	26	)	)	PUNCT
ejnm-325	241	27	.	.	PUNCT
ejnm-325	242	1	this	this	PRON
ejnm-325	242	2	is	be	AUX
ejnm-325	242	3	an	an	DET
ejnm-325	242	4	open	open	ADJ
ejnm-325	242	5	access	access	NOUN
ejnm-325	242	6	article	article	NOUN
ejnm-325	242	7	which	which	PRON
ejnm-325	242	8	licensed	license	VERB
ejnm-325	242	9	under	under	ADP
ejnm-325	242	10	the	the	DET
ejnm-325	242	11	terms	term	NOUN
ejnm-325	242	12	and	and	CCONJ
ejnm-325	242	13	conditions	condition	NOUN
ejnm-325	242	14	of	of	ADP
ejnm-325	242	15	the	the	DET
ejnm-325	242	16	creative	creative	ADJ
ejnm-325	242	17	commons	common	NOUN
ejnm-325	242	18	attribution	attribution	NOUN
ejnm-325	242	19	-	-	PUNCT
ejnm-325	242	20	noncommercial	noncommercial	ADJ
ejnm-325	242	21	-	-	PUNCT
ejnm-325	242	22	sharealike	sharealike	ADJ
ejnm-325	242	23	4.0	4.0	NUM
ejnm-325	242	24	international	international	ADJ
ejnm-325	242	25	license	license	NOUN
ejnm-325	242	26	.	.	PUNCT
ejnm-325	243	1	it	it	PRON
ejnm-325	243	2	permits	permit	VERB
ejnm-325	243	3	no	no	DET
ejnm-325	243	4	additional	additional	ADJ
ejnm-325	243	5	restrictions	restriction	NOUN
ejnm-325	243	6	on	on	ADP
ejnm-325	243	7	use	use	NOUN
ejnm-325	243	8	,	,	PUNCT
ejnm-325	243	9	distribution	distribution	NOUN
ejnm-325	243	10	,	,	PUNCT
ejnm-325	243	11	and	and	CCONJ
ejnm-325	243	12	reproduction	reproduction	NOUN
ejnm-325	243	13	in	in	ADP
ejnm-325	243	14	any	any	DET
ejnm-325	243	15	medium	medium	NOUN
ejnm-325	243	16	provided	provide	VERB
ejnm-325	243	17	the	the	DET
ejnm-325	243	18	original	original	ADJ
ejnm-325	243	19	work	work	NOUN
ejnm-325	243	20	is	be	AUX
ejnm-325	243	21	properly	properly	ADV
ejnm-325	243	22	cited	cite	VERB
ejnm-325	243	23	.	.	PUNCT
ejnm-325	244	1	https://creativecommons.org/licenses/by-nc-sa/4.0/	https://creativecommons.org/licenses/by-nc-sa/4.0/	PROPN
ejnm-325	245	1	https://doi.org/10.15218/ejnm.2025.05	https://doi.org/10.15218/ejnm.2025.05	PROPN
ejnm-325	245	2	erbil	erbil	PROPN
ejnm-325	245	3	j.	j.	PROPN
ejnm-325	245	4	nurs	nurs	PROPN
ejnm-325	245	5	.	.	PUNCT
ejnm-325	246	1	midwifery	midwifery	ADJ
ejnm-325	246	2	,	,	PUNCT
ejnm-325	246	3	vol	vol	NOUN
ejnm-325	246	4	.	.	PROPN
ejnm-325	246	5	8	8	NUM
ejnm-325	246	6	,	,	PUNCT
ejnm-325	246	7	no	no	INTJ
ejnm-325	246	8	.	.	PUNCT
ejnm-325	247	1	(	(	PUNCT
ejnm-325	247	2	1	1	NUM
ejnm-325	247	3	)	)	PUNCT
ejnm-325	247	4	,	,	PUNCT
ejnm-325	247	5	may2025	may2025	ADJ
ejnm-325	247	6	original	original	ADJ
ejnm-325	247	7	article	article	NOUN
ejnm-325	247	8	[	[	X
ejnm-325	247	9	4	4	X
ejnm-325	247	10	]	]	X
ejnm-325	247	11	docherty	docherty	PROPN
ejnm-325	247	12	ab	ab	PROPN
ejnm-325	247	13	,	,	PUNCT
ejnm-325	247	14	harrison	harrison	PROPN
ejnm-325	247	15	em	em	PRON
ejnm-325	247	16	,	,	PUNCT
ejnm-325	247	17	green	green	PROPN
ejnm-325	247	18	ca	ca	PROPN
ejnm-325	247	19	,	,	PUNCT
ejnm-325	247	20	hardwick	hardwick	VERB
ejnm-325	247	21	he	he	PRON
ejnm-325	247	22	,	,	PUNCT
ejnm-325	247	23	pius	pius	PROPN
ejnm-325	247	24	r	r	PROPN
ejnm-325	247	25	,	,	PUNCT
ejnm-325	247	26	norman	norman	PROPN
ejnm-325	247	27	l	l	PROPN
ejnm-325	247	28	,	,	PUNCT
ejnm-325	247	29	et	et	PROPN
ejnm-325	247	30	al	al	PROPN
ejnm-325	247	31	.	.	PROPN
ejnm-325	248	1	features	feature	NOUN
ejnm-325	248	2	of	of	ADP
ejnm-325	248	3	20	20	NUM
ejnm-325	248	4	133	133	NUM
ejnm-325	248	5	uk	uk	PROPN
ejnm-325	248	6	patients	patient	NOUN
ejnm-325	248	7	in	in	ADP
ejnm-325	248	8	hospital	hospital	NOUN
ejnm-325	248	9	with	with	ADP
ejnm-325	248	10	covid-19	covid-19	PROPN
ejnm-325	248	11	using	use	VERB
ejnm-325	248	12	the	the	DET
ejnm-325	248	13	isaric	isaric	NOUN
ejnm-325	248	14	who	who	PRON
ejnm-325	248	15	clinical	clinical	ADJ
ejnm-325	248	16	characterisation	characterisation	NOUN
ejnm-325	248	17	protocol	protocol	NOUN
ejnm-325	248	18	:	:	PUNCT
ejnm-325	248	19	prospective	prospective	ADJ
ejnm-325	248	20	observational	observational	ADJ
ejnm-325	248	21	cohort	cohort	NOUN
ejnm-325	248	22	study	study	NOUN
ejnm-325	248	23	.	.	PUNCT
ejnm-325	249	1	bmj	bmj	PROPN
ejnm-325	249	2	.	.	PUNCT
ejnm-325	250	1	2020	2020	NUM
ejnm-325	250	2	may	may	AUX
ejnm-325	250	3	22;369	22;369	NUM
ejnm-325	250	4	.	.	PUNCT
ejnm-325	251	1	https://doi.org/10.1136/bmj.m1985	https://doi.org/10.1136/bmj.m1985	X
ejnm-325	251	2	.	.	PUNCT
ejnm-325	252	1	[	[	X
ejnm-325	252	2	5	5	NUM
ejnm-325	252	3	]	]	PUNCT
ejnm-325	252	4	drake	drake	NOUN
ejnm-325	252	5	tm	tm	PROPN
ejnm-325	252	6	,	,	PUNCT
ejnm-325	252	7	riad	riad	PROPN
ejnm-325	252	8	am	am	PROPN
ejnm-325	252	9	,	,	PUNCT
ejnm-325	252	10	fairfield	fairfield	PROPN
ejnm-325	252	11	cj	cj	PROPN
ejnm-325	252	12	,	,	PUNCT
ejnm-325	252	13	egan	egan	PROPN
ejnm-325	252	14	c	c	PROPN
ejnm-325	252	15	,	,	PUNCT
ejnm-325	252	16	knight	knight	PROPN
ejnm-325	252	17	sr	sr	PROPN
ejnm-325	252	18	,	,	PUNCT
ejnm-325	252	19	pius	pius	PROPN
ejnm-325	252	20	r	r	PROPN
ejnm-325	252	21	,	,	PUNCT
ejnm-325	252	22	et	et	PROPN
ejnm-325	252	23	al	al	PROPN
ejnm-325	252	24	.	.	PROPN
ejnm-325	252	25	characterisation	characterisation	NOUN
ejnm-325	252	26	of	of	ADP
ejnm-325	252	27	in	in	ADP
ejnm-325	252	28	-hospital	-hospital	ADJ
ejnm-325	252	29	complications	complication	NOUN
ejnm-325	252	30	associated	associate	VERB
ejnm-325	252	31	with	with	ADP
ejnm-325	252	32	covid-19	covid-19	PROPN
ejnm-325	252	33	using	use	VERB
ejnm-325	252	34	the	the	DET
ejnm-325	252	35	isaric	isaric	NOUN
ejnm-325	252	36	who	who	PRON
ejnm-325	252	37	clinical	clinical	ADJ
ejnm-325	252	38	characterisation	characterisation	NOUN
ejnm-325	252	39	protocol	protocol	NOUN
ejnm-325	252	40	uk	uk	PROPN
ejnm-325	252	41	:	:	PUNCT
ejnm-325	252	42	a	a	DET
ejnm-325	252	43	prospective	prospective	ADJ
ejnm-325	252	44	,	,	PUNCT
ejnm-325	252	45	multicentre	multicentre	NOUN
ejnm-325	252	46	cohort	cohort	NOUN
ejnm-325	252	47	study	study	NOUN
ejnm-325	252	48	.	.	PUNCT
ejnm-325	253	1	the	the	DET
ejnm-325	253	2	lancet	lancet	PROPN
ejnm-325	253	3	.	.	PUNCT
ejnm-325	254	1	2021	2021	NUM
ejnm-325	254	2	jul	jul	PROPN
ejnm-325	254	3	17;398(10296):223	17;398(10296):223	NUM
ejnm-325	254	4	-	-	SYM
ejnm-325	254	5	37	37	NUM
ejnm-325	254	6	.	.	PUNCT
ejnm-325	255	1	https://	https://	PROPN
ejnm-325	255	2	doi.org/10.1016/s0140-6736(21)00799-6	doi.org/10.1016/s0140-6736(21)00799-6	NOUN
ejnm-325	255	3	[	[	X
ejnm-325	255	4	6	6	NUM
ejnm-325	255	5	]	]	X
ejnm-325	255	6	george	george	PROPN
ejnm-325	255	7	pm	pm	PROPN
ejnm-325	255	8	,	,	PUNCT
ejnm-325	255	9	wells	wells	PROPN
ejnm-325	255	10	au	au	PROPN
ejnm-325	255	11	,	,	PUNCT
ejnm-325	255	12	jenkins	jenkins	PROPN
ejnm-325	255	13	rg	rg	PROPN
ejnm-325	255	14	.	.	PUNCT
ejnm-325	255	15	pulmonary	pulmonary	ADJ
ejnm-325	255	16	fibrosis	fibrosis	NOUN
ejnm-325	255	17	and	and	CCONJ
ejnm-325	255	18	covid-19	covid-19	PROPN
ejnm-325	255	19	:	:	PUNCT
ejnm-325	255	20	the	the	DET
ejnm-325	255	21	potential	potential	ADJ
ejnm-325	255	22	role	role	NOUN
ejnm-325	255	23	for	for	ADP
ejnm-325	255	24	antifibrotic	antifibrotic	ADJ
ejnm-325	255	25	therapy	therapy	NOUN
ejnm-325	255	26	.	.	PUNCT
ejnm-325	256	1	the	the	DET
ejnm-325	256	2	lancet	lancet	ADJ
ejnm-325	256	3	respiratory	respiratory	ADJ
ejnm-325	256	4	medicine	medicine	NOUN
ejnm-325	256	5	.	.	PUNCT
ejnm-325	257	1	2020	2020	NUM
ejnm-325	257	2	aug	aug	PROPN
ejnm-325	257	3	1;8(8):807	1;8(8):807	NOUN
ejnm-325	257	4	-	-	SYM
ejnm-325	257	5	15	15	NUM
ejnm-325	257	6	.	.	PUNCT
ejnm-325	258	1	https://doi.org/10.1016/s2213-2600(20	https://doi.org/10.1016/s2213-2600(20	ADJ
ejnm-325	258	2	)	)	PUNCT
ejnm-325	258	3	30225	30225	NUM
ejnm-325	258	4	-	-	SYM
ejnm-325	258	5	3	3	NUM
ejnm-325	259	1	[	[	X
ejnm-325	259	2	7	7	NUM
ejnm-325	259	3	]	]	PUNCT
ejnm-325	259	4	horby	horby	VERB
ejnm-325	259	5	p	p	X
ejnm-325	259	6	,	,	PUNCT
ejnm-325	259	7	lim	lim	PROPN
ejnm-325	259	8	ws	ws	PROPN
ejnm-325	259	9	,	,	PUNCT
ejnm-325	259	10	emberson	emberson	NOUN
ejnm-325	259	11	jr	jr	PROPN
ejnm-325	259	12	.	.	PROPN
ejnm-325	259	13	recovery	recovery	PROPN
ejnm-325	259	14	collaborative	collaborative	ADJ
ejnm-325	259	15	group	group	PROPN
ejnm-325	259	16	dexamethasone	dexamethasone	NOUN
ejnm-325	259	17	in	in	ADP
ejnm-325	259	18	hospitalized	hospitalize	VERB
ejnm-325	259	19	patients	patient	NOUN
ejnm-325	259	20	with	with	ADP
ejnm-325	259	21	covid-19	covid-19	PROPN
ejnm-325	259	22	-	-	PUNCT
ejnm-325	259	23	preliminary	preliminary	ADJ
ejnm-325	259	24	report	report	NOUN
ejnm-325	259	25	.	.	PUNCT
ejnm-325	260	1	n	n	PRON
ejnm-325	260	2	engl	engl	PROPN
ejnm-325	260	3	j	j	PROPN
ejnm-325	260	4	med	med	PROPN
ejnm-325	260	5	.	.	PUNCT
ejnm-325	261	1	https://	https://	PROPN
ejnm-325	261	2	doi.org/10.1056/nejmoa2021436	doi.org/10.1056/nejmoa2021436	PROPN
ejnm-325	262	1	[	[	X
ejnm-325	262	2	8	8	NUM
ejnm-325	262	3	]	]	X
ejnm-325	262	4	huang	huang	PROPN
ejnm-325	262	5	c	c	PROPN
ejnm-325	262	6	,	,	PUNCT
ejnm-325	262	7	huang	huang	PROPN
ejnm-325	262	8	l	l	PROPN
ejnm-325	262	9	,	,	PUNCT
ejnm-325	262	10	wang	wang	PROPN
ejnm-325	262	11	y	y	PROPN
ejnm-325	262	12	,	,	PUNCT
ejnm-325	262	13	li	li	PROPN
ejnm-325	262	14	x	x	PROPN
ejnm-325	262	15	,	,	PUNCT
ejnm-325	262	16	ren	ren	PROPN
ejnm-325	262	17	l	l	PROPN
ejnm-325	262	18	,	,	PUNCT
ejnm-325	262	19	gu	gu	NOUN
ejnm-325	262	20	x	x	PROPN
ejnm-325	262	21	,	,	PUNCT
ejnm-325	262	22	et	et	PROPN
ejnm-325	262	23	al	al	PROPN
ejnm-325	262	24	.	.	PROPN
ejnm-325	262	25	6	6	NUM
ejnm-325	262	26	-	-	PUNCT
ejnm-325	262	27	month	month	NOUN
ejnm-325	262	28	consequences	consequence	NOUN
ejnm-325	262	29	of	of	ADP
ejnm-325	262	30	covid-19	covid-19	PROPN
ejnm-325	262	31	in	in	ADP
ejnm-325	262	32	patients	patient	NOUN
ejnm-325	262	33	discharged	discharge	VERB
ejnm-325	262	34	from	from	ADP
ejnm-325	262	35	hospital	hospital	NOUN
ejnm-325	262	36	:	:	PUNCT
ejnm-325	262	37	a	a	DET
ejnm-325	262	38	cohort	cohort	NOUN
ejnm-325	262	39	study	study	NOUN
ejnm-325	262	40	.	.	PUNCT
ejnm-325	263	1	the	the	DET
ejnm-325	263	2	lancet	lancet	NOUN
ejnm-325	263	3	.	.	PUNCT
ejnm-325	264	1	2023	2023	NUM
ejnm-325	264	2	jun	jun	PROPN
ejnm-325	264	3	17;401	17;401	NUM
ejnm-325	264	4	(	(	PUNCT
ejnm-325	264	5	10393):e21	10393):e21	NUM
ejnm-325	264	6	-	-	SYM
ejnm-325	264	7	33	33	NUM
ejnm-325	264	8	.	.	PUNCT
ejnm-325	265	1	https://doi.org/10.1016/	https://doi.org/10.1016/	PROPN
ejnm-325	265	2	s0140	s0140	PROPN
ejnm-325	265	3	-	-	PUNCT
ejnm-325	265	4	6736(20)32656	6736(20)32656	NUM
ejnm-325	265	5	-	-	SYM
ejnm-325	265	6	8	8	NUM
ejnm-325	265	7	[	[	X
ejnm-325	265	8	9	9	NUM
ejnm-325	265	9	]	]	X
ejnm-325	265	10	hui	hui	PROPN
ejnm-325	265	11	ds	ds	PROPN
ejnm-325	265	12	,	,	PUNCT
ejnm-325	265	13	wong	wong	PROPN
ejnm-325	265	14	kt	kt	PROPN
ejnm-325	265	15	,	,	PUNCT
ejnm-325	265	16	ko	ko	PROPN
ejnm-325	265	17	fw	fw	PROPN
ejnm-325	265	18	,	,	PUNCT
ejnm-325	265	19	tam	tam	PROPN
ejnm-325	265	20	ls	ls	PROPN
ejnm-325	265	21	,	,	PUNCT
ejnm-325	265	22	chan	chan	PROPN
ejnm-325	265	23	dp	dp	PROPN
ejnm-325	265	24	,	,	PUNCT
ejnm-325	265	25	woo	woo	VERB
ejnm-325	265	26	j	j	PROPN
ejnm-325	265	27	,	,	PUNCT
ejnm-325	265	28	et	et	PROPN
ejnm-325	265	29	al	al	PROPN
ejnm-325	265	30	.	.	PUNCT
ejnm-325	266	1	the	the	DET
ejnm-325	266	2	1	1	NUM
ejnm-325	266	3	-	-	PUNCT
ejnm-325	266	4	year	year	NOUN
ejnm-325	266	5	impact	impact	NOUN
ejnm-325	266	6	of	of	ADP
ejnm-325	266	7	severe	severe	ADJ
ejnm-325	266	8	acute	acute	ADJ
ejnm-325	266	9	respiratory	respiratory	ADJ
ejnm-325	266	10	syndrome	syndrome	NOUN
ejnm-325	266	11	on	on	ADP
ejnm-325	266	12	pulmonary	pulmonary	ADJ
ejnm-325	266	13	function	function	NOUN
ejnm-325	266	14	,	,	PUNCT
ejnm-325	266	15	exercise	exercise	NOUN
ejnm-325	266	16	capacity	capacity	NOUN
ejnm-325	266	17	,	,	PUNCT
ejnm-325	266	18	and	and	CCONJ
ejnm-325	266	19	quality	quality	NOUN
ejnm-325	266	20	of	of	ADP
ejnm-325	266	21	life	life	NOUN
ejnm-325	266	22	in	in	ADP
ejnm-325	266	23	a	a	DET
ejnm-325	266	24	cohort	cohort	NOUN
ejnm-325	266	25	of	of	ADP
ejnm-325	266	26	survivors	survivor	NOUN
ejnm-325	266	27	.	.	PUNCT
ejnm-325	267	1	chest	chest	NOUN
ejnm-325	267	2	.	.	PUNCT
ejnm-325	268	1	2005	2005	NUM
ejnm-325	268	2	oct	oct	NOUN
ejnm-325	268	3	1;128(4):2247	1;128(4):2247	PROPN
ejnm-325	268	4	-	-	SYM
ejnm-325	268	5	61	61	NUM
ejnm-325	268	6	.	.	PUNCT
ejnm-325	269	1	https://doi.org/10.1378/	https://doi.org/10.1378/	PROPN
ejnm-325	269	2	chest.128.4.2247	chest.128.4.2247	PROPN
ejnm-325	270	1	[	[	X
ejnm-325	270	2	10	10	NUM
ejnm-325	270	3	]	]	X
ejnm-325	270	4	jin	jin	PROPN
ejnm-325	270	5	jm	jm	PROPN
ejnm-325	270	6	,	,	PUNCT
ejnm-325	270	7	bai	bai	PROPN
ejnm-325	270	8	p	p	X
ejnm-325	270	9	,	,	PUNCT
ejnm-325	270	10	he	he	PRON
ejnm-325	270	11	w	w	PROPN
ejnm-325	270	12	,	,	PUNCT
ejnm-325	270	13	wu	wu	PROPN
ejnm-325	270	14	f	f	PROPN
ejnm-325	270	15	,	,	PUNCT
ejnm-325	270	16	liu	liu	PROPN
ejnm-325	270	17	xf	xf	PROPN
ejnm-325	270	18	,	,	PUNCT
ejnm-325	270	19	han	han	PROPN
ejnm-325	270	20	dm	dm	PROPN
ejnm-325	270	21	,	,	PUNCT
ejnm-325	270	22	et	et	PROPN
ejnm-325	270	23	al	al	PROPN
ejnm-325	270	24	.	.	PUNCT
ejnm-325	270	25	gender	gender	NOUN
ejnm-325	270	26	differences	difference	NOUN
ejnm-325	270	27	in	in	ADP
ejnm-325	270	28	patients	patient	NOUN
ejnm-325	270	29	with	with	ADP
ejnm-325	270	30	covid-19	covid-19	PROPN
ejnm-325	270	31	:	:	PUNCT
ejnm-325	270	32	focus	focus	VERB
ejnm-325	270	33	on	on	ADP
ejnm-325	270	34	severity	severity	NOUN
ejnm-325	270	35	and	and	CCONJ
ejnm-325	270	36	mortality	mortality	NOUN
ejnm-325	270	37	.	.	PUNCT
ejnm-325	271	1	frontiers	frontier	NOUN
ejnm-325	271	2	in	in	ADP
ejnm-325	271	3	public	public	ADJ
ejnm-325	271	4	health	health	NOUN
ejnm-325	271	5	.	.	PUNCT
ejnm-325	272	1	2020	2020	NUM
ejnm-325	272	2	apr	apr	VERB
ejnm-325	272	3	29;8:545030	29;8:545030	PROPN
ejnm-325	272	4	.	.	PUNCT
ejnm-325	273	1	https://doi.org/10.3389/	https://doi.org/10.3389/	PROPN
ejnm-325	273	2	fpubh.2020.00152	fpubh.2020.00152	PUNCT
ejnm-325	274	1	[	[	X
ejnm-325	274	2	11	11	NUM
ejnm-325	274	3	]	]	X
ejnm-325	274	4	libby	libby	PROPN
ejnm-325	274	5	p	p	PROPN
ejnm-325	274	6	,	,	PUNCT
ejnm-325	274	7	lüscher	lüscher	NOUN
ejnm-325	274	8	t.	t.	PROPN
ejnm-325	274	9	covid-19	covid-19	PROPN
ejnm-325	274	10	is	be	AUX
ejnm-325	274	11	,	,	PUNCT
ejnm-325	274	12	in	in	ADP
ejnm-325	274	13	the	the	DET
ejnm-325	274	14	end	end	NOUN
ejnm-325	274	15	,	,	PUNCT
ejnm-325	274	16	an	an	DET
ejnm-325	274	17	endothelial	endothelial	ADJ
ejnm-325	274	18	disease	disease	NOUN
ejnm-325	274	19	.	.	PUNCT
ejnm-325	275	1	european	european	ADJ
ejnm-325	275	2	heart	heart	PROPN
ejnm-325	275	3	journal	journal	PROPN
ejnm-325	275	4	.	.	PUNCT
ejnm-325	276	1	2020	2020	NUM
ejnm-325	276	2	aug	aug	PROPN
ejnm-325	276	3	21;41(32):3038	21;41(32):3038	NUM
ejnm-325	276	4	-	-	SYM
ejnm-325	276	5	44	44	NUM
ejnm-325	276	6	.	.	PUNCT
ejnm-325	277	1	https://	https://	PROPN
ejnm-325	277	2	doi.org/10.1093/eurheartj/ehaa623	doi.org/10.1093/eurheartj/ehaa623	VERB
ejnm-325	278	1	[	[	X
ejnm-325	278	2	12	12	NUM
ejnm-325	278	3	]	]	X
ejnm-325	278	4	lorent	lorent	ADJ
ejnm-325	278	5	n	n	CCONJ
ejnm-325	278	6	,	,	PUNCT
ejnm-325	278	7	weygaerde	weygaerde	PROPN
ejnm-325	278	8	yv	yv	PROPN
ejnm-325	278	9	,	,	PUNCT
ejnm-325	278	10	claeys	claeys	PROPN
ejnm-325	278	11	e	e	PROPN
ejnm-325	278	12	,	,	PUNCT
ejnm-325	278	13	fajardo	fajardo	PROPN
ejnm-325	278	14	ig	ig	PROPN
ejnm-325	278	15	,	,	PUNCT
ejnm-325	278	16	de	de	X
ejnm-325	278	17	vos	vos	NOUN
ejnm-325	278	18	n	n	CCONJ
ejnm-325	278	19	,	,	PUNCT
ejnm-325	278	20	de	de	X
ejnm-325	278	21	wever	wever	PROPN
ejnm-325	278	22	w	w	PROPN
ejnm-325	278	23	,	,	PUNCT
ejnm-325	278	24	et	et	PROPN
ejnm-325	278	25	al	al	PROPN
ejnm-325	278	26	.	.	PROPN
ejnm-325	278	27	prospective	prospective	ADJ
ejnm-325	278	28	longitudinal	longitudinal	ADJ
ejnm-325	278	29	evaluation	evaluation	NOUN
ejnm-325	278	30	of	of	ADP
ejnm-325	278	31	hospitalised	hospitalise	VERB
ejnm-325	278	32	covid-19	covid-19	PROPN
ejnm-325	278	33	survivors	survivor	NOUN
ejnm-325	278	34	3	3	NUM
ejnm-325	278	35	and	and	CCONJ
ejnm-325	278	36	12	12	NUM
ejnm-325	278	37	months	month	NOUN
ejnm-325	278	38	after	after	ADP
ejnm-325	278	39	discharge	discharge	NOUN
ejnm-325	278	40	.	.	PUNCT
ejnm-325	279	1	erj	erj	PROPN
ejnm-325	279	2	open	open	ADJ
ejnm-325	279	3	research	research	NOUN
ejnm-325	279	4	.	.	PUNCT
ejnm-325	280	1	2022	2022	NUM
ejnm-325	280	2	apr	apr	NOUN
ejnm-325	280	3	1;8	1;8	NUM
ejnm-325	280	4	(	(	PUNCT
ejnm-325	280	5	2).https://doi.org/10.1183/23120541.00004	2).https://doi.org/10.1183/23120541.00004	NOUN
ejnm-325	280	6	-2022	-2022	NOUN
ejnm-325	280	7	and	and	CCONJ
ejnm-325	280	8	spirometry	spirometry	NOUN
ejnm-325	280	9	patterns	pattern	NOUN
ejnm-325	280	10	in	in	ADP
ejnm-325	280	11	post	post	ADJ
ejnm-325	280	12	-	-	ADJ
ejnm-325	280	13	covid-19	covid-19	ADJ
ejnm-325	280	14	patients	patient	NOUN
ejnm-325	280	15	.	.	PUNCT
ejnm-325	281	1	these	these	DET
ejnm-325	281	2	findings	finding	NOUN
ejnm-325	281	3	align	align	VERB
ejnm-325	281	4	with	with	ADP
ejnm-325	281	5	emerging	emerge	VERB
ejnm-325	281	6	research	research	NOUN
ejnm-325	281	7	suggesting	suggest	VERB
ejnm-325	281	8	that	that	SCONJ
ejnm-325	281	9	spirometry	spirometry	NOUN
ejnm-325	281	10	can	can	AUX
ejnm-325	281	11	serve	serve	VERB
ejnm-325	281	12	as	as	ADP
ejnm-325	281	13	a	a	DET
ejnm-325	281	14	valuable	valuable	ADJ
ejnm-325	281	15	tool	tool	NOUN
ejnm-325	281	16	for	for	ADP
ejnm-325	281	17	assessing	assess	VERB
ejnm-325	281	18	disease	disease	NOUN
ejnm-325	281	19	severity	severity	NOUN
ejnm-325	281	20	and	and	CCONJ
ejnm-325	281	21	guiding	guide	VERB
ejnm-325	281	22	clinical	clinical	ADJ
ejnm-325	281	23	management	management	NOUN
ejnm-325	281	24	in	in	ADP
ejnm-325	281	25	post	post	ADJ
ejnm-325	281	26	-	-	ADJ
ejnm-325	281	27	covid-19	covid-19	ADJ
ejnm-325	281	28	care	care	NOUN
ejnm-325	281	29	.	.	PUNCT
ejnm-325	282	1	previous	previous	ADJ
ejnm-325	282	2	studies	study	NOUN
ejnm-325	282	3	have	have	AUX
ejnm-325	282	4	also	also	ADV
ejnm-325	282	5	highlighted	highlight	VERB
ejnm-325	282	6	the	the	DET
ejnm-325	282	7	utility	utility	NOUN
ejnm-325	282	8	of	of	ADP
ejnm-325	282	9	spirometry	spirometry	NOUN
ejnm-325	282	10	in	in	ADP
ejnm-325	282	11	identifying	identify	VERB
ejnm-325	282	12	respiratory	respiratory	ADJ
ejnm-325	282	13	impairments	impairment	NOUN
ejnm-325	282	14	and	and	CCONJ
ejnm-325	282	15	predicting	predict	VERB
ejnm-325	282	16	clinical	clinical	ADJ
ejnm-325	282	17	outcomes	outcome	NOUN
ejnm-325	282	18	in	in	ADP
ejnm-325	282	19	covid-19	covid-19	PROPN
ejnm-325	282	20	patients	patient	NOUN
ejnm-325	282	21	(	(	PUNCT
ejnm-325	282	22	george	george	PROPN
ejnm-325	282	23	et	et	PROPN
ejnm-325	282	24	al	al	PROPN
ejnm-325	282	25	.	.	PROPN
ejnm-325	282	26	,	,	PUNCT
ejnm-325	282	27	2020	2020	NUM
ejnm-325	282	28	;	;	PUNCT
ejnm-325	282	29	torres	torre	NOUN
ejnm-325	282	30	-	-	PUNCT
ejnm-325	282	31	castro	castro	NOUN
ejnm-325	282	32	et	et	PROPN
ejnm-325	282	33	al	al	PROPN
ejnm-325	282	34	.	.	PROPN
ejnm-325	282	35	,	,	PUNCT
ejnm-325	282	36	2021	2021	NUM
ejnm-325	282	37	)	)	PUNCT
ejnm-325	282	38	.	.	PUNCT
ejnm-325	283	1	however	however	ADV
ejnm-325	283	2	,	,	PUNCT
ejnm-325	283	3	the	the	DET
ejnm-325	283	4	association	association	NOUN
ejnm-325	283	5	between	between	ADP
ejnm-325	283	6	spirometry	spirometry	NOUN
ejnm-325	283	7	patterns	pattern	NOUN
ejnm-325	283	8	and	and	CCONJ
ejnm-325	283	9	comorbidities	comorbiditie	NOUN
ejnm-325	283	10	warrants	warrant	NOUN
ejnm-325	283	11	further	further	ADJ
ejnm-325	283	12	investigation	investigation	NOUN
ejnm-325	283	13	,	,	PUNCT
ejnm-325	283	14	as	as	SCONJ
ejnm-325	283	15	it	it	PRON
ejnm-325	283	16	may	may	AUX
ejnm-325	283	17	have	have	VERB
ejnm-325	283	18	implications	implication	NOUN
ejnm-325	283	19	for	for	ADP
ejnm-325	283	20	personalized	personalized	ADJ
ejnm-325	283	21	treatment	treatment	NOUN
ejnm-325	283	22	approaches	approach	NOUN
ejnm-325	283	23	and	and	CCONJ
ejnm-325	283	24	longterm	longterm	NOUN
ejnm-325	283	25	management	management	NOUN
ejnm-325	283	26	strategies	strategy	NOUN
ejnm-325	283	27	in	in	ADP
ejnm-325	283	28	postcovid-19	postcovid-19	PROPN
ejnm-325	283	29	care	care	NOUN
ejnm-325	283	30	.	.	PUNCT
ejnm-325	284	1	in	in	ADP
ejnm-325	284	2	conclusion	conclusion	NOUN
ejnm-325	284	3	,	,	PUNCT
ejnm-325	284	4	spirometry	spirometry	NOUN
ejnm-325	284	5	patterns	pattern	NOUN
ejnm-325	284	6	exhibit	exhibit	VERB
ejnm-325	284	7	a	a	DET
ejnm-325	284	8	significant	significant	ADJ
ejnm-325	284	9	association	association	NOUN
ejnm-325	284	10	with	with	ADP
ejnm-325	284	11	the	the	DET
ejnm-325	284	12	severity	severity	NOUN
ejnm-325	284	13	of	of	ADP
ejnm-325	284	14	post	post	ADJ
ejnm-325	284	15	-	-	ADJ
ejnm-325	284	16	covid-19	covid-19	ADJ
ejnm-325	284	17	symptoms	symptom	NOUN
ejnm-325	284	18	,	,	PUNCT
ejnm-325	284	19	highlighting	highlight	VERB
ejnm-325	284	20	their	their	PRON
ejnm-325	284	21	potential	potential	ADJ
ejnm-325	284	22	utility	utility	NOUN
ejnm-325	284	23	as	as	ADP
ejnm-325	284	24	prognostic	prognostic	ADJ
ejnm-325	284	25	markers	marker	NOUN
ejnm-325	284	26	in	in	ADP
ejnm-325	284	27	clinical	clinical	ADJ
ejnm-325	284	28	practice	practice	NOUN
ejnm-325	284	29	.	.	PUNCT
ejnm-325	285	1	while	while	SCONJ
ejnm-325	285	2	the	the	DET
ejnm-325	285	3	association	association	NOUN
ejnm-325	285	4	between	between	ADP
ejnm-325	285	5	spirometry	spirometry	NOUN
ejnm-325	285	6	patterns	pattern	NOUN
ejnm-325	285	7	and	and	CCONJ
ejnm-325	285	8	comorbidities	comorbiditie	NOUN
ejnm-325	285	9	appears	appear	VERB
ejnm-325	285	10	non	non	ADJ
ejnm-325	285	11	-	-	ADJ
ejnm-325	285	12	significant	significant	ADJ
ejnm-325	285	13	in	in	ADP
ejnm-325	285	14	this	this	DET
ejnm-325	285	15	study	study	NOUN
ejnm-325	285	16	,	,	PUNCT
ejnm-325	285	17	further	further	ADJ
ejnm-325	285	18	research	research	NOUN
ejnm-325	285	19	is	be	AUX
ejnm-325	285	20	needed	need	VERB
ejnm-325	285	21	to	to	PART
ejnm-325	285	22	elucidate	elucidate	VERB
ejnm-325	285	23	the	the	DET
ejnm-325	285	24	complex	complex	ADJ
ejnm-325	285	25	interplay	interplay	NOUN
ejnm-325	285	26	between	between	ADP
ejnm-325	285	27	these	these	DET
ejnm-325	285	28	factors	factor	NOUN
ejnm-325	285	29	and	and	CCONJ
ejnm-325	285	30	their	their	PRON
ejnm-325	285	31	implications	implication	NOUN
ejnm-325	285	32	for	for	ADP
ejnm-325	285	33	patient	patient	ADJ
ejnm-325	285	34	management	management	NOUN
ejnm-325	285	35	.	.	PUNCT
ejnm-325	286	1	[	[	X
ejnm-325	286	2	1	1	X
ejnm-325	286	3	]	]	X
ejnm-325	286	4	bradley	bradley	PROPN
ejnm-325	286	5	bt	bt	PROPN
ejnm-325	286	6	,	,	PUNCT
ejnm-325	286	7	maioli	maioli	PROPN
ejnm-325	286	8	h	h	NOUN
ejnm-325	286	9	,	,	PUNCT
ejnm-325	286	10	johnston	johnston	PROPN
ejnm-325	286	11	r	r	PROPN
ejnm-325	286	12	,	,	PUNCT
ejnm-325	286	13	chaudhry	chaudhry	PROPN
ejnm-325	286	14	i	i	PROPN
ejnm-325	286	15	,	,	PUNCT
ejnm-325	286	16	fink	fink	PROPN
ejnm-325	286	17	sl	sl	PROPN
ejnm-325	286	18	,	,	PUNCT
ejnm-325	286	19	xu	xu	PROPN
ejnm-325	286	20	h	h	PROPN
ejnm-325	286	21	,	,	PUNCT
ejnm-325	286	22	et	et	PROPN
ejnm-325	286	23	al	al	PROPN
ejnm-325	286	24	.	.	PROPN
ejnm-325	286	25	histopathology	histopathology	PROPN
ejnm-325	286	26	and	and	CCONJ
ejnm-325	286	27	ultrastructural	ultrastructural	ADJ
ejnm-325	286	28	findings	finding	NOUN
ejnm-325	286	29	of	of	ADP
ejnm-325	286	30	fatal	fatal	ADJ
ejnm-325	286	31	covid-19	covid-19	PROPN
ejnm-325	286	32	infections	infection	NOUN
ejnm-325	286	33	in	in	ADP
ejnm-325	286	34	washington	washington	PROPN
ejnm-325	286	35	state	state	PROPN
ejnm-325	286	36	:	:	PUNCT
ejnm-325	286	37	a	a	DET
ejnm-325	286	38	case	case	NOUN
ejnm-325	286	39	series	series	NOUN
ejnm-325	286	40	.	.	PUNCT
ejnm-325	287	1	the	the	DET
ejnm-325	287	2	lancet	lancet	PROPN
ejnm-325	287	3	.	.	PUNCT
ejnm-325	288	1	2020	2020	NUM
ejnm-325	288	2	aug	aug	PROPN
ejnm-325	288	3	1;396(10247):320	1;396(10247):320	NUM
ejnm-325	288	4	-	-	SYM
ejnm-325	288	5	32	32	NUM
ejnm-325	288	6	.	.	PUNCT
ejnm-325	289	1	https://doi.org/10.1016/s0140-6736(20	https://doi.org/10.1016/s0140-6736(20	ADJ
ejnm-325	289	2	)	)	PUNCT
ejnm-325	289	3	31305	31305	NUM
ejnm-325	289	4	-	-	SYM
ejnm-325	289	5	2	2	NUM
ejnm-325	289	6	.	.	PUNCT
ejnm-325	290	1	[	[	X
ejnm-325	290	2	2	2	NUM
ejnm-325	290	3	]	]	PUNCT
ejnm-325	290	4	carfì	carfì	NOUN
ejnm-325	290	5	a	a	X
ejnm-325	290	6	,	,	PUNCT
ejnm-325	290	7	bernabei	bernabei	PROPN
ejnm-325	290	8	r	r	NOUN
ejnm-325	290	9	,	,	PUNCT
ejnm-325	290	10	landi	landi	PROPN
ejnm-325	290	11	f.	f.	PROPN
ejnm-325	290	12	persistent	persistent	PROPN
ejnm-325	290	13	symptoms	symptom	NOUN
ejnm-325	290	14	in	in	ADP
ejnm-325	290	15	patients	patient	NOUN
ejnm-325	290	16	after	after	ADP
ejnm-325	290	17	acute	acute	PROPN
ejnm-325	290	18	covid-19	covid-19	PROPN
ejnm-325	290	19	.	.	PROPN
ejnm-325	290	20	jama	jama	PROPN
ejnm-325	290	21	.	.	PUNCT
ejnm-325	291	1	2020	2020	NUM
ejnm-325	291	2	aug	aug	PROPN
ejnm-325	291	3	11;324(6):603	11;324(6):603	NUM
ejnm-325	291	4	-	-	SYM
ejnm-325	291	5	5	5	NUM
ejnm-325	291	6	.	.	PUNCT
ejnm-325	292	1	https://	https://	PROPN
ejnm-325	292	2	doi:10.1001	doi:10.1001	NOUN
ejnm-325	292	3	/	/	SYM
ejnm-325	292	4	jama.2020.12603	jama.2020.12603	PROPN
ejnm-325	293	1	[	[	X
ejnm-325	293	2	3	3	NUM
ejnm-325	293	3	]	]	SYM
ejnm-325	293	4	cordier	cordier	NOUN
ejnm-325	293	5	jf	jf	PROPN
ejnm-325	293	6	.	.	PUNCT
ejnm-325	293	7	organising	organise	VERB
ejnm-325	293	8	pneumonia	pneumonia	NOUN
ejnm-325	293	9	.	.	PUNCT
ejnm-325	294	1	thorax	thorax	NOUN
ejnm-325	294	2	.	.	PUNCT
ejnm-325	295	1	2000	2000	NUM
ejnm-325	295	2	apr	apr	NOUN
ejnm-325	295	3	1;55(4):318	1;55(4):318	NUM
ejnm-325	295	4	-	-	SYM
ejnm-325	295	5	28	28	NUM
ejnm-325	295	6	.	.	PUNCT
ejnm-325	296	1	https://	https://	PROPN
ejnm-325	296	2	doi.org/10.1136/thorax.55.4.318	doi.org/10.1136/thorax.55.4.318	PROPN
ejnm-325	296	3	47	47	NUM
ejnm-325	296	4	copyright	copyright	NOUN
ejnm-325	296	5	©	©	PROPN
ejnm-325	296	6	2025	2025	NUM
ejnm-325	296	7	the	the	DET
ejnm-325	296	8	author(s	author(s	NOUN
ejnm-325	296	9	)	)	PUNCT
ejnm-325	296	10	.	.	PUNCT
ejnm-325	297	1	this	this	PRON
ejnm-325	297	2	is	be	AUX
ejnm-325	297	3	an	an	DET
ejnm-325	297	4	open	open	ADJ
ejnm-325	297	5	access	access	NOUN
ejnm-325	297	6	article	article	NOUN
ejnm-325	297	7	which	which	PRON
ejnm-325	297	8	licensed	license	VERB
ejnm-325	297	9	under	under	ADP
ejnm-325	297	10	the	the	DET
ejnm-325	297	11	terms	term	NOUN
ejnm-325	297	12	and	and	CCONJ
ejnm-325	297	13	conditions	condition	NOUN
ejnm-325	297	14	of	of	ADP
ejnm-325	297	15	the	the	DET
ejnm-325	297	16	creative	creative	ADJ
ejnm-325	297	17	commons	common	NOUN
ejnm-325	297	18	attribution	attribution	NOUN
ejnm-325	297	19	-	-	PUNCT
ejnm-325	297	20	noncommercial	noncommercial	ADJ
ejnm-325	297	21	-	-	PUNCT
ejnm-325	297	22	sharealike	sharealike	ADJ
ejnm-325	297	23	4.0	4.0	NUM
ejnm-325	297	24	international	international	ADJ
ejnm-325	297	25	license	license	NOUN
ejnm-325	297	26	.	.	PUNCT
ejnm-325	298	1	it	it	PRON
ejnm-325	298	2	permits	permit	VERB
ejnm-325	298	3	no	no	DET
ejnm-325	298	4	additional	additional	ADJ
ejnm-325	298	5	restrictions	restriction	NOUN
ejnm-325	298	6	on	on	ADP
ejnm-325	298	7	use	use	NOUN
ejnm-325	298	8	,	,	PUNCT
ejnm-325	298	9	distribution	distribution	NOUN
ejnm-325	298	10	,	,	PUNCT
ejnm-325	298	11	and	and	CCONJ
ejnm-325	298	12	reproduction	reproduction	NOUN
ejnm-325	298	13	in	in	ADP
ejnm-325	298	14	any	any	DET
ejnm-325	298	15	medium	medium	NOUN
ejnm-325	298	16	provided	provide	VERB
ejnm-325	298	17	the	the	DET
ejnm-325	298	18	original	original	ADJ
ejnm-325	298	19	work	work	NOUN
ejnm-325	298	20	is	be	AUX
ejnm-325	298	21	properly	properly	ADV
ejnm-325	298	22	cited	cite	VERB
ejnm-325	298	23	.	.	PUNCT
ejnm-325	299	1	conclusion	conclusion	NOUN
ejnm-325	299	2	references	reference	NOUN
ejnm-325	299	3	https://creativecommons.org/licenses/by-nc-sa/4.0/	https://creativecommons.org/licenses/by-nc-sa/4.0/	PROPN
ejnm-325	299	4	https://doi.org/10.15218/ejnm.2025.05	https://doi.org/10.15218/ejnm.2025.05	PROPN
ejnm-325	299	5	erbil	erbil	PROPN
ejnm-325	299	6	j.	j.	PROPN
ejnm-325	299	7	nurs	nurs	PROPN
ejnm-325	299	8	.	.	PUNCT
ejnm-325	300	1	midwifery	midwifery	ADJ
ejnm-325	300	2	,	,	PUNCT
ejnm-325	300	3	vol	vol	NOUN
ejnm-325	300	4	.	.	PROPN
ejnm-325	300	5	8	8	NUM
ejnm-325	300	6	,	,	PUNCT
ejnm-325	300	7	no	no	INTJ
ejnm-325	300	8	.	.	PUNCT
ejnm-325	301	1	(	(	PUNCT
ejnm-325	301	2	1	1	NUM
ejnm-325	301	3	)	)	PUNCT
ejnm-325	301	4	,	,	PUNCT
ejnm-325	301	5	may2025	may2025	ADJ
ejnm-325	301	6	original	original	ADJ
ejnm-325	301	7	article	article	NOUN
ejnm-325	301	8	hospitalized	hospitalize	VERB
ejnm-325	301	9	with	with	ADP
ejnm-325	301	10	covid-19	covid-19	PROPN
ejnm-325	301	11	in	in	ADP
ejnm-325	301	12	the	the	DET
ejnm-325	301	13	new	new	PROPN
ejnm-325	301	14	york	york	PROPN
ejnm-325	301	15	city	city	PROPN
ejnm-325	301	16	area	area	NOUN
ejnm-325	301	17	.	.	PUNCT
ejnm-325	302	1	jama	jama	PROPN
ejnm-325	302	2	.	.	PUNCT
ejnm-325	303	1	2020	2020	NUM
ejnm-325	303	2	may	may	AUX
ejnm-325	303	3	26;323(20):20529	26;323(20):20529	NUM
ejnm-325	303	4	.	.	PUNCT
ejnm-325	304	1	https://doi.org/10.1001/jama.2020.6775	https://doi.org/10.1001/jama.2020.6775	PROPN
ejnm-325	305	1	[	[	X
ejnm-325	305	2	23	23	NUM
ejnm-325	305	3	]	]	X
ejnm-325	305	4	rothan	rothan	PROPN
ejnm-325	305	5	ha	ha	INTJ
ejnm-325	305	6	,	,	PUNCT
ejnm-325	305	7	byrareddy	byrareddy	PROPN
ejnm-325	305	8	sn	sn	PROPN
ejnm-325	305	9	.	.	PUNCT
ejnm-325	306	1	the	the	DET
ejnm-325	306	2	epidemiology	epidemiology	NOUN
ejnm-325	306	3	and	and	CCONJ
ejnm-325	306	4	pathogenesis	pathogenesis	NOUN
ejnm-325	306	5	of	of	ADP
ejnm-325	306	6	coronavirus	coronavirus	NOUN
ejnm-325	306	7	disease	disease	NOUN
ejnm-325	306	8	(	(	PUNCT
ejnm-325	306	9	covid-19	covid-19	PROPN
ejnm-325	306	10	)	)	PUNCT
ejnm-325	306	11	outbreak	outbreak	NOUN
ejnm-325	306	12	.	.	PUNCT
ejnm-325	307	1	journal	journal	PROPN
ejnm-325	307	2	of	of	ADP
ejnm-325	307	3	autoimmunity	autoimmunity	NOUN
ejnm-325	307	4	.	.	PUNCT
ejnm-325	308	1	2020	2020	NUM
ejnm-325	308	2	may	may	AUX
ejnm-325	308	3	1;109:102433	1;109:102433	NUM
ejnm-325	308	4	.	.	PUNCT
ejnm-325	309	1	https://	https://	PROPN
ejnm-325	309	2	doi.org/10.1016/j.jaut.2020.102433	doi.org/10.1016/j.jaut.2020.102433	PROPN
ejnm-325	309	3	.	.	PUNCT
ejnm-325	310	1	[	[	X
ejnm-325	310	2	24	24	NUM
ejnm-325	310	3	]	]	PUNCT
ejnm-325	310	4	sanchez	sanchez	PROPN
ejnm-325	310	5	-	-	PUNCT
ejnm-325	310	6	ramirez	ramirez	PROPN
ejnm-325	310	7	dc	dc	PROPN
ejnm-325	310	8	,	,	PUNCT
ejnm-325	310	9	mackey	mackey	PROPN
ejnm-325	310	10	d.	d.	PROPN
ejnm-325	310	11	underlying	underlie	VERB
ejnm-325	310	12	respiratory	respiratory	ADJ
ejnm-325	310	13	diseases	disease	NOUN
ejnm-325	310	14	,	,	PUNCT
ejnm-325	310	15	specifically	specifically	ADV
ejnm-325	310	16	copd	copd	NOUN
ejnm-325	310	17	,	,	PUNCT
ejnm-325	310	18	and	and	CCONJ
ejnm-325	310	19	smoking	smoking	NOUN
ejnm-325	310	20	are	be	AUX
ejnm-325	310	21	associated	associate	VERB
ejnm-325	310	22	with	with	ADP
ejnm-325	310	23	severe	severe	ADJ
ejnm-325	310	24	covid19	covid19	NOUN
ejnm-325	310	25	outcomes	outcome	NOUN
ejnm-325	310	26	:	:	PUNCT
ejnm-325	310	27	a	a	DET
ejnm-325	310	28	systematic	systematic	ADJ
ejnm-325	310	29	review	review	NOUN
ejnm-325	310	30	and	and	CCONJ
ejnm-325	310	31	metaanalysis	metaanalysis	NOUN
ejnm-325	310	32	.	.	PUNCT
ejnm-325	311	1	respiratory	respiratory	ADJ
ejnm-325	311	2	medicine	medicine	NOUN
ejnm-325	311	3	.	.	PUNCT
ejnm-325	312	1	2020	2020	NUM
ejnm-325	312	2	sep	sep	PROPN
ejnm-325	312	3	1;171:106096	1;171:106096	NOUN
ejnm-325	312	4	.	.	PUNCT
ejnm-325	313	1	https://doi.org/10.1016/	https://doi.org/10.1016/	PROPN
ejnm-325	313	2	j.rmed.2020.106096	j.rmed.2020.106096	NOUN
ejnm-325	313	3	[	[	X
ejnm-325	313	4	25	25	NUM
ejnm-325	313	5	]	]	PUNCT
ejnm-325	313	6	sterne	sterne	PROPN
ejnm-325	313	7	ja	ja	PROPN
ejnm-325	313	8	,	,	PUNCT
ejnm-325	313	9	murthy	murthy	PROPN
ejnm-325	313	10	sw	sw	PROPN
ejnm-325	313	11	,	,	PUNCT
ejnm-325	313	12	diaz	diaz	PROPN
ejnm-325	313	13	jv	jv	PROPN
ejnm-325	313	14	,	,	PUNCT
ejnm-325	313	15	slutsky	slutsky	PROPN
ejnm-325	313	16	as	as	ADP
ejnm-325	313	17	,	,	PUNCT
ejnm-325	313	18	villar	villar	PROPN
ejnm-325	313	19	jw	jw	PROPN
ejnm-325	313	20	,	,	PUNCT
ejnm-325	313	21	angus	angus	PROPN
ejnm-325	313	22	dc	dc	PROPN
ejnm-325	313	23	,	,	PUNCT
ejnm-325	313	24	et	et	PROPN
ejnm-325	313	25	al	al	PROPN
ejnm-325	313	26	.	.	PROPN
ejnm-325	314	1	who	who	PRON
ejnm-325	314	2	rapid	rapid	ADJ
ejnm-325	314	3	evidence	evidence	NOUN
ejnm-325	314	4	appraisal	appraisal	NOUN
ejnm-325	314	5	for	for	ADP
ejnm-325	314	6	covid-19	covid-19	PROPN
ejnm-325	314	7	therapies	therapy	NOUN
ejnm-325	314	8	(	(	PUNCT
ejnm-325	314	9	react	react	PROPN
ejnm-325	314	10	)	)	PUNCT
ejnm-325	314	11	working	working	NOUN
ejnm-325	314	12	group	group	NOUN
ejnm-325	314	13	.	.	PUNCT
ejnm-325	315	1	association	association	NOUN
ejnm-325	315	2	between	between	ADP
ejnm-325	315	3	administration	administration	NOUN
ejnm-325	315	4	of	of	ADP
ejnm-325	315	5	systemic	systemic	ADJ
ejnm-325	315	6	corticosteroids	corticosteroid	NOUN
ejnm-325	315	7	and	and	CCONJ
ejnm-325	315	8	mortality	mortality	NOUN
ejnm-325	315	9	among	among	ADP
ejnm-325	315	10	critically	critically	ADV
ejnm-325	315	11	ill	ill	ADJ
ejnm-325	315	12	patients	patient	NOUN
ejnm-325	315	13	with	with	ADP
ejnm-325	315	14	covid-19	covid-19	PROPN
ejnm-325	315	15	:	:	PUNCT
ejnm-325	315	16	a	a	DET
ejnm-325	315	17	meta	meta	ADJ
ejnm-325	315	18	-	-	PUNCT
ejnm-325	315	19	analysis	analysis	NOUN
ejnm-325	315	20	.	.	PUNCT
ejnm-325	316	1	jama	jama	NOUN
ejnm-325	316	2	.	.	PUNCT
ejnm-325	317	1	2020	2020	NUM
ejnm-325	317	2	oct	oct	NOUN
ejnm-325	317	3	6;324(13):1330	6;324(13):1330	PROPN
ejnm-325	317	4	-	-	PUNCT
ejnm-325	317	5	41	41	NUM
ejnm-325	317	6	.	.	PUNCT
ejnm-325	318	1	https://	https://	PROPN
ejnm-325	318	2	doi.org/10.1001/jama.2020.17023	doi.org/10.1001/jama.2020.17023	PROPN
ejnm-325	318	3	[	[	X
ejnm-325	318	4	26	26	NUM
ejnm-325	318	5	]	]	X
ejnm-325	318	6	sze	sze	PROPN
ejnm-325	318	7	s	s	PROPN
ejnm-325	318	8	,	,	PUNCT
ejnm-325	318	9	pan	pan	PROPN
ejnm-325	318	10	d	d	PROPN
ejnm-325	318	11	,	,	PUNCT
ejnm-325	318	12	nevill	nevill	PROPN
ejnm-325	318	13	cr	cr	PROPN
ejnm-325	318	14	,	,	PUNCT
ejnm-325	318	15	gray	gray	ADJ
ejnm-325	318	16	lj	lj	PROPN
ejnm-325	318	17	,	,	PUNCT
ejnm-325	318	18	martin	martin	PROPN
ejnm-325	318	19	ca	ca	PROPN
ejnm-325	318	20	,	,	PUNCT
ejnm-325	318	21	nazareth	nazareth	PROPN
ejnm-325	318	22	j	j	PROPN
ejnm-325	318	23	,	,	PUNCT
ejnm-325	318	24	et	et	PROPN
ejnm-325	318	25	al	al	PROPN
ejnm-325	318	26	.	.	PUNCT
ejnm-325	318	27	ethnicity	ethnicity	NOUN
ejnm-325	318	28	and	and	CCONJ
ejnm-325	318	29	clinical	clinical	ADJ
ejnm-325	318	30	outcomes	outcome	NOUN
ejnm-325	318	31	in	in	ADP
ejnm-325	318	32	covid-19	covid-19	PROPN
ejnm-325	318	33	:	:	PUNCT
ejnm-325	318	34	a	a	DET
ejnm-325	318	35	systematic	systematic	ADJ
ejnm-325	318	36	review	review	NOUN
ejnm-325	318	37	and	and	CCONJ
ejnm-325	318	38	meta	meta	ADJ
ejnm-325	318	39	-	-	PUNCT
ejnm-325	318	40	analysis	analysis	NOUN
ejnm-325	318	41	.	.	PUNCT
ejnm-325	319	1	e	e	X
ejnm-325	319	2	clinical	clinical	ADJ
ejnm-325	319	3	medicine	medicine	NOUN
ejnm-325	319	4	.	.	PUNCT
ejnm-325	320	1	2020	2020	NUM
ejnm-325	320	2	dec	dec	PROPN
ejnm-325	320	3	1;29	1;29	NUM
ejnm-325	320	4	.	.	PUNCT
ejnm-325	321	1	https://doi.org/10.1016/	https://doi.org/10.1016/	PROPN
ejnm-325	321	2	j.eclinm.2020.100630	j.eclinm.2020.100630	PROPN
ejnm-325	322	1	[	[	X
ejnm-325	322	2	27	27	NUM
ejnm-325	322	3	]	]	PUNCT
ejnm-325	322	4	torres	torre	NOUN
ejnm-325	322	5	-	-	PUNCT
ejnm-325	322	6	castro	castro	NOUN
ejnm-325	322	7	r	r	NOUN
ejnm-325	322	8	,	,	PUNCT
ejnm-325	322	9	vasconcello	vasconcello	PROPN
ejnm-325	322	10	-	-	PUNCT
ejnm-325	322	11	castillo	castillo	PROPN
ejnm-325	322	12	l	l	PROPN
ejnm-325	322	13	,	,	PUNCT
ejnm-325	322	14	alsina	alsina	NOUN
ejnm-325	322	15	-	-	PUNCT
ejnm-325	322	16	restoy	restoy	NOUN
ejnm-325	322	17	x	x	PROPN
ejnm-325	322	18	,	,	PUNCT
ejnm-325	322	19	solis	solis	PROPN
ejnm-325	322	20	-	-	PROPN
ejnm-325	322	21	navarro	navarro	PROPN
ejnm-325	322	22	l	l	PROPN
ejnm-325	322	23	,	,	PUNCT
ejnm-325	322	24	burgos	burgos	PROPN
ejnm-325	322	25	f	f	PROPN
ejnm-325	322	26	,	,	PUNCT
ejnm-325	322	27	puppo	puppo	PROPN
ejnm-325	322	28	h	h	PROPN
ejnm-325	322	29	,	,	PUNCT
ejnm-325	322	30	et	et	PROPN
ejnm-325	322	31	al	al	PROPN
ejnm-325	322	32	.	.	PUNCT
ejnm-325	323	1	respiratory	respiratory	ADJ
ejnm-325	323	2	function	function	NOUN
ejnm-325	323	3	in	in	ADP
ejnm-325	323	4	patients	patient	NOUN
ejnm-325	323	5	post	post	NOUN
ejnm-325	323	6	-	-	NOUN
ejnm-325	323	7	infection	infection	NOUN
ejnm-325	323	8	by	by	ADP
ejnm-325	323	9	covid-19	covid-19	PROPN
ejnm-325	323	10	:	:	PUNCT
ejnm-325	323	11	a	a	DET
ejnm-325	323	12	systematic	systematic	ADJ
ejnm-325	323	13	review	review	NOUN
ejnm-325	323	14	and	and	CCONJ
ejnm-325	323	15	meta	meta	ADJ
ejnm-325	323	16	-	-	PUNCT
ejnm-325	323	17	analysis	analysis	NOUN
ejnm-325	323	18	.	.	PUNCT
ejnm-325	324	1	pulmonology	pulmonology	NOUN
ejnm-325	324	2	.	.	PUNCT
ejnm-325	325	1	2021	2021	NUM
ejnm-325	325	2	jul	jul	PROPN
ejnm-325	325	3	1;27(4):328	1;27(4):328	NUM
ejnm-325	325	4	-	-	SYM
ejnm-325	325	5	37	37	NUM
ejnm-325	325	6	.	.	PUNCT
ejnm-325	326	1	https://	https://	PROPN
ejnm-325	326	2	doi.org/10.1016/j.pulmoe.2020.10.013	doi.org/10.1016/j.pulmoe.2020.10.013	PUNCT
ejnm-325	327	1	[	[	X
ejnm-325	327	2	28	28	NUM
ejnm-325	327	3	]	]	X
ejnm-325	327	4	wang	wang	PROPN
ejnm-325	327	5	y	y	PROPN
ejnm-325	327	6	,	,	PUNCT
ejnm-325	327	7	dong	dong	PROPN
ejnm-325	327	8	c	c	PROPN
ejnm-325	327	9	,	,	PUNCT
ejnm-325	327	10	hu	hu	PROPN
ejnm-325	327	11	y	y	PROPN
ejnm-325	327	12	,	,	PUNCT
ejnm-325	327	13	li	li	PROPN
ejnm-325	327	14	c	c	PROPN
ejnm-325	327	15	,	,	PUNCT
ejnm-325	327	16	ren	ren	PROPN
ejnm-325	327	17	q	q	PROPN
ejnm-325	327	18	,	,	PUNCT
ejnm-325	327	19	zhang	zhang	PROPN
ejnm-325	327	20	x	x	PROPN
ejnm-325	327	21	,	,	PUNCT
ejnm-325	327	22	et	et	PROPN
ejnm-325	327	23	al	al	PROPN
ejnm-325	327	24	.	.	PUNCT
ejnm-325	327	25	temporal	temporal	ADJ
ejnm-325	327	26	changes	change	NOUN
ejnm-325	327	27	of	of	ADP
ejnm-325	327	28	ct	ct	PROPN
ejnm-325	327	29	findings	finding	NOUN
ejnm-325	327	30	in	in	ADP
ejnm-325	327	31	90	90	NUM
ejnm-325	327	32	patients	patient	NOUN
ejnm-325	327	33	with	with	ADP
ejnm-325	327	34	covid-19	covid-19	PROPN
ejnm-325	327	35	pneumonia	pneumonia	NOUN
ejnm-325	327	36	:	:	PUNCT
ejnm-325	327	37	a	a	DET
ejnm-325	327	38	longitudinal	longitudinal	ADJ
ejnm-325	327	39	study	study	NOUN
ejnm-325	327	40	.	.	PUNCT
ejnm-325	328	1	radiology	radiology	NOUN
ejnm-325	328	2	.	.	PUNCT
ejnm-325	329	1	2020	2020	NUM
ejnm-325	329	2	aug;296	aug;296	NOUN
ejnm-325	329	3	(	(	PUNCT
ejnm-325	329	4	2):e55	2):e55	NUM
ejnm-325	329	5	-	-	SYM
ejnm-325	329	6	64	64	NUM
ejnm-325	329	7	.	.	PUNCT
ejnm-325	330	1	https://doi.org/10.1148/	https://doi.org/10.1148/	PROPN
ejnm-325	330	2	radiol.2020200843	radiol.2020200843	PROPN
ejnm-325	331	1	[	[	X
ejnm-325	331	2	29	29	NUM
ejnm-325	331	3	]	]	X
ejnm-325	331	4	williamson	williamson	PROPN
ejnm-325	331	5	ej	ej	PROPN
ejnm-325	331	6	,	,	PUNCT
ejnm-325	331	7	walker	walker	PROPN
ejnm-325	331	8	aj	aj	PROPN
ejnm-325	331	9	,	,	PUNCT
ejnm-325	331	10	bhaskaran	bhaskaran	NOUN
ejnm-325	331	11	k	k	NOUN
ejnm-325	331	12	,	,	PUNCT
ejnm-325	331	13	bacon	bacon	NOUN
ejnm-325	331	14	s	s	PROPN
ejnm-325	331	15	,	,	PUNCT
ejnm-325	331	16	bates	bates	PROPN
ejnm-325	331	17	c	c	PROPN
ejnm-325	331	18	,	,	PUNCT
ejnm-325	331	19	morton	morton	PROPN
ejnm-325	331	20	ce	ce	PROPN
ejnm-325	331	21	,	,	PUNCT
ejnm-325	331	22	et	et	PROPN
ejnm-325	331	23	al	al	PROPN
ejnm-325	331	24	.	.	PUNCT
ejnm-325	331	25	factors	factor	NOUN
ejnm-325	331	26	associated	associate	VERB
ejnm-325	331	27	with	with	ADP
ejnm-325	331	28	covid-19	covid-19	PROPN
ejnm-325	331	29	-	-	PUNCT
ejnm-325	331	30	related	relate	VERB
ejnm-325	331	31	death	death	NOUN
ejnm-325	331	32	using	use	VERB
ejnm-325	331	33	opensafely	opensafely	ADV
ejnm-325	331	34	.	.	PUNCT
ejnm-325	332	1	nature	nature	NOUN
ejnm-325	332	2	.	.	PUNCT
ejnm-325	333	1	2020	2020	NUM
ejnm-325	333	2	aug	aug	X
ejnm-325	333	3	20;584	20;584	NUM
ejnm-325	333	4	(	(	PUNCT
ejnm-325	333	5	7821):430	7821):430	NOUN
ejnm-325	333	6	-	-	SYM
ejnm-325	333	7	6	6	NUM
ejnm-325	333	8	.	.	PUNCT
ejnm-325	334	1	https://doi.org/10.1038/	https://doi.org/10.1038/	NOUN
ejnm-325	334	2	s41586	s41586	PROPN
ejnm-325	334	3	-	-	PUNCT
ejnm-325	334	4	020	020	NUM
ejnm-325	334	5	-	-	PUNCT
ejnm-325	334	6	2521	2521	NUM
ejnm-325	334	7	-	-	SYM
ejnm-325	334	8	4	4	NUM
ejnm-325	334	9	[	[	SYM
ejnm-325	334	10	30	30	NUM
ejnm-325	334	11	]	]	X
ejnm-325	334	12	zhao	zhao	PROPN
ejnm-325	334	13	w	w	PROPN
ejnm-325	334	14	,	,	PUNCT
ejnm-325	334	15	zhong	zhong	PROPN
ejnm-325	334	16	z	z	PROPN
ejnm-325	334	17	,	,	PUNCT
ejnm-325	334	18	xie	xie	PROPN
ejnm-325	334	19	x	x	PROPN
ejnm-325	334	20	,	,	PUNCT
ejnm-325	334	21	yu	yu	PROPN
ejnm-325	334	22	q	q	PROPN
ejnm-325	334	23	,	,	PUNCT
ejnm-325	334	24	liu	liu	PROPN
ejnm-325	334	25	j.	j.	PROPN
ejnm-325	334	26	relation	relation	PROPN
ejnm-325	334	27	between	between	ADP
ejnm-325	334	28	chest	chest	NOUN
ejnm-325	334	29	ct	ct	NUM
ejnm-325	334	30	findings	finding	NOUN
ejnm-325	334	31	and	and	CCONJ
ejnm-325	334	32	clinical	clinical	ADJ
ejnm-325	334	33	conditions	condition	NOUN
ejnm-325	334	34	of	of	ADP
ejnm-325	334	35	coronavirus	coronavirus	NOUN
ejnm-325	334	36	disease	disease	NOUN
ejnm-325	334	37	(	(	PUNCT
ejnm-325	334	38	covid-19	covid-19	PROPN
ejnm-325	334	39	)	)	PUNCT
ejnm-325	334	40	pneumonia	pneumonia	NOUN
ejnm-325	334	41	:	:	PUNCT
ejnm-325	334	42	a	a	DET
ejnm-325	334	43	multicenter	multicenter	ADJ
ejnm-325	334	44	study	study	NOUN
ejnm-325	334	45	.	.	PUNCT
ejnm-325	335	1	american	american	ADJ
ejnm-325	335	2	journal	journal	PROPN
ejnm-325	335	3	of	of	ADP
ejnm-325	335	4	roentgenology	roentgenology	NOUN
ejnm-325	335	5	.	.	PUNCT
ejnm-325	336	1	2020	2020	NUM
ejnm-325	337	1	may;214	may;214	NOUN
ejnm-325	337	2	(	(	PUNCT
ejnm-325	337	3	5):10727.https	5):10727.https	NUM
ejnm-325	337	4	:	:	PUNCT
ejnm-325	337	5	doi.org/10.2214ajr.20.22976	doi.org/10.2214ajr.20.22976	NOUN
ejnm-325	337	6	[	[	X
ejnm-325	337	7	13	13	NUM
ejnm-325	337	8	]	]	X
ejnm-325	337	9	lu	lu	NOUN
ejnm-325	337	10	r	r	PROPN
ejnm-325	337	11	,	,	PUNCT
ejnm-325	337	12	zhao	zhao	PROPN
ejnm-325	337	13	x	x	PROPN
ejnm-325	337	14	,	,	PUNCT
ejnm-325	337	15	li	li	PROPN
ejnm-325	337	16	j	j	PROPN
ejnm-325	337	17	,	,	PUNCT
ejnm-325	337	18	niu	niu	PROPN
ejnm-325	337	19	p	p	PROPN
ejnm-325	337	20	,	,	PUNCT
ejnm-325	337	21	yang	yang	PROPN
ejnm-325	337	22	b	b	PROPN
ejnm-325	337	23	,	,	PUNCT
ejnm-325	337	24	wu	wu	PROPN
ejnm-325	337	25	h	h	PROPN
ejnm-325	337	26	,	,	PUNCT
ejnm-325	337	27	et	et	PROPN
ejnm-325	337	28	al	al	PROPN
ejnm-325	337	29	.	.	PUNCT
ejnm-325	338	1	genomic	genomic	ADJ
ejnm-325	338	2	characterisation	characterisation	NOUN
ejnm-325	338	3	and	and	CCONJ
ejnm-325	338	4	epidemiology	epidemiology	NOUN
ejnm-325	338	5	of	of	ADP
ejnm-325	338	6	2019	2019	NUM
ejnm-325	338	7	novel	novel	ADJ
ejnm-325	338	8	coronavirus	coronavirus	NOUN
ejnm-325	338	9	:	:	PUNCT
ejnm-325	338	10	implications	implication	NOUN
ejnm-325	338	11	for	for	ADP
ejnm-325	338	12	virus	virus	NOUN
ejnm-325	338	13	origins	origin	NOUN
ejnm-325	338	14	and	and	CCONJ
ejnm-325	338	15	receptor	receptor	NOUN
ejnm-325	338	16	binding	bind	VERB
ejnm-325	338	17	.	.	PUNCT
ejnm-325	339	1	the	the	DET
ejnm-325	339	2	lancet	lancet	NOUN
ejnm-325	339	3	.	.	PUNCT
ejnm-325	340	1	2020	2020	NUM
ejnm-325	340	2	feb	feb	X
ejnm-325	340	3	22;395(10224):565	22;395(10224):565	NUM
ejnm-325	340	4	-	-	SYM
ejnm-325	340	5	74	74	NUM
ejnm-325	340	6	.	.	PUNCT
ejnm-325	341	1	https://	https://	PROPN
ejnm-325	341	2	doi.org/10.1016/s0140-6736(20)30251-8	doi.org/10.1016/s0140-6736(20)30251-8	PROPN
ejnm-325	341	3	.	.	PUNCT
ejnm-325	342	1	[	[	X
ejnm-325	342	2	14	14	NUM
ejnm-325	342	3	]	]	X
ejnm-325	342	4	mehta	mehta	PROPN
ejnm-325	342	5	p	p	PROPN
ejnm-325	342	6	,	,	PUNCT
ejnm-325	342	7	rosas	rosas	PROPN
ejnm-325	342	8	io	io	PROPN
ejnm-325	342	9	,	,	PUNCT
ejnm-325	342	10	singer	singer	NOUN
ejnm-325	342	11	m.	m.	NOUN
ejnm-325	342	12	understanding	understand	VERB
ejnm-325	342	13	post	post	ADJ
ejnm-325	342	14	-	-	ADJ
ejnm-325	342	15	covid-19	covid-19	ADJ
ejnm-325	342	16	interstitial	interstitial	ADJ
ejnm-325	342	17	lung	lung	NOUN
ejnm-325	342	18	disease	disease	NOUN
ejnm-325	342	19	(	(	PUNCT
ejnm-325	342	20	ild	ild	PROPN
ejnm-325	342	21	):	):	PUNCT
ejnm-325	342	22	a	a	DET
ejnm-325	342	23	new	new	ADJ
ejnm-325	342	24	fibroinflammatory	fibroinflammatory	ADJ
ejnm-325	342	25	disease	disease	NOUN
ejnm-325	342	26	entity	entity	NOUN
ejnm-325	342	27	.	.	PUNCT
ejnm-325	343	1	intensive	intensive	ADJ
ejnm-325	343	2	care	care	NOUN
ejnm-325	343	3	medicine	medicine	NOUN
ejnm-325	343	4	.	.	PUNCT
ejnm-325	344	1	2022	2022	NUM
ejnm-325	344	2	dec;48(12):1803	dec;48(12):1803	NOUN
ejnm-325	344	3	-6	-6	ADV
ejnm-325	344	4	.	.	PUNCT
ejnm-325	345	1	https://doi.org/10.1007/s00134-02206877-w	https://doi.org/10.1007/s00134-02206877-w	NUM
ejnm-325	346	1	[	[	X
ejnm-325	346	2	15	15	NUM
ejnm-325	346	3	]	]	X
ejnm-325	346	4	munblit	munblit	PROPN
ejnm-325	346	5	d	d	PROPN
ejnm-325	346	6	,	,	PUNCT
ejnm-325	346	7	o'hara	o'hara	PROPN
ejnm-325	346	8	me	me	PROPN
ejnm-325	346	9	,	,	PUNCT
ejnm-325	346	10	akrami	akrami	VERB
ejnm-325	346	11	a	a	PRON
ejnm-325	346	12	,	,	PUNCT
ejnm-325	346	13	perego	perego	PROPN
ejnm-325	346	14	e	e	NOUN
ejnm-325	346	15	,	,	PUNCT
ejnm-325	346	16	olliaro	olliaro	VERB
ejnm-325	346	17	p	p	X
ejnm-325	346	18	,	,	PUNCT
ejnm-325	347	1	needham	needham	PROPN
ejnm-325	347	2	dm	dm	PROPN
ejnm-325	347	3	.	.	PUNCT
ejnm-325	347	4	long	long	PROPN
ejnm-325	347	5	covid	covid	PROPN
ejnm-325	347	6	:	:	PUNCT
ejnm-325	347	7	aiming	aim	VERB
ejnm-325	347	8	for	for	ADP
ejnm-325	347	9	a	a	DET
ejnm-325	347	10	consensus	consensus	NOUN
ejnm-325	347	11	.	.	PUNCT
ejnm-325	348	1	the	the	DET
ejnm-325	348	2	lancet	lancet	ADJ
ejnm-325	348	3	respiratory	respiratory	ADJ
ejnm-325	348	4	medicine	medicine	NOUN
ejnm-325	348	5	.	.	PUNCT
ejnm-325	349	1	2022	2022	NUM
ejnm-325	349	2	jul	jul	PROPN
ejnm-325	349	3	1;10(7):632	1;10(7):632	NUM
ejnm-325	349	4	-	-	PUNCT
ejnm-325	349	5	4	4	NUM
ejnm-325	349	6	.	.	PUNCT
ejnm-325	350	1	https://	https://	PROPN
ejnm-325	350	2	doi.org/10.1016/s2213-2600(22)00135-7	doi.org/10.1016/s2213-2600(22)00135-7	PUNCT
ejnm-325	351	1	[	[	X
ejnm-325	351	2	16	16	NUM
ejnm-325	351	3	]	]	X
ejnm-325	351	4	nalbandian	nalbandian	PROPN
ejnm-325	351	5	a	a	X
ejnm-325	351	6	,	,	PUNCT
ejnm-325	351	7	sehgal	sehgal	PROPN
ejnm-325	351	8	k	k	PROPN
ejnm-325	351	9	,	,	PUNCT
ejnm-325	351	10	gupta	gupta	PROPN
ejnm-325	351	11	a	a	PROPN
ejnm-325	351	12	,	,	PUNCT
ejnm-325	351	13	madhavan	madhavan	PROPN
ejnm-325	351	14	mv	mv	PROPN
ejnm-325	351	15	,	,	PUNCT
ejnm-325	351	16	mcgroder	mcgroder	NOUN
ejnm-325	351	17	c	c	PROPN
ejnm-325	351	18	,	,	PUNCT
ejnm-325	351	19	stevens	stevens	PROPN
ejnm-325	351	20	js	js	PROPN
ejnm-325	351	21	,	,	PUNCT
ejnm-325	351	22	et	et	PROPN
ejnm-325	351	23	al	al	PROPN
ejnm-325	351	24	.	.	PROPN
ejnm-325	351	25	postacute	postacute	PROPN
ejnm-325	351	26	covid-19	covid-19	PROPN
ejnm-325	351	27	syndrome	syndrome	PROPN
ejnm-325	351	28	.	.	PUNCT
ejnm-325	352	1	nature	nature	NOUN
ejnm-325	352	2	medicine	medicine	NOUN
ejnm-325	352	3	.	.	PUNCT
ejnm-325	353	1	2021	2021	NUM
ejnm-325	353	2	apr;27(4):601	apr;27(4):601	NOUN
ejnm-325	353	3	-	-	PUNCT
ejnm-325	353	4	15	15	NUM
ejnm-325	353	5	.	.	PUNCT
ejnm-325	354	1	https://	https://	NOUN
ejnm-325	354	2	doi.org/10.1038/s41591-021-01283-z	doi.org/10.1038/s41591-021-01283-z	NOUN
ejnm-325	354	3	[	[	X
ejnm-325	354	4	17	17	NUM
ejnm-325	354	5	]	]	X
ejnm-325	354	6	ngai	ngai	PROPN
ejnm-325	354	7	jc	jc	PROPN
ejnm-325	354	8	,	,	PUNCT
ejnm-325	354	9	ko	ko	PROPN
ejnm-325	354	10	fw	fw	PROPN
ejnm-325	354	11	,	,	PUNCT
ejnm-325	354	12	ng	ng	PROPN
ejnm-325	354	13	ss	ss	PROPN
ejnm-325	354	14	,	,	PUNCT
ejnm-325	354	15	to	to	ADP
ejnm-325	354	16	kw	kw	PROPN
ejnm-325	354	17	,	,	PUNCT
ejnm-325	354	18	tong	tong	PROPN
ejnm-325	354	19	m	m	PROPN
ejnm-325	354	20	,	,	PUNCT
ejnm-325	354	21	hui	hui	PROPN
ejnm-325	354	22	ds	ds	PROPN
ejnm-325	354	23	.	.	PUNCT
ejnm-325	355	1	the	the	DET
ejnm-325	355	2	long‐term	long‐term	NOUN
ejnm-325	355	3	impact	impact	NOUN
ejnm-325	355	4	of	of	ADP
ejnm-325	355	5	severe	severe	ADJ
ejnm-325	355	6	acute	acute	ADJ
ejnm-325	355	7	respiratory	respiratory	ADJ
ejnm-325	355	8	syndrome	syndrome	NOUN
ejnm-325	355	9	on	on	ADP
ejnm-325	355	10	pulmonary	pulmonary	ADJ
ejnm-325	355	11	function	function	NOUN
ejnm-325	355	12	,	,	PUNCT
ejnm-325	355	13	exercise	exercise	NOUN
ejnm-325	355	14	capacity	capacity	NOUN
ejnm-325	355	15	and	and	CCONJ
ejnm-325	355	16	health	health	NOUN
ejnm-325	355	17	status	status	NOUN
ejnm-325	355	18	.	.	PUNCT
ejnm-325	356	1	respirology	respirology	NOUN
ejnm-325	356	2	.	.	PUNCT
ejnm-325	357	1	2010	2010	NUM
ejnm-325	357	2	apr;15(3):543	apr;15(3):543	NOUN
ejnm-325	357	3	-	-	SYM
ejnm-325	357	4	50	50	NUM
ejnm-325	357	5	.	.	PUNCT
ejnm-325	358	1	https://	https://	PROPN
ejnm-325	358	2	doi.org/10.1111/j.1440-1843.2010.01720.x	doi.org/10.1111/j.1440-1843.2010.01720.x	PROPN
ejnm-325	358	3	[	[	X
ejnm-325	358	4	18	18	NUM
ejnm-325	358	5	]	]	X
ejnm-325	358	6	ong	ong	PROPN
ejnm-325	358	7	kc	kc	PROPN
ejnm-325	358	8	,	,	PUNCT
ejnm-325	358	9	ng	ng	PROPN
ejnm-325	358	10	ak	ak	PROPN
ejnm-325	358	11	,	,	PUNCT
ejnm-325	358	12	lee	lee	PROPN
ejnm-325	358	13	lu	lu	PROPN
ejnm-325	358	14	,	,	PUNCT
ejnm-325	358	15	kaw	kaw	PROPN
ejnm-325	358	16	g	g	PROPN
ejnm-325	358	17	,	,	PUNCT
ejnm-325	358	18	kwek	kwek	PROPN
ejnm-325	358	19	sk	sk	PROPN
ejnm-325	358	20	,	,	PUNCT
ejnm-325	358	21	leow	leow	PROPN
ejnm-325	358	22	ms	ms	PROPN
ejnm-325	358	23	,	,	PUNCT
ejnm-325	358	24	et	et	PROPN
ejnm-325	359	1	al	al	PROPN
ejnm-325	359	2	.	.	PUNCT
ejnm-325	359	3	pulmonary	pulmonary	ADJ
ejnm-325	359	4	function	function	NOUN
ejnm-325	359	5	and	and	CCONJ
ejnm-325	359	6	exercise	exercise	NOUN
ejnm-325	359	7	capacity	capacity	NOUN
ejnm-325	359	8	in	in	ADP
ejnm-325	359	9	survivors	survivor	NOUN
ejnm-325	359	10	of	of	ADP
ejnm-325	359	11	severe	severe	ADJ
ejnm-325	359	12	acute	acute	ADJ
ejnm-325	359	13	respiratory	respiratory	ADJ
ejnm-325	359	14	syndrome	syndrome	NOUN
ejnm-325	359	15	.	.	PUNCT
ejnm-325	360	1	european	european	ADJ
ejnm-325	360	2	respiratory	respiratory	ADJ
ejnm-325	360	3	journal	journal	NOUN
ejnm-325	360	4	.	.	PUNCT
ejnm-325	361	1	2004	2004	NUM
ejnm-325	361	2	sep	sep	PROPN
ejnm-325	361	3	1;24(3):436	1;24(3):436	NUM
ejnm-325	361	4	-	-	SYM
ejnm-325	361	5	42	42	NUM
ejnm-325	361	6	.	.	PUNCT
ejnm-325	362	1	https://	https://	PROPN
ejnm-325	362	2	doi.org/10.1136/thx.2004.030205	doi.org/10.1136/thx.2004.030205	PROPN
ejnm-325	362	3	[	[	X
ejnm-325	362	4	19	19	NUM
ejnm-325	362	5	]	]	X
ejnm-325	362	6	ong	ong	PROPN
ejnm-325	362	7	kc	kc	PROPN
ejnm-325	362	8	,	,	PUNCT
ejnm-325	362	9	ng	ng	PROPN
ejnm-325	363	1	aw	aw	INTJ
ejnm-325	363	2	,	,	PUNCT
ejnm-325	363	3	lee	lee	PROPN
ejnm-325	363	4	ls	ls	PROPN
ejnm-325	363	5	,	,	PUNCT
ejnm-325	363	6	kaw	kaw	PROPN
ejnm-325	363	7	g	g	PROPN
ejnm-325	363	8	,	,	PUNCT
ejnm-325	363	9	kwek	kwek	PROPN
ejnm-325	363	10	sk	sk	PROPN
ejnm-325	363	11	,	,	PUNCT
ejnm-325	363	12	leow	leow	PROPN
ejnm-325	363	13	mk	mk	PROPN
ejnm-325	363	14	,	,	PUNCT
ejnm-325	363	15	et	et	PROPN
ejnm-325	363	16	al	al	PROPN
ejnm-325	363	17	.	.	PROPN
ejnm-325	363	18	1	1	NUM
ejnm-325	363	19	-	-	PUNCT
ejnm-325	363	20	year	year	NOUN
ejnm-325	363	21	pulmonary	pulmonary	ADJ
ejnm-325	363	22	function	function	NOUN
ejnm-325	363	23	and	and	CCONJ
ejnm-325	363	24	health	health	NOUN
ejnm-325	363	25	status	status	NOUN
ejnm-325	363	26	in	in	ADP
ejnm-325	363	27	survivors	survivor	NOUN
ejnm-325	363	28	of	of	ADP
ejnm-325	363	29	severe	severe	ADJ
ejnm-325	363	30	acute	acute	ADJ
ejnm-325	363	31	respiratory	respiratory	ADJ
ejnm-325	363	32	syndrome	syndrome	NOUN
ejnm-325	363	33	.	.	PUNCT
ejnm-325	364	1	chest	chest	NOUN
ejnm-325	364	2	.	.	PUNCT
ejnm-325	365	1	2005	2005	NUM
ejnm-325	365	2	sep	sep	NOUN
ejnm-325	365	3	1;128	1;128	NUM
ejnm-325	365	4	(	(	PUNCT
ejnm-325	365	5	3):1393	3):1393	NUM
ejnm-325	365	6	-	-	SYM
ejnm-325	365	7	400	400	NUM
ejnm-325	365	8	.	.	PUNCT
ejnm-325	366	1	https://doi.org/10.1378/	https://doi.org/10.1378/	PROPN
ejnm-325	366	2	chest.128.3.1393	chest.128.3.1393	PROPN
ejnm-325	367	1	[	[	X
ejnm-325	367	2	20	20	NUM
ejnm-325	367	3	]	]	PUNCT
ejnm-325	367	4	pan	pan	PROPN
ejnm-325	367	5	f	f	PROPN
ejnm-325	367	6	,	,	PUNCT
ejnm-325	367	7	ye	ye	PROPN
ejnm-325	367	8	t	t	PROPN
ejnm-325	367	9	,	,	PUNCT
ejnm-325	367	10	sun	sun	NOUN
ejnm-325	367	11	p	p	NOUN
ejnm-325	367	12	,	,	PUNCT
ejnm-325	367	13	gui	gui	NOUN
ejnm-325	367	14	s	s	PROPN
ejnm-325	367	15	,	,	PUNCT
ejnm-325	367	16	liang	liang	PROPN
ejnm-325	367	17	b	b	PROPN
ejnm-325	367	18	,	,	PUNCT
ejnm-325	367	19	li	li	PROPN
ejnm-325	367	20	l	l	PROPN
ejnm-325	367	21	,	,	PUNCT
ejnm-325	367	22	et	et	PROPN
ejnm-325	367	23	al	al	PROPN
ejnm-325	367	24	.	.	PROPN
ejnm-325	367	25	time	time	PROPN
ejnm-325	367	26	course	course	NOUN
ejnm-325	367	27	of	of	ADP
ejnm-325	367	28	lung	lung	NOUN
ejnm-325	367	29	changes	change	NOUN
ejnm-325	367	30	at	at	ADP
ejnm-325	367	31	chest	chest	NOUN
ejnm-325	367	32	ct	ct	NUM
ejnm-325	367	33	during	during	ADP
ejnm-325	367	34	recovery	recovery	NOUN
ejnm-325	367	35	from	from	ADP
ejnm-325	367	36	coronavirus	coronavirus	NOUN
ejnm-325	367	37	disease	disease	NOUN
ejnm-325	367	38	2019	2019	NUM
ejnm-325	367	39	(	(	PUNCT
ejnm-325	367	40	covid-19	covid-19	PROPN
ejnm-325	367	41	)	)	PUNCT
ejnm-325	367	42	.	.	PUNCT
ejnm-325	368	1	radiology	radiology	NOUN
ejnm-325	368	2	.	.	PUNCT
ejnm-325	369	1	2020	2020	NUM
ejnm-325	369	2	jun;295(3):71521.https://doi.org/10.114radiol.2020200370	jun;295(3):71521.https://doi.org/10.114radiol.2020200370	VERB
ejnm-325	370	1	[	[	X
ejnm-325	370	2	21	21	NUM
ejnm-325	370	3	]	]	X
ejnm-325	370	4	park	park	NOUN
ejnm-325	370	5	wb	wb	PROPN
ejnm-325	370	6	,	,	PUNCT
ejnm-325	370	7	jun	jun	PROPN
ejnm-325	370	8	ki	ki	PROPN
ejnm-325	370	9	,	,	PUNCT
ejnm-325	370	10	kim	kim	PROPN
ejnm-325	370	11	g	g	PROPN
ejnm-325	370	12	,	,	PUNCT
ejnm-325	370	13	choi	choi	NOUN
ejnm-325	370	14	jp	jp	PROPN
ejnm-325	370	15	,	,	PUNCT
ejnm-325	370	16	rhee	rhee	PROPN
ejnm-325	370	17	jy	jy	PROPN
ejnm-325	370	18	,	,	PUNCT
ejnm-325	370	19	cheon	cheon	PROPN
ejnm-325	370	20	s	s	PROPN
ejnm-325	370	21	,	,	PUNCT
ejnm-325	370	22	et	et	PROPN
ejnm-325	370	23	al	al	PROPN
ejnm-325	370	24	.	.	PROPN
ejnm-325	370	25	correlation	correlation	NOUN
ejnm-325	370	26	between	between	ADP
ejnm-325	370	27	pneumonia	pneumonia	NOUN
ejnm-325	370	28	severity	severity	NOUN
ejnm-325	370	29	and	and	CCONJ
ejnm-325	370	30	pulmonary	pulmonary	ADJ
ejnm-325	370	31	complications	complication	NOUN
ejnm-325	370	32	in	in	ADP
ejnm-325	370	33	middle	middle	PROPN
ejnm-325	370	34	east	east	PROPN
ejnm-325	370	35	respiratory	respiratory	ADJ
ejnm-325	370	36	syndrome	syndrome	NOUN
ejnm-325	370	37	.	.	PUNCT
ejnm-325	371	1	journal	journal	NOUN
ejnm-325	371	2	of	of	ADP
ejnm-325	371	3	korean	korean	ADJ
ejnm-325	371	4	medical	medical	ADJ
ejnm-325	371	5	science	science	NOUN
ejnm-325	371	6	.	.	PUNCT
ejnm-325	372	1	2018	2018	NUM
ejnm-325	372	2	jun	jun	PROPN
ejnm-325	372	3	6;33(24	6;33(24	NUM
ejnm-325	372	4	)	)	PUNCT
ejnm-325	372	5	.	.	PUNCT
ejnm-325	373	1	https://doi.org/10.3346/jkms.2018.33.e169	https://doi.org/10.3346/jkms.2018.33.e169	X
ejnm-325	374	1	[	[	X
ejnm-325	374	2	22	22	NUM
ejnm-325	374	3	]	]	X
ejnm-325	374	4	richardson	richardson	PROPN
ejnm-325	374	5	s	s	PROPN
ejnm-325	374	6	,	,	PUNCT
ejnm-325	374	7	hirsch	hirsch	PROPN
ejnm-325	374	8	js	js	PROPN
ejnm-325	374	9	,	,	PUNCT
ejnm-325	374	10	narasimhan	narasimhan	PROPN
ejnm-325	374	11	m	m	PROPN
ejnm-325	374	12	,	,	PUNCT
ejnm-325	374	13	crawford	crawford	PROPN
ejnm-325	374	14	jm	jm	PROPN
ejnm-325	374	15	,	,	PUNCT
ejnm-325	374	16	mcginn	mcginn	PROPN
ejnm-325	374	17	t	t	PROPN
ejnm-325	374	18	,	,	PUNCT
ejnm-325	374	19	davidson	davidson	PROPN
ejnm-325	374	20	kw	kw	PROPN
ejnm-325	374	21	,	,	PUNCT
ejnm-325	374	22	et	et	PROPN
ejnm-325	374	23	al	al	PROPN
ejnm-325	374	24	.	.	PUNCT
ejnm-325	375	1	presenting	present	VERB
ejnm-325	375	2	characteristics	characteristic	NOUN
ejnm-325	375	3	,	,	PUNCT
ejnm-325	375	4	comorbidities	comorbiditie	NOUN
ejnm-325	375	5	,	,	PUNCT
ejnm-325	375	6	and	and	CCONJ
ejnm-325	375	7	outcomes	outcome	NOUN
ejnm-325	375	8	among	among	ADP
ejnm-325	375	9	5700	5700	NUM
ejnm-325	375	10	patients	patient	NOUN
ejnm-325	375	11	48	48	NUM
ejnm-325	375	12	copyright	copyright	NOUN
ejnm-325	375	13	©	©	PROPN
ejnm-325	375	14	2025	2025	NUM
ejnm-325	375	15	the	the	DET
ejnm-325	375	16	author(s	author(s	NOUN
ejnm-325	375	17	)	)	PUNCT
ejnm-325	375	18	.	.	PUNCT
ejnm-325	376	1	this	this	PRON
ejnm-325	376	2	is	be	AUX
ejnm-325	376	3	an	an	DET
ejnm-325	376	4	open	open	ADJ
ejnm-325	376	5	access	access	NOUN
ejnm-325	376	6	article	article	NOUN
ejnm-325	376	7	which	which	PRON
ejnm-325	376	8	licensed	license	VERB
ejnm-325	376	9	under	under	ADP
ejnm-325	376	10	the	the	DET
ejnm-325	376	11	terms	term	NOUN
ejnm-325	376	12	and	and	CCONJ
ejnm-325	376	13	conditions	condition	NOUN
ejnm-325	376	14	of	of	ADP
ejnm-325	376	15	the	the	DET
ejnm-325	376	16	creative	creative	ADJ
ejnm-325	376	17	commons	common	NOUN
ejnm-325	376	18	attribution	attribution	NOUN
ejnm-325	376	19	-	-	PUNCT
ejnm-325	376	20	noncommercial	noncommercial	ADJ
ejnm-325	376	21	-	-	PUNCT
ejnm-325	376	22	sharealike	sharealike	ADJ
ejnm-325	376	23	4.0	4.0	NUM
ejnm-325	376	24	international	international	ADJ
ejnm-325	376	25	license	license	NOUN
ejnm-325	376	26	.	.	PUNCT
ejnm-325	377	1	it	it	PRON
ejnm-325	377	2	permits	permit	VERB
ejnm-325	377	3	no	no	DET
ejnm-325	377	4	additional	additional	ADJ
ejnm-325	377	5	restrictions	restriction	NOUN
ejnm-325	377	6	on	on	ADP
ejnm-325	377	7	use	use	NOUN
ejnm-325	377	8	,	,	PUNCT
ejnm-325	377	9	distribution	distribution	NOUN
ejnm-325	377	10	,	,	PUNCT
ejnm-325	377	11	and	and	CCONJ
ejnm-325	377	12	reproduction	reproduction	NOUN
ejnm-325	377	13	in	in	ADP
ejnm-325	377	14	any	any	DET
ejnm-325	377	15	medium	medium	NOUN
ejnm-325	377	16	provided	provide	VERB
ejnm-325	377	17	the	the	DET
ejnm-325	377	18	original	original	ADJ
ejnm-325	377	19	work	work	NOUN
ejnm-325	377	20	is	be	AUX
ejnm-325	377	21	properly	properly	ADV
ejnm-325	377	22	cited	cite	VERB
ejnm-325	377	23	.	.	PUNCT
ejnm-325	378	1	https://creativecommons.org/licenses/by-nc-sa/4.0/	https://creativecommons.org/licenses/by-nc-sa/4.0/	PROPN